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Abstract 
An age-related loss of muscle mass is associated with increased frailty in the elderly. The effect 
is felt at both a national scale, with an increased budgetary demand for health services directed 
towards the ageing population, and by the individual where reduced mobility significantly 
reduces their quality of life. It is unclear whether all skeletal muscle types are affected in the 
same manner. This thesis considered how thiol signalling, facilitated through reactive thiol 
groups on cysteine amino acids, may affect skeletal muscle ageing as it is crucial for normal 
intracellular function. Several studies have identified reactive oxygen species (ROS) as crucial 
signalling molecules in healthy muscle and various proteins can detect and respond to changes 
in their concentration. The cysteines are evolutionarily conserved in functionally important 
locations and have a direct impact on protein function, affecting either its active site or 
conformation. In healthy muscle, proteins can quickly and efficiently respond to changes in 
ROS concentrations via this mechanism whereas in aged muscle these responses appear to be 
impaired. 
The quadriceps and soleus muscles were selected because of their differing primary metabolic 
pathways and physiology, reflecting fast and slow twitch muscle respectively. This enabled 
determination of age related changes to the redox proteome between two different skeletal 
muscles. They are hypothesised to age differently and to determine this, adult (12 months) and 
old (24 months) tissue were subjected to a deep proteomics investigation, elucidating changes 
to the global proteome of ageing mouse muscle as well as using differential labelling of reduced 
and reversibly oxidised cysteine residues to identify redox-susceptible locations on individual 
proteins. Prior to this a proteomics study had not analysed changes to the redox proteome 
between two skeletal muscle tissues before.  
Analysis of the quadriceps label free results identified changes to redox protein abundance such 
as a significant increase in Protein Disulphide Isomerase, crucial to disulphide bond formation 
and breakage. HSC70, important for protein folding, was significantly decreased with age. 
Differential labelling of specific cysteine residues demonstrated Cys46 increased in its reduced 
form with age in PARK7. Furthermore, many changes observed in the label free analysis 
highlighted cytoskeletal proteins as those primarily affected. 
The soleus label free results demonstrated significant decreases in abundance of a number of 
mitochondrial proteins involved in the electron transport chain such as NAD(P)H 
dehydrogenase and ATP Synthase. One example of differential labelling highlighted ATP 
Synthase Cys101 as becoming increasingly reduced with age. This increase in a reduced redox 
state of cysteines was observed across a range of other mitochondrial proteins, possibly 
indicating a negative impact on energy metabolism in the soleus with age. 
A successful preliminary study considered the effect of stretching C2C12 mouse skeletal 
muscle cells in vitro. A protocol for testing the effect of mechanical stretching on C2C12 cells 
was optimised with a future goal of producing replicable in vitro proteomics data and thereby 
reducing the requirement for animal tissue.  
The studies in this thesis identified various redox proteome changes in quadriceps and soleus 
muscle with age. This data will provide a basis for a targeted analysis of musculoskeletal 
proteins with a view to a better understanding of musculoskeletal ageing and its impact via the 
proteome. 
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1.1 Physiology of Skeletal Muscle 
 Skeletal muscle is crucial for movement and in humans makes up about 40% of the 
total body mass (Janssen et al., 2000). Striated skeletal muscle is so called because of the 
repeating contractile units first observed under the microscope by van Leeuwenhoek in the 
1670s (Salmons, 2017). The apparent striations are caused by the I and A bands within the 
sarcomere which enable the muscle to contract. A highly adaptable organ, it retains a plasticity 
enabling adaptation to changing physiological conditions throughout an organisms’ lifespan 
(Zierath and Hawley, 2004). Innervation by a motor nerve causes depolarization of the 
myofibres leading to a contraction of the muscle and the force generated is transferred to the 
skeletal system via tendons that link muscle to bone. Muscles are often arranged in opposing 
pairs to enable controlled movement of limbs via regular contraction and relaxation. In addition 
to locomotion, muscle groups involved in posture control undergo semi-permanent contraction 
and each muscle’s primary function is reflected by their fibre type (Barclay et al., 1993). There 
are two general categories of fibre type which are based on the Myosin Heavy Chain (MHC) 
content of the cells. In mice, slow twitch or type I muscles, such as the soleus, produce energy 
via oxidative phosphorylation. In contrast, fast twitch type II muscles, such as the quadriceps, 
produce energy via glycolysis. 
Skeletal muscle originates with precursor stem cells called satellite cells. These are 
produced throughout the lifetime of the organism and after production are located between the 
basal lamina and the sarcolemma (Garcia et al., 2017). The cells are mitotically quiescent until 
activated via injury or growth stimuli which causes them to enter the cell cycle and proliferate 
before exiting to either differentiate, forming new myocytes and subsequently new muscle, or 
they form more satellite cells to enable future regeneration of the muscle (Motohashi and 
Asakura, 2012, Dumont et al., 2015). Differentiation of the myocytes causes them to combine 
forming multinucleated myotubes that stretch longitudinally forming myofibres (Sherwood et 
20 
 
al., 2004). The basic unit of a muscle fibre is the sarcomere which refers to the actin and myosin 
cross bridges as a single contractile unit (Vasilaki et al., 2017). Intracellularly, they contain a 
range of components with specialised terms related to the muscle function. The equivalent of 
the cytoplasm is referred to as sarcoplasm and contains an abundance of myosin and actin fibres 
for contraction, titin for elasticity of the cell and glycogen as a ready source of energy for 
contraction (Bohnert et al., 2018, Linsley et al., 2017). A sarcoplasmic reticulum surrounds the 
myofibrils. Activation of ryanodine receptors, specifically dihydropyridine receptors in the 
case of skeletal muscle, control the release of calcium (Ca2+) from the sarcoplasmic reticulum. 
This causes the cell to depolarise and inducing a contraction by removing the tropomyosin 
from its inhibitory location on an actin fibre (Bohnert et al., 2018, Linsley et al., 2017, Santulli 
and Marks, 2015). Action potential frequency induced via motor neuron innervation controls 
the extent of skeletal muscle contractions (Vasilaki et al., 2017). Where single twitches are 
induced, only a small amount of force is generated. However, higher frequencies of action 
potentials produce a cumulative effect on the muscle, increasing tension and leading to muscle 
contraction. Innervation of a motor neuron at neuromuscular junctions causes the release of 
acetylcholine (ACh) into the pre-synaptic cleft resulting in stimulation of acetylcholine 
receptors on the myofibres. This action potential is translated through the plasma membrane 
and via transverse (T) tubules into the fibre’s sarcoplasm, causing the release of calcium (Ca2+) 
from the sarcoplasmic reticulum causing the cell to depolarise and inducing a contraction by 
removing the tropomyosin from its inhibitory location on an actin fibre (Linsley et al., 2017). 
The location of tropomyosin is controlled by the troponin complex (Campbell and Reece, 
2005). Meanwhile magnesium (Mg2+) causes the myosin head to convert ATP (Adenosine 
triphosphate) to ADP (Adenosine diphosphate) with the release of an inorganic Phosphate 
molecule (Pi). The myosin head then releases the ADP and binds new ATP causing it to return 
to its initial state. At the same time, calcium ions are released by the Troponin. If the Calcium 
21 
 
concentration is high enough, the cycle repeats allowing the contraction to continue, if not then 
contraction stops (Campbell and Reece, 2005). This general mechanism is true of all muscle 
fibres and it is in addition to these contractions that reactive oxygen species (ROS) appear to 
be generated as cellular demand for energy increases (Goljanek-Whysall et al., 2016, Campbell 
and Reece, 2005, Devasagayam et al., 2004).  
 
Figure 1.1.1 Actin-myosin binding. At rest the black binding site for the myosin head is 
blocked by the red double-ringed troponin but initiation via an increase in intracellular calcium 
leads to the dissociation of troponin (indicated with the red arrow) enabling attachment of the 
purple myosin heads to the actin binding site. Adapted from (Huxley and Niedergerke, 1954, 
Huxley and Hanson, 1954). 
 
The current understanding of skeletal muscle contractions is based on the cross-bridge 
theory (Huxley and Niedergerke, 1954, Huxley and Hanson, 1954). Each muscle cell contains 
a single neuromuscular junction however, one motor neuron can have multiple branches 
attaching to several muscle fibres, together termed the motor unit. These muscle fibre bundles 
are then packaged together forming fascicles. When innervation occurs, the action potential is 
spread across whole fascicles causing large scale contraction and movement as previously 
described. At the intracellular level, within myotubes, are myofibrils that contain the 
sarcomeric filaments (Huxley and Niedergerke, 1954, Huxley and Hanson, 1954). It is these 
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sarcomeres that contain interlocking fibres of thin filaments (I bands) which contain actin and 
thick filaments (Z discs) which contain myosin heads enabling contraction as defined in figure 
1.1.1 (Campbell and Reece, 2005). The interlocking units within the sarcomere are shown in 
figure 1.1.2 and demonstrate the different bands and indicates how each of the individual units 
combine to form a contracting mechanism (Spudich and Watt, 1971). 
 
Figure 1.1.2 The sarcomere with a central myosin fibre in green and the outer actin filaments. 
The I and A bands, H zone and Z discs refer to the histological markers of appearance for 
skeletal muscle fibre giving its striated appearance. Contraction causes a narrowing of the H 
zone as the Z discs move towards each other, pulled in by the cross-bridge action of the myosin 
heads on the actin filaments. 
 
1.2 Energy Metabolism 
Energy metabolism in skeletal muscle falls into one of two categories: aerobic or 
anaerobic metabolism (Westerblad et al., 2010). The former utilises oxidative phosphorylation 
whereas the latter uses glycolysis. To this end, oxidative phosphorylation is a more sustained 
form of metabolism than glycolysis. Muscles offer a high level of plasticity throughout life and 
this is reflected in the ability to change constituent fibre types to suit long term demands of the 
muscle. 
Some early skeletal muscle studies reflected this with the notable work of Salmons 
demonstrating a change in twitch intensity led to changes in muscle fibre type composition 
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(Salmons, 2017, Salmons and Sreter, 1976). Further detailed work led to understanding muscle 
in terms of its fibre type which today are defined as: slow twitch, oxidative fibres Type β/I, α, 
I/IIA, through to slow-medium (aka fast oxidative-glycolytic fibres) twitch type IIA, IIA/IIX, 
IIX, IIX/IIB and the fast glycolytic fibres type IIB and IIM as the major adult forms based on 
myosin heavy chain content (Schiaffino and Reggiani, 2011, Sciote and Morris, 2000). There 
are also extra-ocular, embryonic and neonatal forms of MHC which are beyond the scope of 
this thesis (Sciote and Morris, 2000).  
Energy is most simply described as ‘the capacity to do work’ (Atkins and De Paula, 
2010). Within a biological setting it is fundamental for all organic processes, sustaining life. 
Skeletal muscle has a number of ways it generates the energy required for contractions, each 
of which depend upon the muscle and its fibre type composition. Adenosine triphosphate 
(ATP) is the main energy currency and is a coenzyme required to enable the majority of 
biochemical reactions to take place (Itoh et al., 2004, Imamura et al., 2009).  
The anaerobic metabolic pathways include Phosphocreatine breakdown via Creatine 
kinase leading to the production of Creatine and ATP (Westerblad et al., 2010, Imamura et al., 
2009). However, an alternative route metabolises Glycogen into lactate and hydrogen ions via 
Glycogen phosphorylase causing the well-known painful build-up of lactic acid within muscle 
and a reduction in function. The reverse mechanism requires a different enzyme: Glycogen 
synthase, causing the two directions to be independently controllable. Both glycogen enzymes 
rely on phosphorylation for control of their activity (Westerblad et al., 2010, Roach, 2002).  
Aerobic metabolism includes the degradation of triglycerides that are stored within 
skeletal muscle or adipose tissue. The hydrolysis of these triglycerides produces fatty acids that 
are a crucial energy source during exercise as they are involved in the production of the 
coenzymes NADH and FADH2 which are then utilised in oxidative phosphorylation (Watt and 
Cheng, 2017, Achten et al., 2002). One key mechanism that is still not fully understood is 
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glucose uptake. Although AMP-dependent protein kinase (AMPK) has been implicated to a 
limited extent, it appears to perform a signalling role rather than to have a direct involvement. 
AMPK is involved in cellular energy metabolism control such as fatty acid and cholesterol 
synthesis and is activated by low levels of ATP or high levels of AMP/ADP. This follows a 
demonstration that reactive oxygen species induce glucose uptake during contractions, as 
signalled, by AMPK (Westerblad et al., 2010, Hardie and Sakamoto, 2006, Sandstrom et al., 
2006, O'Neill, 2013). 
Quadriceps are predominantly fast twitch muscles and therefore primarily produce 
energy via glycolysis (Saey et al., 2011). The process is initiated with the phosphorylation of 
glucose via Hexokinase to Glucose 6-phosphate following its active transport into the cell. This 
chemically destabilises it prior to the conversion by Phosphoglucomutase isomerase into 
Fructose 6-phosphate. Phosphofructokinase then converts Fructose 6-phosphate into Fructose 
1,6-bisphosphate. At this point Aldolase produces two interchangeable three carbon molecules: 
Glyceraldehyde 3-phosphate (G3P) and Dihydroxyacetone phosphate. Triosephosphate 
isomerase can interchange these molecules with G3P continuing through to the final stage of 
glycolysis. The thermodynamics of the reaction ensures the process sees G3P as the primary 
successor to continue the reaction with the production of two ATP molecules. G3P 
dehydrogenase phosphorylates the aldehyde group of Glyceraldehyde 3-phosphate converting 
it to 1,3 Bisphosphoglycerate and in doing so also reduces the oxidised form of Nicotinamide 
adenine dinucleotide (NAD+) to the reduced form of Nicotinamide adenine dinucleotide 
(NADH). Phosphoglycerate kinase removes this phosphate group leaving 3-Phosphoglycerate 
and in doing so the detached phosphate ion is added to a molecule of Adenosine diphosphate 
(ADP) producing Adenosine triphosphate (ATP). The phosphate group is subsequently moved 
by Phosphoglycerate mutase producing 2-Phosphoglycerate. Enolase removes this phosphate 
group via a condensation reaction, releasing water, and producing Phosphoenolpyruvate. 
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Finally, this is converted to Pyruvate by Pyruvate kinase which moves the phosphate group 
onto ADP producing ATP. At this stage Pyruvate has a number of potential fates as Lactate 
dehydrogenase can reversibly convert Pyruvate to Lactate or a reaction with NAD+ and Co-
enzyme A (CoA) leads to the production of Acetyl-Co-enzyme A (Acetyl CoA), Carbon 
dioxide (CO2) and NADH. Notably, if the muscle produces lactate at a high rate (faster than it 
can be broken down) for example through sprinting, its concentration increases leading to the 
slowing of the energy production mechanism (Berg et al., 2002). 
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Figure 1.2.1 The glycolysis energy production pathway in skeletal muscle, which is 
predominant in the quadriceps. Enzymes are abbreviated and those common to glycolysis are 
highlighted in green along with the associated energy production from ATP. Glycolysis 
abbreviations: HK (Hexosekinase), PGI (Phosphoglucose isomerase), PFK 
(Phosphofructokinase), A (Aldolase), TPI (Triosephosphate isomerase), GAPDH 
(Glyceraldehyde 3-phosphate dehydrogenase), PGK (Phosphoglycerate kinase), PGM 
(Phosphoglycerate mutase), E (Enolase), PK (Pyruvate kinase), ATP (Adenosine triphosphate), 
ADP (Adenosine diphosphate), NADH (Reduced nicotinamide dinucleotide), NAD+ (Oxidised 
nicotinamide dinucleotide) (adapted from (Berg et al., 2002)). 
 
The soleus, on the other hand, predominantly uses oxidative phosphorylation via the 
electron transport chain for energy production and these processes occur in the mitochondria. 
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In discussing oxidative phosphorylation consideration must first be given to the citric acid cycle 
(abbreviated to TCA cycle, see figure 1.2.2) as it takes the Pyruvate produced by glycolysis 
and converts it to Acetyl CoA via a poly-enzyme complex which includes Transacetylase, 
Pyruvate dehydrogenase and Dihydrolipoyl dehydrogenase (Krebs and Holzach, 1952, 
Mitchell, 1961, Kalckar, 1974, Friedkin and Lehninger, 1949, Kalckar, 1991).  
 
Figure 1.2.2 A citric acid cycle diagram representing the core of mitochondrial energy 
production. 
 
Over several steps carbon dioxide is released, NAD+ is reduced to NADH during which 
an acetate molecule is produced and finally Co-enzyme A is added. Then citrate is produced 
from Oxaloacetate and Acetyl Co-A via citrate synthase, requiring water. Aconitase converts 
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Citrate to cis-Aconitate, releasing water and then on to D-Isocitrate, again requiring water for 
the reaction. Isocitrate dehydrogenase produces α-Ketoglutarate whilst reducing NAD+ to 
NADH and releasing a Hydrogen ion (H+) before α-ketoglutarate dehydrogenase converts this 
to Succinyl-Co-enzyme A. This involves the reduction of NAD+ to NADH, the release of H+ 
and CO2. Succinyl Co-enzyme A synthetase utilises GDP and Pi producing Co-enzyme A-SH 
and GTP while also producing Succinate. The conversion of GTP to GDP, powering this 
reaction also leads to the production of ATP from ADP. Succinate dehydrogenase converts 
Succinate to Fumarate. This mechanism also converts Ubiquinone (Q) to Ubiquinol (QH2) 
while requiring Flavin adenine dinucleotide (FAD) which is reduced to FADH2. Fumarase 
converts Fumarate to L-Malate requiring water. L-Malate then gets converted to Oxaloacetate 
by Malate dehydrogenase whilst also reducing NAD+ to NADH and producing one H+. Finally, 
the cycle is back at the start where Oxaloacetate is joined with Acetyl Co-enzyme A and with 
water produce Citrate and Acetyl Co-enzyme A-SH via Citrate synthase and so the process 
repeats itself. In summary the TCA cycle produces three molecules of NADH, three Hydrogen 
ions, a molecule of Ubiquinol, a molecule of GTP, two molecules of CO2 and  one molecule 
of Co-enzyme A-SH (Berg et al., 2002). 
At this point chemiosmosis links the electron transport chain to oxidative 
phosphorylation. Chemiosmosis is the use of a proton gradient, in this case across the 
mitochondrial membrane to move energy from redox reactions to cellular work (Berg et al., 
2002).  
Oxidative phosphorylation is so called due to the loss of electrons during this process 
and the production of ATP as the final stage which uses the proton gradient. The process 
requires NADH-Q oxidoreductase (Complex I), Q-cytochrome c oxidoreductase (Complex III) 
and cytochrome c oxidase (Complex IV) for electron transport. Also involved is Succinate-Q-
Reductase (Complex II) however this is not involved in proton transport. Electron transport 
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between NADH-Q oxidoreductase and Q-cytochrome c oxidoreductase is carried out by 
Ubiquinone (Q) which easily disseminates within the inner mitochondrial membrane. Then 
cytochrome c transports electrons between Q-cytochrome c oxidoreductase and Cytochrome c 
oxidase, the final enzyme reducing Oxygen (O2) to water (Berg et al., 2002). As the electron 
transport chain causes a proton gradient via the production of water from oxygen this leads to 
the emission of H+ from the mitochondrial matrix producing a gradient that drives ATP 
synthase and therefore the production of ATP (Berg et al., 2002, Kalckar, 1991). 
In summary, aerobic respiration of glucose leads to the production of 36 molecules of 
ATP. 2 ATP molecules are produced via glycolysis, 2 via the tricarboxylic acid cycle and 32 
via the electron transport chain. 
1.3 Reactive Oxygen Species in Skeletal Muscle 
The term reactive oxygen species (ROS) refers to reactive oxygen-containing 
molecules (Devasagayam et al., 2004). Initially they were thought to be predominantly negative 
in their actions due to their reactivity with other intracellular proteins (Davies et al., 1982, 
Murphy and Kehrer, 1986). Following thirty years of study and the initial observation that 
contracting skeletal muscle produces an increase in ROS, they are now understood to be crucial 
signalling molecules (Jackson, 2016a, Nagahisa et al., 2016, Nathan and Cunningham-Bussel, 
2013). Indeed, they are required for the normal function of skeletal muscle and the removal of 
ROS or the proteins involved in their control have demonstrated negative effects on muscle 
function such as increased oxidative damage and neurodegeneration as observed in SOD1 
knockout mice (Smith and Reid, 2006, Radak et al., 2001, Sakellariou et al., 2018). 
 A redox reaction is one that involves a simultaneous and usually reversible chemical 
reaction between two compounds where one is reduced whilst the other is simultaneously 
oxidised. Reduction is defined as the loss of oxygen, the gain of hydrogen and the gain of 
electrons. Oxidation is the reverse and defined as the gain of oxygen and the loss of hydrogen 
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and electrons (Powers and Jackson, 2008). This provides a reversible mechanism by which fast 
and efficient signalling can occur between molecules within the cell. Furthermore, this enables 
the cell to respond to changes in ROS concentrations and induce a response. This redox 
flexibility is facilitated on the molecular scale by the amino acid Cysteine due to its 
evolutionary conservation and via its ability to form and break disulphide bonds. 
Skeletal muscle generates superoxide or Nitric oxide (NO) as part of normal function 
(Jackson et al., 2007, Barbieri and Sestili, 2012). ROS generation occurs via a range of 
mechanisms however their source is still unclear. Although previously believed to be electron 
transport chain leakage recent studies now suggest a cytosolic origin (Jackson et al., 2007, Di 
Meo and Venditti, 2001, Kozlov et al., 2005, Goljanek-Whysall et al., 2016). 
Free Radicals and Reactive Oxygen Species 
The superoxide free radical (O2 
. -) is produced via a number of reactions resulting from 
the partial reduction of oxygen, most notably from the electron transport chain (Powers et al., 
2011). The negative charge makes it impermeable to the cell membrane however it has been 
suggested that further reactions can lead to the addition of a proton, producing a Hydroperoxyl 
radical (HO2
.) which can transfer across membranes. This molecule has a longer half-life 
allowing it to diffuse throughout the cell. It can also remove metal ions from the active sites of 
enzymes containing Iron-Sulphur or [Fe-S] clusters. This liberated Iron may then act to produce 
Hydroxyl free radicals via the Fenton reaction (Powers et al., 2011, Salvador et al., 2001, 
Liochev and Fridovich, 1999, McArdle et al., 2001). 
Hydrogen peroxide (H2O2) is produced by the combination of a superoxide radical and 
water by one of three isoforms of Superoxide dismutase. They differ depending on their 
location (Batinic-Haberle et al., 2015) with the cytosolic Cu-Zn-Superoxide dismutase 
(SOD1), mitochondrial Mn-Superoxide dismutase (SOD2) and the extracellular Cu-Zn 
Superoxide Dismutase (SOD3). H2O2 is a relatively long lasting ROS molecule due to its 
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stability compared to free radicals which may provide a greater benefit in terms of signalling, 
but also a potentially greater threat in terms of damage to other proteins (Powers et al., 2011). 
 The hydroxyl radical (.OH) can be formed following incomplete breakdown of H2O2 
via the Fenton reaction where oxidation of H2O2 by Fe
2+ leads to .OH production. A highly 
reactive molecule, this also makes them short lived as they react with whatever they meet and 
can be highly damaging to cells and their processes (Salvador et al., 2001, Powers et al., 2011). 
Singlet oxygen (1O2) is not a radical but Oxygen with its valence electrons in an excited 
state. It has two energy states, one is an excited state described as 1ΔgO2 and a second more 
highly excited state described as 2ΣgO2. The second excitation state has a higher reactivity than 
the first. Like the hydroxyl radical, singlet oxygen is very highly reactive and reacts with 
whatever it contacts due to a lack of spin restriction. This high reactivity also gives  it a short 
half-life (Powers et al., 2011). 
NAD(P)H oxidases (NOX) have been identified as a major source of ROS within 
skeletal muscle. Several isoforms of NOX enzymes have been identified and all require 
additional proteins for activation with the exception of NOX5 which produces homodimers 
(Brandes et al., 2014). The proteins and mechanisms required for functionality are not 
completely understood however for NOX1, NOX2 and NOX4, p22phox is required for 
assembly at the plasma membrane, followed by the requirement of p47phox for binding 
NOX1/NOX2 to the plasma membrane. In addition to this, DUOX1/2 and NOX5 homodimers 
require intracellular calcium for activation via EF hand proteins (Bedard and Krause, 2007). 
Furthermore, the enzymes require the GTPases RAC1/2 for either non-myeloid cells or 
leukocytes, respectively to control the protein-protein interactions described previously 
(Martyn et al., 2005). NOX1, NOX2 and NOX5 all produce superoxide radicals via the 
oxidation of NADPH while it is currently thought NOX4 produces Hydrogen peroxide along 
with DUOX1 and DUOX2. Within skeletal muscle NOX1, NOX2 and NOX4 have been 
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identified in muscle cell cultures and shown to co-precipitate with Protein disulphide 
isomerase, indicating their potential importance in a redox-sensitive protein chaperone 
mechanism (Ferreira and Laitano, 2016, Janiszewski et al., 2005). In relation to skeletal muscle, 
NOX5 contains an intracellular domain bound with calcium (Vendrov et al., 2015, Sakellariou 
et al., 2014, Paulsen and Carroll, 2013) and NOX2 has been identified as a source of skeletal 
muscle ROS (Espinosa et al., 2016). It should be noted that NOX3 is primarily expressed in 
foetal tissues and therefore not discussed here (Cheng et al., 2001). NOX4 appears to be located 
in the nucleus, thereby regulating gene expression via changes in ROS concentration within 
the nucleus (Kuroda et al., 2005). 
Reactive Nitrogen Species 
Reactive nitrogen species (RNS) which are produced via the enzymatic reactions of 
nitric oxide synthases (NOS). This leads to the generation of the nitric oxide free radical (NO.), 
nitric oxide (NO) molecule or the strong oxidising agent Peroxinitrite ion (ONOO-) (Halliwell, 
1994). NO. is synthesised from L-arginine by NOS enzymes and is required for healthy muscle 
function. Sustained concentrations of NO. can lead to reactions with O2 
. – producing the 
Peroxinitrite ion (ONOO-) (Allen and Tresini, 2000, Collins et al., 2012, D'Autreaux and 
Toledano, 2007). The reactive properties of RNS can cause nitration of proteins, deplete thiol 
groups and damage DNA (Powers et al., 2011, Jackson, 2016b).  
Nitric oxide synthases occur in three forms, all of which are found in skeletal muscle: 
NOS1 or neuronal NOS (nNOS) is located throughout a range of cell types while NOS2 (or 
iNOS) is inducible via inflammation and NOS3 (or eNOS) occurs in the endothelium (Oliveira-
Paula et al., 2014, Stamler and Meissner, 2001). Of particular interest in skeletal muscle 
research is nNOS because during skeletal muscle contractions the NO concentration increases 
and leads to an increase in RNS however their reactivity suggests a localised reaction rather 
than diffusing throughout the cytoplasm (Silveira et al., 2003, Poole, 2015). Furthermore, 
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NOS1 and NOS3 have been shown to include a calmodulin binding site thereby linking them 
directly to skeletal muscle contractions and homeostatic mechanisms (Stamler and Meissner, 
2001, De Palma et al., 2014). 
Lipoxygenases 
An alternative source of ROS is Lipoxygenases. Phospholipase A2 (PLA2) produces 
Arachidonic acid which, following secretion, becomes a superoxide precursor for lipoxygenase 
enzymes (Zuo et al., 2004). Alternatively, PLA2 can induce ROS production within the 
mitochondria, cytosol or release into the extracellular space (Powers and Jackson, 2008, Zuo 
et al., 2004, Woo et al., 2000). Another method is via the stimulation of NOXs leading to an 
overall increase in mitochondrial and cytosolic superoxide production and release into the 
extracellular space (Barbieri and Sestili, 2012, Brash, 1999). 
1.4 The Importance of Cysteine in Redox Signalling 
 Cysteine is an amino acid encoded by UGU and UGC codons. Cysteine residues are 
among the least conserved amino acids, except for where they occur at active sites of proteins 
when they become one of the most highly conserved residues (Marino and Gladyshev, 2012). 
Cysteine has a functionally important thiol group which can be rapidly oxidised or reduced 
thereby forming disulphide bridges with other thiols. It usually undergoes nucleophilic 
reactions as determined by its pKa of 8.3 meaning its intracellular ‘reactive’ state is in the form 
of a thiolate at physiological pKa. However this value is related to the local environment’s pH 
which can therefore impact cysteine reactivity (Paulsen and Carroll, 2013). It is also important 
to note that a low pKa doesn’t necessarily determine whether the reactive cysteine has increased 
oxidant sensitivity (Roos et al., 2013). The surrounding microenvironment has a major impact, 
as demonstrated by peroxiredoxins, upon cysteine activation where peroxide substrate and the 
transition state combine to enable an efficient nucleophilic substitution reaction (Le Moal et 
al., 2017). 
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Redox Signalling in Skeletal Muscle 
 Cysteine can undergo a range of modifications, many of which are reversible. This 
enables them to rapidly reflect changes to the intracellular oxidation state. In skeletal muscle 
this may include changes to ROS concentrations due to muscle contractions (Le Moal et al., 
2017). However, a sustained increase in ROS concentration over time can lead to irreversible 
modifications (see figure 1.3.2.1) (Chung et al., 2013). Disulphide bridges (-S-S-) between 
thiol groups can temporarily affect protein function by changing their conformation thereby 
impacting the active site or metal ion binding mechanism. High concentrations of ROS such as 
H2O2 can produce sulphenic groups (-SOH) as an intermediate to disulphide bridges. Though 
it should be noted that in the thiolate form, cysteine will readily form -SOH without H2O2. 
Further reactions via sustained ROS can lead to the formation of sulphinic (-SOOH) and 
sulfonic acids (-SOOOH). Each step causing a reduction in the ability of the cell to reverse 
these modifications which leads to consistently reduced protein activity or ability to react to 
future changes in ROS concentrations (Chung et al., 2013). Interestingly, Sulfiredoxin has been 
demonstrated to be capable of reducing sulphinic acids on certain peroxiredoxins (Jeong et al., 
2012). The inactivation of a protein by its substrate and subsequent re-activation would suggest 
that these proteins may play a signalling role in response to endogenous generation of H2O2 
(Chung et al., 2013). Another intermediate from sulphenic acid is the reaction with RNS 
producing a sulphenylamide (-SN-). Both –SOH and –SN can react with glutathione (GSH) to 
produce reversibly modified glutathionylated thiols (-SSG) (Chung et al., 2013, Hazelton and 
Lang, 1980). Glutathionylated thiols can be reduced by another set of proteins called 
glutaredoxins using GSH and NADPH. S-Nitrosothiols (-SNO) are an intermediate of the 
reactions between glutathionylated thiols and Sulphydrated thiols. S-nitrosylation, is the 
covalent attachment of a nitric oxide group to the thiol side chain of cysteine and is an important 
mechanism for post-translational regulation of a large range of proteins. This also highlights 
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part of the ubiquitous influence of nitric oxide (NO) on cellular signal transduction providing 
a mechanism for redox-based physiological regulation. Sulphydrated thiols (-SSH) can occur 
via glutathionylation of S-Nitrosothiols or by Hydrogen sulphide (H2S). Sulphydration of thiols 
is not well documented however it has been proposed that this can occur due to an increase in 
H2S reflecting sarcoplasmic reticulum stress (Chung et al., 2013, Lo Conte and Carroll, 2013, 
Hess et al., 2005). 
 
Figure 1.4.1 Cysteine modifications following an increase in the concentration of reactive 
oxygen species, specifically H2O2. The antioxidant glutathione (GSH) can reduce certain 
modifications and its reduced form (GSSG) can lead to reversible reactions producing free 
thiols. Nitrosylation produces Nitrosothiols (-SNO) which can be produced by S-
Nitrosoglutathione (GSNO) involving the nitric oxide signalling pathways. The orange arrow 
indicates possible reversal of Peroxiredoxin-sulphinilation via Sulfiredoxin (adapted from 
(Chung et al., 2013)). 
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Redox signalling is a crucial mechanism that enables a cell to respond to changes in its 
oxidation state. A range of redox response systems have been identified such as those in the 
mitochondria, linking energy metabolism to changes in the cellular redox state, protein folding 
response involving heat-shock proteins such as HSP70 acting in combined roles as both redox 
sensors and protein chaperones (Collins et al., 2012, Vasilaki et al., 2006b). This thesis 
specifically considers skeletal muscle redox proteins, however similar mechanisms occur 
across a range of other biological systems. They enable a fast and efficient means of responding 
to changes in the cellular redox state. In skeletal muscle, a range of redox signalling 
mechanisms have been identified including the glutathione and thioredoxin systems, along with 
various antioxidant proteins such as peroxiredoxins and superoxide dismutases. The former 
can act both as a redox sensor and as an antioxidant protein. These systems enable the muscle 
to detect and respond to changes in the intracellular microenvironment. All systems rely on the 
previously described reduction-oxidation chemical mechanism and utilise cysteine amino acids 
thanks to their ability to form and break disulphide bonds (Forman et al., 2014). Furthermore, 
recent work has gone so far as to demonstrate the requirement of ROS in signalling for 
maintenance and repair of plasma membranes via the requirement of mitochondria (Horn et al., 
2017). 
Irrespective of the origin of the ROS, the mechanism relies on the reversible formation 
of disulphide bonds utilising the thiol group of a cysteine amino acid, enabling a response to 
changes in intracellular ROS concentrations.  
A range of protein systems exist to finely react to and control intracellular ROS. 
Peroxiredoxins are antioxidant enzymes that reduce hydrogen peroxide to water in the presence 
of an electron donor. Six isoforms have been identified in mammals with Peroxiredoxin 3 and 
5 occurring in the mitochondria and 1, 2, 4 and 6 being cytosolic (Sobotta et al., 2015). Their 
presence in all species indicates their importance for survival across a wide range of organisms 
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(Rhee et al., 2001). Peroxiredoxins 1-5 contain two redox cysteines which enables them to be 
reduced by Thioredoxin. Peroxiredoxin 6 contains one cysteine which can be reduced by 
glutathione with Glutathione S-Transferase π (Monteiro et al., 2007). Peroxiredoxin 4 is 
membrane-bound but appears to be secretory in nature as it contains an amino-tail group that 
may be subject to a post translational cleavage (Sasagawa et al., 2001, Rhee et al., 2001). 
The Thioredoxin system contains the low molecular weight oxidoreductase enzyme 
Thioredoxin. It maintains substrates such as the peroxiredoxins in their active form. 
Thioredoxin relies on Thioredoxin Reductase (and NAD(P)H) to maintain it in a reduced, 
active form. Both proteins contain a selenocysteine at their active sites and occur in two forms: 
Thioredoxin 1/Thioredoxin Reductase 1 which are cytosolic and Thioredoxin2/Thioredoxin 
Reductase 2 which are mitochondrial. A third form of Thioredoxin Reductase has been 
identified in the testes called Thioredoxin glutathione reductase (TGR) and it is this third form 
that demonstrates the conjunction between Thioredoxin and Glutathione systems. Additionally, 
a secreted form of Thioredoxin is known although few details are known about its specific 
effects (Kalinina et al., 2008).  
The glutathionylation system reacts to changes in hydrogen peroxide by oxidation of 
reduced glutathione (GSH) to its oxidised form (GSSG). These changes can lead to S-
glutathionylation of other proteins as a post-translational modification, thus affecting their 
activities. This is another mechanism that links redox changes within the cell to protein 
modifications and enables a response to those changes (Munro and Treberg, 2017). Glutathione 
reduces the oxidised glutaredoxin proteins followed by reactivation of glutathione by 
glutathione reductase (Fernandes and Holmgren, 2004). Glutaredoxins are small redox 
sensitive proteins that contain a redox-active cysteine at their active sites (Holmgren, 1988). 
One paper has described glutaredoxin as a neuronal cell back-up to maintain Thioredoxin 
Reductase in a reduced state to maintain Thioredoxin functionality during times of high stress 
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(Branco et al., 2017). Glutathione peroxidases consist of eight currently known variants which 
convert Hydrogen peroxide to water in addition to reducing lipid hydroperoxides (Bhabak and 
Mugesh, 2010). These are also of importance for reducing oxidative stress within an organism. 
Chronic exposure to high concentrations of ROS (as seen in figure 1.3.2.1) may lead to 
either the formation of disulphide bonds, or irreversible modifications of the redox cysteine 
residues in a range of redox sensitive proteins. This may negatively affect a protein’s ability to 
react to changes in intracellular ROS due to conformational changes or steric hindrance of the 
enzyme’s active site (Poole, 2015). 
1.5 Skeletal Muscle Ageing 
 Skeletal muscle ageing is associated with a loss of muscle mass and force which is 
generally referred to as sarcopenia. By 70 years old, human muscle cross sectional area is 
reduced by 25-30% and strength by up to 40% and a similar reduction is observed in rodents 
(Jackson, 2013). As the current work was performed on mouse skeletal muscle, consideration 
was given to how they change with age. Mouse skeletal muscle ageing involves the loss of 
muscle mass and force and hence are an appropriate model for investigating the changes in 
different skeletal muscles with age. One example is the autophagy response which has been 
demonstrated to react to the metabolic adaptation to exercise. In aged models the autophagic 
response appears to be impaired (O'Leary et al., 2013, Ferraro et al., 2014). 
Mouse quadriceps are fast glycolytic muscles responsible for swift responses to 
movement and sprinting in short bursts. As previously described, quadriceps energy 
metabolism predominantly utilises glycolysis to produce energy which can lead to a build-up 
of lactic acid due to an inability for the muscle to degrade it quickly enough. In comparison 
soleus muscles predominantly contain slow twitch fibres and use oxidative phosphorylation for 
the majority of their energy production. They are recruited for longer lasting muscle 
requirements such as maintaining posture and long-distance running. Studies of fast twitch 
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fibres has revealed they are more susceptible to age related loss than slow twitch fibres and fast 
twitch fibres appear to be more greatly affected by fibre type and size changes with age than 
their slow-twitch counterparts (Lexell, 1995). Oxidative phosphorylation appears to also 
change with age, with one study suggesting a decrease in mitochondrial ability to react to 
increased energy demand with age although this study examined liver samples from rats 
(Darnold et al., 1990). 
While there are several theories of ageing there is no one alone wholly explains the 
cellular mechanisms that underlie it (Jang et al., 2009). One theory is the DNA damage theory 
of ageing which postulates that defects in DNA machinery or chromatin affect the genes 
required for normal cellular function. Therefore when transcribed in later life, having been 
accessed many times already, the errors in the gene code build to a point where the protein 
loses functionality, either partially or wholly (Lenart and Krejci, 2016). Of specific interest to 
this thesis is the free radical theory of ageing (Harman, 1956). This has been developed over 
more than 50 years of biochemical research and suggests that the cellular production of ROS 
leads to the partial or full destruction of various proteins (Harman, 1956). ROS were initially 
considered as only having a negative impact on cellular function but more recently they have 
been observed as necessary for normal cellular function. Indeed, some studies have also 
demonstrated that reducing ROS across the board may have a negative impact upon cellular 
signalling responses to changes in oxidation states (Schieber and Chandel, 2014, D'Autreaux 
and Toledano, 2007, Ray et al., 2012).  
1.6 Thesis Aims and Hypothesis 
The aim of the work reported in this thesis was to assess changes to two murine skeletal 
muscle types, differentiated by their primary energy production mechanism for contractions, 
via the use of global label free proteomics and differential labelling for redox proteomics. This 
will increase the understanding of how ageing affects two metabolically distinct murine 
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skeletal muscles at the proteomic scale and in relation to the redox state of individual cysteine 
residues. Thiol signalling was specifically investigated since it provided a rapid and reversible 
mechanism for intracellular redox concentrations to be controlled in a healthy cell and the 
mechanism by which this is controlled is thought to be susceptible to changes in the 
intracellular redox state. 
The novelty of the work in this thesis is the proteomics analysis of how mouse skeletal 
muscle changes with age in relation to its redox proteome as this has not been previously 
performed. The study considered the quadriceps and soleus tissues from the mouse hind limbs 
due to their differences in physiological function and energy metabolism as described earlier. 
LC-MS/MS or tandem mass spectrometry was the primary technique employed. 
Widely used and quantitative, it’s ideal for studying complex samples such as tissues and 
characterising them. A two-pronged strategy used the relative quantitation of global label free 
proteomics data to determine large scale changes to the muscles along with differential 
labelling of specific cysteine residues which enabled the identification of changes to the redox 
state of individual proteins with age. 
It was hypothesised that the two muscle types will age differently due to their different 
metabolic and functional backgrounds. This was because the quadriceps, as a fast twitch muscle 
using predominantly glycolysis for energy metabolism, uses a different set of proteins for 
structure and function compared to the slow twitch soleus that uses oxidative phosphorylation 
for its energy metabolism. 
It was also hypothesised that differences in the changes to the redox state of each muscle 
type with age would be observed. It was thought this may be demonstrated by changes to 
quadriceps proteins involved in glycolysis (e.g. GAPDH) or soleus proteins involved in 
oxidative phosphorylation (e.g. ATP Synthase) which may decline in abundance with age. 
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2.1 Chemical Reagents 
Unless otherwise stated, all reagents used were obtained from Sigma Chemical 
Company, Dorset, UK. 
2.2 C57BL/6 Mice: Quadriceps and Soleus Muscles Dissection 
C57BL/6 male mice were purchased from Charles River and housed in the Specific 
Pathogen-Free (SPF) facility at the University of Liverpool for a minimum of 2 weeks prior to 
use. All mice had free access to standard chow and water. Experiments were performed under 
U.K. Home Office guide lines in accordance with the U.K. Animals (Specific Procedures) Act 
1986 and received ethical approval from the University of Liverpool Animal Welfare and 
Ethical Review Board. Sacrifice was by cervical dislocation. Only healthy, male mice were 
used to reduce variability and effects of hormones. Mice were selected at adult (12 months) 
and old (24 months) ages for mass spectrometry. Later, young (3 months old) mice became 
available and these tissues were used in western blotting and enzyme activity assays. 
Quadriceps and soleus muscles were removed and one of each type was cut and 
mounted transversely on a cork block in OCT before being frozen prior to histological 
examination. A portion of each was prepared for redox proteomic analysis the muscles were 
placed in 25 mM d0-N-ethylmaleimide (NEM) and 25 mM Ammonium Bicarbonate (pH 8). 
Whilst the remaining muscle was used for western blotting and immediately frozen in liquid 
nitrogen prior to storage at -80°C. 
2.3 Skeletal Muscle Homogenisation for Western Blotting 
Homogenisation required the samples to be kept on ice throughout the process. Samples 
were moved to a 1.5 mL microcentrifuge tube containing ≤ 200 μL RIPA 
(Radioimmunoprecipitation Assay lysis buffer containing 50 mM Tris-HCl (pH=7.5), 1 mM 
EDTA, 150 mM NaCl, 0.1% w/v Sodium Deoxycholate and 1:1000 Protease Inhibitor 
Cocktail). The samples were initially minced with scissors followed by disruption with a 
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handheld homogeniser (Kontes Pellet Pestle Motor, Sigma Aldrich, Dorset) to further break 
down the muscle using three one-minute full-power bursts per sample. The samples were then 
centrifuged at 13,000 g for one minute at room temperature and the pellet formed was 
homogenised again (one one-minute burst per sample). A second centrifugation step at 12,000 
g for 15 minutes at 4°C was then performed. The supernatant was decanted into a new 0.5 mL 
microcentrifuge tube and stored at -80°C for further use and the pellet was discarded. 
2.4 Proteomics Sample Preparation and Analysis 
2.4.1 Proteomics Sample Preparation: Muscle Homogenisation 
 The samples were removed from -80°C storage, defrosted on ice and briefly centrifuged 
at 5,000 g for three minutes at 4°C. Samples were minced with scissors then homogenised 
using a hand-held homogeniser (Kontes Pellet Pestle Motor) in a solution of ≤ 200 μL 
containing 20 μM Ammonium Bicarbonate and 25 μM N-ethylmaleimide (NEM) was used to 
block free thiols on proteins in the sample. A Bradford assay was performed to calculate initial 
protein concentrations (see 2.5.1, p.50). Desalting removed excess NEM using Zebra spin 
columns (Thermo Scientific, Hemel Hempstead, UK) and a second Bradford assay performed 
to recalculate protein concentrations and determine any protein loss during the desalting step. 
2.4.2 Proteomics Sample Preparation: Differential Labelling 
  100 μg of desalted protein extract was added to 25 mM Ammonium Bicarbonate up to 
a volume of 160 μL followed by 10 μL RapiGest (Waters, Hertfordshire, UK) with a 1% (w/v) 
starting concentration and ~0.05% (w/v) final concentration. Samples were incubated at 80°C 
for 10 minutes followed by reduction with the addition of 10 μL TCEP (100 mM). Samples 
were incubated at 60°C for ten minutes then allowed to cool to room temperature and briefly 
centrifuged to collect liquid. Alkylation was performed by adding 10 μL of d5-NEM (200 mM). 
Samples were incubated in darkness at room temperature for 30 minutes. Following this quality 
control sample “A” was collected by sampling 10 μL into a new microcentrifuge tube. 10 μL 
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of a 200 μg/mL stock solution containing Trypsin and Ammonium Bicarbonate (in a 50:1 
protein:trypsin ratio) was then added and samples were incubated at 37°C for twelve to sixteen 
hours. Quality control sample “B” (10 μL per sample) was collected following Trypsin 
digestion. Samples were briefly microcentrifuged to collect the digest and Trypsin was 
inactivated using Trifluoroacetic Acid (TFA) and incubated at 37°C for thirty to forty-five 
minutes. Samples were centrifuged at 13,000 g for fifteen minutes to remove any insoluble 
particles and the supernatant was carefully removed for immediate use in mass spectrometry. 
Quality control sample “C” was collected at this point (10 μL).  
2.4.3 Tandem Mass Spectrometry and Label Free Relative Quantification 
An Ultimate 3000 RSLC (fast liquid chromatography) Nano system (Thermo 
Scientific) was coupled to a Q-Exactive mass spectrometer (Thermo Scientific) to perform the 
data-dependent label free analysis.  
5 μL (250 ng of protein) of sample was loaded onto a trapping column (Thermo 
Scientific, PepMap100, C18, 75 μm x 20 mm), using partial loop injection, for seven minutes 
at a flow rate of 4 μL /min with 0.1% (v/v) TFA. Resolution was performed on an analytical 
column (Easy Spray C18, 75 μm x 500 mm, 2 μm column) by preparing two solutions 
individually, prior to mixing in a specific ratio. An A gradient of 97% (containing 0.1% formic 
acid) and 3% B (99.9% Acetonitrile (CAN) and 0.1% Formic acid) to 60% A and 40% B over 
two hours at a flow rate of 300 nL/min. The program for data dependent acquisition consisted 
of a 70,000 resolution full scan for MS (Automated gain control (AGC) was set to 106 ions 
with a maximum fill time of 250 ms). The ten most abundant peaks were selected for MS/MS 
using a 17,000 resolution scan (AGC set to 5 x 104 ions with a maximum fill time of 250 ms) 
with an ion selection window of 3 m/z and a normalised collision energy of 30. A 30 s dynamic 
exclusion window was used to avoid repeat peptide selection in MS/MS. Detection of the 
peptides was performed by data dependent acquisition (DDA) which takes a select number of 
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peptide peaks from the initial scan according to a rule set and the corresponding ions were then 
verified against this initial set via tandem mass spectrometry (MS/MS).  
Raw spectra were converted to Mascot Generated Files (.mgf) using the Proteome 
Discoverer software (Thermo Scientific). These .mgf files were then searched against the 
Uniprot mouse sequence database (database last updated on 12th May 2012; 16,376 sequences 
were identified for Mus musculus) via an in-house Mascot database server (Matrix Science, 
London, UK). The search parameters were: peptide mass tolerances, 10 ppm; fragment mass 
tolerance, 0.01 Da, 1+, 2+ and 3+ ions; missed cleavages, 1; instrument type, ESI-TRAP. 
Variable modifications were included as: d0-NEM, d5-NEM, mono-, di-, and tri-oxidation of 
cysteine residues and oxidation of methionine. 
Label-free relative quantification software PEAKS 7 (Bioinformatics Solutions Inc., 
Waterloo, Canada) was used to analyse RAW data files against the same mouse protein 
database for identifications with Mascot (Zhang et al., 2012). Proteins were considered 
significantly changed between muscles in adult and old mice samples using the following 
criteria: -10 log P score of >20 (equivalent to a p value of 0.01), a fold change ≥ 1.5 and using 
a quality value of 0.8. Data normalisation was performed using the total ion current (McDonagh 
et al., 2014b). 
 PEAKS7 software includes a post-translational modification (PTM) algorithm applying 
the de novo sequencing module to search for a limited number of PTMs. All identified PTMs 
using this method adhere to the above search criteria and FDR validation.  
2.4.4 Targeted Analysis of Differential Cysteine Labelling 
Redox cysteines were detected as being simultaneously reduced and oxidised, giving 
rise to their cellular redox flexibility as they can adjust to changes in predominantly reduced or 
oxidised environments. In our experiment cysteine containing peptides that were labelled with 
both d5-NEM and d0-NEM were identified as redox cysteine residues, those that reacted with 
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only d0-NEM were reduced and those with only d5-NEM were reversibly oxidised. Redox 
cysteine peptides were identified by detecting identical amino acid sequences containing d0 
and d5-NEM, confidence was determined by using a peptide score of >20.  
 Peptides detected from Proteome Discoverer analysis of RAW files were selected for 
targeted analysis using m/z data and retention with the open software Skyline (version 3.5) 
(MacLean et al., 2010). Targeted analysis applying m/z, retention times and fragmentation 
spectra for peptide selection allowed the calculation of the reduced/oxidised ratio (or d0/d5-
NEM) of the individual cysteine residues using the individual parent ion intensities with 
Skyline. For redox peptides the individual reduced/oxidised ratio for each redox cysteine 
peptide was used to calculate an average ratio of specific cysteine oxidised/reduced peptides.  
  Filtration parameters for proteomics results of the label free comparison contained a 
false detection rate (FDR) of 1%, a mass error tolerance of 10.0 ppm and a retention time shift 
tolerance of 0.5 minutes.  
2.4.5 Proteomic Data Analysis 
Skyline (MacLean et al., 2010) was used to quantify redox peptides. The ratio of the 
peptide labelled with light/heavy NEM allowed the calculation of an estimated of redox state 
of individual cysteine residues. This was performed on adult and old muscle enabling a change 
in redox state of individual cysteine amino acids to be determined. 
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Figure 2.4.5.1 Schematic demonstrating differential labelling of proteins with light and heavy 
N-Ethylmaleimide. Following homogenisation, the protein free thiol groups are blocked with 
light NEM (d0-NEM). Excess NEM was removed and oxidised thiol groups are reduced in 
TCEP, the heavy isoform (d5-NEM) was then added to label the reversibly oxidised thiol 
groups within the protein and the excess removed. The labelled proteins are digested with 
Trypsin and injected into the HPLC column for mass spectrometry analysis. This approach 
enables a label free analysis of all detected peptides within the sample along with differentially 
labelled proteins which can indicate changes to their redox state. Peaks was used to analyse the 
label free data whilst Skyline was used for analysis of the differentially labelled peptides 
(reproduced with permission from B. McDonagh (McDonagh et al., 2014b)). 
 
 Figure 2.4.5.2 describes the layout of the Skyline desktop used for quantifying the redox 
state of specific cysteine residues. The left-hand panel contains the list of redox cysteine-
containing peptides identified using Proteome Discoverer (v 1.4). The highlighted peptide then 
has its corresponding information displayed in the other three panels onscreen. The peptide 
information corresponds to a peptide library as identified by MS/MS fragmentation and 
corresponding to the mass of the peptide plus the d0-NEM (+125.14) or d5-NEM (+130.14). 
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The upper central pane contains the chromatogram for the selected peptide strand, the lower 
central panel contains the peptide retention times and the right-hand panel contains the peak 
area. It is this final panel that is used to determine the differences in oxidation state of the redox 
cysteine. The red line indicates the peak intensity for a peptide fragment detected with a redox 
cysteine labelled with d0-NEM (light isotope), and the blue is d5-NEM (heavy isotope) labelled 
redox cysteine. The samples are quadriceps and soleus muscles from five adult mice and six 
old mice. 
The supplementary information at the end of this thesis contains label free protein 
details for the appropriate Venn diagrams and tables However the proteomics data was 
submitted to an online repository called DataCat at the University of Liverpool due to the size 
and formatting of the data. The online archive contains the following files in their original 
Excel (.xlsx) format. The files submitted are: S1 - Quadriceps All Detected Proteins; S2 – 
Quadriceps Significantly Changed Proteins; S3 – Adult Quadriceps Redox Proteins; S4 – Old 
Quadriceps Redox Proteins, S5 – Soleus All Detected Proteins; S6 – Soleus Significantly 
Changed Proteins; S7 – Soleus Adult Redox Proteins; S8 – Soleus Old Redox Proteins). They 
can be accessed at 10.17638/datacat.liverpool.ac.uk/437. 
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Figure 2.4.5.2 Skyline example desktop layout. Left-hand panel contains the redox peptide sequences, upper centre contains the chromatogram of 
the selected peptide and beneath it is the retention time for the samples containing this peptide. Right-hand panel contains the relative intensity 
(peak area) of the peptides as detected by the mass spectrometer and was used to determine redox ratio shifts for individual cysteine amino acids. 
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(B) 
2.5 SDS-PAGE and Western Blotting 
2.5.1 Determining Protein Concentration – Bradford Assay 
 A standard curve of known Bovine Serum Albumin (BSA) protein concentrations was 
prepared with a range of 0 to 10 μg/mL. Protein samples were removed from -80°C storage, 
defrosted on ice and briefly mixed using a pipette before diluting 1:1000 for quadriceps 
samples and 1:500 for soleus samples, in dH2O. Quick Start Bradford Reagent (BioRad) was 
diluted 1:5. A Corning 96-well plate (Sigma Aldrich, Dorset, UK) was loaded with 100 μL of 
protein sample dilution and 100 μL of diluted Quick Start Bradford Reagent. The plate was 
analysed using a Spectrostar Nano (BMG-Labtech) spectrophotometer at 595 nm. The protein 
concentrations were determined using the standard curve. Confirmation of equal protein 
loading was initially performed via a Coomassie Blue stain for each sample at the beginning 
of the study. Subsequent equal loading checks were performed using the Ponceau S stain. 
 
Figure 2.5.1 (A) Example Ponceau S stain showing the layout of a western blot of gels with a 
secondary antibody control sample (only used for the initial experiment with a new antibody). 
Dual Color marker was used to determine the relative molecular weights. Protein samples (25 
μg) were loaded from left to right in ascending age. (B) An example standard curve produced 
with BSA for determining protein concentration following homogenisation. 
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2.5.2 Western Blotting 
Protein concentrations were determined using a Bradford Assay (figure 2.5.1.1 (B)) and 
a specified amount of protein (in μg) was added to Laemmli buffer (Glycerol, Bromophenol 
Blue & 5% β-Mercaptoethanol). N-ethylmaleimide was added to inhibit oxidation of any 
remaining free thiols. Samples were denatured by heating to 95°C for 10 minutes then allowed 
to cool before loading 25 μg protein on 10% or 12% acrylamide resolving gels (comprising 
Acrylamide, Tris-HCl (pH 8.8), dH2O, Ammonium Persulphate and TEMED (N, N, N’, N’-
Tetramethylethylenediamine). Separation of proteins based on molecular weight was 
performed at 120 V over two hours. Subsequently, the proteins were transferred to 
nitrocellulose membranes (unless otherwise stated) at 100 mA per gel over one hour. Ponceau 
S stain identified a successful transfer and even loading of the gel by highlighting the protein 
bands of similar size and location on the gel across all samples. Multiple band intensities per 
lane were used for image normalisation via total protein amount. Membranes were blocked 
using 3-5% non-fat dry milk (NFDM) dissolved in TBS-Tween20 (distilled H2O, 20 mM Tris-
HCl, 150 mM NaCl and 0.1% Tween 20, pH adjusted to 7.40) for one hour at room temperature, 
followed by washing three times for five minutes with TBS-T.  A range of primary antibodies 
were used (Table 1) which were obtained from Abcam and Cell Signalling Technologies 
(diluted as required in either 3-5% NFDM or BSA). Primary antibodies were incubated with 
the membrane overnight at 4°C with constant agitation. Membranes were then washed with 
TBS-T three times for five minutes. Horseradish peroxidase-conjugated secondary antibodies 
(anti-mouse (7076 S, 1:3000) and anti-rabbit (7074 S, 1:3000) IgG (Cell Signalling 
Technologies, Hitchin, UK) and anti-goat IgG (A5420, 1:2000, Thermo Scientific, 
Loughborough, UK), were all diluted in TBS-T. Peroxidase activity was detected using the 
enhanced chemiluminescence (ECL) kit (Amersham International, Cardiff, UK) and band 
intensities were analysed on a BioRad ChemiDoc XRS+ (BioRad, US) using ImageLab (v5; 
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BioRad, US). Any potential cross reactivity of secondary antibodies was examined in initial 
blots by incubating protein samples with only the secondary antibody. Molecular weight was 
determined using Dual Color markers (BioRad, US).  
In a handful of cases, it was necessary to re-probe a membrane due to the limited 
availability of soleus muscle tissue. In this case the membrane would first be washed three 
times with TBS-T at room temperature, followed by using a mild stripping buffer containing 
15 g glycine, 1 g SDS and 10 mL Tween20 all in distilled H2O and pH adjusted to 2.2. This 
was done with enough solution to cover the membrane and at room temperature whilst rocking 
for ten minutes. The solution was discarded, fresh buffer applied for another 10 minutes with 
rocking at room temperature. Finally, three washes with TBS-T were performed for five 
minutes each before checking the membrane with ECL to ensure sufficient removal of the 
antibodies. The membrane was washed again three times for five minutes each in TBS-T before 
adding the new primary antibody and following the protocol as previously detailed. 
Normalisation of Data 
Normalisation of the blots used the corresponding Ponceau S band intensities. Several 
bands per lane were measured in ImageLab (v5; BioRad, US) and the mean determined before 
dividing the band intensity by the corresponding Ponceau S value. This was performed for all 
western blot experiments.
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Table 1 Western Blotting Primary Antibodies 
 
 
 
Table 1. List of all primary antibodies used throughout this study, with their accompanying details, including, where noted, their product codes/Lot#.
Name Abbreviation Mw Company Product Code LOT # Dilution
Blocking 
Agent
Secondary Reqd.
AMP kinase alpha AMPk 62 kDa Cell Signalling Technology #19 1:1000 3% BSA Anti-Rabbit
p-AMPKinase-alpha p-AMPKa 60 kDa Cell Signalling Technology 2531 S #13 1:1000 3% BSA Anti-Rabbit
beta-Actin b-Actin 42 kDa Abcam ab8224 GR180618-1 1:5000 3% Milk Anti-Rabbit
Aconitase Acon. 86 kDa Abcam ab129069 GR81376-7 1:5000 3% Milk Anti-Rabbit
Carbonylation (Whole Blot) Anti-DNP Full Blot Invitrogen 713500 1:1000 5% Milk Anti-Rabbit
Catalase Cat 60 kDa Abcam ab16731 1:2000 3% Milk Anti-Rabbit
Copper-Zinc Super Oxide Dismutase SOD1 16 kDa Enzo ADI-SOD-100 1051228 1:1000 3% Milk Anti-Rabbit
DJ-1/PARK7 DJ-1/PARK7 20 kDa Abcam ab76241 YF021904 1:1000 3% Milk Anti-Rabbit
DJ-1/PARK7 - SO3H DJ-1/PARK7-SO3H 20 kDa Abcam ab169520 GR121877-7 1:1000 3% Milk Anti-Rabbit
Glutathione-S-Transferase mu GST-mu 26 kDa Abcam ab108524 YK080204PS 1:1000 3% Milk Anti-Rabbit
Glucose regulated protein-78 (or Binding immunoglobulin protein) Grp78 72 kDa Enzo ADI-SPA-826 1:1000 3% Milk Anti-Goat
Glutathionylation (Whole Blot) GSH Full Blot Virogen 101-A-100 1:3000 3% Milk Anti-Mouse
Glyceraldehyde-3-Phosphate Dehydrogenase GAPDH 36 kDa Abcam ab8245-100 GR663132 1:30000 3% Milk Anti-Mouse
Glutaredoxin 1 Grxn1 12 kDa Abcam ab187507 GR198757-1 1:2500 3% BSA Anti-Rabbit
Glutaredoxin 2 Grx2 18 kDa Abcam ab85267 GR26904-9 1:500 5% Milk Anti-Rabbit
Glutathione Peroxidase 1 Gprx 1 22 kDa Abcam ab22604 GR172870-1 1:500 5% Milk Anti-Rabbit
HSC70 HSC70 73 kDa Stressgen Bioreagents #04190606 1:4000 5% Milk Anti-Rat
HSP70/HSP72 (Inducible form under RO stress) HSP70 70 kDa Enzo ADI-SPA-810 #12071118 1:1000 3% Milk Anti-Rabbit
Manganese Superoxide Dismutase SOD2 25 kDa Enzo ADI-SOD-111 1:1000 3% Milk Anti-Rabbit
Mitochondrial Brown Fat Uncoupling Protein 1 UCP1 32 kDa Abcam ab10983 GR169579-4 1:1000 5% Milk Anti-Rabbit
Mitochondrial Uncoupling Protein 3 UCP3 36 kDa Abcam ab3477 GR150688-5 1:1000 3% BSA Anti-Rabbit
Sulfiredoxin 1 Srxn1 14 kDa Abcam ab92298 GR40165-6 1:1000 3% Milk Anti-Goat
Peroxiredoxin 1 Prdx1 22 kDa Abcam ab15571 GR49827-2 1:1000 3% Milk Anti-Rabbit
Peroxiredoxin 2 Prdx2 27 kDa Abcam ab59539 GR106211-1 1:1000 3% Milk Anti-Rabbit
Peroxiredoxin 3 Prdx3 27 kDa Abcam ab16751 GR40935-1 1:1000 3% Milk Anti-Rabbit
Peroxiredoxin 4 Prdx4 29 kDa Abcam ab16943 GR140162-1 1:1000 3% Milk Anti-Mouse
Peroxiredoxin 5 Prx5 22 kDa Abcam ab16944 GR64420-11 1:1000 3% Milk Anti-Mouse or Anti Human
Peroxiredoxin 6 Prdx6 25 kDa Abcam ab133348 GR145006-1 1:1000 3% Milk Anti-Rabbit
Peroxiredoxin-SO3 Prx-SO3 Full Blot Abcam ab16830 1:1000 3% Milk Anti-Rabbit
Protein Disulphide Isomerase PDI/P4HB 57 kDa Abcam ab137110 GR104170-8 1:1000 3% Milk Anti-Rabbit
Sirtuin 1 Sirt1 80-110 kDa Abcam ab12193 GR79677-24 1:1000 5% Milk Anti-Rabbit
Sulfiredoxin 1 Srxn1 14 kDa Abcam ab92298 GR40165-6 1:1000 3% Milk Anti-Goat
Thioredoxin 1 Trx1 12 kDa Abcam ab86255 GR43357-5 1:1000 3% Milk Anti-Rabbit
Thioredoxin 2 Trx2 26 kDa Abcam ab16857 GR53127-10 1:1000 3% Milk Anti-Goat
Thioredoxin Reductase 1 TrxR1 55 kDa Santa Cruz sc20147; H-270 A1604 1:1000 3% Milk Anti-Rabbit
Thioredoxin Reductase 1 TXNRD1 55 kDa Abcam ab16840 GR172892-1 1:2000 3% BSA Anti-Rabbit
Thioredoxin Reductase 2 TXNRD2 55 kDa Abcam ab16841 GR779345 1:1000 3% Milk Anti-Mouse
Thioredoxin Interacting Protein TXNIP 45 kDa Abcam ab86993 GR132784-1 1:1000 3% Milk Anti-Mouse
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2.6 Analysis of Carbonylation 
 A denaturation solution (50 mM Tris-HCl (pH 7.50), 8M Urea, 2% (w/v) CHAPS (3-
[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate)) was prepared along with 4 μM 
DNPH ((2, 4-dinitrophenyl) hydrazine) solution (initially prepared as 40 μM DNPH in 100 μL 
TFA followed by a 1:10 dilution in dH2O due to DNPH’s poor solubility). 100 μg protein was 
denatured with 10 μL denaturation solution then 10 μL DNPH solution. Samples were briefly 
vortexed then incubated at room temperature (25°C) for fifteen minutes, agitated throughout. 
2 M Tris neutralised the denaturants and a colour change from light to very dark orange was 
observed. Excess acetone was then added to precipitate the protein and incubation at -20°C for 
less than one hour (vortexing throughout). Samples were then pelleted at 12,000 g for five 
minutes at 4°C. Supernatant was removed and 50 μL dH2O was added to remove salts along 
with another excess of acetone. Precipitation was repeated for >1 hour at -20°C, vortexing 
throughout and pelleting again at 12,000 g for five minutes at 4°C. The supernatant was 
removed, and the pellet allowed to air dry. The pellet was resuspended in denaturation solution 
and a Bradford Assay indicates the carbonylated protein concentration. 
2.7 Analysis of Glutathionylation 
 The glutathionylation blot shows proteins conjugated to glutathione suggesting a 
change in overall cellular redox state. Samples were prepared under non-reducing conditions, 
containing no β-Mercaptoethanol. All other aspects of the blot were the same as performed for 
a standard western blot. 
2.8 Enzyme Activity Assays 
2.8.1 Aconitase Enzyme Activity 
 The enzyme activity of aconitase was determined by measuring the reaction of citrate 
to isocitrate. This is a coupled reaction requiring aconitase along with the conversion of NAD+ 
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to NADH and the outcome is measured using colorimetry. Throughout the experiment all 
samples and reagents were kept on ice. 
 A stock solution of 50 mM Tris-HCl was prepared and adjusted to pH 7.40. Two buffer 
solutions were prepared: 5 mM Tri-sodium citrate dehydrate and 0.6 mM Manganese (II) 
chloride tetrahydrate. Finally, the enzymatic reagents were prepared: 20 mM β-NADP+ 
(Nicotinamide adenine dinucleotide phosphate) and two units of IDH (Isocitrate 
Dehydrogenase; 9.4 mg/mL equal to 9.4 units/mg). The reaction solution was then prepared by 
mixing the β-NADP+, IDH, 50 μg protein and the buffer solution in a 50 μL reaction mixture 
for each well. Experiments used a Costar 3603 96-well glass bottomed plate (Sigma-Aldrich 
UK, Dorset) and measurements made on a Fluostar Optima (BMG Labtech, Germany) with 
emission at 340 nm and absorption at 440 nm with controls measured against blanks. Results 
are expressed as nmol/min/mg protein. 
2.8.2 Thioredoxin and Thioredoxin Reductase Enzyme Activity Assays 
 Enzyme activity for Thioredoxin and Thioredoxin Reductase was determined using an 
end-point insulin-dependent reduction assay or Ellman assay. This utilises the reaction between 
thiols and TNB- which produces a yellow colour that can be quantified by spectrometry. A 
buffer solution was prepared containing 84 mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) at pH 7.60, 1.3 mM NADPH (reduced nicotinamide adenine 
dinucleotide phosphate), 12.5 mM EDTA (Ethylene diamine tetra-acetic acid) and 314 µM 
Insulin. An activating solution contained 1 M HEPES at pH 7.60 and 1mM DTNB (5,5'-
dithiobis-(2-nitrobenzoic acid). Finally, a stopping solution was prepared containing 6 M 
Guanidine-HCl and 1 mM DTNB. A Costar 3603 96-well glass bottomed plate (Sigma-Aldrich 
UK, Dorset) was used and 50 μg protein was added to the buffer and activating solutions mixed 
in a well. Control wells contain buffer and activating reagents, no sample and have stopping 
solution added immediately. Following preparation of the plate, it was incubated at 37°C for 
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forty minutes after which an excess of stopping solution was added to all wells and the plate 
analysed at 412 nm on a Fluostar Optima (BMG Labtech, Germany). The resulting units were 
expressed as nano-moles per minute per milligram of protein (nmol/min/mg Protein) (Arner et 
al., 1999, Prigge et al., 2012). 
2.9 Cell culture 
2.9.1 Media Preparation 
C2C12 standard growth and maintenance used Dulbecco’s Modified Eagle’s Medium 
High Glucose (DMEM; Sigma-Aldrich, Dorset, UK) containing 10% Foetal Bovine Serum 
(Gibco, Thermo-Fisher Scientific, Paisley, UK), 1% L-Glutamine (Lonza, Yorkshire, UK; 
200mM) and 1% Penicillin-Streptomycin (5,000 units of penicillin and 5 mg/mL 
streptomycin).  
Phosphate buffered saline (PBS; Sigma-Aldrich, Dorset, UK) contained 1% Penicillin-
Streptomycin. 
Differentiation of cells required DMEM with 2% horse serum (HS; Sigma-Aldrich, 
Dorset, UK), 1% L-Glutamine (200mM) and 1% Penicillin-Streptomycin. 
Cell storage media contains 80% standard DMEM + 20% DMSO (Dimethyl sulfoxide; 
Sigma-Aldrich, Dorset, UK). As DMSO is toxic to the cells at room temperature, this time was 
minimised. All percentage values are final concentrations unless otherwise stated. 
2.9.2 C2C12 Myoblast Culture, Differentiation and Storage 
1-1.5 mL aliquots of C2C12 cells were stored in 2 mL cryovials in liquid nitrogen. Cells 
were thawed at 37°C for five minutes, resuspended in standard media and centrifuged at 1,000 
rpm for ten minutes. The supernatant was discarded, and the pellet resuspended in 1 mL fresh 
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media. Cells were seeded in a T25 containing 4 mL standard DMEM and grown to 70% 
confluence. In all cases cells were checked daily to ensure normal and regular growth. 
At 70% confluency cells were detached from the T25 surface using 1 mL Trypsin-
EDTA solution (Sigma-Aldrich, Dorset, UK) and incubated at 37°C for 5 minutes followed by 
a brief but severe agitation to dislodge any remaining cells. Successful trypsinisation was 
confirmed by light microscopy. Trypsinised cells were suspended in standard media and 
pelleted at 1,000 g for ten minutes. The supernatant was discarded, and the pellet resuspended 
in 10 mL standard media. Cell numbers were determined using a Trypan Blue stain (Sigma-
Aldrich, Dorset, UK) via haemocytometry. 10 μL of cells were mixed with 10 μL Trypan Blue 
and allowed to stand for five minutes. 2 x 10 μL of mixture was then loaded onto a 
haemocytometer on each grid. A glass cover slip was applied ensuring no bubbles were present 
in the cell counting regions. Cells were manually counted using a light microscope at 10X 
magnification. 
For general cell maintenance after pellet resuspension C2C12s were diluted 1:10, 
seeded in a T75 and grown to 70% confluence over twenty-four hours. Incubator conditions 
were 37°C, 5% CO2 and 21% O2. Seeding of 6-well plates required 5.0-7.5x10
5 cells per well 
in standard media. 70% confluency was achieved in less than twenty-four hours. 
Differentiation of C2C12 myoblasts to myotubes was performed in their flask or plate. At 
approximately 80% confluency the standard growth media was removed and replaced with 
differentiation media. Storage of C2C12 cells required removal of DMEM and washing twice 
in 12 mL standard PBS. 2 mL Trypsin was added to each flask and incubated for approximately 
three minutes. Then 10 mL fresh standard DMEM was added to dilute the Trypsin and the cells 
moved to a falcon tube for centrifugation at 1000 rpm for five minutes. The old DMEM was 
removed and replaced with freezing media. 1-2 mL freezing media was added per 2.5 mL 
cryovials. The vials were labelled with cell type, name, date of freezing and the passage number 
58 
 
of the cells. Initially the vials were cooled for two to four hours at -80°C before being moved 
to a liquid nitrogen dewar for long term storage.  
2.9.3 C2C12 Myotube Stretching 
C2C12 cells were isolated and seeded at 7.5x105 cells per well onto three BioFlex® 
Culture Plates coated with Collagen I. These plates had a flexible bottom membrane that 
allowed stretching of cell in a radial and circumferential manner. >90% confluency was 
achieved in twenty-four hours after which standard media was removed, the cells washed twice 
with PBS and differentiating media added. Cells were allowed to grow under differentiating 
conditions for two days before the differentiation media was renewed. Cells were not washed 
with PBS during differentiation stage. Following four days differentiation, the cells were 
stretched on the FlexCell® Loading Station™ attached to a PC with FlexCell’s FX-4000 
International v4.0 software for controlling experimental parameters. 
 
Figure 2.9.3.1 (A) FlexCell 6-well plates with stretchable bases. (B) The rubber gasket and 
loading station. P indicates one of the platforms for the well to sit on. The vacuum then pulls 
the edges of the well at intervals set in the software (see also figure 2.10.3.2). This was stationed 
in the incubator to maintain experiments at 37°C and 5%CO2. Silicone gel was spread around 
the edge of the plates to ensure an air-tight seal with the gasket. The image was adapted from 
FlexCell™ marketing media. 
 
A) B)
59 
 
 
Figure 2.9.3.2 The left hand image is representative of normal set up under atmospheric 
conditions. The right hand image indicates how the vacuum pulls down on the edges of the 
elasticated well causing biaxial stretching of cells adhered to the membrane. The image is 
adapted from FlexCell™ marketing media. 
 
The device applied radial and circumferential force to the membranes across three 
experiments. The membranes were subjected to 12% elongation (69.94 kPa pressure or 0.120 
strain) at 1 Hz over a varying time course. A control plate was cultured with no force applied 
to the membranes. A second plate was stretched for fifteen minutes and a third plate was 
stretched for two hours to identify differences in cells following stimulation. 
2.10 Analysis of Succinate Dehydrogenase in Histological Sections of Mouse 
Skeletal Muscle 
All reagents were obtained from Sigma Aldrich, Dorset, UK unless otherwise stated. 
The following solutions were prepared: 
• 0.2 M Sodium phosphate monobasic 
• 0.2 M Sodium phosphate dibasic 
Strain
Vacuum
Media
Rubber membrane
Gaskets
Equal Tension 
Across Well
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• 0.2 M Phosphate buffer, pH 7.6 
• 0.2 M Sodium succinate solution 
• NBT solution (0.1 g Nitrotetrazolium Blue in 50 mL dH2O) 
• Incubation medium contained 5 ml 0.2 M phosphate buffer, 5 ml sodium succinate 
solution, 5 ml NBT solution and 5 ml dH2O. 
• Physiological Saline contained 8.5 g NaCl in 1 L dH2O. 
• 50 mL of 10% Formalin-saline solution contained physiological saline and 40% 
formaldehyde 
• 100 mL of 15% ethanol solution 
Dissected quadriceps or soleus skeletal muscle from either adult or old mice was 
transversely orientated in OCT on cork following excision and snap-frozen in liquid nitrogen 
prior to storage. For histological analysis the samples were moved from -80°C storage to the 
Cryostat (Leica, Milton Keynes, UK) to acclimatise to -20°C. Cryo sections were cut at a 
thickness of 10 μm and stained for succinate dehydrogenase (SDH) activity. Individual Coplin 
jars containing each solution were prepared prior to the staining. First the slides were placed in 
incubation medium at 37°C for thirty minutes.  Slides were rinsed in physiological saline then 
fixed in 10% formalin-saline solution for five minutes. Slides were rinsed in 15% ethanol 
solution for five5 minutes and finally aqueous mounting media was applied to the stained 
sample and a cover slip was applied. Slides were initially checked under a light microscope for 
sufficient staining or possible cryodamage. Analysis of the stain was performed on a Zeiss 
Axiovert 200M microscope connected to a PC running Windows XP and Axiovision 4.8.2 (SP3 
08-2013). Images were taken using Axiocam ICc5 under bright field conditions at 10x/0.30 
magnification for an exposure time of 2 ms giving a 2452 x 2056 pixel image with scale factors 
of x 0.55 μm/pixel, y 0.55 μm/pixel and z 1.00 pixel/pixel. 
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2.11 Software and Statistics 
GOrilla 
GOrilla highlighted protein interactions based on experimental evidence and highlights 
these linked processes, components or functions visually with flow diagrams. It also offers 
exporting of code into R for further adjustment of the visual output (Eden et al., 2009, Eden et 
al., 2007). 
Motif-X 
Motif-X showed overrepresented data patterns in protein sequences, also known as 
recurring short sequence elements, by searching a data set for a selected residue. Users can 
define the level of significance, the width or number of surrounding peptides, the occurrence 
(a minimum value for the number of times a sequence occurs) and the background data set (and 
foreground if so required) (Chou and Schwartz, 2011, Schwartz and Gygi, 2005). For our 
experiments, a cysteine was selected as the central amino acid and any conserved amino acids 
in surrounding sequences for each of the differentially labelled datasets reduced (d0-NEM), 
redox (d5-NEM + d0-NEM) and reversibly oxidised (d5-NEM) were identified. Search 
parameters were varied accordingly to identify, where possible, one conserved sequence. This 
enabled an alternative means of identification of potentially conserved amino acids and hence 
protein motifs within the reversibly labelled data sets. 
PathVisio 
PathVisio (v.3.2.3) is an open source software that was used to highlight proteins of 
particular pathways of interest using the global label free proteomics data (Kutmon et al., 2015, 
van Iersel et al., 2008). WikiPathways was used for the initial pathway layout before inserting 
the proteomics data on top to indicate up or down regulation of individual proteins (Kutmon et 
al., 2016, Kelder et al., 2012). 
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Perseus 
Perseus software was used to identify statistical similarities based on a Pearson cluster 
of the accession numbers of proteins identified in the significantly changed global label free 
proteomics dataset (Tyanova et al., 2016). 
Prism GraphPad 
Prism’s GraphPad (v6.0) software was used to produce the western blot and enzyme 
activity assays charts, displaying all individual data points. Statistical analysis of the 
normalised western blot data used GraphPad’s internal analysis tool for analysis of age effect, 
ANOVA was performed with Tukey’s post-hoc test. All significant differences relate to this 
analysis unless otherwise stated. Biological repeats were denoted by “N” and technical repeats 
by “n”. 
R Studio 
R Studio (version 0.98.1102) was used to prepare the volcano plots of the label free 
proteomics data using the plot command within R Studio (RStudio Team (2015)). The volcano 
plot used input data from the global label free results for significantly changed proteins (those 
with a significance of -10logP (equivalent to p = 0.01) and a fold change of >1.5). 
STRING 
The STRING database (from here-on referred to simply as STRING) contains 
experimental evidence for protein-protein interactions based on both physical and functional 
associations. It enables pathway analysis of both the label free and differentially labelled 
proteomics data. These interactions can be defined with multiple coloured lines indicating the 
different forms of evidence or a single line whereby the thickness indicates the strength of that 
interaction. After input the data can be enriched for cellular components, functions or processes 
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highlighting specific aspects of changes between the muscle types and ages. Enrichment for 
KEGG pathway information highlights cell-wide information from molecular-level data. 
PFAM protein domains uses the protein family database and hidden Markov models (a 
statistical method for predicting future interactions based solely on current information) to 
identify evolutionarily related proteins. InterPro uses knowledge of current protein functions 
as applied to new protein sequences to identify domains and features that are currently 
uncharacterised. A combination of these enrichments then gives a clearer understanding of 
interactions within quadriceps for significantly changed proteins and those proteins detected in 
redox, reduced or reversibly oxidised conditions (Szklarczyk et al., 2015).  
VennDIS 
VennDIS (version 1.0.1) was used to prepare Venn diagrams for the visual comparison 
of detected protein numbers for age and muscle type comparison (Ignatchenko et al., 2015). 
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CHAPTER 3 
 
STUDY OF THE QUADRICEPS MUSCLE 
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3.1 Introduction 
Quadriceps skeletal muscles are located on the mouse hind limbs. The quadriceps 
contain four distinct muscles: the rectus femoris, vastus lateralis, vastus intermedius and the 
vastus medialis. The fibre type of quadriceps is a combination of fast twitch type IIa 
(glycolytic), type IIb (predominantly glycolytic) and type IIx (predominantly oxidative 
phosphorylation) fibres (Booth and Thomason, 1991). This combination of fibre type enables 
the rapid and explosive generation of force required for initial and short bursts of activity and 
as a consequence fatigue resistance is reduced (Khodabukus and Baar, 2015).  
Contraction of skeletal muscle leads to an increase in the production of reactive oxygen 
species (ROS) by endogenous processes detailed in Chapter 1, p.30. A number of different 
ROS molecules are generated, ranging from the shorter-lived .OH and O2
.- species to the more 
sustained H2O2. Healthy skeletal muscle cells require these molecules to adapt to cellular 
fluctuations in ROS concentration, however high concentrations can lead to irreversible protein 
modifications. There are a number of mechanisms in place to control variations in these 
molecules. For instance, superoxide dismutases convert the superoxide radical to H2O2 whilst 
peroxiredoxins catalyse the conversion of H2O2 to H2O. Of interest in this study are the 
intracellular ROS and the post translational modifications that are formed. Examples include 
sulphenic and sulphinic acids produced by increased H2O2 thereby affecting the activity of 
redox sensitive proteins and impacting some intracellular pathways causing an adaptive 
response of skeletal muscle to contractions. Healthy muscle can control these changes in ROS 
concentration and return proteins’ functionality following exercise (Jackson, 2016b, 
McDonagh et al., 2014a, Jackson, 2009).  
Several techniques have been used in this study to determine the changes in quadriceps 
muscles from ageing mice. One method used was succinate dehydrogenase (SDH) staining 
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which identified a decrease in mitochondrial complex III activity of the electron transport chain 
with age. This technique enabled visual identification of the changes in fibres between adult 
and old samples since the intensity of staining reflects the mitochondrial activity (Sher and 
Cardasis, 1976, Bloemberg and Quadrilatero, 2012). A two-pronged proteomics approach was 
performed to identify (i) global changes to the muscle protein content with age via label free 
relative quantification and (ii) changes to the redox proteome via differential labelling of 
cysteine amino acids with age. The abundance of specific proteins involved in redox signalling, 
metabolism and heat shock response proteins were also analysed via western blotting. The label 
free relative quantification together with western blot data complimented with enzyme activity 
assays elucidated changes in specific pathways. This is important as the overall protein 
abundance of individual proteins may not change with age, but reversible redox modification 
of regulatory cysteine residues can affect protein enzymatic activity, therefore where possible 
the label free proteomic data, redox analysis of individual cysteine residues of the protein 
together with analysis of activity allow for a broad understanding of the effects of age on 
selected proteins. 
 Pathway analysis of reduction and oxidation within the cell utilised GOrilla gene 
ontology to identify statistically significant pathways identified as altered with age via the label 
free proteomics data. STRING database analysis for protein-protein interaction also added to 
the evidence of various changes observed in mouse quadriceps with age. This combination of 
approaches enables a global analysis of mouse quadriceps ageing ranging from physiological 
analysis of the muscles through to the molecular changes observed for specific redox cysteines 
giving a thorough understanding of how they are affected by age. 
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3.2 Aims & Hypothesis 
The aim of the work in this chapter was to identify age-related changes in the quadriceps 
using mass spectrometry for proteomic analysis of changes to intracellular proteins and their 
redox states. It was hypothesised that changes to the redox state of key intracellular proteins 
would occur with age. 
3.3 RESULTS 
3.3.1 Muscle Weights 
Quadriceps were dissected from male C57BL/6 mice at 3 months (young), 12 months 
(adult) and 24 months (old) of age. Figure 3.3.1.1A indicates the whole mouse body weight 
and shows that one mouse at 24 months was significantly lighter than the others. This outlier 
was omitted from future analyses as western blotting only used three biological samples at 24 
months of age while the mass spectrometry analyses shows six 12 months old and five 24 
months old mice were used. The overall body weight of the mice increased from 3 to 12 
months, as seen in figure 3.4.1.1A after which the body mass plateaued. Sarcopenia is the loss 
of muscle mass with age and the data in figure 3.3.1.1B demonstrates that between 12 and 24 
months, mouse quadriceps mass decreased in agreement with previous studies (Romanick et 
al., 2013, Schiaffino et al., 2013). 
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(A) (B) 
  
Figure 3.3.1.1 (A) Whole body weights of mice. (B) Quadriceps muscle weight. N=6 
biological replicates were obtained for analysis. Significance p <0.05, *. 
 
3.3.2 Succinate Dehydrogenase Activity of the Quadriceps Muscle 
Succinate dehydrogenase (SDH) staining identified the oxidative capacity of cells by 
indicating the extent to which oxidation of NADH occurred via labelling with nitro-blue 
tetrazolium (NBT). Highly oxidised fibres stained a darker blue showing increased oxidative 
capacity (figure 3.3.2.1A and B). These images were not quantified and are presented to 
highlight the differences with age between fibres from adult and old mice prior to the detailed 
proteomic and biochemical analysis. 
 
Figure 3.3.2.1 (A) SDH stain of quadriceps muscle from adult mice and (B) old mice showing 
a decrease in oxidative capacity of quadriceps fibres with age. 
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 SDH staining suggested a decrease in oxidative capacity of the quadriceps fibre with 
age where figure 3.3.2.1A had a more intense blue stain identifying higher levels of oxidative 
fibres compared with figure 3.3.2.1B which has a less intense blue staining. The small white 
dots within cells of figure 3.3.2.1B are artefacts of the cryopreservation process and may affect 
apparent size by the formation of ice crystals within the cells. 
3.3.3 Global Label Free Proteomics Data Analysis 
A total of 640 proteins were detected via the label free method in mouse quadriceps 
(combining both adult and old samples) and of these 67 proteins were significantly changed 
with age from adult to old. The proteomics data were obtained from n=6 adult and n=5 old 
quadriceps muscle samples. The data is archived online as: S1 - Quadriceps All Detected 
Proteins; S2 – Quadriceps Significantly Changed Proteins at: 
10.17638/datacat.liverpool.ac.uk/437. 
A multicomponent analysis (MCA) acted as a quality control measure of the proteomics 
data. It indicates the extent of variance between samples and compared each adult sample with 
each old sample. Performed on the adult and old quadriceps samples, figure 3.3.3.1 highlights 
positive correlations within each age group. The blue values at the top of each box represent 
the R2 value, indicating the statistical measure of fit for the regression line of the data. A higher 
value indicates a tighter fit to this line. The results in figure 3.3.3.1 showed high similarity 
within the adult and old mouse muscle sample data sets respectively and a high level of variance 
when comparing the data sets to each other. 
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Figure 3.3.3.1 Multi-component analysis of proteins detected across all samples. Values in 
blue represent R2 value for that data set. 
 
Label free proteomics analysis utilised PEAKS7 to identify the proteins in the samples 
and perform label free relative quantification. For label free relative quantification, proteins 
were considered as significantly changed when they had a –10 log P of >20 (equivalent to p 
value of 0.01), fold change of >1.5 between adult and old and a quality value of 0.8, these 
parameters ensured a good minimum standard of confidence in the comparison of protein 
abundance (Ting et al., 2009, Oberg and Mahoney, 2012). The heat map in figure 3.3.3.2 shows 
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significantly changed proteins identified in quadriceps from adult and old mice. The datasets 
are included in an online data storage facility provided by Datacat a University of Liverpool 
data repository for research data. Excel files containing the combined label free and the 
differentially labelled proteomics data for the redox proteins as per the output from Proteome 
Discoverer are stored at 10.17638/datacat.liverpool.ac.uk/437. 
Significant differences were observed between muscle from adult and old mice for a 
number of proteins. For example, significant increases with age were seen for cytoskeletal 
proteins such as troponins, tropomyosin and actin. Significant decreases were seen in the 
protein folding response and energy metabolism proteins such as HSP70 and phosphoglycerate 
mutase. Figure 3.3.3.3 indicates the log2 fold change as normalised against the total ion current 
for each run of proteins in adult and old samples.  
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Figure 3.3.3.2 Heat map of the log2 ratio fold change of significantly changed quadriceps 
muscle proteins comparing adult (n=6) and old (n=5) mice. Red indicates an increase and green 
a decrease in fold change. Label free significance was determined using a minimum fold 
change of ≥ 1.5, a peptide quality of 0.8 and a significance p < 0.01. 
 
A volcano plot was produced using the basic R Studio (version 0.98.1102) application 
and shows significantly changed proteins from a dataset of combined adult and old results. 
Figure 3.3.3.3 shows all significantly changed proteins identified in the label free proteomics 
assessment of the quadriceps samples. Those highlighted in red are significantly up-regulated 
and green shows those significantly down-regulated proteins (where a minimum fold change 
of ≥ 1.5, a peptide quality of 0.8 and a significance p < 0.01). 
Quadriceps
Min. Fold change 1.5; Quality 0.8; Significance p<0.01
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Significantly up-regulated proteins in quadriceps include the cytoskeletal proteins 
Tropomyosin 1 (TPM1), Troponin T (TNNT3), Myosin Light Chain 3 (MYL3) in addition to 
those involved in protein folding such as Grp78 (HSPA5) and Protein Disulphide Isomerase 
A3 (PDIA3). Significantly down-regulated proteins included the chaperone proteins HSP70 
(HS71A) and HSPB6, both of which are involved in the heat-shock response. Nascent 
polypeptide-associated protein complex subunit α muscle specific form (NACAM) was also 
identified as down regulated with age in the quadriceps. This is involved in thick and thin 
myofibril assembly. 
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Figure 3.3.3.3 Volcano plot showing structural proteins identified from analysis of global label free proteomics data of all detected proteins in quadriceps (adult 
and old mice combined). Significantly up-regulated proteins highlighted are Calsequestrin1 (CASQ1), Tropomyosin α-1 chain (TPM1), Actin α skeletal muscle 
(ACTS), Tropomyosin β chain (TPM2), Troponin T fast skeletal muscle (TNNT3), Troponin α-3 chain (TPM3), Protein disulphide isomerase (PDIA1), Troponin-
I fast skeletal muscle (TNNI2), Myosin regulatory light chain 2 skeletal muscle isoform (MLRS), Myosin light chain 3 (MYL3), Myosin heavy chain 8 (MYH8), 
Grp78 (GRP78) and Α actin 3 (ACTN3).  Significantly down-regulated proteins highlighted are HSP70 1A (HS71A), HSP β-6 (HSPB6) and Nascent polypeptide-
associated protein complex subunit α muscle specific form (NACAM). Green indicates significantly decreased proteins and red indicates significantly increased 
proteins. Significance is defined as having –10 log P of >20 (equivalent to p value of 0.01), a >1.5 fold change. 
Volcano Plot of Quadriceps Proteins Significantly Changed with Age 
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3.3.4 Western Blotting and Enzyme Activity Assays 
Western blots and enzyme activity assays were performed as described in Methods (2.5, 
p.53 and 2.8, p.56 respectively). The western blot primary and secondary antibodies used are 
presented on p.62-63. Where global label free proteomics data are included, significance values 
were defined as > 1.5 fold change, a significance score of -10 log P, > 20 (equivalent to p < 
0.01) and a peptide quality of 0.8. In this section, mouse muscle ages are referred to as 3, 12 or 
24 months for clarity. 
Thioredoxin 1 (TRX1) was selected for western blot analysis due to its role in 
intracellular control of ROS (Dimauro et al., 2012, Munro and Treberg, 2017). It is a 12 kDa 
cytosolic antioxidant enzyme that performs the crucial task of reducing cytosolic 
Peroxiredoxins (PRDX1, PRDX2, & PRDX4). Oxidised TRX1 is inactive and requires 
Thioredoxin Reductase 1 (TRXR1) to reduce it back to its active form. In figure 3.3.4.1 no 
significant change was observed in protein abundance for TRX1 which agreed with the global 
label free proteomics data. TRXR1 also demonstrated no significant change in protein 
abundance between 12 and 24 months as shown in figure 3.3.4.2. Enzyme activities for both 
Thioredoxin and Thioredoxin Reductase showed no change with age. 
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Figure 3.3.4.1 (A) Densiometric measurement for immunodetection by western blotting of 
Thioredoxin 1 (TRX1) in mouse quadriceps muscle. (B) Enzyme activity assay performed for 
Thioredoxin (non-specific, detecting both TRX1 and TRX2. (C) The Ponceau S stain used for 
normalisation of (A). (D) Label free proteomics result for Thioredoxin. N=3 biological 
replicates. Short bars indicate upper and lower interquartile range while the middle represents 
the median value following statistical analysis using ANOVA with Tukey’s post-hoc test. 
 
Figure 3.3.4.2 (A) Densiometric measurement for immunodetection by western blotting of 
Thioredoxin reductase (TRXR1) from 3, 12 and 24 month samples of quadriceps muscle. (B) 
The Ponceau S stain used for normalisation of (A). (C) Enzyme activity assay performed for 
Thioredoxin Reductase (non-specific, detecting both TRXR1 and TRXR2). Thioredoxin. N=3 
biological replicates. Short bars indicate upper and lower interquartile range while the middle 
represents the median value following statistical analysis using ANOVA with Tukey’s post-
hoc test. 
 
Accession Label Significance (-10lgP) Group Profile (Ratio) Description
P10639 THIO_MOUSE 2.59 1.00:1.17 Thioredoxin OS=Mus musculus GN=Txn PE=1 SV=3
C)
D)
12 kDa
3 12 24 M
w
25 kDa -
20 kDa -
15 kDa -
10 kDa -
37 kDa -
50 kDa -
75 kDa -
100 kDa -
150 kDa -
250 kDa -
B)A)
3 Months 12 Months 24 Months
3  M o n th s 1 2  M o n th s 2 4  M o n th s
0 .0 0
0 .0 1
0 .0 2
0 .0 3
0 .0 4
A g e
R
e
la
ti
v
e
 I
n
te
n
s
it
y
W e s te rn  B lo t
3  M o n th s 1 2  M o n th s 2 4  M o n th s
0 .0 0
0 .0 1
0 .0 2
0 .0 3
0 .0 4
A g e
R
e
la
ti
v
e
 I
n
te
n
s
it
y
W e s te rn  B lo t
3  M o n th s 1 2  M o n th s 2 4  M o n th s
0 .0
0 .5
1 .0
1 .5
2 .0
A g e
A
c
ti
v
it
y
 (
n
m
o
l/
m
in
/m
g
 P
r
o
te
in
)
E n z y m e  A c tiv ity  A s s a y
12 Months 24 Months3 Months
55 kDa 
A) B) C)
M
w
25 kDa -
20 kDa -
15 kDa -
10 kDa -
37 kDa -
50 kDa -
75 kDa -
100 kDa -
150 kDa -
12 243
3  M o n th s 1 2  M o n th s 2 4  M o n th s
0 .0
0 .5
1 .0
1 .5
W e s te rn  B lo t
A g e
R
e
la
ti
v
e
 I
n
te
n
s
it
y
3  M o n th s 1 2  M o n th s 2 4  M o n th s
0
5 0 0
1 0 0 0
1 5 0 0
2 0 0 0
2 5 0 0
E n z y m e  A c tiv ity  A s s a y
A g e
A
c
ti
v
it
y
 (
n
m
o
l/
m
in
/m
g
 P
r
o
te
in
)
77 
 
Thioredoxin 2 (TRX2) is a 26 kDa redox enzyme located in the mitochondria that has 
the same biochemical function as TRX1 and, along with Thioredoxin Reductase 2 (the 
mitochondrial equivalent of TRXR1) returns PRDX3 and PRDX5 back to activity. No 
significant change in protein abundance of either TRX2 or TRXR2 were observed with age 
and TRX2 was not detected in the global label free proteomics data. 
 
Figure 3.3.4.3 (A) Densiometric measurement for immunodetection by western blotting of 
TRX2. (B) Ponceau S stain used for normalisation of band intensities of (A). N=3 biological 
replicates. Short bars indicate upper and lower interquartile range while the middle represents 
the median value following statistical analysis using ANOVA with Tukey’s post-hoc test. 
 
Figure 3.3.4.4 (A) Densiometric measurement for immunodetection by western blotting of 
Thioredoxin Reductase 2 (TRXR2). (B) Ponceau S stain used for normalisation of (A). N=3 
biological replicates. Short bars indicate upper and lower interquartile range while the middle 
represents the median value following statistical analysis using ANOVA with Tukey’s post-
hoc test. 
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Thioredoxin interacting protein (TXNIP) may limit the availability of Thioredoxin in 
the cytosol, affecting the rate of turn-over of redox controlling proteins such as the 
Peroxiredoxins (Jeon et al., 2005). The data showed no significant change and was not detected 
in the total label free proteomic data set. 
 
Figure 3.3.4.5 (A) Densiometric measurement for immunodetection by western blotting of 
Thioredoxin Interacting Protein (TXNIP). (B) Ponceau S stain used for normalisation of (A). 
N=3 biological replicates. Short bars indicate upper and lower interquartile range while the 
middle represents the median value following statistical analysis using ANOVA with Tukey’s 
post-hoc test. 
  
Peroxiredoxins (1-6) directly regulate intracellular ROS concentrations coupled with 
Thioredoxin 1 and 2. Thioredoxin 1 and 2. They catalyse the reduction of H2O2 to H2O which 
causes the formation of a disulphide bond between the peroxidatic cysteine and resolving 
cysteine residues of the active site that can be reversed by Thioredoxin 1 or 2 depending on 
whether it is located in the cytosol or mitochondria respectively. Western blot data identified 
significant increases in protein abundance for mitochondrial PRDX3 (3 and 12 to 24 months, 
both p <0.01) and PRDX5 (3 to 24 months, p <0.05) with age. PRDX1, 2, 4 and 6 (all cytosolic) 
did not change in protein abundance with age. Relative quantification via global label free 
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proteomics (figure 3.3.4.6G) identified no significant changes to any of the peroxiredoxins with 
age.  
 
Figure 3.3.4.6 Densiometric measurement for immunodetection by western blotting of 
Peroxiredoxins 1-6. (A) PRDX1, (B) PRDX2, (C) PRDX3 (**, p < 0.01), (D) PRDX4, (E) 
PRDX5 (*, p <0.05), (F) PRDX6. (G) Label free proteomics data for PRDX1-6 between 12 
months and 24 months. N=3 biological replicates. Short bars indicate upper and lower 
interquartile range while the middle represents the median value following statistical analysis 
using ANOVA with Tukey’s post-hoc test. 
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Figure 3.3.4.7 Ponceau S images used for normalisation of the corresponding blots in figure 
3.3.4.6. 
 
 In addition to the individual peroxiredoxin blots and label free analysis, sulphonylated 
Peroxiredoxins 1-4 (Prdx-SO3H) were analysed via western blot to identify long term effects 
of sustained ROS on peroxiredoxins. Figure 1.4.1 (p.36) describes the various post translational 
modifications resulting from changing and sustained intracellular ROS concentrations. The 
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results in figure 3.3.4.8 (A) showed a significant increase in the abundance of sulphonylated 
proteins with age (3 to 24 months ** p < 0.01 and 12 to 24 months *** p < 0.001). 
 
Figure 3.3.4.8 (A) Densiometric measurement for immunodetection by western blotting of 
sulphonylated peroxiredoxins (Prdx-SO3H). ** p < 0.01, *** p < 0.001. (B) Ponceau S stain 
used for normalisation of (A). N=3 biological replicates. Short bars indicate upper and lower 
interquartile range while the middle represents the median value following statistical analysis 
using ANOVA with Tukey’s post-hoc test. 
 
 Cu-Zn Superoxide dismutase (SOD1, cytosolic) and Mn Superoxide dismutase (SOD2, 
mitochondrial) were analysed via western blot to identify changes to these enzymes that are 
directly involved in the attenuation of superoxide free radicals. The results shown in figure 
3.3.4.9A identified a significant increase in protein abundance from 3 to 12 months in SOD1, 
although there was no significant change in SOD2 (figure 3.3.4.9C) protein abundance and the 
label free proteomics data identified no change with age. 
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Figure 3.3.4.9 (A) Densiometric measurement for immunodetection by western blotting of Cu-
Zn Superoxide Dismutase (SOD1). ** p < 0.01. (B) Ponceau S stain used for normalisation of 
(A). (C) Mn-Superoxide Dismutase (SOD2). (D) Ponceau S stain used for normalisation of 
(A). N=3 biological replicates. Short bars indicate upper and lower interquartile range while 
the middle represents the median value following statistical analysis using ANOVA with 
Tukey’s post-hoc test. 
 
Glutathione peroxidase 1 (GPX1) is one of several isoforms of glutathione peroxidase 
and catalyses the conversion of H2O2 to H2O. Western blot analysis (figure 3.3.4.10A) 
identified no significant change in protein abundance with age. This protein was not detected 
in the label free proteomics analysis. 
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Glutaredoxin 2 (GRX2) is a mitochondrial based protein that contains an Fe-S (iron-
sulphur) cluster. Western blot data shown in figure 3.3.4.11A showed a significant increase in 
protein abundance with age (p <0.05) from 12 to 24 months but this was not detected in the 
label free proteomics data. 
 
Figure 3.3.4.10 (A) Glutathione Peroxidase 1 (Gpx1). (B) Ponceau S stain used for 
normalisation of (A). N=3 biological replicates. Short bars indicate upper and lower 
interquartile range while the middle represents the median value following statistical analysis 
using ANOVA with Tukey’s post-hoc test. 
 
Figure 3.3.4.11 Glutaredoxin 2 (Grx2). (A) Densiometric measurement for immunodetection 
by western blotting, * p <0.05. (B) Ponceau S stain used for normalisation of (A). N=3 
biological replicates. Short bars indicate upper and lower interquartile range while the middle 
represents the median value following statistical analysis using ANOVA with Tukey’s post-
hoc test. 
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 Sulfiredoxin 1 (SRXN1) is involved in maintaining peroxiredoxin activity by reducing 
thiol groups. Western blotting data in figure 3.3.4.12A demonstrated no change in protein 
abundance with age and it was not detected in the label free proteomic analysis. 
  
Figure 3.3.4.12 Sulfiredoxin 1 (Srxn1). (A) Densiometric measurement for immunodetection 
by western blotting. (B) Ponceau S stain used for normalisation of (A). N=3 biological 
replicates. Short bars indicate upper and lower interquartile range while the middle represents 
the median value following statistical analysis using ANOVA with Tukey’s post-hoc test. 
  
The heat shock and protein folding response are alternative indicators of both short-
term and sustained cellular stress. In figure 3.3.4.13A, the constitutively expressed HSC70 
showed a significant decrease (p <0.05) in protein abundance from 12 to 24 months in 
quadriceps muscle. Figure 3.3.4.13B shows the inducible form, HSP70, which did not 
significantly change with age. However relative quantification of these proteins in the label 
free proteomics data highlighted a significant decrease in the inducible HSP70 with age and no 
significant change to HSC70. Note that a 15% resolving gel was used for the HSC70 blot alone. 
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Figure 3.3.4.13 Densiometric measurement for immunodetection by western blotting of (A) 
Constitutively expressed HSC70, * p <0.05. (B) Inducible variant HSP70. (C) Ponceau S stain 
used for normalisation of (A). (D) Ponceau S stain used for normalisation of (B). (E) Global 
label free proteomics data for HSP70 (HS71A) and HSC70 (HS70C). (A) Used a 15% resolving 
gel. N=3 biological replicates. Short bars indicate upper and lower interquartile range while 
the middle represents the median value following statistical analysis using ANOVA with 
Tukey’s post-hoc test. 
 
 Protein disulphide isomerase analyses are shown in figure 3.3.4.14. The western blot 
identified a significant increase in Protein disulphide isomerase (P4HB) abundance from both 
3 to 24 months (*** p <0.001) and 12 to 24 months (* p <0.05). This result was reflected in 
the label free global proteomics result where a significant increase with age was also observed.  
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Figure 3.3.4.14 (A) Protein Disulphide Isomerase (PDI), * p <0.05, *** p <0.001 (B) Ponceau 
S stain used for normalisation of (A). (C) Label free data for PDI/P4HB. N=3 biological 
replicates. Short bars indicate upper and lower interquartile range while the middle represents 
the median value following statistical analysis using ANOVA with Tukey’s post-hoc test. 
 
Glutathione S-transferase μ (GST-μ) is a protein involved in conjugation of reduced 
glutathione for detoxification within the cell. In figure 3.3.4.15A data on protein abundance 
showed no change with age, however the global label free proteomics result showed a 
significant increase in protein abundance with age. 
 
 
Figure 3.3.4.15 (A) Glutathione S-Transferase μ (GST- μ). (B) Ponceau S stain used for 
normalisation of (A). (C) Global label free proteomics result for GST-μ 2 isoform. N=3 
biological replicates. Short bars indicate upper and lower interquartile range while the middle 
represents the median value following statistical analysis using ANOVA with Tukey’s post-
hoc test. 
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 PARK7 is a protein with a multitude of functions including as a redox sensor in addition 
to its protein chaperone duties, western blot data in figure 3.3.4.16A showed significant 
increases (*, p <0.05) in protein abundance between both 3 and 12 to 24 months of age, 
however this was not reflected in the global label free data (Jin et al., 2016, Yu et al., 2014, 
Wang et al., 2016). 
 
Figure 3.3.4.16 (A) Densiometric measurement for immunodetection by western blotting of 
PARK7 in mouse quadriceps. * p <0.05. (B) Ponceau S stain used for normalisation of (A). 
(C) Label free analysis of PARK7 indicating no significant change with age. N=3 biological 
replicates. Short bars indicate upper and lower interquartile range while the middle represents 
the median value following statistical analysis using ANOVA with Tukey’s post-hoc test. 
 
The sulphonylated form of PARK7 (PARK7-SO3H) is thought to reflect the effects of 
sustained intracellular ROS upon proteins involved in chaperone and folding mechanisms. 
Figure 3.3.4.17A shows a substantial increase in protein abundance with age for PARK7-
SO3H. No protein was detected at 3 or 12 months, however clear bands were seen at 24 months. 
This significant increase (* p <0.05) in the modified form of PARK7 suggests that as a 
chaperone it is highly likely to be affected by sustained increased concentrations of ROS. 
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Figure 3.3.4.17 Sulphonylated PARK7 (PARK7-SO3H) reflects the response to sustained 
reactive oxygen species over time leading to increasing modifications of the protein with 
sulfonyl groups. (A) Densiometric measurement for immunodetection by western blotting of 
PARK7-SO3H. *, p < 0.05. (B) Ponceau S stain used for normalisation of (A). N=3 biological 
replicates. Short bars indicate upper and lower interquartile range while the middle represents 
the median value following statistical analysis using ANOVA with Tukey’s post-hoc test. 
 
Cellular energy metabolism changes with age were considered by assessing Aconitase, 
AMPK, its active form p-AMPK and GAPDH.  
Aconitase demonstrated no change in protein abundance with age as shown in figure 
3.3.4.18A with no change seen for enzymic activity. These results combined with the global 
label free proteomics data all indicate no change to Aconitase with age. 
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Figure 3.3.4.18 (A) Densiometric measurement for immunodetection by western blotting of 
Aconitase in mouse quadriceps muscle. (B) Enzyme activity assay of Aconitase. (C) Ponceau 
S stain used for normalisation of (A). (D) Global label free proteomics data. N=3 biological 
replicates. Short bars indicate upper and lower interquartile range while the middle represents 
the median value following statistical analysis using ANOVA with Tukey’s post-hoc test. 
 
AMP-kinase and p-AMP kinase (PRKAA1) are shown in figure 3.3.4.19A and 
3.3.4.19D respectively. They both indicate no change in protein abundance which was 
supported by the global label free proteomics data for the two subunits of AMPK (PRKAR1A 
and PRKAR2A) both of which showed no significant change with age.  
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Figure 3.3.4.19 (A) Densiometric measurement for immunodetection by western blotting of 
AMPK. (B) Ponceau S stain used for normalisation of (A). (C) Label free data indicating no 
significant change with age. (D) Densiometric measurement for immunodetection by western 
blotting of Phosphorylated AMPK subunit (Prkaa1). (E) Ponceau S stain used for normalisation 
of (D). N=3 biological replicates. Short bars indicate upper and lower interquartile range while 
the middle represents the median value following statistical analysis using ANOVA with 
Tukey’s post-hoc test. 
 
 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is another crucial energy 
metabolism enzyme involved in glycolysis which is the predominant energy generating 
pathway in the quadriceps as previously described. Western blot results in figure 3.3.4.20A 
indicate a significant decrease in protein abundance with age from 3 to 24 months and 12 to 24 
months of age. The global label free proteomics data did not reflect this, indicating no 
significant change with age. 
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P12367 KAP2_MOUSE 2.66 1.00:0.76 cAMP-dependent protein kinase type II-alpha regulatory subunit OS=Mus musculus GN=Prkar2a PE=1 SV=2
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Figure 3.3.4.20 (A) Densiometric measurement for immunodetection by western blotting of 
Glyceraldehyde Phosphate Dehydrogenase (GAPDH). ** p < 0.01, *** p < 0.001.  (B) Ponceau 
S stain used for normalisation of (A). (C) Label free proteomics data indicating no significant 
change with age. N=3 biological replicates. Short bars indicate upper and lower interquartile 
range while the middle represents the median value following statistical analysis using 
ANOVA with Tukey’s post-hoc test. 
 
P70-S6 Kinase was examined due to potential changes in the intracellular redox state 
affecting the mTOR (mammalian Target Of Rapamycin) signalling pathway as this pathway is 
crucial to adult skeletal muscle development (Marabita et al., 2016, Zhang et al., 2016a). The 
western blot data in figure 3.3.4.21A showed no significant change in protein abundance with 
age and the protein was not detected in the global label free data. 
Sirtuin 1 (SIRT1) deacetylates proteins involved in cellular regulation. Therefore, it 
was considered whether this may be affected with age potentially impacting some cellular 
regulators downstream. The western blot result shown in figure 3.3.4.22A showed no 
significant change in protein abundance with age. 
 
Accession Label Significance (-10lgP) Group Profile (Ratio) Description
P16858 G3P_MOUSE 8.18 1.00:1.02 Glyceraldehyde-3-phosphate dehydrogenase OS=Mus musculus GN=Gapdh PE=1 SV=2
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Figure 3.3.4.21 P70 S-6 Kinase (P70S6K). (A) Densiometric measurement for 
immunodetection by western blotting of P70S6K in mouse quadriceps muscle. (B) Ponceau S 
stain used for normalisation of (A). N=3 biological replicates. Short bars indicate upper and 
lower interquartile range while the middle represents the median value following statistical 
analysis using ANOVA with Tukey’s post-hoc test. 
   
Figure 3.3.4.22 Sirtuin 1 (SIRT1). (A) Densiometric measurement for immunodetection by 
western blotting of Sirt1 in mouse quadriceps muscle. (B) Ponceau S stain used for 
normalisation of (A). N=3 biological replicates. Short bars indicate upper and lower 
interquartile range while the middle represents the median value following statistical analysis 
using ANOVA with Tukey’s post-hoc test. 
 
Carbonylation blots identify proteins modified with a carbonyl group (C=O) and is one 
of several indicators of sustained ROS within the cell that affects proteins over the long-term. 
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There was a significant decrease in carbonylated proteins with age in mouse quadriceps (figure 
3.3.4.23A) when measuring the most abundant band at 37 kDa. 
An alternative measure of oxidised protein is glutathionylation where cysteine residues 
are modified with the addition of a glutathione molecule. The process is redox dependent and 
thought to play a role in cellular signalling. The result of the glutathionylation blot shown in 
figure 3.3.4.24A indicates an increase in Glutathionylation of quadriceps proteins from 3 to 12 
and 3 to 24 months.  
 
Figure 3.3.4.23 Carbonyl blot reflecting sustained intracellular ROS. (A) Densiometric 
measurement for immunodetection by western blotting of carbonylated proteins. The bands of 
interest are highlighted by the red arrows. * p < 0.05. (B) Ponceau S stain used for normalisation 
of (A). N=3 biological replicates. Short bars indicate upper and lower interquartile range while 
the middle represents the median value following statistical analysis using ANOVA with 
Tukey’s post-hoc test. 
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Figure 3.3.4.24 Glutathionylation blot. (A) Densiometric measurement for immunodetection 
by western blotting protein glutathionylation in mouse quadriceps. * p < 0.05. (B) Ponceau S 
stain used for normalisation of (A). N=3 biological replicates. Short bars indicate upper and 
lower interquartile range while the middle represents the median value following statistical 
analysis using ANOVA with Tukey’s post-hoc test. 
 
3.3.5 GOrilla Pathway Analysis 
Use of GOrilla enabled a gene ontological (GO) pathway analysis of the quadriceps 
muscle label free proteomics data. This shows protein pathway associations and covers three 
aspects: biological processes, cellular components and molecular function.  Significance was 
determined within the GOrilla software and the colour of the text box showed the associated p 
value described in figure. 
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Figure 3.3.5.1 GOrilla biological process analysis of all detected proteins from the global label free analysis of quadriceps muscle. Statistically significant change 
in identified gene ontology relating to muscle contraction were identified (p ≤ 1 x 10-9) with a number of other processes also shown to be significantly changed 
(p ≥ 1 x 10-3 ≤ 1 x 10-5) which were predominantly contractile proteins.
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Figure 3.3.5.2 GOrilla analysis of the cellular components from all detected proteins from the global label free analysis of quadriceps muscle. Several cellular 
components were identified from the label free proteomics data such as ‘contractile fibre part’ (significantly changed, p ≥ 1 x 10-7 ≤ 1 x 10-9), ‘I band’, ‘Z disc’, 
‘troponin complex’, ‘myosin complex’ and ‘protein-DNA complexes’ all with a significance of p ≥ 1 x 10-3 ≤ 1 x 10-5. 
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Figure 3.3.5.3 GOrilla analysis of molecular function from the global label free proteomics data from mouse quadriceps muscle. This identified two pathways: 
one highlighting ‘structural constituent of muscle’ and the other ‘protein binding’, both with a significance of p ≥1 x 10-3 ≤ 1 x 10-5. 
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GOrilla analysis of quadriceps muscle highlighted significant GO enrichment in 
biological processes (figure 3.3.5.1) for muscle contraction, chromatin assembly, actin 
mediated cell contraction and regulation of protein kinase activity for quadriceps muscle. 
Analysis of cellular components in figure 3.3.5.2 identified contractile fibre parts, the I band, 
Z disc, troponin complex, myosin complex and protein-DNA complexes. Analysis of 
molecular function in figure 3.3.5.3 identified significant GO enrichment for structural 
constituents of muscle and the other ‘protein binding. Together this information highlights that 
the predominant quadriceps proteins detected using the global label free proteomics data were 
associated with the cytoskeleton. 
3.3.6 STRING Analysis of Significantly Changed Quadriceps Proteins 
 STRING analysis identified protein-protein interactions within the label free global 
proteomics data set. The reference to gene ontologies enables classification of groups of 
proteins detected to identify changes to protein-protein interactions within a group. 
Consideration is given to both protein-protein interactions as well as groups of proteins that 
perform a similar function. The analysis was performed on the quadriceps proteomics data for 
those proteins that showed significant changes between adult and old mice. Figures show the 
full, unenriched image to highlight all proteins used in the analysis and the enrichment for a 
specific trait e.g. cytoskeletal protein binding. 
STRING analysis shown in figure 3.3.6.1 examined proteins detected in the quadriceps 
that were significantly up regulated in muscle from old compared with adult mice to determine 
any protein interactions within that data set. Figure 3.3.6.1A indicates the overall proteomics 
data examined in STRING prior to enrichment demonstrated in figure 3.3.6.1B. The overall 
analysis highlighted interactions between F-actin capping protein subunit β (CAPZB) and 
cytoplasmic actin (ACTB) on the left of the image and between Tropomyosin α-1 (TPM1), 
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Troponin T fast skeletal muscle (TNNT3), Troponin fast skeletal muscle (TNNI2) and Myosin 
light chain 3 (MYL3) on the right. Figure 3.3.6.1C Indicates the GO pathway ID for the 
analysis, the description of the pathway, the number of proteins used in this analysis and the 
false discovery rate (FDR). Figure 3.3.6.1D Is the global label free proteomics data for the 
significantly increased proteins shown in figures 3.3.6.1A and 3.3.6.1B. 
 
 
Figure 3.3.6.1 STRING analysis of protein interactions in quadriceps for proteins that were 
significantly up regulated between adult and old mice using the global label free proteomics 
data. (A) The overall, unenriched protein dataset for significantly up regulated quadriceps 
proteins. (B) The data set for enriched cytoskeletal protein binding in which several interactions 
were identified. (C) Table containing STRING pathway analysis information. (D) Global label 
free protein data for the significantly changed proteins in (A) and (B).  
 
 Figure 3.3.6.2 shows proteins that were significantly down regulated between 
quadriceps from adult and old mice. This figure shows the entire protein set submitted to 
STRING analysis prior to enrichment and following enrichment for myofibrils. This 
#pathway ID pathway description observed gene count false discovery rate
GO.0008092 cytoskeletal protein binding 7 0.0054
A) B)
Accession Significance (-10lgP) Group Profile (Ratio) Description
P58771 115.68 1.00:2.60 Tropomyosin alpha-1 chain OS=Mus musculus GN=Tpm1 PE=1 SV=1
P47757 28.59 1.00:2.43 F-actin-capping protein subunit beta OS=Mus musculus GN=Capzb PE=1 SV=3
P60710 22.54 1.00:13.12 Actin  cytoplasmic 1 OS=Mus musculus GN=Actb PE=1 SV=1
O88990 22.46 1.00:1.71 Alpha-actinin-3 OS=Mus musculus GN=Actn3 PE=2 SV=1
Q9QZ47 86.85 1.00:2.52 Troponin T  fast skeletal muscle OS=Mus musculus GN=Tnnt3 PE=1 SV=3
P09542 44.1 1.00:1.80 Myosin light chain 3 OS=Mus musculus GN=Myl3 PE=1 SV=4
P13412 52.67 1.00:2.32 Troponin I  fast skeletal muscle OS=Mus musculus GN=Tnni2 PE=1 SV=2
D) 
C) 
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enrichment only highlighted an interaction between Myomesin-1 (MYOM1) and myosin-11 
(MYH-11) proteins. Both are involved in muscle contraction and Myomesin may link the 
intermediate filament of the cytoskeleton to the M disk (Gonzalez-Morales et al., 2017). 
 
 
Figure 3.3.6.2 STRING analysis of protein-proteins interactions for significantly down 
regulated proteins. (A) Demonstrates the entire dataset. (B) Following enrichment for 
myofibrillar proteins, 5 proteins were identified. (C) STRING pathway information. (D) Global 
label free proteomics data for proteins enriched in (A). 
  
3.3.7 Redox Changes in Mouse Quadriceps with Age 
Differentially labelled proteins were analysed from the samples from adult and old 
mice. The total number of redox-cysteine containing proteins detected were 179 in adult and 
166 in old mice. The difference in protein numbers between adult and old reflects a number of 
different proteins detected in each tissue set, rather than several proteins detected in one and 
not the other. 
#pathway ID pathway description observed gene count false discovery rate
GO.0030016 myofibril 5 0.00289
A) B)
Accession Significance (-10lgP) Group Profile (Ratio) Description
P23927 21.96 1.00:0.47 Alpha-crystallin B chain OS=Mus musculus GN=Cryab PE=1 SV=2
P48036 21.96 1.00:0.52 Annexin A5 OS=Mus musculus GN=Anxa5 PE=1 SV=1
Q62234 29.22 1.00:0.67 Myomesin-1 OS=Mus musculus GN=Myom1 PE=1 SV=2
O08638 23.37 1.00:0.29 Myosin-11 OS=Mus musculus GN=Myh11 PE=1 SV=1
Q8BZF8 32.93 1.00:0.13 Phosphoglucomutase-like protein 5 OS=Mus musculus GN=Pgm5 PE=1 SV=2
C) 
D) 
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Differential labelling of cysteine residues followed by mass spectrometry analysis was 
used to determine changes to the redox state of individual cysteine containing peptides. They 
are of interest because under normal conditions their flexible oxidation states enable a swift 
response to changes in intracellular ROS. Our hypothesis was that they will change with age. 
Figure 3.3.7.1 shows a reduction in the total number of redox proteins with an increase 
in the number of reduced proteins, with age. This change to intracellular redox flexibility with 
age may be related to exposure to sustained intracellular ROS which will be assessed in the 
next section looking at specific proteins and changes to their redox state with age. The online 
DataCat archive for the adult and old quadriceps redox protein lists S3 – Adult Quadriceps 
Redox Proteins; S4 – Old Quadriceps Redox Proteins are accessible at 
10.17638/datacat.liverpool.ac.uk/437. 
 
Figure 3.3.7.1 Numbers of proteins containing redox, reduced and reversibly oxidised 
cysteine-containing peptides from quadriceps muscle in adult and old mice. 
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Table 2 shows the combined data for redox proteins and includes protein accession 
number and name of the identified protein in the label free data along with the abundance 
change in label free data with age, the significance of that change (-10 log P), the redox peptide 
identified, the specific redox cysteine being analysed and the adult and old reduced:oxidised 
ratio change with age. 
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Table 2. Redox Cysteines in Quadriceps Muscle
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Table 2. Redox-cysteine containing proteins detected via differential labelling. Significantly changed proteins are highlighted in bold and tryptic peptides are 
denoted with an asterisk (*).
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Figure 3.3.7.1 shows the whole dataset of redox proteins listed in Table 2 that were 
identified via differential labelling of quadriceps muscle from adult and old mice. Specific 
cysteine residues highlighted in the figure show marked increased in reduced state for Cofilin 
2 (Cys80, increased by 7.21 fold), Glucose 6-phosphate isomerase (Cys404, increased by 6.06 
fold) and Malate dehydrogenase (Cys154, increased by 6.8 fold). Conversely, Aconitase 
(Cys126, decreased by 0.42 fold), mitochondrial Aspartate aminotransferase (Cys295, 
decreased by 0.38) and Glycogen phosphorylase (Cys581, decreased by 0.41).
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Figure 3.3.7.2 All detected redox labelled cysteine proteins demonstrating changes to the reduced:reversibly oxidised ratios with age in quadriceps. Values > 
1.0 are reduced, values < 1.0 are reversibly oxidised. Higher values indicate an increased reduced state. Data are derived from table 2.  
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3.3.8 Comparison of Differentially Labelled Proteins 
Venn diagrams were produced using VennDIS (version 1.0.1) software to compare 
redox, reduced and reversibly oxidised proteins to identify those that were conserved or 
changed with age.  
Figure 3.3.8.1 compares the redox, reduced and reversibly oxidised through differential 
labelling of cysteine in adult and old quadriceps muscles. This highlighted 133 proteins that 
were present in both adult and old quadriceps muscles, 44 proteins only in adult and 33 only in 
old. In the adult dataset, proteins detected included the energy metabolism proteins ATP 
Synthase polypeptides and subunits (ATP1A2, ATP5C1 and ATP5F1 respectively), redox 
proteins Glutathione peroxidase (Gpx4) and Thioredoxin (Txn1) and the Heat shock proteins 
(HSPA1A and HSPB6). The 133 proteins identified in both adult and old muscle for all forms 
of differentially labelled proteins highlighted a range of different types covering energy 
metabolism (NADH dehydrogenases 1 α sub-complexes and ATP Synthase subunits), 
cytoskeleton (Tropomyosin 1 α and Tropomyosin 4, Troponin 1 and C2, various Myosins, 
Myomesins etc.) and redox control (e.g. Peroxiredoxins 1, 3 and 5). The proteins found only 
in old were fewer but of note were Glutathione S-Transferase π 1 and Peroxiredoxin 6 (see the 
supplementary information “Table 3.3.8.1 A/B/C” (p.262-264) for the lists of individual 
proteins in each section of the Venn diagram). 
Further to this initial information, the lists of differentially labelled proteins were later 
separated to determine any age or effects to redox proteins in quadriceps muscle. 
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Figure 3.3.8.1 Venn diagram comparing redox, reduced and reversibly oxidised protein 
numbers in quadriceps muscle from adult and old mice. See also the supplementary information 
table 3.3.8.1 A/B/C on p.262-264 for the lists of proteins in individual segments. 
 
  Figure 3.3.8.2 highlights the redox proteins (labelled with both d0-NEM and d5-NEM) 
identified from quadriceps muscle in adult and old mice. This highlighted 21 redox proteins 
solely in the adult, 8 in the old and 43 in both adult and old quadriceps muscle. In tissue from 
adult mice, the redox control chaperone protein PARK7 was observed along with the Myosin 
binding protein C (MBPC2) and the glycolytic enzyme Phosphoglycerate kinase 1-related 
sequence (PGK-RS7) and the folding protein Peptidylprolyl isomerase A (PPIA). In tissue from 
both adult and old mice several energy metabolism enzymes such as Enolase 1 and 3 (ENO1 
and ENO3), Creatine kinase (both muscle (CKM) and mitochondrial (CKMT2) forms) and the 
redox control protein Superoxide dismutase 1 (SOD1) were present. The dataset from old mice 
only highlighted 8 proteins, mostly involved in energy metabolism and one Myosin heavy 
polypeptide 2 (MYH2) (see the supplementary information “Table 3.3.8.2 A/B/C” (p.265-266) 
for the lists of proteins included in this Venn diagram). 
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Figure 3.3.8.2 Venn diagram of redox proteins detected in mouse quadriceps. See also the 
supplementary information table 3.3.8.2 A/B/C on p.265-266 for diagram segment protein lists 
of individual segments. 
 
 Figure 3.3.8.3 compared reduced proteins found in the adult, old and both datasets. The 
37 proteins only found in muscle from adult mice included the Heat shock protein Hspb6, the 
redox protein Thioredoxin 1 (TXN1) and Glutathione peroxidase (GPX4) along with a range 
of energy metabolism proteins such as ATP synthases (ATP1A2, ATP5C1, ATP5F1), 
Isocitrate dehydrogenase 3 (IDH3) and Protein kinases (PRKAR2A and PRKAB2). Of the 43 
proteins found in both datasets, Glutathione S-transferase μ-1, 2 and 5 (GSTM1, GSTM2 and 
GSTM5), cytoskeletal proteins Myosin 1 (MYL1) and Myosin 3 (MYL3) and redox proteins 
Peroxiredoxin 1, 3 and 5 (PRDX1, PRDX3 and PRDX5). In the proteins found in muscle from 
old mice a number were involved in energy metabolism such as Citrate synthase (CS), ATP 
Synthase (ATP5H) and Fructose bisphosphatase 2 (FBP2) were found in addition to the 
chaperone and redox sensor PARK7 (see the supplementary information “Table 3.3.8.3 A/B/C” 
(p.267-269) for the lists of proteins included in this Venn diagram). 
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Figure 3.3.8.3 Venn diagram of reduced proteins detected in mouse quadriceps. See also the 
supplementary information table 3.3.8.3 A/B/C on p.267-269 for protein lists of individual 
segments. 
 
 Figure 3.3.10.4 shows reversibly oxidised proteins found in muscle from adult, old and 
both ages of mice. Few proteins of note were observed in each of the datasets. Example proteins 
found in the adult included the Heat shock protein Hspa1a and the energy metabolism protein 
Cytochrome c oxidase (COX5B). In the protein datasets from both adult and old mice, the 
energy protein NADH dehydrogenase (NDUFB7) and the endoplasmic reticulum folding 
control protein Calreticulin (CALR) were observed. In the proteins found in old mice, 
Peroxiredoxin 6 (PRDX6) and two immunoglobulins (Ig κ chain V-V regions and Ig heavy 
chain V region and lysosome degradation proteins Cathepsin B and D (CTSB and CTSD) were 
observed (see supplementary information “Table 3.3.8.4 A/B/C” (p.270) for the lists of proteins 
included in this Venn diagram). 
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Figure 3.3.8.4 Venn diagram of reversibly oxidised proteins in mouse quadriceps. See also the 
supplementary information table 3.3.8.4 A/B/C on p.270 for the protein lists of individual 
segments. 
  
The VennDIS highlighted the variety of proteins from muscle in adult, old and both 
ages of mice. Interestingly fewer cytoskeletal proteins were observed in the differential 
labelling data when compared with the global label free proteomics results. These data were 
used for the subsequent STRING pathway analysis of the individual label datasets in the 
following section 3.3.9. 
 
3.3.9 STRING Analysis of Differentially Labelled Proteins 
STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) analysis was 
performed on the differentially labelled proteins, described previously for quadriceps muscle 
from adult and old mice. The STRING database enables identification of protein-protein 
interactions based on experimental evidence. The thickness of the lines joining two proteins 
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indicates the strength of the experimental evidence for the interaction. STRING requires a 
minimum number of proteins available to be input to enable statistically accurate results to be 
determined. Due to the limited number of proteins identified for reversibly oxidised proteins 
from adult, redox proteins from old and the reversibly oxidised proteins from old mice, their 
interactions were unable to be computed using STRING.  
To perform the analysis accession numbers of proteins highlighted in the Venn 
diagrams of section 3.3.8 and identified as redox-flexible cysteine containing proteins that may 
have changed with age (see Table 2, p.105-106), were inserted into STRING to determine 
redox protein specific interactions. 
Figure 3.3.9.1 shows interactions of the reduced proteins and highlights oxidative 
phosphorylation in quadriceps from adult mice. In (A) this highlights two ATP Synthase 
subunits (ATP5G1 and ATP5C1), the mitochondrial Acyl carrier protein (NDUFAB1) and 
NADH dehydrogenase 1 α sub-complex subunit 5 (NDUFA5). The GO pathway information 
and descriptions are shown in (B) along with three identified genes from within the pathway. 
(C) Shows the global label free proteomics results for the proteins highlighted in (A). This 
result showed interactions between reduced ATP synthase and NADH dehydrogenase protein 
subunits in adult quadriceps. 
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Figure 3.3.9.1 STRING analysis of reduced protein interactions in mouse quadriceps muscle 
from adult mice. (A) Protein interactions highlighted following STRING enrichment for 
oxidative phosphorylation. (B) Pathway information, description gene count and false 
discovery rate. 3 genes are highlighted due to Ndufa5 being a sub-complex subunit. (C) Global 
label free proteomics results for proteins in (A).  
 
Figure 3.3.9.2 shows redox protein interactions in muscle from adult and old mice. The 
proteins were enriched for glycolysis/gluconeogenesis and highlighted interactions between a 
number of energy metabolism proteins: Triosephosphate isomerase 1 (TPI1), 6-
Phosphofructokinase muscle-type (PFKM), α-Enolase (ENO1), β-Enolase (ENO3), 
Phosphoglycerate mutase 2 (PGAM2), Pyruvate kinase isozymes M1/M2 (PKM) and Fructose 
bisphosphate aldolase A (ALDOA). This result indicates the sensitivity of certain proteins 
involved in glycolysis to changes in the intracellular redox environment. 
#pathway ID pathway description observed gene count false discovery rate
190 Oxidative phosphorylation 3 0.025
Accession Label Significance (-10lgP) Group Profile (Ratio) Description
Q9CPP6 NDUA5_MOUSE 1.92 1.00:0.62 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 OS=Mus musculus GN=Ndufa5 PE=1 SV=3
Q9CQQ7 AT5F1_MOUSE 1.14 1.00:1.05 ATP synthase subunit b  mitochondrial OS=Mus musculus GN=Atp5f1 PE=1 SV=1
Q91VR2 ATPG_MOUSE 10.69 1.00:0.65 ATP synthase subunit gamma  mitochondrial OS=Mus musculus GN=Atp5c1 PE=1 SV=1
Q9CR21 ACPM_MOUSE 0.68 1.00:1.36 Acyl carrier protein  mitochondrial OS=Mus musculus GN=Ndufab1 PE=1 SV=1
(A) 
(B) 
(C) 
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Figure 3.3.9.2 STRING analysis of redox proteins from mouse quadriceps muscle in adult and 
old mice. (A) Protein interactions following enrichment for glycolysis/gluconeogenesis. (B) 
Pathway information, description and false discovery rate for the enrichment performed for 
(A). (C) Global label free proteomics data for proteins highlighted in (A). 
 
 Figure 3.3.9.3 presents reduced proteins of adult and old mice and used STRING to 
enrich for protein interactions of both oxidoreductase activity and oxidative phosphorylation. 
The interactions show proteins involved in oxidoreductase activity and highlighted three main 
groups of proteins. Reading from left to right, the first group consisted of three proteins 
interacting strongly based on various forms of experimental and computational evidence: 
Trifunctional enzyme subunit α (HADHA), short chain acyl-co-A dehydrogenase (ACADS; 
mitochondrial), very long chain specific acyl co-A dehydrogenase (ACADYL; mitochondrial) 
Accession Label Significance (-10lgP) Group Profile (Ratio) Description
O08749 DLDH_MOUSE 4.49 1.00:1.99 Dihydrolipoyl dehydrogenase  mitochondrial OS=Mus musculus GN=Dld PE=1 SV=2
Q9D051 ODPB_MOUSE 6.78 1.00:0.82 Pyruvate dehydrogenase E1 component subunit beta  mitochondrial OS=Mus musculus GN=Pdhb PE=1 SV=1
P17751 TPIS_MOUSE 8.68 1.00:0.84 Triosephosphate isomerase OS=Mus musculus GN=Tpi1 PE=1 SV=3
P52480 KPYM_MOUSE 3.86 1.00:0.98 Pyruvate kinase isozymes M1/M2 OS=Mus musculus GN=Pkm2 PE=1 SV=4
P17182 ENOA_MOUSE 1.46 1.00:1.32 Alpha-enolase OS=Mus musculus GN=Eno1 PE=1 SV=3
P21550 ENOB_MOUSE 5.88 1.00:0.89 Beta-enolase OS=Mus musculus GN=Eno3 PE=1 SV=3
P05064 ALDOA_MOUSE 2.12 1.00:1.04 Fructose-bisphosphate aldolase A OS=Mus musculus GN=Aldoa PE=1 SV=2
P47857 K6PF_MOUSE 8.36 1.00:0.70 6-phosphofructokinase  muscle type OS=Mus musculus GN=Pfkm PE=1 SV=3
O70250 PGAM2_MOUSE 30.92 1.00:0.71 Phosphoglycerate mutase 2 OS=Mus musculus GN=Pgam2 PE=1 SV=3
(A) 
(B) 
(C) 
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and Aldehyde dehydrogenase (ALDH; mitochondrial). A central group of five proteins 
included three Succinate dehydrogenases (SDHA, SDHB and SDHC), Isocitrate 
dehydrogenase subunit γ (IDH3G; mitochondrial) and Pyruvate dehydrogenase E1 (PDHA1). 
Finally, the third group of four proteins on the right included three peroxiredoxins (PRDX1, 
PRDX3 and PRDX5) and Protein disulphide isomerase (P4HB). These interactions highlight 
the range of energy metabolism proteins involved in oxidoreductase activity and a number of 
antioxidant proteins. Combined with the global proteomics information. Furthermore, as these 
proteins were all reduced in samples from adult and old mice, suggesting a marked impact on 
energy metabolism in terms of redox biochemistry as the quadriceps age. 
 Figure 3.3.9.3B shows the reduced proteins from adult and old mice following 
enrichment for oxidative phosphorylation. This identified links between succinate 
dehydrogenase (SDHA, SDHB and SDHC) and ATP synthase subunits (ATP5A1) and then 
via the NADH dehydrogenase subunit (NDUFA10) to NADH ubiquinone oxidoreductase 
(MTND3). From these data, the STRING results demonstrate redox changes to energy 
metabolism proteins with age. 
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Figure 3.3.9.3 STRING analysis of interactions of reduced proteins in quadriceps muscle of 
adult and old mice. (A) Enrichment of proteins for oxidoreductase activity. (B) Enrichment of 
proteins for oxidative phosphorylation. (C) STRING pathway information. (D) Global label 
free data for proteins in (A). (E) Global label free data for proteins in (B). 
 
 Figure 3.3.9.4 shows STRING analysis of reversibly oxidised proteins from quadriceps 
muscle from adult and old mice. Figure 3.3.9.4A shows protein interactions between 
Cytochrome c oxidase (COX6B1), NADH dehydrogenase (NDUFB7) and Cytochrome b-c1 
complex (UQCRH). Figure 3.3.9.4B shows the STRING pathway information and figure 
3.3.9.4C shows the global proteomics data for the enriched proteins in figure 3.3.9.4A. As the 
#pathway ID pathway description observed gene count false discovery rate
GO.0016491 oxidoreductase activity 15 1.04E-07
190 Oxidative phosphorylation 6 4.41E-05
Accession Significance (-10lgP) Group Profile (Ratio) Description
P47738 3.95 1.00:1.09 Aldehyde dehydrogenase  mitochondrial OS=Mus musculus GN=Aldh2 PE=1 SV=1
P70404 1.16 1.00:0.77 Isocitrate dehydrogenase [NAD] subunit gamma  mitochondrial OS=Mus musculus GN=Idh3g PE=1 SV=1
Q99LC3 1.42 1.00:0.71 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10  mitochondrial OS=Mus musculus GN=Ndufa10 PE=1 SV=1
P03899 0.42 1.00:1.12 NADH-ubiquinone oxidoreductase chain 3 OS=Mus musculus GN=Mtnd3 PE=3 SV=3
P35700 4.04 1.00:0.88 Peroxiredoxin-1 OS=Mus musculus GN=Prdx1 PE=1 SV=1
P99029 20.42 1.00:0.75 Peroxiredoxin-5  mitochondrial OS=Mus musculus GN=Prdx5 PE=1 SV=2
P09103 53.41 1.00:2.47 Protein disulfide-isomerase OS=Mus musculus GN=P4hb PE=1 SV=1
P35486 19.44 1.00:0.71 Pyruvate dehydrogenase E1 component subunit alpha  somatic form  mitochondrial OS=Mus musculus GN=Pdha1 PE=1 SV=1
Q07417 4.45 1.00:1.35 Short-chain specific acyl-CoA dehydrogenase  mitochondrial OS=Mus musculus GN=Acads PE=2 SV=1
Q8K2B3 0.97 1.00:1.03 Succinate dehydrogenase [ubiquinone] flavoprotein subunit  mitochondrial OS=Mus musculus GN=Sdha PE=1 SV=1
Q9CQA3 3.5 1.00:0.78 Succinate dehydrogenase [ubiquinone] iron-sulfur subunit  mitochondrial OS=Mus musculus GN=Sdhb PE=1 SV=1
Q9CZB0 1.05 1.00:0.65 Succinate dehydrogenase cytochrome b560 subunit  mitochondrial OS=Mus musculus GN=Sdhc PE=2 SV=1
P20108 1.93 1.00:0.98 Thioredoxin-dependent peroxide reductase  mitochondrial OS=Mus musculus GN=Prdx3 PE=1 SV=1
Q8BMS1 3.9 1.00:1.44 Trifunctional enzyme subunit alpha  mitochondrial OS=Mus musculus GN=Hadha PE=1 SV=1
P50544 1.47 1.00:1.13 Very long-chain specific acyl-CoA dehydrogenase  mitochondrial OS=Mus musculus GN=Acadvl PE=1 SV=3
Accession Significance (-10lgP) Group Profile (Ratio) Description
Q03265 6.54 1.00:0.85 ATP synthase subunit alpha  mitochondrial OS=Mus musculus GN=Atp5a1 PE=1 SV=1
Q99LC3 1.42 1.00:0.71 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10  mitochondrial OS=Mus musculus GN=Ndufa10 PE=1 SV=1
P03899 0.42 1.00:1.12 NADH-ubiquinone oxidoreductase chain 3 OS=Mus musculus GN=Mtnd3 PE=3 SV=3
Q8K2B3 0.97 1.00:1.03 Succinate dehydrogenase [ubiquinone] flavoprotein subunit  mitochondrial OS=Mus musculus GN=Sdha PE=1 SV=1
Q9CQA3 3.5 1.00:0.78 Succinate dehydrogenase [ubiquinone] iron-sulfur subunit  mitochondrial OS=Mus musculus GN=Sdhb PE=1 SV=1
Q9CZB0 1.05 1.00:0.65 Succinate dehydrogenase cytochrome b560 subunit  mitochondrial OS=Mus musculus GN=Sdhc PE=2 SV=1
(C) 
(A) (B) 
(D) 
(E) 
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proteins were reversibly oxidised, this showed that disulphide bridges could have been formed 
within these proteins in quadriceps muscle from adult and old mice. The interactions identified 
via STRING demonstrated that only a handful of proteins involved in energy metabolism were 
observed with this modification. 
 
Figure 3.3.9.4 STRING of reversibly oxidised protein interactions for proteins identified in 
both quadriceps muscle from adult and old mice. (A) Protein interactions following enrichment 
for oxidative phosphorylation. (B) STRING pathway information. (C) Global label free 
proteomics data for proteins in (A). 
 
3.3.10 Motif-X Analysis of the Cysteine Microenvironment 
Motif-X enabled the identification of a recurring short sequence element or motif 
surrounding a selected central amino acid. Parameters can be set for the foreground and 
background search data sets as well as significance, frequency of occurrence and the width of 
the amino acid string. Analysis of data for redox, reduced and reversibly oxidised proteins from 
the adult mouse revealed a motif containing a central cysteine, surrounded by seven peptides. 
#pathway ID pathway description observed gene count false discovery rate
190 Oxidative phosphorylation 3 0.00694
Accession Label Significance (-10lgP) Group Profile (Ratio) Description
P56391 CX6B1_MOUSE 0.86 1.00:1.07 Cytochrome c oxidase subunit 6B1 OS=Mus musculus GN=Cox6b1 PE=1 SV=2
Q9CR61 NDUB7_MOUSE 1.85 1.00:1.31 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 OS=Mus musculus GN=Ndufb7 PE=1 SV=3
P99028 QCR6_MOUSE 2.6 1.00:1.25 Cytochrome b-c1 complex subunit 6  mitochondrial OS=Mus musculus GN=Uqcrh PE=1 SV=2
(A) 
(B) 
(C) 
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This analysis helped in determining whether the surrounding microenvironment of redox, 
reduced or reversibly oxidised cysteines would encourage oxidation. 
Figure 3.3.10A shows a conserved threonine amino acid was identified in redox 
peptides from adult muscle. It contains an aliphatic hydroxyl group making the molecule 
hydrophilic along with a chiral centre. The amino acid is uncharged but polar meaning that 
while it has no overall charge, specific groups are particularly electronegative giving a 
tendency to hold electrons slight closer and thereby giving a slight (δ) charge. Only one isomer 
of threonine is present in proteins (Berg et al., 2002). 
Glycine is the simplest amino acid and in figure 3.3.10B it was detected as conserved 
in reduced peptides from quadriceps muscle of adult mice. Like isoleucine below, it is a 
hydrophobic molecule and its small size enables the formation of particularly compact 
structures when in water (Berg et al., 2002). 
Aspartate, the deprotonated form of aspartic acid, was identified in reversibly oxidised 
peptides in quadriceps of adult mice (figure 3.3.10C). It contains a carboxylate side chain and 
in certain instances can accept a proton making it functionally important (Berg et al., 2002). 
Figure 3.3.10D identified an Isoleucine as a conserved amino acid sequence at +4 from 
the central cysteine. Isoleucine contains one less hydrogen atom than leucine giving it a chiral 
centre. The aliphatic side gives the molecule hydrophobic properties enabling stabilisation in 
water (Berg et al., 2002). 
Glutamate (the deprotonated form of glutamic acid, giving an overall negative charge 
to the molecule) was detected as a conserved amino acid in reduced peptides of old mice (figure 
3.3.10E). Similar in structure to aspartate, it also contains an acidic side chain (Berg et al., 
2002). 
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Reversibly oxidised peptides in muscle from old mice (figure 3.3.10F) appeared to 
also have a conserved glutamate amino acid at -5 from the central cysteine. As previously 
described glutamate contains an acidic side chain and is negatively charged (Berg et al., 
2002).
 
Figure 3.3.10. Motif-X analysis of redox cysteine-containing proteins. (A) Redox peptides 
from adult mouse quadriceps muscle and identifying a conserved threonine residue at +1, next 
to the central cysteine. (B) Reduced peptides from quadriceps muscle of adult mice and 
identifying a conserved glycine -7 away from the central cysteine. (C) Reversibly oxidised 
peptides from quadriceps from adult mice identifying a conserved aspartic acid -4 away from 
the central cysteine. (D) Redox peptides from quadriceps muscle of old mice and identifying 
isoleucine as a conserved residue +4 from the central cysteine. (E) Reduced peptides in 
quadriceps muscle from old mice and identifying Glutamic acid +7 from the central cysteine. 
(F) Reversibly oxidised peptides in quadriceps muscle of old mice and identifying glutamic 
acid -5 from the central cysteine. 
 
The changes identified in quadriceps muscle using Motif-X analysis to highlight 
amino acid modifications may help in understanding changes to protein conformations via 
Parameters:
Name  Adult Quads Redox
Foreground Type  'fasta'
Foreground Central Residue  'C'
Peptide Width  '15'
Amino Acid Occurrences  '12'
Significance  '0.01'
Background Database  'ipi.MOUSE.fasta'
Background Type  'fasta'
Background Central Residue  'C'
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Matches Fold Increase
1 .......CT...... 2.36 12 100 15431 307729 2.39
Parameters:
Name  Adult Quads Reduced
Foreground Type  'fasta'
Foreground Central Residue  'C'
Peptide Width  '15'
Amino Acid Occurrences  '32'
Significance  '0.001'
Background Database  'ipi.MOUSE.fasta'
Background Type  'fasta'
Background Central Residue  'C'
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Matches Fold Increase
1 G......C....... 3.29 34 271 21091 307729 1.83
Parameters:
Name  Adult Quads Rev Ox
Foreground Type  'fasta'
Foreground Central Residue  'C'
Peptide Width  '15'
Amino Acid Occurrences  '12'
Significance  '0.001'
Background Database  'ipi.MOUSE.fasta'
Background Type  'fasta'
Background Central Residue  'C'
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Matches Fold Increase
1 ...D...C....... 4.37 14 89 13815 307729 3.5
Parameters for this run:
Name  Old Quads Redox
Foreground Type  'fasta'
Foreground Central Residue  'C'
Peptide Width  '15'
Amino Acid Occurrences  '10'
Significance  '0.01'
Background Database  'ipi.MOUSE.fasta'
Background Type  'fasta'
Background Central Residue  'C'
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Matches Fold Increase
1 .......C...I... 3.34 10 67 12876 307729 3.57
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Matches Fold Increase
1 .......C......E 4.69 33 269 17127 307729 2.2
Parameters for this run:
Name  Old Quads Reduced
Foreground Type  'fasta'
Foreground Central Residue  'C'
Peptide Width  '15'
Amino Acid Occurrences  '15'
Significance  '0.0001'
Background Database  'ipi.MOUSE.fasta'
Background Type  'fasta'
Background Central Residue  'C'
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Matches Fold Increase
1 ..E....C....... 2.83 13 76 20517 307729 2.57
Parameters for this run:
Name  Old Quads Rev Ox
Foreground Type  'fasta'
Foreground Central Residue  'C'
Peptide Width  '15'
Amino Acid Occurrences  '13'
Significance  '0.01'
Background Database  'ipi.MOUSE.fasta'
Background Type  'fasta'
Background Central Residue  'C'
(A) (B)
(C) (D)
(E) (F)
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changes to the microenvironment of specific amino acids. A future step would be to combine 
this information with structural biology data to characterise these changes. 
3.4 Discussion 
In a healthy adult the quadriceps muscle is responsible for the fast and explosive action 
of a sprint start. With age, a loss of muscle mass and strength is referred to as sarcopenia (Deepa 
et al., 2017, Sakellariou et al., 2016). In quadriceps, several proteins were observed to change 
in activity and redox state between adult and old mice. I hypothesised that a change in the redox 
state of intracellular proteins would occur with age (section 3.2, p.67) and the results generally 
supported this hypothesis, demonstrating that predominantly cytoskeletal proteins were 
detected as being down regulated with age in the label free data. Differential labelling identified 
changes to specific redox control proteins too, perhaps affecting protein function in relation to 
both redox intracellular sensitivity and redox control. 
In figure 3.3.3.3 the volcano plot highlighted some cytoskeletal proteins such as the 
Tropomyosin 1, 2 and 3 (TPM1, TPM2, TPM3), Troponins (TNNT3, TNNI2), Myosin light 
chain 3 (MYL3), Myosin heavy chain 8 (MYH8), Α-actin 3 (ACTN3) and Myosin regulatory 
light chain (MLRS). In addition, the ER stress proteins Grp78 and Protein disulphide isomerase 
(PDIA or P4HB) were significantly up regulated with age in mouse quadriceps. Tropomyosin 
has over 40 isoforms and is a key component of the actin cytoskeleton (Kee et al., 2004), 
therefore an increase in protein abundance with age within the quadriceps may suggest an 
increase in muscle physiological stiffness thereby reducing physical flexibility as observed 
previously in humans (Palmer and Thompson, 2016). This, in addition to work by Lexell & 
Brooks then demonstrated muscle fibre atrophy with age (Lexell et al., 1988, Brooks and 
Faulkner, 1988, Lexell et al., 1986, Lexell et al., 1984). Conversely, significantly down 
regulated proteins included Heat shock protein 70kDa (HSP70), Heat-shock protein β-6 
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(HSPB6) and Nascent polypeptide-associated complex subunit α (NACAM). HSP70 is a 
crucial for protein folding and involved in the heat shock response (the rest of the associated 
data will be discussed later in this chapter, see p.126). HSPB6 is also involved in protein folding 
control and chaperoning and was reduced in quadriceps muscle for old mice. Finally, NACAM 
is a transcription factor involved in regulation of thick and thin filaments during muscle growth 
and regeneration (Yotov and St-Arnaud, 1996, Park et al., 2010). The significant reduction in 
abundance found in quadriceps from old mice may suggest a partial reduction in skeletal 
muscle regeneration capabilities although why this occurs, in addition to the reduction in 
HSP70 and HSPB6 is unclear. These results support the concept of age-related physiological 
decline in skeletal muscle flexibility to respond to changes in the intracellular redox balance 
(Brook et al., 2016).  
Mouse body weights and quadriceps muscle weights were measured to identify any 
general physiological differences between individual mice and between individual quadriceps 
muscles. Figure 3.3.1.1A showed a significant increase in body weight from 3 to 12 months 
which was expected due to growth. A single outlier with lower weight than the rest of the mice 
was identified. The quadriceps showed a significant decrease in weight with age. Both the 
whole body and quadriceps tissue-specific data agreed with another study that identified 
significant increases in mouse body weight between 3 and 12 months of age and a decrease in 
“hind limb muscle mass” between 18 and 24 months of age (Hamrick et al., 2006). 
Redox Ageing 
Redox control proteins such as Peroxiredoxin 3 and 5 (mitochondrial based) 
demonstrated an increase in abundance (via western blotting) with age. The sulphonylated 
versions of Peroxiredoxins 1-4 also showed an increase in ROS with age to levels that cause 
sustained changes to free thiol groups. Interestingly protein carbonylation, another indicator or 
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sustained ROS showed a decrease with age in mouse quadriceps muscle while the protein 
chaperone PARK7 increased in abundance with age along with the sulphonylated form. 
Briefly, these results indicate some of the changes observed in ageing mouse quadriceps muscle 
and generally support an increase in oxidation with age in quadriceps muscle. The results are 
considered in greater detail below. 
 Changes to numbers of redox proteins were represented in figure 3.3.7.1 and highlight 
a decrease in redox proteins. These are of particular interest as they allow for reduction and 
oxidation of specific cysteine residues which enables the cell to react to changes in ROS 
concentration. An increase in the number of reduced proteins was also observed and this 
indicates a potential loss of protein function with age in the quadriceps. Redox proteins are 
defined in this regard as those involved in the intracellular control of redox reactions and 
maintenance of a balanced redox state. Table 2 listed the redox proteins detected via differential 
labelling in mouse quadriceps and figure 3.3.7.2 highlighted these changes as fold change. This 
indicated significant increases in the reduced state to the actin-controller and translocation 
protein Cofilin-2 (CFL2) at Cys80 by 7.21 fold. The glycolysis and pentose phosphate pathway 
protein Glucose-6-phosphate isomerase (GPI) at Cys404 by 6.06 fold and the cytoplasmic 
Malate dehydrogenase-1 (MDH1) at Cys154 by 6.8 fold (Gillett et al., 1996, Berg et al., 2002). 
This may suggest a significant change to the microenvironment, however this did not appear 
to be translated into changes in protein abundance as none of those mentioned significantly 
changed. Interestingly, Glucose-6-phosphate changed its redox state entirely from being 
reversibly oxidised in adult mouse quadriceps to becoming reduced in old mouse quadriceps. 
Conversely, the metabolism protein Aconitase (ACO2) at Cys126 reducing by 0.42 fold, the 
amino acid metabolism protein Aspartate aminotransferase (GOT2) at Cys295 by 0.38 fold and 
the glyconeogenesis protein Glycogen phosphorylase (PYGM) at Cys581 by 0.41 fold. All 
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appeared to reduce in the redox state, becoming reversibly oxidised in the old mouse 
quadriceps. 
In addition to the differential labelling of redox proteins in skeletal muscle, western 
blotting was performed on a number of proteins of interest in addition to the mass spectrometry 
analysis. The first of those proteins examined was Thioredoxin 1, a cytosolic enzyme 
containing a disulphide bridge at its active site which enables redox signalling and the 
maintenance of normally functioning peroxiredoxins (Dimauro et al., 2012). It is among several 
redox proteins constitutively expressed by skeletal muscle and was assessed to begin with due 
to the integral part of the thioredoxin system in maintaining the functionality of other redox 
control proteins and therefore the regulation of intracellular ROS concentration (Manabe et al., 
2014, Dimauro et al., 2012). No significant change was observed for Thioredoxin 1 or 2 or 
Thioredoxin reductase 1 or 2 suggesting the thioredoxin system for redox sensing and control 
of both cytosolic and mitochondrial proteins was not affected with age. This was a surprising 
result and contradicts previous data from C2C12 myoblasts and myotubes that showed changes 
to the Thioredoxin system do occur (Dimauro et al., 2012). 
Thioredoxin interacting protein (TXNIP) negatively regulates the function and 
expression of Thioredoxin and has been demonstrated to reduce insulin sensitivity in skeletal 
muscle following overexpression (Alhawiti et al., 2017). Figure 3.3.4.5A showed a significant 
increase in protein abundance with age from 3 to 12 months and 3 to 24 months of age (both p 
<0.05). This was a surprising result given the Thioredoxin system proteins did not change in 
abundance or activity and suggests regulation at a number of different levels. 
Peroxiredoxins 1-6 were assessed to determine which of these crucial antioxidant 
proteins are affected by ageing via changes to their protein abundance. Western blots in figure 
3.3.4.6A-F (p.83) showed significant increases in abundance for Peroxiredoxin 3 (3.3.4.6C 
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from 3 to 12 months, p <0.01 and 3 to 24 months p <0.01) and Peroxiredoxin 5 (3.3.4.6E from 
3 to 24 months, p <0.05). Both Peroxiredoxins are located in the mitochondria suggesting that 
ageing in mouse quadriceps affects the organelle more than the general cytosolic systems. None 
of the Peroxiredoxins demonstrated significant changes to abundance in the global proteomics 
data.  
A sustained increase in ROS may affect Peroxiredoxins via oxidation of their thiol 
groups. As described in figure 1.4.1 (p.35), a sustained increase in ROS leads to increasing 
degrees of oxidation of thiol groups starting with sulphenylation (-SOH), then sulphinylation 
(-SO2H) and finally sulphonylation (-SO3H). These modifications inhibit protein activity by 
increasingly irreversible modifications and therefore any increase detected by this blot for –
SO3H would significantly impact protein function. A previous study has highlighted that the 
addition of the –SO3H leads to negative effects impacting health (Pan and Carroll, 2014). One 
study demonstrated a circadian rhythm for PRDX2 hyperoxidation, oscillating over a 24-hour 
period. The study noted this oscillation was not observed for PRDX6 or GAPDH, however this 
suggests that certain redox proteins can function cyclically. This hyperoxidation leads to the 
degradation of PRDX2 and eventually its decline in abundance from the cell surface. One 
aspect of future work would be to assess circadian changes to redox protein in skeletal muscle 
to determine if PRDX2 or others follow a similar oscillation (Cho et al., 2014).  
Figure 3.3.4.8A showed a significant increase in sulphonylated peroxiredoxins (1-4) 
protein abundance from 3 to 24 months of age (p <0.01) and 12 to 24 months of age (p <0.001) 
compared with almost none detected in quadriceps muscle samples from young and adult mice. 
The antibody detects Peroxiredoxins 1-4 and although individual Peroxiredoxins could not be 
distinguished, it represents modifications to both the cytosolic and mitochondrial antioxidant 
proteins with age. 
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Following from the Peroxiredoxin redox sensor and controllers, Cu-Zn Superoxide 
Dismutase (SOD1) and Mn-Superoxide Dismutase (SOD2) were examined as they are key 
antioxidant proteins located in the cytosol and mitochondria respectively. Figure 3.3.4.9A 
showed a significant increase in SOD1 from 3 to 12 months in protein abundance (p <0.01), 
however no change was observed for SOD2 indicating ageing may impact ROS control 
predominantly in the cytosol rather than the mitochondria for mouse quadriceps muscle 
(Powers and Jackson, 2008, Powers et al., 2011). 
To better understand the longer-term effects of reactive oxygen species, protein 
Carbonylation and Glutathionylation western blots were examined. Figure 3.3.4.23A showed 
a significant decrease in protein carbonylation with age. The result showed significant 
decreases for proteins from both 3 to 12 months and 3 to 24 months (both p <0.05). This is 
highly surprising as one would expect an increase in carbonylated proteins with age as an 
indicator of sustained concentrations of ROS due to the variations previously seen in redox 
control proteins. These results contrast with other work that has identified increases in the 
carbonylation of proteins with age (Rabek et al., 2003, Tohma et al., 2014). The 
Glutathionylation blot in figure 3.3.4.24A showed a significant increase in glutathionylated 
proteins with age (p <0.05 for both 3 to 12 months and 3 to 24 months of age). Glutathionylation 
has been described as a reversible form of protein modification following sustained exposure 
to ROS (Fratelli et al., 2002, Brigelius et al., 1983).  
The observations for age related changes to carbonylated and S-glutathionylated 
proteins in mouse quadriceps are supported by two other studies which demonstrate glutathione 
pools and carbonylation work in opposite directions where an increase in carbonylated proteins 
results from a decrease in available glutathione. One caveat regarding these published studies 
is that they were performed in neuronal tissues, whereas our data showed similar changes occur 
in ageing mouse quadriceps (Bizzozero et al., 2006, Dasgupta et al., 2012).  
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In summary the results of the redox proteins indicate a varied number of changes in the 
different redox systems considered. Notwithstanding the differences sometimes observed 
between western blot and proteomics data (to be discussed in detail later in Chapter 7, p.221), 
these results demonstrate that the impact of ageing is complex in relation to the redox proteome 
since both cytosolic and mitochondrial proteins are affected and some redox control systems 
examined are not affected by ageing. 
Protein Folding Response 
Protein folding is crucial to the production of fully functioning proteins. Both the 
constitutively expressed HSC70 (HSPA1, figure 3.3.4.13A) and the inducible HSP70 (HSPA8, 
figure 3.3.4.13B) heat shock proteins were looked at. Western blot data showed a significant 
decrease (p <0.05) in the constitutive variant from 12 to 24 months of age but not for the 
inducible form. Interestingly the proteomics results were the opposite of that observed with 
western blotting. Whilst experimental limitations are discussed in detail later (see Chapter 7, 
p.221), the proteomics result may be considered a more robust due to the stringent requirement 
of at least three peptide fragments required for a confirmed detection and measurement. In 
addition to changes in protein abundance, the redox state for HSC70 was tested via differential 
labelling. Cys584 showed a decrease in the redox ratio (adult reduced: oxidised versus old 
reduced: oxidised) with age from 10.9 to 8.7 reflecting the susceptibility of this particular 
cysteine to changes in the redox environment over time, however this specific cysteine does 
not appear to be crucial to enzyme function (UniProt, 2017d). Overall these results indicate an 
ongoing requirement for the inducible form of HSP70, and a reduced requirement for the 
constitutively expressed variant as mouse quadriceps age. These results support a number of 
other studies in relation to increased inflammation in skeletal muscle ageing (Ferrucci et al., 
2002, Hiona and Leeuwenburgh, 2008, Vabulas et al., 2002). HSP70 was identified as a 
cytokine in 2000 and the increase in abundance observed here, with a the reduction in HSC70, 
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suggests an attempted intracellular response to changing redox environment, perhaps as 
showed by the slight change observed for Cys584 of HSC70 and the work of others identifying 
an increase in misfolded proteins occurring with age and age-related illnesses (Selkoe, 2004, 
Basaiawmoit and Rattan, 2010, Asea et al., 2000). Additionally overexpression of HSP70 has 
been demonstrated to attenuate the age-related reduction in muscle function (McArdle et al., 
2004a).  
A key redox sensor protein involved in the folding response is PARK7. There have 
been a range of functions described for this protein including a requirement for autophagy in 
mitochondria (Krebiehl et al., 2010), stability of the antioxidant transcription regulator NRF2, 
a peroxiredoxin-like function, skeletal muscle calcium homeostasis and effects on myotube 
size and expression where an increase in PARK7 was demonstrated to cause hypertrophy in 
mouse skeletal muscles (Clements et al., 2006, Andres-Mateos et al., 2007, Shtifman et al., 
2011, Yu et al., 2014). The western blot data in figure 3.3.5.17A showed a significant increase 
(both p <0.05) in protein abundance with age from both 3 to 24 and 12 to 24 months, but 
relative quantification via global label free proteomics did not indicate a significant change in 
abundance with age from 12 to 24 months. Furthermore the redox Cys46 of PARK7 was shown 
to be susceptible to oxidation as identified via an increase in the reversibly oxidised form 
suggesting a decrease in redox flexibility via the formation of disulphide bonds (Ito et al., 
2006). Relative quantification to determine any change to the redox state of PARK7 Cys46 
showed an increase in reduced state from 8.5 to 17.5. Interestingly, this cysteine has been 
suggested to undergo conversion to alanine in the presence of hydrogen peroxide which may 
impact enzyme performance (Andres-Mateos et al., 2007). Furthermore, the same conversion 
in humans has been implicated in reduced protein stability (Canet-Aviles et al., 2004). The 
results in figure 3.3.3.17 showing an increase in PARK7 protein abundance, combined with 
the increase in the reduced in redox state of Cys46, may reflect increased oxidative stress with 
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age. Additionally, the redox results for Cys46 also reflect inactivation of PARK7 in the old 
mouse quadriceps (Richarme et al., 2015). To consider this in greater detail a western blot of 
the sulphonylated form of PARK7, PARK7-SO3H was examined and figure 3.3.5.18A shows 
a significant increase (p <0.05) in protein abundance with age. The formation of PARK7-SO3H 
occurs on Cys106 and is due to the ease with which this relatively unstable PARK7-SO2H 
undergoes further oxidation (Wilson, 2011), although this particular cysteine was not observed 
in our differential labelling data. Considering the combined results of PARK7 and PARK7-
SO3H, these suggest an intracellular attempt to control increased reactive oxygen species that 
are known to occur in mouse skeletal muscle with age (McArdle et al., 2001). 
Protein disulphide isomerase (PDI, PDIA or P4HB) is required in the formation and 
breakage of nascent disulphide bonds. However, this dynamic protein has a range of other 
functions described in human studies, such as a chaperone function at high concentrations, an 
aggregation facilitator at low concentrations and a reductase function when localised to the cell 
exterior (Lumb and Bulleid, 2002, Bi et al., 2011). The western blot shown in figure 3.3.5.14A 
demonstrates a significant increase for both 3 to 24 months (p <0.001) and 12 to 24 months (p 
<0.05) of age. Global label free proteomics correlated with this result indicating a significant 
increase in abundance with age between adult and 24 months of age. 
 In summary, protein chaperones perform a vital task in maintaining intracellular 
functions by ensuring misfolded proteins are broken down. They are correctly folded with 
complete proteins being successfully translocated. The results indicate that a number of those 
involved in protein folding were significantly increased in abundance with age in the mouse 
quadriceps. This suggests an increased demand for protein folding control with age also 
supports previous results considering redox control proteins, where those systems were 
sporadically affected by changes observed for some, but not all proteins. Overall this suggests 
an attempt to control the effects of increased intracellular ROS by skeletal muscle is only 
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partially successful for the redox systems and therefore an increase in certain protein chaperone 
abundance is required to mitigate this. 
Energy Metabolism and Ageing 
Mitochondrial activity in the quadriceps was assessed through age-related changes in 
succinate dehydrogenase (SDH) staining, as shown in figure 3.3.2.1A for adult and old (figure 
3.3.2.1B) tissue. The SDH staining method causes the precipitation of nitro-blue tetrazolium 
(NBT) which relates to SDH activity indicating changes to Complex II of the electron transport 
chain with age (Trifunovic et al., 2004). The results in figure 3.4.2.1 highlight a reduction in 
oxidative capacity from adult to old as demonstrated by a decrease in the intensity of from 
3.4.2.1A to 3.4.2.1B. In addition to this a number of human studies have identified a decrease 
in fibre number and size with age in quadriceps muscle (Frontera et al., 2000, Kent-Braun et 
al., 2000), although Sheard and Anderson report more varied fibre type changes with age 
(Sheard and Anderson, 2012).  
Aconitase (mitochondrial form) is a redox sensitive enzyme crucial to the tricarboxylic 
acid cycle as it is involved in the isomerisation of Citrate to Isocitrate via cis-Aconitase. It 
contains an Iron-Sulphur cluster at its active site that is readily oxidised thus impacting its 
redox performance (Larsen et al., 2016). Figure 3.3.5.18 shows no significant change in 
Aconitase abundance with age (supported by the proteomics result) and no significant change 
in enzyme activity. Redox analysis of Aconitase showed that Cys126 decreased its reduced 
state from 61.4 to 26.2. Cys385 changed from a reversibly oxidised form in quadriceps from 
adult mice to a reduced form in quadriceps from old mice, moving from 0.7 to 0.1. Given its 
crucial role, this modification may hinder the enzyme’s ability to correctly function. 
Cys448/451 was found to become slightly more reversibly oxidised with age, changing from 
0.1 to 0.3 and Cys592 to become more reduced with age changing from 19.3 to 22.9. Cys385 
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and Cys448/451 are involved in the Iron-Sulphur active site complex, Cys126 and Cys592 are 
located near the catalytic binding site. It has been widely reported that because of their 
positioning, the four active site cysteines are susceptible to modification by ROS and this 
makes Aconitase vulnerable to increased ROS within the cell. Furthermore, the location of 
Cys126 and Cys592 means that any effect upon these cysteines will affect protein function 
(Talib and Davies, 2016, Han et al., 2005, Kennedy et al., 1988). While other studies have 
identified changes to Aconitase abundance in different organs such as mouse kidneys (Yarian 
et al., 2006) and mouse heart mitochondria (Yarian et al., 2005), the current results support 
other data from skeletal muscle which demonstrated no significant change in Aconitase : 
Citrate synthase ratio with age (Lyons et al., 2006).  
Glyceraldehyde 3-Phosphate dehydrogenase (GAPDH) is involved in glycolysis and 
has often been used as a housekeeping gene due to its ubiquity. Western blot data (figure 
3.3.5.20) identified a significant decrease in protein abundance from 3 to 24 months (p <0.001) 
and adult to 24 months of age (p <0.01). However, the proteomics data showed no significant 
change to GAPDH protein abundance with age. Despite the discrepancy, it has been identified 
elsewhere that GAPDH changes with age. This questions its reliability as a housekeeping 
protein for western blotting, at least for quadriceps muscle in mice (Vigelso et al., 2015). In 
addition to protein abundance the redox state in adult and old were measured via differentia 
labelling. This highlighted GAPDH Cys150 was increased in redox state from 127 to 554 and 
Cys245 increased from 17 to 26. As Cys150 is located at the enzyme active site, the result 
suggest a direct impact of the increased reduced state on GAPDH’s activity in old mouse 
quadriceps (Kornberg et al., 2010). 
Differential labelling highlighted changes to two other energy metabolism proteins in 
mouse quadriceps. Phosphoglycerate kinase (PGK1) in which Cys379 remained reduced but 
increased from 47.5 to 95.4. This specific cysteine is located near to a nucleotide binding site 
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and a hinge region, thus changes to the redox state of Cys379 may affect protein conformation 
(Lay et al., 2002). ATP Synthase subunit D (ATP5H) was identified as redox sensitive for 
Cys101 and although remaining in reduced form in both adult and aged samples, the reduced 
state decreased from 51.7 to 37.6. 
In summary, although a number of changes were observed in energy metabolism 
proteins in mouse quadriceps, only the changes to GAPDH appeared to have a sufficient impact 
on enzyme function, reducing it with age.  
Label Free Analysis with GOrilla and STRING 
 GOrilla pathway analysis enabled a gene ontology assessment using the label free 
proteomics data and STRING helped to identify protein-protein interactions but also included 
information regarding gene ontology to better categorise functional groups of proteins. 
Combined, these results build on the global label free data heat map (figure 3.3.3.2) and 
volcano plot (figure 3.3.3.3) by highlighting the quadriceps proteomics data containing key 
proteins involved in the cytoskeleton and contractile activity. This is an important finding as it 
indicates which types of proteins are predominantly susceptible to ageing in the mouse 
quadriceps. 
Differentially Labelled Protein Datasets Comparison using VennDIS Followed by STRING 
Analysis of this Data 
 Initially the data was prepared via VennDIS to isolate just redox proteins in muscle 
from adult, old or both ages of mice. This was repeated for reduced and reversibly oxidised 
proteins. In summary, the VennDIS analysis of differentially labelled proteins helped to 
identify some changes to proteins of interest. In the redox and reduced proteins many energy 
metabolism proteins were observed in adult but not old mice indicating a change in energy 
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metabolism. This initial insight was then taken a stage further to attempt to identify any protein 
interactions via the use of STRING. 
Pathway analysis took the differentially labelled proteins and used VennDIS to initially 
examine data from muscles of adult and old mice (section 3.3.9), and subsequently into redox, 
reduced and reversibly oxidised proteins. Reduced proteins in muscle of adult mice were 
enriched for oxidative phosphorylation in figure 3.3.9.1. This highlighted three interactions 
between two ATP synthase subunits, an NADH dehydrogenase subunit and an acyl carrier 
protein. 
The data in figure 3.3.9.2 looked at redox proteins from adult and old mice enriched for 
glycolysis/gluconeogenesis. This highlighted several metabolomics proteins that had 
undergone redox labelling. Of those Pyruvate dehydrogenase is a key metabolome protein 
which links the tricarboxylic cycle to the glycolytic pathway (Seifert et al., 2007). Reduced 
proteins from adult and old mice enriched for both oxidoreductase figure 3.3.9.2A and 
oxidative phosphorylation (figure 3.3.9.2B). In both figures metabolic proteins were identified. 
In 3.3.9.2A Peroxiredoxin 1 and 5 suggested a maintained requirement for mitochondrial and 
some cytoplasmic control of ROS (specifically H2O2), along with Protein disulphide isomerase 
and a number of metabolic proteins. Enrichment was also performed for oxidative 
phosphorylation and highlighted succinate dehydrogenase and ATP synthase amongst other 
proteins highlighting alternative metabolic pathways. 
Figure 3.3.9.4 shows reversibly oxidised proteins from adult and old mice enriched for 
oxidative phosphorylation. Reversibly oxidised data was enriched for oxidative 
phosphorylation and identified two cytochrome b-c1 complex proteins and NADH 
dehydrogenase both of which are involved in the mitochondrial respiratory chain. Reversibly 
oxidised proteins suggest disulphide bridge formation prior to detection.  
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The cytochrome b-c1 complex is involved in the mitochondrial respiratory chain and 
changes have been implicated due to increases in ROS with age (Crofts, 2004, Boffoli et al., 
1996). Furthermore, the redox cysteine data for subunits 1 and 2 of cytochrome b-c1 complex 
became more reversibly oxidised with age. This was seen in the reversibly oxidised data for 
old mice and may suggest irreversible modifications of the protein with age in quadriceps. 
Another energy metabolism protein, NADH dehydrogenase, is a known producer of ROS in 
mitochondria (Marchi et al., 2012) and was observed in the reversibly oxidised list. 
Interestingly, one study identified a mutation to NADH dehydrogenase which imparted 
longevity on fibroblasts (Schauer et al., 2015). Reversibly oxidised protein from adult and old 
mice had no STRING datasets due to limited numbers of identified proteins within these 
categories therefore no statistically significant interactions could be inferred by the software. 
Overall, the STRING protein-protein interactions analysis of the redox cysteine data 
has highlighted a range of protein interactions that support other data regarding the 
predominant changes in quadriceps with age affecting cytoskeletal proteins.  
Motif-X Analysis of Redox Data 
Motif-X analysed conserved amino acids in redox, reduced and reversibly oxidised 
peptides lists for adult and old mice with all parameters including a significance of p ≤ 0.01. 
Figure 3.3.10A (redox peptides from adult mice) highlighted a conserved threonine at +1 from 
a central cysteine residue in adult quadriceps muscle. Figure 3.3.10D (quadriceps from old 
mice) highlighted a conserved isoleucine at +4 from the central cysteine. These two results 
highlight the likelihood of changes to the amino acid sequence and in addition to previous data 
demonstrating the effect of a change in redox state. Furthermore, both serve to highlight the 
variety of changes that a protein can undergo with age and lead the way to investigating how 
this impacts protein function as a possibility for future studies.  
134 
 
3.5 Conclusions 
 In conclusion this work has successfully identified changes to redox-sensitive and 
cytoskeletal proteins that occur in the quadriceps with increasing age. The results indicate that 
the predominant change with age affects cytoskeletal and contractile proteins. Other changes 
seen included redox sensitive proteins such as PARK7 and its sulphonylated form. This and 
the differential labelling data together indicate an increase in the reduced state of a range of 
proteins. It is thought this may impart an increased ‘redox stiffness’ as the proteins are less able 
to react to redox changes. The physiological outcome may be the observed increase in 
‘stiffening’ of skeletal muscle, caused by this increase in abundance of cytoskeletal proteins. 
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CHAPTER 4 
 
STUDY OF THE SOLEUS MUSCLE 
 
 
 
 
 
 
 
4.1 Introduction 
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The soleus muscle is predominantly made up of slow twitch fibres and is located under 
the quadriceps on the lower mouse hind limbs (Wang and Kernell, 2001, Kammoun et al., 
2014). This muscle was selected for study due to its primary use of oxidative phosphorylation 
for energy generation and to investigate if ageing affects this muscle in a similar way to the 
quadriceps. Energy metabolism for soleus muscle is predominantly via oxidative 
phosphorylation, an aerobic mechanism that occurs in the inner mitochondrial membrane and 
produces Adenosine Triphosphate (ATP) following the degradation of succinate produced via 
the tricarboxylic acid cycle (TCA). This takes longer to act and therefore soleus muscle fibres 
are utilised in endurance actions (Leijendekker and Elzinga, 1990). The techniques performed 
in this chapter and details regarding proteins of interest have been discussed previously in the 
overall Introduction of chapter one and the introduction to the Quadriceps muscle results 
(chapter 3). 
4.2 Aims and Hypothesis 
The aim of this study was to identify age-related changes to the soleus via the use of 
mass spectrometry for proteomics analysis of intracellular proteins and their redox states.  
It was hypothesised that the redox state of intracellular soleus proteins would change 
with age. 
4.3 RESULTS 
4.3.1 Muscle Weights 
Soleus muscles were dissected from male C57BL/6 mice at 3, 12 and 24 months of age 
and the weights of both the mice and the individual soleus muscles were recorded. Body 
weights (figure 3.4.1.1A) demonstrated a significant increase from 3 to 12 months. Figure 
4.4.1.1, below, shows no significant change occurred in soleus muscle weight with age. 
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Figure 4.3.1.1 Soleus muscle weights. N=6 biological replicates for each age. 
4.3.2 Succinate Dehydrogenase Staining of Soleus Muscle 
Succinate dehydrogenase (SDH) staining showed the overall oxidative capacity mouse 
skeletal muscle cells. The data in figure 4.3.2.1 highlights differences in the soleus muscles 
between adult (4.3.2.1A) and old (4.3.2.1B). Visual analysis of the images shows a reduction 
in the cellular oxidative capacity with age by the reduction in intensity of the blue/purple dye. 
As per the previous chapter, these images were not quantified and are presented to highlight 
the differences with age between fibres from adult and old mice prior to the detailed proteomic 
and biochemical analysis that follows. 
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Figure 4.3.2.1 (A) Adult soleus muscle stained for succinate dehydrogenase and (B) old soleus 
muscle. 
 
4.3.3 Global Label Free Proteomics Data Analysis 
For proteomic assessment, PEAKS7 was used to identify detected proteins in the 
samples and perform label free relative quantification. For label free relative quantification, 
proteins were deemed significantly changed when they had a –10 log P of >20 (equivalent to 
p value of 0.01), a fold change of >1.5 and a quality value of 0.8. These parameters ensured a 
good minimum standard of confidence in the comparison of protein abundance. The heat map 
in figure 4.3.3.1 shows the significantly changed proteins identified in soleus muscle from adult 
and old mice. Red signifies an up regulation and green a down regulation of the protein via the 
log2 ratio. The label free proteomics data can be accessed online as S5 – Soleus All Detected 
Proteins; S6 – Soleus Significantly Changed Proteins at 10.17638/datacat.liverpool.ac.uk/437. 
A multicomponent analysis (MCA) of the global label free proteomics data highlighted 
correlations within each data set and between the adult and old data. The blue value at the top 
of each box is the R2 value, indicating the statistical measure of the data to the fitted regression 
A) B)
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line. A high value indicates a tight fit to the regression line. A number of data points appear to 
be more widely spread suggesting increased variation amongst proteins in the soleus samples. 
 
Figure 4.3.3.1 Multicomponent analysis of detected soleus proteins when compared across 
different samples to identify variation between samples. 
 
The heat map in figure 4.3.3.2 illustrates differential expression of a number of 
proteins including many involved in the energy metabolism pathways such as the cytosolic 
proteins cAMP dependent protein kinase (KAP2), Glycogen phosphorylase (PYGM) and 
Glyceraldehyde 3-Phosphate dehydrogenase (G3P) all of which were significantly decreased 
with age. Conversely, Heat shock protein β-3 (HSPB3) occurs in the cytoplasm (and nucleus) 
and was significantly increased with age. Mitochondrial proteins detected include Isocitrate 
dehydrogenase (IDH3A), 2-oxoglutarate dehydrogenase (ODO1), Pyruvate dehydrogenase 
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(ODPB) and Cytochrome c oxidase (COX7C) all of which are significantly decreased with 
age and mitochondrial Aconitate hydratase (ACON) was significantly increased with age. 
 
Figure 4.3.3.2 Heat map of the log2 ratio fold change of significantly changed soleus muscle 
proteins comparing muscle of adult (n=5) and old (n=5) mice. Clear differences in up and down 
regulation of detected proteins are identified. Red indicates an increase and green a decrease in 
fold change. Label free significance was determined using a peptide quality of 0.8, a 
significance score of –10 log P of >20 (equivalent to p value of < 0.01) and a fold change of 
>1.5. 
Soleus
Min. Fold change 1.5; Quality 0.8; Significance p<0.01
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 A volcano plot was used to highlight a number of significantly changed metabolic 
proteins from the global label free proteomics data by comparing significance -10 log P 
significance with log2 fold change (figure 4.3.3.3). Proteins significantly down-regulated 
according to the label free proteomics data were highlighted and included a large number of 
energy metabolism proteins such as cAMP-dependent protein kinase type II-α regulatory 
subunit (KAP2/PRKAR2A), trifunctional enzyme subunit β (ECHB/HADHB, mitochondrial), 
glyceraldehyde-3-phosphate dehydrogenase (G3P/GAPDH), pyruvate dehydrogenase E1 
component subunit α (ODPA/PDHA1, mitochondrial), dihydrolipoyllysine-residue 
acetyltransferase component of pyruvate dehydrogenase complex (ODP2/DLAT, 
mitochondrial), 2-oxoglutarate dehydrogenase (ODO1/OGDH, mitochondrial), pyruvate 
dehydrogenase E1 component subunit β (ODPB/PDHB, mitochondrial), ATP synthase subunit 
d (ATP5H, mitochondrial), cytochrome c oxidase subunit 7C (COX7C, mitochondrial), 
Aldehyde dehydrogenase (ALDH2, mitochondrial), 3-ketoacyl-CoA thiolase (THIM/ACAA2, 
mitochondrial), acetyl-CoA acetyltransferase (THIL/ACAT1, mitochondrial), cytochrome b-
c1 complex subunit 6 (QCR6/UQCRFS1, mitochondrial), cytochrome b-c1 complex subunit 9 
(QCR9/UQCR10), NADH dehydrogenase 1 β subcomplex subunit 10 (NDUBA/NDUFB10), 
ATP synthase subunit g (ATP5L, mitochondrial). Another protein, the four and a half LIM 
domains protein 1 (FHL1) has been implicated in maintaining striated muscle function by 
aiding development or hypertrophy (Chu et al., 2000). Galectin-1 (LEG1/LGALS1) is involved 
in apoptosis, proliferation and differentiation, possibly enabling the physiological adaptation 
of skeletal muscle (Kami and Senba, 2005). The glycolytic and muscle contraction protein 
phosphoglycerate mutase 2 (PGAM2), prostaglandin G/H synthase 1 (COX1/PTGS1) involved 
in a range of functions and the phosphate transporter phosphate carrier protein (MPCP  
SLC25A3, mitochondrial). The significantly up-regulated proteins were highlighted in red and 
included Ig μ chain C region (IGHM), the key energy metabolism proteins aconitate hydratase 
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(ACON/ACO2, mitochondrial), ATP synthase subunit α (ATPA/ATP5A1, mitochondrial), 
electron transfer flavoprotein subunit β (ETFB), fructose-bisphosphate aldolase A (ALDOA). 
The lipid peroxidation protection protein phospholipid hydroperoxide glutathione peroxidase 
(GPX41/GPX4, mitochondrial) and the Calcium binding and storage protein calsequestrin-1 
(CASQ1). Significance is defined as -10 log P (equivalent to p <0.01), a fold change >1.5 and 
a peptide quality of 0.8. Together these results indicate a general down regulation of energy 
metabolism proteins in the soleus muscle as it ages in mice. 
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Figure 4.3.3.3 Volcano plot highlighting proteins from the global label free proteomics data for soleus muscle. The significantly down-regulated proteins 
highlighted in green are Four and a half LIM domains protein 1 (FHL1), cAMP-dependent protein kinase type II-α regulatory subunit (KAP2), Trifunctional 
enzyme subunit β (ECHB, mitochondrial), Glyceraldehyde-3-phosphate dehydrogenase (G3P), Pyruvate dehydrogenase E1 component subunit α (ODPA, 
mitochondrial), Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex (ODP2, mitochondrial), 2-oxoglutarate 
dehydrogenase (ODO1, mitochondrial), Pyruvate dehydrogenase E1 component subunit β (ODPB, mitochondrial), ATP synthase subunit d (ATP5H, 
mitochondrial), Cytochrome c oxidase subunit 7C (COX7C, mitochondrial), Galectin-1 (LEG1), Aldehyde dehydrogenase (ALDH2, mitochondrial), 3-ketoacyl-
CoA thiolase (THIM, mitochondrial), Acetyl-CoA acetyltransferase (THIL, mitochondrial), Cytochrome b-c1 complex subunit 6 (QCR6, mitochondrial), 
Cytochrome b-c1 complex subunit 9 (QCR9), NADH dehydrogenase 1 β subcomplex subunit 10 (NDUBA), Phosphoglycerate mutase 2 (PGAM2), ATP synthase 
subunit g (ATP5L, mitochondrial), Prostaglandin G/H synthase 1 (COX1), Phosphate carrier protein (MPCP, mitochondrial). The significantly up-regulated 
proteins highlighted in red are Ig μ chain C region (IGHM), Aconitate hydratase (ACON, mitochondrial), Calsequestrin-1 (CASQ1), ATP synthase subunit α 
(ATPA, mitochondrial), Electron transfer flavoprotein subunit β (ETFB), Fructose-bisphosphate aldolase A (ALDOA), Phospholipid hydroperoxide glutathione 
peroxidase (GPX41, mitochondrial). Significance is defined as a significance of –10 log P of >20 (equivalent to p value of 0.01), a fold change >1.5 and a peptide 
quality of 0.8.
Proteins Significantly Changed in Abundance for Soleus Muscle 
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4.3.4 Western Blotting and Enzyme Activity Assays 
 Western blotting complimented the label free proteomics analysis and where possible 
verified the observed results. Enzyme activities were included along-side the appropriate blots 
for Thioredoxin, Thioredoxin Reductase and Aconitase. Label free proteomics data was 
determined using a peptide quality of 0.8, a significance score of –10 log P of >20 (equivalent 
to p value of 0.01) and a fold change >1.5. Table 3 lists the primary antibodies used here. 
The thioredoxin system proteins across 3, 12 and 24 months of age are shown in figure 
4.3.4.1A-D demonstrating no significant change to Thioredoxin 1 abundance with age as was 
supported by the label free proteomics data. The enzyme activity assay for both Thioredoxin 1 
and Thioredoxin Reductase 1 also showed no change with age in figures 4.3.4.1B and D 
respectively. Figure 4.3.4.1E shows a significant decrease in protein abundance for 
Thioredoxin Interacting Protein (TXNIP) with a significant decrease from 3 to 12 months (p 
<0.001) and from 3 to 24 months (p <0.001). Peroxiredoxin 1 showed a significant decrease (p 
<0.05) in protein abundance from 12 to 24 months in figure 4.3.4.1F. Peroxiredoxin 4 showed 
a significant increase in abundance from 3 to 24 (p <0.01) and 12 to 24 months (p <0.05) in 
figure 4.3.4.1G. Peroxiredoxin 6 (figure 4.3.4.1H) showed no significant change in abundance 
with age. In contrast the relative quantitation using global label free analysis demonstrated no 
significant changes to thioredoxin or any of the peroxiredoxins between adult and old soleus 
muscle samples (figures 4.3.4.1I and J). Note that the analysis was performed on two gels 
simultaneously, hence the two Ponceau stains (figures 4.3.4.1K and L). Thioredoxin 1, 
Thioredoxin Reductase 1 and Peroxiredoxin 6 were tested on the first gel and Peroxiredoxin 1, 
Peroxiredoxin 4 and Thioredoxin Interacting Protein tested on the second gel due to their 
respective molecular weights. Furthermore, as described later, Aconitase was tested using the 
same blot following stripping and re-probing of the membrane as described in the methods 
(p.52). 
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Table 3. Primary and Secondary Antibody List for Western Blotting 
 
Table 3. Primary and HRP-conjugated secondary antibodies used for soleus western blotting. N.B. “Full Blot” required the whole membrane for 
imaging. 
Name Abbreviation Mw Company Product Code LOT # Dilution
Blocking 
Agent
Secondary Reqd.
Aconitase Acon. 86 kDa Abcam ab129069 GR81376-7 1:5000 3% Milk Anti-Rabbit
AMP kinase alpha AMPk 62 kDa Cell Signalling Technology - #19 1:1000 3% BSA Anti-Rabbit
Carbonylation Anti-DNP Full Blot Invitrogen 713500 - 1:1000 5% Milk Anti-Rabbit
Copper-Zinc Super Oxide Dismutase SOD1 16 kDa Enzo ADI-SOD-100 1051228 1:1000 3% Milk Anti-Rabbit
DJ-1/PARK7 - SO3H DJ-1/PARK7-SO3H 20 kDa Abcam ab169520 GR121877-7 1:1000 3% Milk Anti-Rabbit
Peroxiredoxin 1 Prdx1 22 kDa Abcam ab15571 GR49827-2 1:1000 3% Milk Anti-Rabbit
Peroxiredoxin 3 Prdx3 27 kDa Abcam ab16751 GR40935-1 1:1000 3% Milk Anti-Rabbit
Peroxiredoxin 4 Prdx4 29 kDa Abcam ab16943 GR140162-1 1:1000 3% Milk Anti-Mouse
Peroxiredoxin 6 Prdx6 25 kDa Abcam ab133348 GR145006-1 1:1000 3% Milk Anti-Rabbit
Peroxiredoxin-SO3H Prx-SO3H Full Blot Abcam ab16830 - 1:1000 3% Milk Anti-Rabbit
Thioredoxin 1 Trx1 12 kDa Abcam ab86255 GR43357-5 1:1000 3% Milk Anti-Rabbit
Thioredoxin Reductase 1 TXNRD1 55 kDa Abcam ab16840 GR172892-1 1:2000 3% BSA Anti-Rabbit
Thioredoxin Interacting Protein TXNIP 45 kDa Abcam ab86993 GR132784-1 1:1000 3% Milk Anti-Mouse
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Figure 4.3.4.1. (A) Densiometric measurement for immunodetection by western blotting of 
Thioredoxin 1.  (B) Enzyme activity assay performed for Thioredoxin (non-specific, detecting 
both TRX1 and TRX2). (C) Densiometric measurement for immunodetection by western 
blotting data for Thioredoxin Reductase 1 (TRXR1). (D) Enzyme activity assay performed for 
Thioredoxin Reductase (non-specific, detecting both TRXR1 and TRXR2). (E) Densiometric 
measurement for immunodetection by western blotting for Thioredoxin Interacting Protein 
(TXNIP), ** p < 0.01, *** p < 0.001. (F) Densiometric measurement for immunodetection by 
western blotting of Peroxiredoxins 1, * p < 0.05. (G) Densiometric measurement for 
immunodetection by western blotting of Peroxiredoxins 4. * p < 0.05, ** p < 0.01. (H) 
Densiometric measurement for immunodetection by western blotting of Peroxiredoxins 6. (I) 
Label free proteomics result for Thioredoxin 1 comparing 12 and 24 month old muscle. (J) 
Label free proteomics result for Peroxiredoxins 1, 2, 5 and 6, comparing 12 and 24 month old 
muscle. (K) The Ponceau S stain used for normalisation of (A, C & H) with the soleus section 
highlighted in red. (L) The Ponceau S stain used for normalisation of (E, F & G) with the soleus 
section highlighted in red. In all cases n=3 biological replicates. Short bars indicate upper and 
lower interquartile range while the middle represents the median value following statistical 
analysis using ANOVA with Tukey’s post-hoc test. 
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Cu-Zn Superoxide Dismutase (SOD1) is shown in figure 4.3.4.2 and indicates a 
significant increase in protein abundance from 3 to 24 months of age although the proteomics 
result did not indicate a significant change from adult (12 months) to old (24 months). 
 
Figure 4.3.4.2. (A) Densiometric measurement for immunodetection by western blotting of 
Cu-Zn Superoxide Dismutase (SOD1). * p < 0.05. (B) Ponceau S stain used for normalisation. 
(C) Label free proteomics result for SOD1 in soleus muscle between adult and old mice. N=3 
biological replicates. Short bars indicate upper and lower interquartile range while the middle 
represents the median value following statistical analysis using ANOVA with Tukey’s post-
hoc test. 
 
Figure 4.3.4.3 shows sulphonylated peroxiredoxins in which the western blot 
demonstrated no significant changes with age. However, only one protein band out of three 
appeared for the 24 months samples and taking the sole protein sample at 24 months into 
account, there appears to be little change in protein abundance with age.  
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Figure 4.3.4.3. Sulphonylated Peroxiredoxins (Prdx-SO3H) demonstrate sustained 
intracellular reactive oxygen species leading to irreversible modifications of Peroxiredoxins in 
soleus muscle. (A) The Densiometric measurement for immunodetection by western blotting 
antibody detected Peroxiredoxins 1-4 at 22 kDa. (B) Ponceau S stain used for normalisation. 
N=3 biological replicates. Short bars indicate upper and lower interquartile range while the 
middle represents the median value following statistical analysis using ANOVA with Tukey’s 
post-hoc test. 
 
 Following the analysis of several redox sensitive proteins, energy metabolism proteins 
were then analysed. Figure 4.3.4.4 shows mitochondrial Aconitase protein abundance and the 
results show no significant change with age. The enzyme activity assay showed a significant 
increase (p <0.01) in activity with age from 3 to 12 months. In contrast the global label free 
proteomics analysis of Aconitase identified a significant increase in abundance with age from 
12 to 24 months of age in soleus muscle. When conflicting results between western blot and 
mass spectrometry occur, we assume the mass spectrometry data takes precedence due to the 
increased sensitivity of the technique. This is discussed in detail in experimental considerations 
and limitations (p.221). Furthermore, this was performed on a stripped membrane following its 
prior use for protein abundances detailed in figure 4.3.4.1. The details of this method are 
described in methods (p.53). 
 
3 Months 12 Months 24 Months
22 kDa 
3 12 24M
w
25 kDa -
20 kDa -
15 kDa -
37 kDa -
50 kDa -
75 kDa -
100 kDa -
150 kDa -
A) B)
3  M o n th s 1 2  M o n th s 2 4  M o n th s
0 .0 0
0 .0 5
0 .1 0
0 .1 5
S u lp h o n y la te d  P e ro x ir e d o x in s  (P rd x 1 -4 )
A g e
R
e
la
ti
v
e
  
In
te
n
s
it
y
149 
 
 
Figure 4.3.4.4. Aconitase (ACO2) in mouse soleus muscle. (A) Densiometric measurement for 
immunodetection by western blotting of 3, 12 and 24 month samples. (B) Enzyme activity 
assay performed for Aconitase. ** p < 0.01. (C) The Ponceau S stain used for normalisation of 
(A) with the relevant soleus samples highlighted in red. (D) Global label free proteomics result 
for Aconiotase. N=3 biological replicates. Short bars indicate upper and lower interquartile 
range while the middle represents the median value following statistical analysis using 
ANOVA with Tukey’s post-hoc test. 
 
Figure 4.3.4.5A shows the sulphonylated form of PARK7 (PARK7-SO3H) and showed 
no significant change in protein abundance. However, two samples did not show any band 
anticipated for the 24 month samples. No significant difference was observed between 3 and 
12 months. The global label free proteomics analysis (figure 4.3.4.5C) showed no significant 
change with age from 12 to 24 months in the mouse soleus. Additionally the energy metabolism 
protein Adenosine monophosphate kinase (AMPK) (figure 4.3.4.5B) was analysed. The 
western blot results showed no significant change to protein abundance with age if the single 
band present at 24 months is taken into consideration due to a similar issue as presented in 
figure 4.3.4.5A with only one of the three 24 month protein bands observable. The global label 
free proteomics results (figure 4.3.4.5D) identified the subunits of AMPK and showed no 
change to KAPCA (or PRKACA). However, KAP2 (or PRKAR2A) did show a significant 
decrease with age from 12 to 24 months. 
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Figure 4.3.4.5. (A) Densiometric measurement for immunodetection by western blotting of 
sulphonylated Park7 (PARK7-SO3H). (B) Densiometric measurement for immunodetection by 
western blotting of AMP-kinase. (C) Global label free proteomics result for PARK7-SO3H.  
(D) Global label free proteomics results for two subunits of AMPK: KAPCA (or PRKACA) 
and Kap2 (PRKAR2A). (E) Ponceau S stain used for normalisation of both A and B. N=3 
biological replicates. Short bars indicate upper and lower interquartile range while the middle 
represents the median value following statistical analysis using ANOVA with Tukey’s post-
hoc test. 
 
 Carbonylated proteins are those modified with a carbonyl group (C=O) and is another 
product of sustained increases in intracellular ROS concentrations with age. The data are shown 
in figure 4.3.4.6 and showed no significant change in protein carbonyl abundance with age.  
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Figure 4.3.4.6. A Carbonyl blot used to identify carbonylated proteins in soleus muscle 
samples. (A) Densiometric measurement for immunodetection by western blotting of protein 
carbonylation in mouse soleus muscle at 3, 12 and 24 months. (B) Ponceau S stain used for 
normalisation of (A). N=3 biological replicates. Short bars indicate upper and lower 
interquartile range while the middle represents the median value following statistical analysis 
using ANOVA with Tukey’s post-hoc test. 
 
The results of various protein abundance changes in mouse soleus therefore showed a 
varied response to ageing. Significantly less protein was obtained due to the size of the mouse 
soleus compared with the quadriceps muscle, this was reflected in the number of western blots 
that could be performed compared to the quadriceps. This directly impacted the extent of the 
analysis of ageing using western blotting since several proteins were not detected and repeat 
blots unfeasible. 
4.3.5 GOrilla Pathway Analysis 
 GOrilla analysis uses the global label free proteomics data to determine pathway 
relationships between ontological terms. In the soleus there was an emphasis on energy 
metabolism terms and this was reflected in the pathways highlighted with significance and 
includes mitochondrial components, metabolic proteins and oxido-reductase activity.  
GOrilla analysis of biological processes highlighted a number of potential pathways 
from the initial label free proteomics dataset. Thioester metabolic process and Acyl Co-A 
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metabolic process; TCA metabolic process, Citrate metabolic process and TCA cycle; Acyl 
Co-A biosynthetic process from pyruvate and mitochondrial Acyl Co-A biosynthetic process 
from pyruvate. These pathways suggest a predominance of the metabolic pathway proteins 
identified in soleus muscle. 
GOrilla analysis of cellular components highlights pyruvate dehydrogenase complex, 
mitochondrion, organelle inner membrane, mitochondrial membrane and mitochondrial inner 
membrane. As per the biological processes identified in figure 4.3.5.1, this suggests a 
predominance in energy metabolism, specifically of proteins located to the mitochondrial 
membrane. 
Molecular function analysis via GOrilla highlighted a number of functions by 
identifying significant ontological changes to terms connected predominantly with 
mitochondrial metabolic processes including a number of oxido-reductase activities and certain 
energy metabolism pathways such as pyruvate dehydrogenase activities. This range of 
pathways identify coenzyme factor turnover in the soleus and overall the analysis highlights an 
emphasis on metabolic in activity in the soleus supported by previous global label free data 
such as the heat map and volcano plots of figures 4.3.3.1 and 4.3.3.2 respectively.
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Figure 4.3.5.1 GOrilla analysis of biological process in soleus muscle. Highlighted terms were those determined to contain statistically significant relationships 
(p ≥ 10-3 ≤ 10-5). 
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Figure 4.3.5.2 GOrilla cellular components in soleus muscle. Terms highlighted were those determined to contain statistically significant relationships (p ≥ 10-3 
≤ 10-5). 
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Figure 4.3.5.3 GOrilla analysis of soleus muscle molecular function. Terms highlighted were those determined to contain statistically significant relationships 
(p ≥ 10-3 ≤ 10-5).
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4.3.6 STRING Analysis of Significantly Changed Label Free Data 
 STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) analysis 
highlights protein-protein interactions based on experimental evidence. The reference to gene 
ontologies enables the classification of groups of proteins from those detected in the mouse 
soleus label-free proteomics dataset. This enables identification of changes to protein-protein 
interactions within a group of similarly-functioning proteins. This was only performed on the 
significantly down regulated proteomics data as only a few proteins that were significantly up 
regulated were detected in the soleus muscle. 
Figure 4.3.6.1 used the significantly down regulated dataset to highlight protein 
interactions for oxidation-reduction processes. This showed a large number of mitochondrial 
specific proteins involved in the electron transport chain such as subunits of Cytochrome b-c1 
complex (UQCRH and UQCRC10) to three NADH dehydrogenases and GAPDH. The data 
presented here is detailed in table 4 which includes all proteins plus their associated label free 
proteomics data. 
 
Figure 4.3.6.1 Significantly down regulated proteins in the soleus muscle. (A) The whole 
dataset of 78 proteins. (B) Following enrichment for oxidation-reduction processes, 23 proteins 
are highlighted. (C) STRING data including the false detection rate for the interaction analysis. 
#pathway ID pathway description observed gene count false discovery rate
GO.0055114 oxidation-reduction process 23 2.00E-11
A) B)
(C) 
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Table 4 Significantly Down Regulated Proteins for STRING Analysis 
 
Table 4. Global label free proteomics results for the significantly down regulated proteins used in figure 4.3.6.1 for STRING analysis. 
Accession Label Significance (-10lgP) Group Profile (Ratio) Description
Q60597 ODO1 80.24 1.00:0.41 2-oxoglutarate dehydrogenase  mitochondrial OS=Mus musculus GN=Ogdh PE=1 SV=3
P42125 D3D2 58.75 1.00:0.62 3 2-trans-enoyl-CoA isomerase  mitochondrial OS=Mus musculus GN=Dci PE=2 SV=1
P47738 ALDH2 42.86 1.00:0.35 Aldehyde dehydrogenase  mitochondrial OS=Mus musculus GN=Aldh2 PE=1 SV=1
P45376 ALDR 21.53 1.00:0.57 Aldose reductase OS=Mus musculus GN=Akr1b1 PE=1 SV=3
Q924X2 CPT1B 27.12 1.00:0.14 Carnitine O-palmitoyltransferase 1  muscle isoform OS=Mus musculus GN=Cpt1b PE=2 SV=1
P50172 DHI1 21.23 1.00:0.23 Corticosteroid 11-beta-dehydrogenase isozyme 1 OS=Mus musculus GN=Hsd11b1 PE=1 SV=3
P99028 QCR6 39.21 1.00:0.61 Cytochrome b-c1 complex subunit 6  mitochondrial OS=Mus musculus GN=Uqcrh PE=1 SV=2
Q8R1I1 QCR9 35.15 1.00:0.48 Cytochrome b-c1 complex subunit 9 OS=Mus musculus GN=Uqcr10 PE=1 SV=1
P17665 COX7C 58.1 1.00:0.52 Cytochrome c oxidase subunit 7C  mitochondrial OS=Mus musculus GN=Cox7c PE=1 SV=1
Q8BMF4 ODP2 86.07 1.00:0.30 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex  mitochondrial OS=Mus musculus GN=Dlat PE=1 SV=2
P16858 G3P 93.31 1.00:0.44 Glyceraldehyde-3-phosphate dehydrogenase OS=Mus musculus GN=Gapdh PE=1 SV=2
Q9WUB3 PYGM 22.63 1.00:0.59 Glycogen phosphorylase  muscle form OS=Mus musculus GN=Pygm PE=1 SV=3
Q9R062 GLYG 20.45 1.00:0.62 Glycogenin-1 OS=Mus musculus GN=Gyg1 PE=2 SV=3
Q9D6R2 IDH3A 84.62 1.00:0.21 Isocitrate dehydrogenase [NAD] subunit alpha  mitochondrial OS=Mus musculus GN=Idh3a PE=1 SV=1
Q9JHI5 IVD 33.04 1.00:0.29 Isovaleryl-CoA dehydrogenase  mitochondrial OS=Mus musculus GN=Ivd PE=1 SV=1
Q8VCD7 KDM4C 89.79 1.00:0.24 Lysine-specific demethylase 4C OS=Mus musculus GN=Kdm4c PE=1 SV=1
Q9CQ91 NDUA3 22.19 1.00:0.54 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 OS=Mus musculus GN=Ndufa3 PE=1 SV=1
Q9DCS9 NDUBA 34.34 1.00:0.53 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 OS=Mus musculus GN=Ndufb10 PE=1 SV=3
Q9DC70 NDUS7 21.78 1.00:0.64 NADH dehydrogenase [ubiquinone] iron-sulfur protein 7  mitochondrial OS=Mus musculus GN=Ndufs7 PE=1 SV=1
P35486 ODPA 80.8 1.00:0.13 Pyruvate dehydrogenase E1 component subunit alpha  somatic form  mitochondrial OS=Mus musculus GN=Pdha1 PE=1 SV=1
Q8BMS1 ECHA 50.21 1.00:0.02 Trifunctional enzyme subunit alpha  mitochondrial OS=Mus musculus GN=Hadha PE=1 SV=1
Q99JY0 ECHB 92.84 1.00:0.15 Trifunctional enzyme subunit beta  mitochondrial OS=Mus musculus GN=Hadhb PE=1 SV=1
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A significant number of mitochondrial proteins were down regulated in the soleus with 
age. This highlights a distinct change to energy metabolism requirements in mouse soleus 
muscle as it ages. 
4.3.7 Redox Changes in Mouse Soleus with Age 
 Redox cysteines were identified via differential labelling of soleus proteins using (d0-
NEM and d5-NEM). It was postulated that a reduction in redox sensitive cysteines may impact 
the activity and therefore function of proteins. 
 Figure 4.3.7.1 indicates the numbers of redox, reduced and reversibly oxidised proteins 
in mouse soleus muscles for adult and old mice. The numbers indicate an overall increase in 
reversibly oxidised and reduced proteins in samples from old mice whereas a decrease in redox 
proteins was observed in adult mice. In the adult soleus, 173 proteins were detected and in the 
24 month old, 174 were detected. Within the numbers of proteins detected there were a variety 
of differences between the different ages. The redox protein lists for adult and old soleus files 
archived as S7 – Soleus Adult Redox Proteins; S8 – Soleus Old Redox Proteins can be accessed 
at 10.17638/datacat.liverpool.ac.uk/437. 
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Figure 4.3.7.1 Numbers of proteins containing redox, reduced and reversibly oxidised 
cysteine-containing peptides in soleus muscle from adult and old mice. 
 
 The reduction in the number of redox sensitive cysteine containing proteins in soleus 
muscles of old mice may indicate a reduced flexibility in the protein to perform its function, or 
on a larger scale, a reduced ability of the cell to control or react to change in intracellular ROS 
concentrations.  
Table 5 combines the global label free data on changes in protein significance with the 
group ratio difference of adult and old to indicate whether a protein changes its redox state with 
age. There was a significant representation of mitochondrial specific proteins as demonstrated 
by the proportion of energy metabolism proteins (e.g. cytochromes) relative to the number of 
cytoskeletal proteins when this data is compared to the quadriceps (see Chapter 5, p.184 for 
greater detail in comparing the muscles).
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Table 5. Redox Cysteines in Soleus Muscle 
 
Table 5. Redox-cysteine containing proteins detected via differential labelling. Significantly changed proteins are highlighted in bold and tryptic peptides are 
denoted with an asterisk (*).
161 
 
Together these protein modifications, in addition to those tested using western blotting 
support the initial global proteomics data indicating ageing in mouse soleus muscle 
predominantly affects energy metabolism proteins by causing an increase in their reduced 
redox state. 
Figure 4.3.7.2 shows redox peptides identified with both the d0-NEM and d5-NEM tags 
via tandem mass spectrometry and the figure reflects the data shown in Table 5. Several 
proteins are highlighted as increasing in their reduced state with age (suggesting a possible 
reduction in function) including a number of energy metabolism proteins such as NADH 
ubiquinone oxidoreductase (NDUFS1) Cys78 increasing 28.7 fold, Aspartate aminotransferase 
(GOT2) Cys295 6.86 fold, 2-oxoglutarate dehydrogenase (OGDH) Cys566 5.45 fold, ATP 
synthase subunit d (ATP5H) Cys101 5.19 fold, Cofilin-2 (CFL2) Cys80 5.12 fold and 
cytoplasmic Malate dehydrogenase (MDH1) Cys154 5.34 fold. Conversely Cytochrome b-c1 
complex subunit 2 (UQCRC2) Cys192, Cytochrome b-c1 complex subunit 6 (UQCRH) Cys51, 
Β-enolase (ENO3) 337/339*, Four and a half LIM domains proteins 1 (FHL1) Cys255 and 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) Cys150/154* and Isocitrate 
dehydrogenase (IDH2) Cys113 all demonstrated becoming less reduced with age with 
Isocitrate dehydrogenase being reversibly oxidised in adult mice soleus muscle and becoming 
more reversibly oxidised in old mice soleus muscle.
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Figure 4.3.7.2 Redox-cysteine containing proteins including the specific redox-cysteine number, ratio change with age between adult and old mouse soleus 
muscle. Values > 1.0 indicate a reduced state, values < 1.0 indicate a reversibly oxidised state. Data are derived from Table 5. 
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4.3.8 Comparison of Differentially Labelled Proteins with Age 
 Venn diagrams of the redox, reduced and reversibly oxidised proteins were produced 
using VennDIS software to identify differences between the proteins in the label free 
proteomics data between soleus muscles of adult and old mice. In all diagrams, the colours of 
each slice are arbitrary. The data are subsequently used for STRING analysis in section 4.3.9. 
All tables listing individual proteins for each figure are located in supplementary information. 
In figure 4.3.8.1 the redox, reduced and reversibly oxidised protein numbers were 
combined to consider overall differences between the soleus muscle of adult and old mice. 
Figure 4.3.8.1 highlights 46 proteins from the adult mouse soleus and includes energy 
metabolism proteins such as Aldehyde dehydrogenase (ALDH2) and Isocitrate dehydrogenase 
(IDH3A and IDH3G), Pyruvate dehydrogenase (PDHA1 and PDHB) and the cytosolic redox 
control protein Cu-Zn Superoxide Dismutase (SOD1). Proteins identified in samples of adult 
and old mice (127 proteins) in figure 4.3.8.1 include several energy metabolism proteins such 
as mitochondrial Aconitase (ACO2), various ATP synthases (ATP2A1, ATP2A3, ATP5A1, 
ATP5C1, ATP5E1 and ATP5H) and a number of NADH Oxidases. Data in figure 4.3.8.1 
(containing 47 proteins) from old mice include the energy metabolism ATP synthase subunits 
ATP1A1 and ATP5F1, the H2O2 controlling PRDX6 and protein chaperones PARK7 and 
HSP1 (Chaperonin). The individual proteins identified are in the supplementary information 
(Table 4.3.8.1 A/B/C, p. 254-256). 
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Figure 4.3.8.1 Venn diagram comparing differentially labelled proteins (redox, reduced and 
reversibly oxidised) from soleus muscle in adult and old mice identifying overall changes to 
differentially labelled proteins between the two groups. The individual protein lists are 
presented in the supplementary information (Table 4.3.8.1 A/B/C, p.254-256). 
 
 Figure 4.3.8.2 shows differentially labelled redox-only proteins (with both d0-NEM 
and d5-NEM) for adult mice (17 proteins). These highlight the redox control protein Cu-Zn 
Superoxide dismutase (SOD1) and a range of cellular energy metabolism proteins such as 
Glyceraldehyde 3-phosphate (GAPDH) and Isocitrate dehydrogenase 2 (IDH2). For proteins 
identified in soleus muscles for both adult and old mice (25 proteins) that were redox labelled, 
the list again included many energy metabolism proteins. Of note was Aconitase (ACO2). For 
proteins identified in the dataset for soleus muscle in old mice (5 proteins), of note was the 
ROS control protein Peroxiredoxin 6 (PRDX6). The individual proteins identified are 
presented in the supplementary information (Table 4.3.8.2 A/B/C, p.257-258). 
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Figure 4.3.8.2 Venn diagram of redox proteins in the soleus muscle of adult and old mice from 
those identified as differentially labelled with both standard N-ethylmaleimide (d0-NEM) and 
heavy N-ethylmaleimide (d5-NEM). The individual proteins identified are presented in the 
supplementary information (Table 4.3.8.2 A/B/C, p.257-258). 
 
 The Venn diagram in figure 4.3.8.3 shows proteins that were only reduced, that is 
containing only the d5-NEM labelling. The list from adult mice (35 proteins) includes a number 
of proteins involved in glutathione metabolism such as Glutathione S-transferase κ and π, the 
chaperone and redox sensor protein PARK7 and energy metabolism proteins Isocitrate 
dehydrogenase 3 (IDH3A) and Aldehyde dehydrogenase (ALDH). For the central slice, 
containing proteins identified in soleus muscle for both adult and old mice (83 proteins), a 
range of energy metabolism proteins were identified in addition to Heat shock proteins 3, 4 and 
6, and the mitochondrial ROS control protein Peroxiredoxin 3. In the soleus muscle from old 
mice (43 proteins), proteins of interest included the energy metabolism protein Glyceraldehyde 
3-phosphate dehydrogenase (GAPDH), Protein disulphide isomerase (P4HB), involved in the 
formation and cleavage of disulphide bonds, and Glutathione peroxidase (GPX4). The 
individual proteins identified are presented in the supplementary information (Table 4.3.8.3 
A/B/C, p.259-261). 
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Figure 4.3.8.3 Venn diagram of reduced labelled proteins (d0-NEM) in soleus muscle between 
adult and old mice. The individual proteins are presented in the supplementary information 
(Table 4.3.8.3 A/B/C, p.259-261). 
 
 Figure 4.3.8.4 shows proteins that were reversibly oxidised (containing only d5-NEM 
labelling). This identifies 4 proteins for adult muscles, 9 identified in soleus muscle from both 
adult and old mice and 9 proteins in soleus muscle from old mice. No particular proteins of 
interest to skeletal muscle ageing were observed in this dataset. In the set for adult mice 
collagen binding proteins (such as Fibromodulin) were observed and Cytochrome c oxidase 
(COX6B) for energy metabolism in both ages of mice. Finally, three immunoglobulins were 
observed in the reversibly oxidised data set for old mice. The individual proteins identified are 
presented in the supplementary information (Table 4.3.8.4 A/B/C, p.262). 
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Figure 4.3.8.4 Venn diagram of reversibly oxidised proteins (labelled with only d5-NEM) in 
adult and old soleus muscle. The individual proteins identified are presented in the 
supplementary information (Table 4.3.8.4 A/B/C, p.262). 
 
4.3.9 STRING Analysis of Differentially Labelled Proteins 
 STRING identifies protein-protein interactions between differentially labelled proteins 
of the soleus muscle. Following the differential labelling and mass spectrometry analysis 
indicating whether a protein is redox, reduced or reversibly oxidised, the data were then filtered 
using VennDIS to separate proteins observed in samples from either adult or old mice, or in 
both ages of mice. Due to the low number of redox proteins from old mice, they could not be 
analysed due to the statistical stringencies of the STRING algorithm. 
 The data in figure 4.3.9.1 shows protein interactions following enrichment for 
oxidation-reduction mechanisms in redox proteins of the soleus from adult mice. A strong link 
was observed between two mitochondrial Cytochrome b-c1 complex subunits (UQCRC1 and 
UQCRC2) and NADH dehydrogenase (NDUFV1). The energy metabolism protein 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) appears to weakly link to Isocitrate 
dehydrogenase (IDH2) and Cu-Zn Superoxide dehydrogenase (SOD1) in addition to the 
Cytochrome b-c1 complex subunit (UQCRC1).  
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Figure 4.3.9.1 Soleus redox proteins from adult mice enriched for oxidation-reduction 
processes. (A) Visualisation of protein interactions. (B) GO Pathway ID and FDR for the 
observations. (C) Global label free results for the identified proteins in (A). 
  
Figure 4.3.9.2 shows redox data enriched for oxidative phosphorylation from adult mice 
as this is a key metabolic process in soleus muscle. Protein interactions identified were between 
the energy metabolism proteins UQCRC1, UQCRC2, NDUFV1 and ATP synthase ε 
(mitochondrial) (ATP5E). 
 
#pathway ID pathway description observed gene count false discovery rate
GO.0055114 oxidation-reduction process 6 0.00861
Accession Protein Significance (-10lgP) Group Profile (Ratio) Description
Q9CZ13 QCR1_MOUSE 8.96 1.00:0.89 Cytochrome b-c1 complex subunit 1  mitochondrial OS=Mus musculus GN=Uqcrc1 PE=1 SV=1
Q9DB77 QCR2_MOUSE 3.16 1.00:1.04 Cytochrome b-c1 complex subunit 2  mitochondrial OS=Mus musculus GN=Uqcrc2 PE=1 SV=1
P16858 G3P_MOUSE 93.31 1.00:0.44 Glyceraldehyde-3-phosphate dehydrogenase OS=Mus musculus GN=Gapdh PE=1 SV=2
P54071 IDHP_MOUSE 7.6 1.00:0.93 Isocitrate dehydrogenase [NADP]  mitochondrial OS=Mus musculus GN=Idh2 PE=1 SV=3
Q91YT0 NDUV1_MOUSE 5.73 1.00:1.01 NADH dehydrogenase [ubiquinone] flavoprotein 1  mitochondrial OS=Mus musculus GN=Ndufv1 PE=1 SV=1
P08228 SODC_MOUSE 7.72 1.00:1.06 Superoxide dismutase [Cu-Zn] OS=Mus musculus GN=Sod1 PE=1 SV=2
(A) 
(B) 
(C) 
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Figure 4.3.9.2 STRING analysis of soleus redox proteins enriched for oxidative 
phosphorylation from adult mice. (A) Visualisation of protein interactions. (B) GO Pathway 
ID and FDR for the observations. (C) Global label free results for the identified proteins in (A). 
 
Data enriched for glycolysis and gluconeogenesis interactions from adult and old mice 
are shown in figure 4.3.9.3. These data highlight strong protein interactions between β-Enolase 
(ENO3), L-lactate dehydrogenase A chain (LDHA), L-lactate dehydrogenase B chain (LDHB), 
Triosephosphate isomerase (TPI1) and Fructose-bisphosphate aldolase A (ALDOA). The result 
highlights glycolytic proteins identified in soleus from adult and old mice while STRING 
analysis showed interactions between similar types of proteins. The global label free data 
showed only LDHA was significantly down regulated suggesting different extents of ageing 
affecting glycolytic systems in mouse soleus with age. 
#pathway ID pathway description observed gene count false discovery rate
190 Oxidative phosphorylation 4 0.000213
Accession Significance (-10lgP) Group Profile (Ratio) Description
P56382 2.35 1.00:1.19 ATP synthase subunit epsilon  mitochondrial OS=Mus musculus GN=Atp5e PE=2 SV=2
Q9CZ13 8.96 1.00:0.89 Cytochrome b-c1 complex subunit 1  mitochondrial OS=Mus musculus GN=Uqcrc1 PE=1 SV=1
Q9DB77 3.16 1.00:1.04 Cytochrome b-c1 complex subunit 2  mitochondrial OS=Mus musculus GN=Uqcrc2 PE=1 SV=1
Q91YT0 5.73 1.00:1.01 NADH dehydrogenase [ubiquinone] flavoprotein 1  mitochondrial OS=Mus musculus GN=Ndufv1 PE=1 SV=1
(A) 
(B) 
(C) 
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Figure 4.3.9.3 (A) STRING analysis of redox proteins in the soleus from adult and old mice 
following enrichment for glycolysis/gluconeogenesis. (B) STRING pathway information. (C) 
Global label free proteomics data of proteins highlighted in (A). 
 
Figure 4.3.9.4 shows the reduced proteins from soleus samples enriched for oxidative-
phosphorylation from adult and old mice. This highlighted Acyl carrier protein (NDUFAB1), 
ATP synthase subunits (ATP5A1 and ATP5C1), Cytochrome c1 haeme protein (CYC1), 
NADH dehydrogenases (NDUFA7, NDUFA9, NDUFS2 and NDUFS6), NADH-ubiquinone 
subunit (MTND3) and Succinate dehydrogenase (SDHA), all were mitochondrial-based. The 
STRING pathway shows the global label free proteomics data but none of the proteins 
significantly changed in abundance with age. These results show the proteins in reduced form 
were involved in oxidative phosphorylation in soleus muscle of adult and old mice and 
highlighted interactions between a number of ATP synthases and NADH dehydrogenases for 
cellular energy metabolism. 
#pathway ID pathway description observed gene count false discovery rate
10 Glycolysis / Gluconeogenesis 6 5.26E-09
Accession Protein Significance (-10lgP) Group Profile (Ratio) Description
P21550 ENOB_MOUSE 14.85 1.00:0.79 Beta-enolase OS=Mus musculus GN=Eno3 PE=1 SV=3
O08749 DLDH_MOUSE 6.88 1.00:1.07 Dihydrolipoyl dehydrogenase  mitochondrial OS=Mus musculus GN=Dld PE=1 SV=2
P05064 ALDOA_MOUSE 23.11 1.00:1.43 Fructose-bisphosphate aldolase A OS=Mus musculus GN=Aldoa PE=1 SV=2
P06151 LDHA_MOUSE 25.24 1.00:0.68 L-lactate dehydrogenase A chain OS=Mus musculus GN=Ldha PE=1 SV=3
P16125 LDHB_MOUSE 19.42 1.00:0.82 L-lactate dehydrogenase B chain OS=Mus musculus GN=Ldhb PE=1 SV=2
P17751 TPIS_MOUSE 14.07 1.00:0.98 Triosephosphate isomerase OS=Mus musculus GN=Tpi1 PE=1 SV=3
(A) 
(B) 
(C) 
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Figure 4.3.9.4 STRING analysis of reduced proteins from soleus muscle in adult and old mice. 
(A) Protein interactions following enrichment for oxidative phosphorylation. (B) STRING 
pathway analysis information. (C) Global label free proteomics data for proteins highlighted in 
(A). 
 
Figure 4.3.9.5 shows interactions between proteins with reduced cysteines following 
enrichment for oxidation-reduction processes in adult and old mice. This highlights 13 proteins 
in NADH dehydrogenases (NDUFV1, NDUFA12 and NDUFB9), Cytochrome b-c1 
complexes (UQCRC1 and UQCRC2), the protein chaperone PARK7, Protein disulphide 
isomerase (P4HB), Δ(3,5)-Δ(2,4)-dienoyl-CoA isomerase (ECH1), 2-oxoglutarate 
dehydrogenase (OGDH), Glutamate dehydrogenase (GLUD1), Isocitrate dehydrogenase 2 
(IDH2) and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The result indicates a 
number of reduced proteins with age involved in oxidation-reduction reactions. Furthermore, 
the global label free result showed that two proteins were significantly decreased in protein 
abundance (OGDH and GAPDH). Together this information indicates the effect of ageing to 
different extents on proteins where many can be reduced with age thereby affecting their 
#pathway ID pathway description observed gene count false discovery rate
190 Oxidative phosphorylation 10 2.43E-09
Accession Protein Significance (-10lgP) Group Profile (Ratio) Description
Q9CR21 ACPM_MOUSE 4.66 1.00:0.92 Acyl carrier protein  mitochondrial OS=Mus musculus GN=Ndufab1 PE=1 SV=1
Q03265 ATPA_MOUSE 25.64 1.00:1.34 ATP synthase subunit alpha  mitochondrial OS=Mus musculus GN=Atp5a1 PE=1 SV=1
Q91VR2 ATPG_MOUSE 6.91 1.00:1.09 ATP synthase subunit gamma  mitochondrial OS=Mus musculus GN=Atp5c1 PE=1 SV=1
Q9D0M3 CY1_MOUSE 8.59 1.00:0.88 Cytochrome c1  heme protein  mitochondrial OS=Mus musculus GN=Cyc1 PE=1 SV=1
Q9Z1P6 NDUA7_MOUSE 3.15 1.00:1.01 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 OS=Mus musculus GN=Ndufa7 PE=1 SV=3
Q9DC69 NDUA9_MOUSE 3.58 1.00:1.12 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9  mitochondrial OS=Mus musculus GN=Ndufa9 PE=1 SV=1
Q91WD5 NDUS2_MOUSE 10.18 1.00:0.65 NADH dehydrogenase [ubiquinone] iron-sulfur protein 2  mitochondrial OS=Mus musculus GN=Ndufs2 PE=1 SV=1
P52503 NDUS6_MOUSE 4.29 1.00:0.94 NADH dehydrogenase [ubiquinone] iron-sulfur protein 6  mitochondrial OS=Mus musculus GN=Ndufs6 PE=1 SV=2
P03899 NU3M_MOUSE 3.89 1.00:0.73 NADH-ubiquinone oxidoreductase chain 3 OS=Mus musculus GN=Mtnd3 PE=3 SV=3
Q8K2B3 DHSA_MOUSE 10.12 1.00:0.91 Succinate dehydrogenase [ubiquinone] flavoprotein subunit  mitochondrial OS=Mus musculus GN=Sdha PE=1 SV=1
(A) 
(C) 
(B) 
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performance as enzymes whilst only one or two demonstrate a change in abundance suggesting 
less of an effect on protein transcription. 
 
Figure 4.3.9.5 STRING analysis of reduced proteins enriched for oxidation-reduction 
processes from soleus muscle in old mice. (A) Protein interactions following enrichment for 
oxidation-reduction processes. (B) STRING pathway information. (C) Global label free 
proteomics data for enriched proteins in (A). 
 
Figure 4.3.9.6 shows the reduced cysteines from soleus muscle enriched for oxidative 
phosphorylation due to its prominence in soleus energy metabolism. This highlights seven 
proteins and includes the corresponding label free data from the global proteomics analysis. 
Interactions between ATP synthases (ATP5E, ATP5F1), NADH dehydrogenases (NDUFB9, 
NDUFA12, NDUFV1) and Cytochrome b-c1 complexes (UQCRC2 and UQCRC1) are 
apparent. These results showed fewer interactions between proteins in the soleus for oxidative 
#pathway ID pathway description observed gene count false discovery rate
GO.0055114 oxidation-reduction process 13 1.10E-06
Accession Label Significance (-10lgP) Group Profile (Ratio) Description
Q60597 ODO1_MOUSE 80.24 1.00:0.41 2-oxoglutarate dehydrogenase  mitochondrial OS=Mus musculus GN=Ogdh PE=1 SV=3
Q9CZ13 QCR1_MOUSE 8.96 1.00:0.89 Cytochrome b-c1 complex subunit 1  mitochondrial OS=Mus musculus GN=Uqcrc1 PE=1 SV=1
Q9DB77 QCR2_MOUSE 3.16 1.00:1.04 Cytochrome b-c1 complex subunit 2  mitochondrial OS=Mus musculus GN=Uqcrc2 PE=1 SV=1
O35459 ECH1_MOUSE 15.72 1.00:1.20 Delta(3 5)-Delta(2 4)-dienoyl-CoA isomerase  mitochondrial OS=Mus musculus GN=Ech1 PE=2 SV=1
P26443 DHE3_MOUSE 22.38 1.00:1.27 Glutamate dehydrogenase 1  mitochondrial OS=Mus musculus GN=Glud1 PE=1 SV=1
P16858 G3P_MOUSE 93.31 1.00:0.44 Glyceraldehyde-3-phosphate dehydrogenase OS=Mus musculus GN=Gapdh PE=1 SV=2
P54071 IDHP_MOUSE 7.6 1.00:0.93 Isocitrate dehydrogenase [NADP]  mitochondrial OS=Mus musculus GN=Idh2 PE=1 SV=3
Q9EQ20 MMSA_MOUSE 3.13 1.00:1.36 Methylmalonate-semialdehyde dehydrogenase [acylating]  mitochondrial OS=Mus musculus GN=Aldh6a1 PE=1 SV=1
Q7TMF3 NDUAC_MOUSE 11.61 1.00:0.69 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 OS=Mus musculus GN=Ndufa12 PE=1 SV=2
Q9CQJ8 NDUB9_MOUSE 4.6 1.00:0.63 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 OS=Mus musculus GN=Ndufb9 PE=1 SV=3
Q91YT0 NDUV1_MOUSE 5.73 1.00:1.01 NADH dehydrogenase [ubiquinone] flavoprotein 1  mitochondrial OS=Mus musculus GN=Ndufv1 PE=1 SV=1
P09103 PDIA1_MOUSE 4.16 1.00:1.07 Protein disulfide-isomerase OS=Mus musculus GN=P4hb PE=1 SV=1
Q99LX0 PARK7_MOUSE 1.81 1.00:0.99 Protein DJ-1 OS=Mus musculus GN=Park7 PE=1 SV=1
(A) 
(B) 
(C) 
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phosphorylation when compared to adult data in figure 4.3.9.4 suggesting a reduced demand 
for oxidative phosphorylation in the soleus as the cells age. 
 
 
 
Figure 4.3.9.6 STRING analysis of reduced proteins from soleus muscle in old mice. (A) 
protein interaction following enrichment for oxidative phosphorylation. (B) STRING pathway 
information. (C) Global label free proteomics data for proteins highlighted in (A). 
 
Overall the STRING analysis of protein interactions from the lists produced from soleus 
muscle from adult, old and both ages of mice, indicate many links between energy metabolism 
proteins. This highlighted clusters of proteins involved in specific intracellular functions which 
enabled a focused evaluation of the global label free data combined with the lists of redox-
cysteine containing proteins identified previously. Together, these data gave insight into the 
changing intracellular dynamic of energy metabolism via oxidation-reduction, oxidative 
phosphorylation and glycolysis.  
 
#pathway ID pathway description observed gene count false discovery rate
190 Oxidative phosphorylation 7 2.23E-07
Accession Label Significance (-10lgP) Group Profile (Ratio) Description
Q9CQQ7 AT5F1_MOUSE 5.03 1.00:0.84 ATP synthase subunit b  mitochondrial OS=Mus musculus GN=Atp5f1 PE=1 SV=1
P56382 ATP5E_MOUSE 2.35 1.00:1.19 ATP synthase subunit epsilon  mitochondrial OS=Mus musculus GN=Atp5e PE=2 SV=2
Q9CZ13 QCR1_MOUSE 8.96 1.00:0.89 Cytochrome b-c1 complex subunit 1  mitochondrial OS=Mus musculus GN=Uqcrc1 PE=1 SV=1
Q9DB77 QCR2_MOUSE 3.16 1.00:1.04 Cytochrome b-c1 complex subunit 2  mitochondrial OS=Mus musculus GN=Uqcrc2 PE=1 SV=1
Q7TMF3 NDUAC_MOUSE 11.61 1.00:0.69 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 OS=Mus musculus GN=Ndufa12 PE=1 SV=2
Q9CQJ8 NDUB9_MOUSE 4.6 1.00:0.63 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 OS=Mus musculus GN=Ndufb9 PE=1 SV=3
Q91YT0 NDUV1_MOUSE 5.73 1.00:1.01 NADH dehydrogenase [ubiquinone] flavoprotein 1  mitochondrial OS=Mus musculus GN=Ndufv1 PE=1 SV=1
(A) 
(B) 
(C) 
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4.3.10 Motif-X Analysis of the Cysteine Microenvironment 
 Motif-X enables identification of conserved sequence motifs across a sample of 
peptides. Soleus peptides were selected from the differentially labelled dataset with a central 
cysteine selected and the same parameters as used to analyse the quadriceps were followed. All 
parameters included a significance of p ≤ 0.01. 
Figure 4.3.10A shows glutamic acid was identified in soleus redox peptides from adult 
mice at +5 from the central cysteine. It contains an acidic side chain giving a negative overall 
charge to the molecule (Berg et al., 2002). 
 Isoleucine was detected (figure 4.3.10B) as being conserved at +4 from a central 
cysteine amino acid in proteins with reduced cysteines from adult mice. Isoleucine contains a 
chiral centre around which the other attached molecular groups can rotate leading to 
isomerisation however only one isomer is found in proteins. It is hydrophobic in nature due to 
its aliphatic side chain (Berg et al., 2002). 
In figure 4.3.10C, at -4 from a central cysteine, Aspartate, the deprotonated form of 
Aspartic acid, was identified in soleus samples with reversibly oxidised cysteines from adult 
mice. It has an overall negative charge however in certain circumstances can accept a proton 
thereby affecting its conformation (Berg et al., 2002). 
In soleus for old mice (figure 4.3.10D) Isoleucine was again identified as a conserved 
amino acid at +4 from the central cysteine. As previously described it contains a chiral centre 
although only one isomer is present in proteins. It is hydrophobic due to its aliphatic side chain 
(Berg et al., 2002). 
 Motif-X analysis of reduced soleus peptides from old mice in figure 4.3.10E identified 
a conserved glutamate at +2 from the central cysteine. Glutamate, as previously described, has 
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a negative charge due to its deprotonated form and in certain instances can accept protons. This 
enables important functionality in particular circumstances (Berg et al., 2002). 
Analysis of reversibly oxidised peptides from old soleus of old mice in figure 4.3.10F 
identified an Aspartate at -4. As previously described, this amino acid is the deprotonated form 
of aspartic acid giving it a negative charge since it has a carboxylate side chain. In addition to 
this, changes to amino acids near to redox cysteine will also likely impact their pKa and thereby 
affecting disulphide bond formation which in turn will affect protein function if the cysteine is 
located at an active site or structurally important location (Berg et al., 2002). 
 
Figure 4.3.10. Motif-X analysis of redox cysteine containing proteins. (A) Redox peptide from 
the soleus adult mice highlighting a conserved glutamic acid at +5 from the central cysteine. 
(B) Reduced peptides from soleus muscles in adult mice highlighting a conserved isoleucine 
at +4 from the central cysteine. (C) Reversibly oxidised cysteine in peptides isolated from 
soleus muscle in adult mice with a conserved aspartic acid at -4 from the central cysteine. (D) 
Soleus redox peptide sequences from old mice with an Isoleucine identified at +4 from the 
central cysteine. (E) Soleus reduced peptides from old mice with a conserved glutamic acid at 
+2 from the central cysteine. (F) Soleus reversibly oxidised peptides from old mice with a 
conserved aspartic acid at -4 from the central cysteine. 
 
The Motif-X data showed changes to amino acid sequences within a specific vicinity 
of a central cysteine residue. Future work would consider how this affects protein structure and 
Adult Soleus Redox
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Size Fold Increase
1 .......C....E.. 2.77 11 65 18614 307729 2.8
Parameters:
Job Name  Adult Soleus Redox
fgtype  'fasta'
fgcentralres  'C'
width  '15'
occurrences  '11'
significance  '0.01'
bgdb  'ipi.MOUSE.fasta'
bgtype  'fasta'
bgcentralres  'C'
Adult Soleus Reduced
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Size Fold Increase
1 .......C...I... 6.6 36 332 12876 307729 2.59
Parameters:
Job Name  Adult Soleus Reduced
fgtype  'fasta'
fgcentralres  'C'
width  '15'
occurrences  '15'
significance  '0.0001'
bgdb  'ipi.MOUSE.fasta'
bgtype  'fasta'
bgcentralres  'C'
Adult Soleus R versibly Oxidised
Parameters:
Job Name  Adult Soleus Rev Ox
fgtype  'fasta'
fgcentralres  'C'
width  '15'
occurrences  '14'
significance  '0.001'
bgdb  'ipi.MOUSE.fasta'
bgtype  'fasta'
bgcentralres  'C'
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Size Fold Increase
1 ...D...C....... 5.26 15 85 13815 307729 3.93
Old S leus Redox
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Size Fold Increase
1 .......C...I... 3.35 7 34 12876 307729 4.92
Parameters:
Job Name  Old Soleus Redox
fgtype  'fasta'
fgcentralres  'C'
width  '15'
occurrences  '7'
significance  '0.01'
bgdb  'ipi.MOUSE.fasta'
bgtype  'fasta'
bgcentralres  'C'
Old Soleus Reduced
Parameters:
Job Name  Old Soleus Reduced
fgtype  'fasta'
fgcentralres  'C'
width  '15'
occurrences  '30'
significance  '0.001'
bgdb  'ipi.MOUSE.fasta'
bgtype  'fasta'
bgcentralres  'C'
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Size Fold Increase
1 .......C.E..... 3.22 39 348 19812 307729 1.74
Old Soleus Reversibly Oxidised
Motif Motif Score Foreground Matches Foreground Size Background Matches Background Size Fold Increase
1 ...D...C....... 6.73 18 94 13815 307729 4.27
Parameters:
Job Name  Old Soleus Rev Ox
fgtype  'fasta'
fgcentralres  'C'
width  '15'
occurrences  '16'
significance  '0.001'
bgdb  'ipi.MOUSE.fasta'
bgtype  'fasta'
bgcentralres  'C'
(A) (B)
(D)
(C)
(E) (F)
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function as highlighted in Table 5 (p.161) regarding redox state changes with age. In addition 
to this, proteomics work identifying changes to proteins and peptide sequences may help to 
elucidate age-related changes in the redox biochemistry of the soleus skeletal muscle (Berg et 
al., 2002). 
4.4 Discussion 
The soleus is a slow twitch muscle involved in longer term contractions such as distance 
running and posture control (Deldicque et al., 2010). I hypothesised that the redox state of 
intracellular proteins would change with age (see section 4.2, p.136) and the overall results of 
this chapter support this hypothesis and identified a number of changes to redox control 
proteins with age in the Soleus, in the addition to changes in redox state of proteins of interest. 
Section 4.3.3 looked at the label free proteomics data using a volcano plot. Figure 4.3.3.3 
indicates a range of significantly changed proteins identified via accession numbers between 
individual adult and old mouse muscle samples. Significantly decreased proteins included a 
number of mitochondria-based energy metabolism proteins such as Cytochrome c oxidase 
subunit 7C (COX7C), Glyceraldehyde-3-phosphate dehydrogenase (G3P/GAPDH) and ATP 
synthase subunit d (ATP5H) highlighting a reduction in oxidative energy metabolism in the 
mouse soleus. Conversely, significantly increased proteins included Aconitase (ACON), 
Glutathione Peroxidase 1 (GPX41) and Electron transfer flavoprotein (ETFB). Aconitase and 
Electron transfer flavoprotein are important energy metabolism enzymes involved in the citric 
acid cycle and electron transfers within the mitochondria respectively. Glutathione Peroxidase 
is an antioxidant enzyme that protects against lipid peroxidation (Yant et al., 2003, Seiler et al., 
2008). This examination of the label free data from soleus muscle therefore indicates a 
reduction in energy metabolism with age which is in contrast to the changes observed in the 
quadriceps where cytoskeletal proteins were mainly affected. These changes suggest a disparity 
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between energy metabolism pathways within the cell during ageing which has been identified 
in other rodent studies (Garvey et al., 2014, Yarovaya et al., 2002). It may be an indication of 
effects seen relating to decreased muscle strength with age which may help to explain changes 
in posture observed with age given the function of the soleus in both rodents and humans 
(Goulart et al., 2000, Deldicque et al., 2011). In a more general context other studies have 
demonstrated the effect of increased ROS concentrations having a negative impact on muscle 
force generation (Reid, 2001, Jackson, 2008). The data presented here add to this body of 
increasing knowledge that changes to redox states of proteins, specifically in relation to energy 
metabolism, may eventually provide a direct link between intracellular ROS control and the 
physiological outcome of ageing in skeletal muscle. 
Redox Ageing 
This study assessed certain proteins of interest known to be involved in intracellular redox 
control. Data in figure 4.3.7.1 highlights a decrease in the number of redox-flexible proteins 
and shows an increase in the number of reduced proteins with age in mouse soleus muscle. 
Figure 4.7.3.2 shows the fold change of redox proteins identified via differential labelling. 
Several proteins are highlighted as increasing in their reduced state with age (suggesting a 
possible reduction in function) including a number of energy metabolism proteins such as 
NADH ubiquinone oxidoreductase (NDUFS1) Cys78 increasing by 28.7 fold, Aspartate 
aminotransferase (GOT2) Cys295 6.86 fold, 2-oxoglutarate dehydrogenase (OGDH) Cys566 
by 5.45 fold, ATP synthase subunit d (ATP5H) Cys101 by 5.19 fold, Cofilin-2 (CFL2) Cys80 
by 5.12 fold and cytoplasmic Malate dehydrogenase (MDH1) Cys154 by 5.34 fold. These all 
increased in reduced state with age suggesting a possible reduction in function. Conversely 
Cytochrome b-c1 complex subunit 2 (UQCRC2) Cys192, Cytochrome b-c1 complex subunit 
6 (UQCRH) Cys51, Β-enolase (ENO3) 337/339*, Four and a half LIM domains proteins 1 
(FHL1) Cys255 and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) Cys150/154* 
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(containing a tryptic peptide) and Isocitrate dehydrogenase (IDH2) Cys113 all demonstrated 
becoming less reduced with age with Isocitrate dehydrogenase being reversibly oxidised in 
adult mice soleus muscle and becoming more reversibly oxidised in old mice soleus muscle. 
These changes in energy metabolism proteins with age correspond to another study which 
identified similar changes to energy metabolism proteins, specifically highlighting multiple 
modifications to NDUFS1 with age (Choksi et al., 2008). 
Figure 4.3.4.1 presented western blot data for Thioredoxin 1 (A), Thioredoxin Reductase 1 
(C), Thioredoxin interacting protein (TXNIP, E), Peroxiredoxins 1 (F), 4 (G) and 6 (H). The 
results showed no significant change in protein abundance for Thioredoxin 1, Thioredoxin 
Reductase 1 or Peroxiredoxin 6. The same was true for the enzyme activity tests for 
Thioredoxin and Thioredoxin Reductase, neither of which changed significantly with age. 
However, protein abundance significantly decreased for TXNIP from both 3 to 12 months (p 
<0.001) and 3 to 24 months (p <0.01). As this protein is involved in negative regulation of 
Thioredoxin, it is a part of the Thioredoxin system for maintenance of properly functioning 
Peroxiredoxins (Alhawiti et al., 2017). A significant decrease in protein abundance with no 
change in Thioredoxin 1 or Thioredoxin Reductase 1 may suggest a disconnection within the 
Thioredoxin system with age. Peroxiredoxin 1 (figure 4.3.4.1F) demonstrated a significant 
decrease in abundance from 12 to 24 months. Peroxiredoxin 4 (figure 4.3.4.1G) demonstrated 
a significant increase in abundance from both 3 to 24 (p <0.05) and 12 to 24 months (p <0.01). 
Peroxiredoxin 6 (4.3.4.1H) demonstrated no significant change in protein abundance with age. 
None exhibited a significant change in the global proteomics results (figure 4.3.4.1J). 
Peroxiredoxin 4 has been shown to regulate the transcription factor NF-kB linking intracellular 
redox changes and transcription (Jin et al., 1997). Peroxiredoxin 5 was also identified in the 
label free data but was unchanged with age. Sulphonylated peroxiredoxins (PRDX1-4) were 
also assessed but no significant change in protein abundance was observed. 
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Figure 4.3.4.4 shows Cu-Zn Superoxide Dismutase (SOD1) which demonstrated a 
significant increase in protein abundance with age from 3 to 24 months (p <0.05), however no 
significant change was observed in the global proteomics data. An increase in protein 
abundance may indicate an increased requirement for control of intracellular ROS as SOD1 
mice knock out studies have shown this may lead to an increased rate of ageing and contribute 
to fibre loss (Sakellariou et al., 2011). 
Protein carbonylation (figure 4.3.4.10) shows markers of long term intracellular reactive 
oxygen species stress. The blot showed no significant change with age to carbonylated protein 
abundance which is in contrast to a study that identified an increase in carbonylated soleus 
proteins with age. It was, however, performed on female mice where males were used in this 
study (Tohma et al., 2014). 
Energy Metabolism and Ageing 
To initially determine differences between adult and old soleus muscle tissue in relation to 
energy metabolism, Succinate dehydrogenase (SDH) staining was performed in figure 4.3.2.1 
which highlighted an apparent reduction in oxidative capacity of the muscle cells with age. 
Other studies showed no significant change in SDH staining between adult and old soleus 
muscle cells (Leduc-Gaudet et al., 2015) or a significant loss of mouse soleus muscle fibre 
numbers with age (Sheard and Anderson, 2012). 
 Adenosine monophosphate kinase (AMPK) is involved in a range of roles from 
intracellular energy regulation to cytoskeletal adjustment and acts as an energy sensor for the 
cell by reacting to reductions in AMP/ADP concentrations (Treebak et al., 2006, Kahn et al., 
2005). The data in figure 4.3.4.8 did not show any significant change in protein abundance, 
however the global label free data (figure 4.3.4.8C) identified two subunits of AMPK: 
180 
 
PRKACA (KAPCA) and PRKAR2A (KAP2) and of these only PRKAR2A/KAP2 were 
significantly reduced with age.  
Aconitase (ACON, mitochondrial) data is shown in figure 4.3.4.7 where western blotting 
did not identify any significant change in protein abundance with age. The enzyme activity 
showed a significant increase from 3 months to 12 months (p <0.01) and global proteomics 
data showed a significant increase in abundance with age from adult to old. In Table 6, the 
redox assessment of Aconitase highlighted increases in the reduced state of Cys448/451 from 
3.2 to 8.4, Cys385 from 1.9 to 4.0, and Cys126 from 4.3 to 11.6 with age. Interestingly, these 
changes, combined with the change in proteomics abundance and enzyme activity with age 
may all suggest an increased demand for this enzyme in energy metabolism which was not 
observed in the quadriceps. 
A key protein in terms of a western blotting housekeeping is Glyceraldehyde 3-phosphate 
dehydrogenase and differential labelling identified the Cys150/154 (tryptic peptide) as 
decreased in its reduced state with age in the soleus of ageing mice. Cys150 has been identified 
as undergoing ADP-ribosylation by autocatalysis following irreversible inhibition (Mustafa et 
al., 2009, UniProt, 2017c). Additionally, the label free proteomics showed a significant 
decrease in abundance of the protein with age. Together, the change in redox state combined 
with the reduction in protein abundance may induce autophagy as previously demonstrated by 
Hara and Nakajima (Hara et al., 2005, Nakajima et al., 2007). Furthermore, this presents a 
physiological decline in soleus function with age. 
Mitochondrial respiratory chain Complex III subunit Cytochrome b-c1 (UQCRH) Cys51 
forms part of a disulphide bond between with Cys65. Changes to the redox state of this cysteine 
may affect protein function due to changes in conformation (UniProt, 2017b). Conversely 
NADH ubiquinone oxidoreductase (NDUFS1) became less reduced with age and its Cys78, 
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located in the metal ion binding site, may therefore directly affect protein functionality 
(UniProt, 2017e). The only reversibly oxidised cysteine detected in the soleus belonged to 
Isocitrate dehydrogenase 2 (IDH2) Cys113 which started at 0.023 in the adult form and became 
more reversibly oxidised in old soleus muscle to 0.007 (UniProt, 2017h). Cys113 itself has no 
defined function but is located near a substrate binding site. 
These protein modifications along with those detailed in table 6, and together with western 
blotting data all support the initial global proteomics data in indicating that ageing in mouse 
soleus muscle predominantly affects energy metabolism proteins and their peptides. 
Protein Folding Response to Ageing 
Increases in sulphonylated PARK7 (PARK7-SO3H) may reflect sustained intracellular 
ROS concentrations as PARK7 has a number of roles, most notably as a protein chaperone and 
redox sensor. The western blot data in fig. 4.3.4.9 demonstrated no significant change in protein 
abundance between 3 and 12 months suggesting PARK7 was not heavily modified in the soleus 
due to ROS. The standard PARK7 was identified in the relative quantification proteomics data 
and this also demonstrated no significant change from adult to old. There was a problem 
identifying bands in figure 4.3.4.9 with two of the three lanes apparently containing no protein 
in the soleus samples. Statistical analysis for western blotting of PARK7-SO3H could not be 
performed between adult and old. 
Comparison and STRING Analysis of Differentially Labelled Proteins 
Differential labelling highlighted changes to the redox state of soleus muscle tissue with 
age. Figure 4.3.7.1 identified a decrease in the number of redox proteins and increases in the 
number of reduced and reversibly oxidised proteins with age. Furthermore, VennDIS then 
filtered the results into redox, reduced and reversibly oxidised proteins datasets enabling 
subsequent analysis with STRING to highlight specific interactions within certain protein 
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datasets. Of particular interest were proteins identified in the datasets from adult and old mice 
which highlighted age related changes to the redox state of particular proteins. Figures 4.3.8.1 
to 4.3.8.4 used VennDIS to identify lists of proteins within the different sets of redox, reduced 
and reversibly oxidised proteins. The results highlighted in the label free proteomics results 
helps to build upon the current knowledge of age-related differences in skeletal muscle 
proteomes such as work by Chaves and Hansson (Chaves et al., 2013, Hansson et al., 2005).  
Following identification of changes to specific cysteines, VennDIS highlighted which 
proteins of the differentially labelled dataset affected samples from adult, old or both ages of 
mice. These values were then fed into STRING for protein interaction analysis relating to the 
redox states of the proteins thereby highlighting age related redox changes to the soleus. The 
data in this section highlighted a range of interactions, many of which were to be expected 
within energy metabolism enrichments with a number of figures highlighting interesting 
results. Figure 4.3.9.1 highlighted a link between GAPDH and SOD1. The reduction in 
GAPDH protein abundance suggests a disconnect with age between energy metabolism and 
redox homeostasis may occur. 
The results of the different STRING analyses help to highlight interactome properties 
identified in skeletal muscle ageing and effects encountered with different redox states. Other 
studies have considered skeletal muscle interactomes but in pig (Blandin et al., 2013) and 
humans (Cao et al., 2014) however it appears this is one of the first to perform it in mice. 
Motif-X Analysis of Redox Proteins 
Motif-X was performed on the differentially labelled data sets to identify any conserved 
amino acids in the redox, reduced or reversibly oxidised peptide sequences and the change with 
age. This analysis highlighted similar conserved amino acids in figures 4.3.10B (adult reduced 
data set) and 4.3.10D (old redox data set) with an Isoleucine at +4 from the central cysteine. 
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Previously described as having an involvement in skeletal muscle energy metabolism (Egan 
and Zierath, 2013), this result may indicate a change in energy metabolism pathways with age 
as cysteines’ redox state change. In figure 4.3.10C (adult reversibly oxidised data set) and 
4.3.10F (old reversibly oxidised) an Aspartic acid was highlighted at -4 from the central 
cysteine (Zurlo et al., 1990). It is postulated that the overall negative charge of this amino acid 
is required for a stable microenvironment for a conserved cysteine residue. 
4.5 Conclusions 
 The results demonstrate that age-related changes to mouse soleus muscle primarily 
affect energy metabolism proteins. Global label free data highlighted a number of these 
proteins that changed in abundance with age which was supported by the differential labelling 
that showed redox changes to specific cysteine residues within proteins of interest. Many of 
these are significantly reduced in old tissue and an increasing number of cysteines appeared to 
be either reduced or reversibly oxidised reflecting a change from a responsive range of proteins 
for intracellular redox signalling to a more rigid system that cannot react as quickly to those 
changes. Finally, pathway analysis using GOrilla and STRING, combined with examination of 
any conserved sequence motifs via Motif-X provide a picture of a disparate system when aged. 
The next step will compare soleus and quadriceps muscle to consider how musculoskeletal 
ageing differentially affects these tissues. 
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CHAPTER 5 
 
A COMPARISON OF THE QUADRICEPS AND 
SOLEUS MUSCLES 
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5.1 Introduction 
 Having looked at the quadriceps and soleus in isolation, here they are compared to 
highlight differences between them as they age. A major difference between quadriceps and 
soleus is their primary energy production mechanism due to differences in fibre types (see 
section 1.3, p.29). The soleus contains predominantly slow twitch, type I fibres and is involved 
in posture and walking. It primarily produces its energy via oxidative phosphorylation which 
enables longer lasting energy production for prolonged use. Conversely, the quadriceps contain 
predominantly type II, fast twitch fibres and is used for rapid explosive force such as sprinting. 
This is reflected in the energy metabolism of the fibres within the quadriceps where they 
predominantly use glycolysis to ensure a rapid production and delivery of energy in the form 
of ATP to the actin-myosin complex (Chakkalakal et al., 2012, Kammoun et al., 2014, Barclay 
et al., 1993, Crow and Kushmerick, 1982, Barclay, 1982). 
In relation to ageing the quadriceps appear more susceptible than the soleus given their 
predominance of fast twitch type II fibres (Lexell, 1995, Larsson and Salviati, 1989). This may 
reflect the fibre types of each muscle and therefore the energy metabolism of each may lend to 
increased susceptibility of atrophy within a tissue (Fitts et al., 1984, Larsson and Edstrom, 
1986, Lowe et al., 2000). 
One study analysed the differences between fibre types following incomplete spinal 
cord injury on muscle regeneration. Surprisingly, they observed a significant increase in the 
predominantly type I fibre soleus regeneration compared to the type II Tibialis anterior 
(Jayaraman et al., 2013). In a study by Girgenrath et al. Myostatin expression was demonstrated 
to affect fibre type distribution in fast and slow fibre types and that a loss of Myostatin 
expression causes an increase in type II fibres (Girgenrath et al., 2005). These studies briefly 
highlight the plasticity of skeletal muscle both in terms of regeneration and during formation.  
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Comparisons in this chapter will predominantly consider the label free proteomics data 
using pathway and STRING protein-protein interaction analysis before considering the redox 
differences between the muscles. This will allow identification of age-related changes to thiol 
signalling in the two mouse skeletal muscles as they age. 
5.2 Aim 
 The aim of this chapter is to identify similarities and differences between quadriceps 
and soleus in their proteomics data to better understand how different types of skeletal muscles 
age. 
5.3 The Quadriceps versus the Soleus Muscle with Age 
Label free proteomics identified 946 proteins in adult and old quadriceps and soleus 
muscles combined. In figure 5.3.1 VennDIS was used to determine which proteins occurred in 
each muscle (amalgamating both adult and old data). This shows 205 proteins were detected 
only in the quadriceps, 307 only in the soleus and 434 in both tissues. The individual data used 
in figure 5.3.1 are presented in the supplementary information, Table 5.3.1 (p.263-267). 
The quadriceps data highlighted proteins such as Frataxin (FXN), a protein involved in 
iron-sulphur cluster assembly and maintenance and possible oxidative stress protector (Huang 
et al., 2009), protein disulphide isomerase A6 (PDIA6) which works as a protein chaperone 
(Vekich et al., 2012, UniProt, 2017g) and the cytoskeletal proteins β-actin (ACTNB) and α-
actin 3 (ACTN3) and the redox control protein Peroxiredoxin 4 (PRDX4) (Tasaki et al., 2017). 
Conversely the soleus highlighted a range of metabolomic proteins such as the complex I 
subunit NADH dehydrogenase (NDUFS7), Cytochrome b (MT-CYB), ATP synthase subunits 
(ATPAF2, ATP4A). Glutaredoxin 5, involved in iron-sulphur cluster and regeneration (Linares 
et al., 2009, UniProt, 2017f).  
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The redox control proteins Peroxiredoxin 1-3, 5 & 6, Thioredoxin 1 and heat shock 
proteins (HSP90A1, HSPA1A, HSPB6, HSPA8), the striated muscle function protein β-
enolase (ENO3) and Annexin A6 (ANXA6), potentially involved in Calcium release were 
detected in both muscles at both ages. These are only a small sample of the 434 proteins 
detected, it indicates their importance to skeletal muscle functionality throughout life and 
across the two tissues.  
The combined proteomics data of soleus proteins from adult and old mice showed 
several involved in energy metabolism such as Cytochrome b (MT-CYB), ATP synthase 
(ATPAF2), several of NADH dehydrogenases and their associated subcomplexes (e.g. 
NDUFA2-9, NDUFB1-9, NDUFS1-4 etc.), the Calcium binding protein Calsequestrin 2 
(CASQ2), the Glutathione conjugation proteins Glutathione S-transferase κ-1 (GSTK1) and 
Glutathione S-transferase α-4 (GSTA4) and the cytoplasmic iron-sensing protein Aconitase 1 
(ACO1) (Pickova et al., 2003, Xiao et al., 1999). 
 
Figure 5.3.1. Venn diagram comparing total detected protein numbers between quadriceps and 
soleus muscle in adult and old mice (see supplementary information Table 5.3.1, p. 263-267). 
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Following a brief consideration of the global proteomics results for the tissues, 
PathVisio (v. 3.2.3) was used to highlight changes observed in individual proteins involved in 
specific pathways of interest. The data in figure 5.3.2 shows sarcomeric proteins identified in 
the global label free proteomics dataset for quadriceps. Red indicates proteins significantly 
increased with age while green is significantly decreased with age and yellow indicates no 
change. The graphic indicates that those proteins involved in sarcomeric function in mouse 
quadriceps were predominantly decreased with age such as the Actins, Myosin heavy and light 
chains, Tropomyosins and Troponins. Further to this, soleus sarcomeric proteins were then 
considered using PathVisio to compare changes to those found in quadriceps. Figure 5.3.3 
indicates that some sarcomeric proteins were down regulated with age in the soleus, but not to 
the same extent as observed in the quadriceps with several Troponins, Tropomyosin and 
Myosin heavy chain protein isoforms being unchanged with age. Myosin light chain 1 was up 
regulated with age, whereas the opposite was observed in the quadriceps. Electron transport 
chain proteins in quadriceps are shown in figure 5.3.4 and highlighted several proteins that 
were either unchanged or slightly up regulated in complex I. Only the Succinate dehydrogenase 
subunit (SDHB) was increased with age in complex II. Complex III was predominantly down 
regulated with age and Complex IV was largely unchanged although some specific proteins 
such as COX1 and COX7C were up regulated with age. Complex V showed some up regulated 
proteins such as the ATP synthase subunits Atp5e, ATP5H and ATP5I. The Adenine nucleotide 
translocator showed a down regulation in quadriceps with age for SLC25A4 and SLC25A5. 
The soleus electron transport chain proteins are shown in figure 5.3.5 and the results showed 
an overall down regulation of proteins with age. The few proteins up regulated with age include 
complex I proteins Ndufb2, Ndufs6 and Ndufs8. Complex V highlighted several ATP synthase 
subunits along with the Adenine nucleotide translocator protein SLC25A5 which was up 
regulated in the quadriceps was found to be down regulated in the soleus with age. 
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Figure 5.3.2 PathVisio analysis of quadriceps sarcomeric proteins using the global label free proteomics data. Red indicates an up regulation with 
age, green a down regulation on a sliding scale though yellow which indicates no change.
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Figure 5.3.3 PathVisio analysis of soleus sarcomeric proteins using the global label free proteomics data. Red indicates an up regulation with 
age, green a down regulation on a sliding scale though yellow which indicates no change.
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Figure 5.3.4 PathVisio analysis of electron transport chain proteins in the quadriceps using global label free proteomics data. Red indicates an up 
regulation with age, green a down regulation on a sliding scale though yellow which indicates no change.
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Figure 5.3.5 PathVisio analysis of the soleus electron transport chain proteins using the global label free proteomics data. Red indicates an up 
regulation with age, green a down regulation on a sliding scale though yellow which indicates no change. 
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 The PathVisio assessment of the quadriceps and soleus global proteomics data helped 
to indicate clear differences between the two muscles as they age. Both sarcomeric proteins 
and those involved in the electron transport chain appears to change in abundance with age but 
to differing extents in each muscle. 
 5.4 Redox Comparisons of the Quadriceps and Soleus Muscles 
 Thiol signalling in skeletal muscle ageing requires redox flexible proteins to enable a 
reaction to changing intracellular ROS concentrations. This is performed via a redox cysteine 
amino acid conserved in crucial locations throughout the protein. When comparing how 
quadriceps and soleus muscles age, examination of changes in numbers of differentially 
labelled proteins helped to clarify the extent of changes in the redox state of protein in each 
muscle. 
 Figure 5.4.1 shows a decrease in the numbers of redox-labelled (d0-NEM + d5-NEM) 
proteins with age in both the quadriceps and soleus muscles. 
 
Figure 5.4.1 Cysteine containing redox (d0-NEM + d5-NEM) labelled proteins in quadriceps 
and soleus between adult and old tissue. Sample size data are n=5 in adult and n=6 in old 
quadriceps while int the soleus dataset n=5 in both adult and old. 
 
Redox (D5NEM+NEM) Reduced (NEM) (Reversibly) Oxidised (D5-NEM) Total
Adult 64 95 21 180
Old 51 95 20 166
Redox (D5NEM+NEM) Reduced (NEM) (Reversibly) Oxidised (D5-NEM) Total
Adult 42 118 13 173
Old 30 126 18 174
Quadriceps
Soleus
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 Figure 5.4.2 shows the reduced (d0-NEM) labelled proteins. In both quadriceps and 
soleus muscles they demonstrated an increase in the numbers of these proteins with age. 
 
Figure 5.4.2 Cysteine containing reduced (d0-NEM) labelled proteins in quadriceps and soleus 
between adult and old tissue. Sample sizes data are n=5 in adult and n=6 in old quadriceps 
while int the soleus dataset n=5 in both adult and old. 
 
 Figure 5.4.3 shows reversibly oxidised (d5-NEM) labelled proteins and highlighted 
decreases in the number of proteins in both quadriceps and soleus muscles with age.
 
Figure 5.4.3 Cysteine containing reversibly oxidised (d5-NEM) labelled proteins in quadriceps 
and soleus from adult and old mice. Sample size data are n=5 in adult and n=6 in old quadriceps 
while int the soleus dataset n=5 in both adult and old. 
 
Redox (D5NEM+NEM) Reduced (NEM) (Reversibly) Oxidised (D5-NEM) Total
Adult 64 95 21 180
Old 51 95 20 166
Redox (D5NEM+NEM) Reduced (NEM) (Reversibly) Oxidised (D5-NEM) Total
Adult 42 118 13 173
Old 30 126 18 174
Quadriceps
Sol us
Redox (D5NEM+NEM) Reduced (NEM) (Reversibly) Oxidised (D5-NEM) Total
Adult 64 95 21 180
Old 51 95 20 166
Redox (D5NEM+NEM) Reduced (NEM) (Reversibly) Oxidised (D5-NEM) Total
Adult 42 118 13 173
Old 30 126 18 174
Quadriceps
Soleus
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 The above figures were tabulated below in table 7, highlighting the changes in 
differentially labelled protein numbers with age. 
 
Table 6. Numbers of differentially labelled proteins in quadriceps and soleus muscles 
indicating redox (d0-NEM + d5-NEM), reduced (d0-NEM) and reversibly oxidised (d5-NEM) 
numbers. 
 
 After describing the changes in differentially labelled protein numbers with age in each 
muscle, VennDIS was employed to highlight proteins found in the adult or old mice in both 
muscles. The data tables are presented in the supplementary data (see Table 5.4.4, p.268-278). 
Figure 5.4.4A shows the muscle in adult mice for redox-labelled proteins and a total of 81 
proteins were highlighted. In figure 5.4.4A, the thirty-nine proteins from adult mice that were 
classed as redox proteins in the quadriceps included the redox sensor and chaperone protein 
PARK7, the heat shock/chaperone HSPA8 (HSC71) and cytoskeletal proteins Myomesin 2, 
Myosin binding protein and Myosin heavy polypeptide proteins (Auerbach et al., 1999). In the 
seventeen redox proteins from soleus in the adult mice highlighted, they also included Myosin 
heavy polypeptide 2 and 7 in addition to many energy metabolism proteins such as Lactate 
dehydrogenase and NADHG dehydrogenase. Of the twenty-five proteins identified in both 
muscles, these included mitochondrial Aconitase, Glyceraldehyde-3-phosphate dehydrogenase 
and Superoxide dismutase 1 (Cu-Zn Superoxide dismutase) in addition to Tropomyosin 1-α, 
Tropomyosin 4 and Troponin 1. 
In figure 5.4.4B quadriceps from old mice, thirty-three redox proteins highlighted 
included ATP synthases, Creatine kinases, Glyceraldehyde-3-phosphate dehydrogenase, Heat 
Redox (D5NEM+NEM) Reduced (NEM) (Reversibly) Oxidised (D5-NEM) Total
Adult 64 95 21 180
Old 51 95 20 166
Redox (D5NEM+NEM) Reduced (NEM) (Reversibly) Oxidised (D5-NEM) Total
Adult 42 118 13 173
Old 30 126 18 174
Quadriceps
Soleus
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shock protein 8 and Superoxide dismutase 1 (Cu-Zn Superoxide dismutase). Whereas in the 
soleus muscle from old mice, those highlighted included Peroxiredoxin 6 along with an ATP 
synthase subunit, Lactate dehydrogenase B and NADH dehydrogenase. Of the eighteen 
proteins identified in both muscles, they included mitochondrial Aconitase along with the 
energy metabolism Lactate dehydrogenase A and Malate dehydrogenase 1 and 2 and structural 
proteins Myosin heavy polypeptide 2 and 4 and Tropomyosin 1-α. 
 
Figure 5.4.4. Venn diagram of differentially labelled redox proteins in quadriceps and soleus 
muscles from adult and old mice (see supplementary information Table 5.4.4, p.268-278). 
 
 Subsequent to the VennDIS analysis, STRING was used to assess protein-protein 
interactions in quadriceps and soleus from adult and old mice. This enabled a cross-comparison 
of interacting proteins that may be significantly changed with age and allowing analysis of 
specific pathways or mechanisms. GOrilla was not used here as the number of proteins from 
the redox datasets were too few to perform a pathway analysis. 
 Figure 5.4.5A shows analysis using STRING to examine differentially labelled 
proteomics data for quadriceps and soleus from adult mice to identify any protein interactions 
that occur in both tissues at 12 months of age. Enrichment for glycolysis proteins highlighted 
interactions between mitochondrial Dihydrolipoyl dehydrogenase (DLD), β-enolase (ENO3), 
A) B) 
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α-enolase (ENO1), Triosephosphate isomerase (TPI1) and Fructose bisphosphate aldolase A 
(ALDOA). The data in table 7 highlights the associated proteins in the label free proteomics 
data although none were significantly changed in abundance with age. This result shows basic 
interactions between only a few proteins for glycolysis occur in both quadriceps and soleus 
adult tissues. 
 
Figure 5.4.5 (A) STRING analysis of redox proteins detected in both quadriceps and soleus 
muscles from adult mice enriched for Glycolysis/gluconeogenesis. (B) STRING analysis 
information and FDR. 
 
Table 7. Quadriceps (Q) and soleus (S) global label free proteomics data for the associated 
proteins highlighted in figure 5.4.5. 
A)
#pathway ID pathway description observed gene count false discovery rate
10 Glycolysis / Gluconeogenesis 5 3.76E-07B)
Accession Label Significance (-10lgP) Group Profile (Ratio) Description
S P17182 ENOA_MOUSE 5.8 1.00:1.10 Alpha-enolase OS=Mus musculus GN=Eno1 PE=1 SV=3
S P21550 ENOB_MOUSE 14.85 1.00:0.79 Beta-enolase OS=Mus musculus GN=Eno3 PE=1 SV=3
S O08749 DLDH_MOUSE 6.88 1.00:1.07 Dihydrolipoyl dehydrogenase  mitochondrial OS=Mus musculus GN=Dld PE=1 SV=2
S P05064 ALDOA_MOUSE 23.11 1.00:1.43 Fructose-bisphosphate aldolase A OS=Mus musculus GN=Aldoa PE=1 SV=2
S P17751 TPIS_MOUSE 14.07 1.00:0.98 Triosephosphate isomerase OS=Mus musculus GN=Tpi1 PE=1 SV=3
Accession Labels Significance (-10lgP) Group Profile (Ratio) Description
Q P17182 ENOA_MOUSE 1.46 1.00:1.32 Alpha-enolase OS=Mus musculus GN=Eno1 PE=1 SV=3
Q P21550 ENOB_MOUSE 5.88 1.00:0.89 Beta-enolase OS=Mus musculus GN=Eno3 PE=1 SV=3
Q O08749 DLDH_MOUSE 4.49 1.00:1.99 Dihydrolipoyl dehydrogenase  mitochondrial OS=Mus musculus GN=Dld PE=1 SV=2
Q P05064 ALDOA_MOUSE 2.12 1.00:1.04 Fructose-bisphosphate aldolase A OS=Mus musculus GN=Aldoa PE=1 SV=2
Q P17751 TPIS_MOUSE 8.68 1.00:0.84 Triosephosphate isomerase OS=Mus musculus GN=Tpi1 PE=1 SV=3
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 An equivalent study was performed for quadriceps and soleus muscles of old mice. 
Figure 5.4.5 shows four proteins involved in interactions for glycolysis which were Fructose 
bisphosphate aldolase A (ALDOA), Triosephosphate isomerase (TPI1), β-enolase (Eno3) and 
Dihydrolipoyl dehydrogenase (DLD). Table 9 gives the associated label free proteomics data 
for the proteins in figure 5.4.6A, but none were significantly changed in abundance with age. 
This result highlights a lack of α-enolase (ENO1) when compared with the adult samples. 
 
Figure 5.4.6 (A) STRING analysis of quadriceps and soleus redox proteins from old mice 
enriched for glycolysis/gluconeogenesis protein interactions. (B) STRING analysis 
information and FDR. 
 
 
Table 8. Quadriceps (Q) and soleus (S) global label free proteomics information for the 
associated proteins in figure 5.4.6. 
 
 Figure 5.4.6A shows data for STRING analysis to consider quadriceps and soleus 
muscles from adult mice following enrichment for protein-protein interactions in metabolic 
A)
B) #pathway ID pathway description observed gene count false discovery rate
10 Glycolysis / Gluconeogenesis 4 3.20E-06
Accession Labels Significance (-10lgP) Group Profile (Ratio) Description
S P21550 ENOB_MOUSE 14.85 1.00:0.79 Beta-enolase OS=Mus musculus GN=Eno3 PE=1 SV=3
S O08749 DLDH_MOUSE 6.88 1.00:1.07 Dihydrolipoyl dehydrogenase  mitochondrial OS=Mus musculus GN=Dld PE=1 SV=2
S P05064 ALDOA_MOUSE 23.11 1.00:1.43 Fructose-bisphosphate aldolase A OS=Mus musculus GN=Aldoa PE=1 SV=2
S P17751 TPIS_MOUSE 14.07 1.00:0.98 Triosephosphate isomerase OS=Mus musculus GN=Tpi1 PE=1 SV=3
Accession Labels Significance (-10lgP) Group Profile (Ratio) Description
Q P21550 ENOB_MOUSE 5.88 1.00:0.89 Beta-enolase OS=Mus musculus GN=Eno3 PE=1 SV=3
Q O08749 DLDH_MOUSE 4.49 1.00:1.99 Dihydrolipoyl dehydrogenase  mitochondrial OS=Mus musculus GN=Dld PE=1 SV=2
Q P05064 ALDOA_MOUSE 2.12 1.00:1.04 Fructose-bisphosphate aldolase A OS=Mus musculus GN=Aldoa PE=1 SV=2
Q P17751 TPIS_MOUSE 8.68 1.00:0.84 Triosephosphate isomerase OS=Mus musculus GN=Tpi1 PE=1 SV=3
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pathways. The results highlighted thirteen proteins: α-enolase (ENO1), β-enolase (ENO3), 
Aspartate aminotransferase (GOT2), Creatine kinase (CKMT2), Cytochrome b-c1 complex 
subunit 1 and 2 (UQCRC1 & UQCRC2), Dihydrolipoyl dehydrogenase (DLD), Fructose 
bisphosphate aldolase A (ALDOA), Malate dehydrogenase 1 and 2 (MDH1 & MDH2). Table 
9 shows the label free proteomics data for the proteins in figure 5.4.6A, none were significantly 
changed in abundance with age. This result demonstrated a number of protein interactions that 
occur for metabolic pathways in quadriceps and soleus muscles from adult mice. 
 
Figure 5.4.7 (A) STRING analysis of quadriceps and soleus redox proteins from adult mice 
following enrichment for proteins involved in metabolic pathways. (B) STRING analysis data 
and FDR. 
 
#pathway ID pathway description observed gene count false discovery rate
1100 Metabolic pathways 13 7.62E-09
A)
B)
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Table 9. Quadriceps (Q) and soleus (S) global label free proteomics data for the proteins 
highlighted in figure 5.4.7. 
 
 STRING analysis was also performed on the quadriceps and soleus muscle combined 
redox data from old muscle to identify changes to protein-protein interactions following 
enrichment for metabolic pathways. Figure 5.4.7A shows fewer interactions when compared 
with figure 5.4.6A. The proteins involved here were Fructose bisphosphate aldolase A 
(ALDOA), mitochondrial Aconitase (ACO2), Aspartate aminotransferase (GOT2), β-enolase 
(ENO3), Dihydrolipoyl dehydrogenase (DLD), and Malate dehydrogenase 1 and 2 (MDH1 & 
MDH2). Table 11 shows the label free proteomics data for the associated proteins and 
demonstrated no significant changes in protein abundance with age. This result demonstrated 
a reduction in the number of protein interactions in both quadriceps and soleus muscles that 
occur with age. 
Accession Labels Significance (-10lgP) Group Profile (Ratio) Description
S P17182 ENOA_MOUSE 5.8 1.00:1.10 Alpha-enolase OS=Mus musculus GN=Eno1 PE=1 SV=3
S P05202 AATM_MOUSE 7.39 1.00:1.02 Aspartate aminotransferase  mitochondrial OS=Mus musculus GN=Got2 PE=1 SV=1
S P21550 ENOB_MOUSE 14.85 1.00:0.79 Beta-enolase OS=Mus musculus GN=Eno3 PE=1 SV=3
S Q6P8J7 KCRS_MOUSE 25.16 1.00:1.26 Creatine kinase S-type  mitochondrial OS=Mus musculus GN=Ckmt2 PE=1 SV=1
S Q9CZ13 QCR1_MOUSE 8.96 1.00:0.89 Cytochrome b-c1 complex subunit 1  mitochondrial OS=Mus musculus GN=Uqcrc1 PE=1 SV=1
S Q9DB77 QCR2_MOUSE 3.16 1.00:1.04 Cytochrome b-c1 complex subunit 2  mitochondrial OS=Mus musculus GN=Uqcrc2 PE=1 SV=1
S O08749 DLDH_MOUSE 6.88 1.00:1.07 Dihydrolipoyl dehydrogenase  mitochondrial OS=Mus musculus GN=Dld PE=1 SV=2
S P05064 ALDOA_MOUSE 23.11 1.00:1.43 Fructose-bisphosphate aldolase A OS=Mus musculus GN=Aldoa PE=1 SV=2
S P14152 MDHC_MOUSE 5.01 1.00:0.97 Malate dehydrogenase  cytoplasmic OS=Mus musculus GN=Mdh1 PE=1 SV=3
S P08249 MDHM_MOUSE 3.84 1.00:1.01 Malate dehydrogenase  mitochondrial OS=Mus musculus GN=Mdh2 PE=1 SV=3
Accession Labels Significance (-10lgP) Group Profile (Ratio) Description
Q P17182 ENOA_MOUSE 1.46 1.00:1.32 Alpha-enolase OS=Mus musculus GN=Eno1 PE=1 SV=3
Q P05202 AATM_MOUSE 1.89 1.00:1.13 Aspartate aminotransferase  mitochondrial OS=Mus musculus GN=Got2 PE=1 SV=1
Q P21550 ENOB_MOUSE 5.88 1.00:0.89 Beta-enolase OS=Mus musculus GN=Eno3 PE=1 SV=3
Q Q6P8J7 KCRS_MOUSE 5.14 1.00:0.95 Creatine kinase S-type  mitochondrial OS=Mus musculus GN=Ckmt2 PE=1 SV=1
Q Q9CZ13 QCR1_MOUSE 4.09 1.00:0.92 Cytochrome b-c1 complex subunit 1  mitochondrial OS=Mus musculus GN=Uqcrc1 PE=1 SV=1
Q Q9DB77 QCR2_MOUSE 1.29 1.00:1.09 Cytochrome b-c1 complex subunit 2  mitochondrial OS=Mus musculus GN=Uqcrc2 PE=1 SV=1
Q O08749 DLDH_MOUSE 4.49 1.00:1.99 Dihydrolipoyl dehydrogenase  mitochondrial OS=Mus musculus GN=Dld PE=1 SV=2
Q P05064 ALDOA_MOUSE 2.12 1.00:1.04 Fructose-bisphosphate aldolase A OS=Mus musculus GN=Aldoa PE=1 SV=2
Q P14152 MDHC_MOUSE 2.06 1.00:1.06 Malate dehydrogenase  cytoplasmic OS=Mus musculus GN=Mdh1 PE=1 SV=3
Q P08249 MDHM_MOUSE 10.78 1.00:0.76 Malate dehydrogenase  mitochondrial OS=Mus musculus GN=Mdh2 PE=1 SV=3
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Figure 5.4.8 (A) STRING analysis of old redox proteins in quadriceps and soleus muscles 
following enrichment for metabolic pathway protein interactions. (B) STRING analysis 
information and FDR. 
 
 
Table 10. Quadriceps (Q) and soleus (S) global label free proteomics information for 
associated proteins in figure 5.4.8. 
 
 These results help to highlight differences in protein-protein interactions between the 
quadriceps and soleus muscles. In both cases comparisons of interactions in glycolysis and 
metabolic pathways demonstrated fewer interactions with age. 
A)
B) #pathway ID pathway description observed gene count false discovery rate
1100 Metabolic pathways 9 7.52E-07
Accession Labels Significance (-10lgP) Group Profile (Ratio) Description
S Q99KI0 ACON_MOUSE 53.5 1.00:1.60 Aconitate hydratase  mitochondrial OS=Mus musculus GN=Aco2 PE=1 SV=1
S P05202 AATM_MOUSE 7.39 1.00:1.02 Aspartate aminotransferase  mitochondrial OS=Mus musculus GN=Got2 PE=1 SV=1
S P21550 ENOB_MOUSE 14.85 1.00:0.79 Beta-enolase OS=Mus musculus GN=Eno3 PE=1 SV=3
S O08749 DLDH_MOUSE 6.88 1.00:1.07 Dihydrolipoyl dehydrogenase  mitochondrial OS=Mus musculus GN=Dld PE=1 SV=2
S P05064 ALDOA_MOUSE 23.11 1.00:1.43 Fructose-bisphosphate aldolase A OS=Mus musculus GN=Aldoa PE=1 SV=2
S P14152 MDHC_MOUSE 5.01 1.00:0.97 Malate dehydrogenase  cytoplasmic OS=Mus musculus GN=Mdh1 PE=1 SV=3
S P08249 MDHM_MOUSE 3.84 1.00:1.01 Malate dehydrogenase  mitochondrial OS=Mus musculus GN=Mdh2 PE=1 SV=3
Accession Labels Significance (-10lgP) Group Profile (Ratio) Description
Q Q99KI0 ACON_MOUSE 1.85 1.00:1.00 Aconitate hydratase  mitochondrial OS=Mus musculus GN=Aco2 PE=1 SV=1
Q P05202 AATM_MOUSE 1.89 1.00:1.13 Aspartate aminotransferase  mitochondrial OS=Mus musculus GN=Got2 PE=1 SV=1
Q P21550 ENOB_MOUSE 5.88 1.00:0.89 Beta-enolase OS=Mus musculus GN=Eno3 PE=1 SV=3
Q O08749 DLDH_MOUSE 4.49 1.00:1.99 Dihydrolipoyl dehydrogenase  mitochondrial OS=Mus musculus GN=Dld PE=1 SV=2
Q P05064 ALDOA_MOUSE 2.12 1.00:1.04 Fructose-bisphosphate aldolase A OS=Mus musculus GN=Aldoa PE=1 SV=2
Q P14152 MDHC_MOUSE 2.06 1.00:1.06 Malate dehydrogenase  cytoplasmic OS=Mus musculus GN=Mdh1 PE=1 SV=3
Q P08249 MDHM_MOUSE 10.78 1.00:0.76 Malate dehydrogenase  mitochondrial OS=Mus musculus GN=Mdh2 PE=1 SV=3
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5.5 Discussion 
 This chapter compared the quadriceps and soleus muscles following analysis of them 
individually in chapters three and four respectively. The aim (as stated on p.206) was to identify 
the similarities and differences between quadriceps and soleus muscles seen in proteomics to 
better understand how different types of skeletal muscle age.  
The initial comparisons used PathVisio to place proteins identified from the global label 
free proteomics data into two systems of interest.  
The PathVisio analysis of the label free proteomics data visualised changes to 
quadriceps and soleus proteins with age. Figures 5.3.2 and 5.3.3 looked at the sarcomeric 
proteins involved in skeletal muscle contraction in the quadriceps and soleus respectively. The 
results showed more up-regulated proteins in the quadriceps with age, potentially reflecting an 
increased demand with age. When compared with the soleus results, this showed many of the 
same proteins were either up regulated to a lesser extent or in some cases were down regulated 
in the soleus. This increased requirement for sarcomeric proteins in quadriceps mouse muscle 
with age is reflected by other literature that determined age-related changes to cytoskeletal 
proteins in ageing human muscle related to specific fibre types (Lexell, 1995, Jakobsson et al., 
1990, Fazelzadeh et al., 2016, Chopard et al., 2001, Koh and Escobedo, 2004). The soleus data 
highlights an increase in energy metabolism requirements. Much of the previous literature has 
focused on mitochondrial involvement and specific metabolism effects during ageing rather 
than using a global proteomic view of these changes (Lopez-Lluch et al., 2008, Dirks et al., 
2006, Ramsey et al., 2000). Interestingly skeletal muscle filament regulatory proteins 
myomesin (MYOM1) and small muscular protein (SMPX) were down regulated. When taken 
together the up-regulation of cytoskeleton and myofibrillar proteins and down regulation of 
their associated regulatory proteins points to a potential dysregulation of the muscle fibre. This 
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may contribute to the increased stiffness and loss of muscle force associated with age. These 
changes were in the mitochondrial rich soleus muscle and this generally supports other studies 
that have highlighted how type I slow twitch fibres age more slowly than type II fast twitch 
fibres (Jacobs et al., 2013, Gonzalez et al., 2000).  
The electron transport chain was studied in the quadriceps (figure 5.3.4) and the soleus 
(figure 5.3.5). The quadriceps data indicates many proteins were unchanged whereas the soleus 
demonstrated a number of down-regulated proteins. The soleus data also highlighted NADH 
dehydrogenases as being up regulated with age. This supports a study that reported the down 
regulation of the electron transport chain in mouse skeletal muscle with age, although they 
considered the effects in gastrocnemius and vastus lateralis muscles (Mercken et al., 2017, 
Boengler et al., 2017).  
Following the label free comparison of the tissues, the redox data was also examined 
using STRING. Following the use of VennDIS shown in figure 5.3.1 to filter the adult 
quadriceps and soleus redox proteins and old quadriceps and soleus proteins where each dataset 
was previously described in the individual muscle chapters, here it is presented together as a 
comparison between the quadriceps and soleus muscles. The results highlighted a decrease in 
redox protein numbers (figure 5.4.1) with age for quadriceps from 64 to 51 and soleus from 42 
to 30. The numbers of reduced proteins (figure 5.4.2) increased for the soleus from 118 to 126, 
but there was no effect in the quadriceps, which remained unchanged at 95. Numbers of 
reversibly oxidised proteins (figure 5.4.3) decreased for quadriceps from 21 to 20 with age and 
increased in the soleus from 13 to 18. Previous studies have measured changes to the redox 
environment in mouse skeletal muscle with age, but none have previously gone into this depth 
using differential labelling to identify changes to specific cysteine residues of particular 
proteins (Vasilaki et al., 2006a, Le Moal et al., 2017, Claflin et al., 2015, Lee et al., 2015, Ji, 
2008). 
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VennDIS was again used to separate the data into requisite categories to analyse 
protein-protein interactions via STRING (figure 5.4.4). Only redox proteins were considered 
as these are the primary focus of this thesis. The initial consideration was given to glycolysis, 
the crucial energy metabolism pathway in skeletal muscle. Figure 5.4.5 shows proteins from 
the adult dataset and figure 5.4.6, the proteins from the old dataset. Comparing the results of 
adult and old tissues, and between quadriceps and soleus glycolytic protein interactions showed 
no difference between groups. A recent proteomics study on human vastus lateralis identified 
a reduction in glycolysis for slow twitch muscles and an increase in glycolysis for fast twitch 
muscles, as they age (Murgia et al., 2015, Ohlendieck, 2010). The differences to our data on 
mouse muscle ageing may relate to the different species or it may serve to further highlight 
how tissues age differently since I compared two muscles of predominantly different fibre 
types. 
General metabolism protein interactions were also considered to clarify whether the 
differences in ageing of each muscle reflected changes in protein interactions via different 
pathways. Figure 5.4.7 shows quadriceps and soleus protein interactions from adult mice and 
figure 5.4.8 shows protein interaction of the two muscles from old mice. The results identified 
no marked difference between the tissues regarding protein interactions. The result of both the 
glycolytic and metabolic pathways provided an interesting insight into protein interactions with 
age. In mouse skeletal muscle it appears these protein-protein interactions do not change, 
despite data in previous chapters highlighting changes to protein abundance or their redox state 
with age. 
5.6 Conclusion 
 In conclusion, this chapter set out to consider differences and similarities between the 
quadriceps and soleus muscles as they age. The results demonstrated clear differences in the 
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quadriceps and soleus as they age in relation to sarcomeric and electron transport chain 
proteins. Furthermore, changes to the redox states of proteins showed some similarities 
between muscles in the age-related effects on redox states of proteins whereas protein-protein 
interactions did not appear to be affected. Together these results identified how different 
muscle types can age to differing extents, even within the same crucial systems such as energy 
production. The next stage of this analysis would be to consider other pathways such as 
autophagy, protein folding response and chaperones, and protein-DNA interactions to further 
elucidate how these crucial processes change with age and how these differ in the two different 
forms of skeletal muscle. 
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CHAPTER 6  
 
CELL STRETCHING STUDY 
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6.1 Introduction 
 Thiol signalling in skeletal muscle is reliant on ROS and is required for normal 
homeostasis of skeletal muscle. ROS are recognised as crucial messengers for relaying changes 
to the intracellular redox state. This is facilitated by cysteine residues that are evolutionarily 
conserved at specific locations since they can form disulphide bonds, amongst other covalent 
linkages, that affect protein conformation or interactions with other proteins or molecules. As 
previously demonstrated, ageing of quadriceps and soleus muscles in mice leads to a discordant 
change to redox control systems such as Thioredoxins, Peroxiredoxins and Superoxide 
dismutases. Reactive oxygen species (ROS) are produced under normal conditions during 
skeletal muscle contractions. Further to previous work that addressed the characterisation of 
ageing in two types of mouse skeletal muscle, the next step was to assess ROS induction 
following contractions. After considering several techniques (Kamotani et al., 2008, Wang et 
al., 2014, Kurazumi et al., 2011), an in vitro method was established that would enable three 
time-points of data collection using C2C12 myotubes. The experiment was explained in detail 
in section 2.10, p.59. Briefly, the FlexCell method utilised 6-well plates containing a 
stretchable plastic membrane enabling induced contractions of the C2C12 myotubes via a 
vacuum pump attached to the incubator. The cells were then isolated via scraping and western 
blotting performed to identify any initial differences in protein content as a proof of principle 
prior to a proteomic assessment of changes to C2C12 myotubes following contractions. 
 The C2C12 myocytes used were from in-house stocks although the cell line originates 
from a female mouse at 2 months of age in which cells were isolated 70 hrs after a crush injury 
(Yaffe and Saxel, 1977). The purpose of using cells for this work was to use an accessible 
technique for assessing proteomic changes to skeletal muscle for preliminary experiments. 
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The aim of this chapter is to assess the viability of the cell-stretch technique on C2C12 
myotubes prior to a full analysis of intracellular proteomics before and after stretching. It was 
envisaged that this will enable an in vitro model for assessment of redox responses by skeletal 
muscle cells following bidirectional stimulation. 
6.2 Results  
 C2C12 cells were grown from liquid nitrogen stocks and once confluent in T75s were 
seeded onto stretch plates. Figure 6.2.1 shows the seeding of myocytes (A) and differentiation 
of the cells into myotubes (B) after four days growth on standard 6-well plates. 
 
 
Figure 6.2.1 (A) Undifferentiated C2C12 myocytes. (B) Differentiated C2C12 myotubes 
following 4 days growth in differentiation media. Both images are of cells cultured on standard 
6-well plates. 
 
After preparation the cells were seeded on stretch plates and cyclically stretched at 12% 
for zero minutes (control), 15 minutes or 2 hours. Figure 6.2.2 shows an example image of the 
cells on the plate. The focus appears slightly off due to the custom plate size which did not fit 
plate holders available and the inverted microscopes were at their maximum focal length at this 
point. 
(A) (B) 
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Figure 6.2.2 Differentiated C2C12 cells on 6-well stretch plate. The focus was limited by the 
different depth of the wells compared to standard 6-well plates. 
 
Table 11. Protein content results for the samples determined following a Bradford Assay of 
whole cell protein content. 
 
 Western blots in figure 6.2.3 studied the effects of stretch and used antibodies to the 
protein chaperone and redox sensor PARK7 (figure 6.2.3A) involved in oxidative signalling in 
addition to chaperone activities. The content did not change with the stretching protocol and 
neither did P62 (figure 6.2.3B), a nucleoporin protein involved in autophagy as a receptor and 
mTOR signalling (Andres-Mateos et al., 2007, Sugiyama et al., 2016). Finally, ULK1 (figure 
Sample Label Conc. (ug/ul)
Ctrl 1 1.02
Ctrl 2 1.07
Ctrl 3 1.17
Ctrl 4 1.11
Ctrl 5 0.80
Ctrl 6 0.98
30 mins 1 1.24
30 mins 2 1.23
30 mins 3 1.45
30 mins 4 1.59
30 mins 5 1.24
30 mins 6 1.13
2 hrs 1 1.33
2 hrs 2 1.07
2 hrs 3 1.10
2 hrs 4 0.98
2 hrs 5 1.23
2 hrs 6 1.00
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6.2.3C), a serine/threonine kinase also involved in autophagy (Loffler et al., 2011) was studied 
and demonstrated a significant increase in protein abundance following two hours of stretching. 
These proteins were selected as it was thought autophagy might be implicated in a cellular 
response to stretching due to the physical changes occurring to the cells over the different times. 
  
Figure 6.2.3. Densiometric measurement for immunodetection by western blotting data 
following 0 minutes (control), 15 minutes and 2 hours of cyclical stretching of C2C12 
myotubes. Change in protein abundance was measured for (A) PARK7, (B) P62 and (C) ULK1, 
*p < 0.05. (D) Ponceau S stain used for normalisation of the PARK7 and P62 blots. (E) Ponceau 
S stain used for normalisation of the ULK1 blot. N=3 biological replicates. Short bars indicate 
upper and lower interquartile range while the middle represents the median value following 
statistical analysis using ANOVA with Tukey’s post-hoc test. 
  
6.3 Discussion and Conclusion 
 This experiment was undertaken to enable a preliminary look at an experimental 
protocol for myotube stretching and to optimise the equipment and software. Successful 
implementation of the protocol would enable future experiments to take an in vitro approach 
to examine the effect of mechanical stress on myotubes. Although these cells are being 
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stretched, rather than contracted, the physical change to the cell may cause changes that are 
closer to physiological conditions than cells maintained at rest. 
Takemoto et al. used a 12% stretch intensity which appeared potentially sufficient to 
induce a redox response in the cells without causing excessive damage (Takemoto et al., 2012). 
Other work by Deshmukh et al. compared C2C12 cells and skeletal muscle tissue. They 
highlighted a 44% (significant) difference between proteomes of mouse skeletal muscle 
(triceps) and C2C12 cells (Deshmukh et al., 2015).  
 The Western blot of PARK7, P62 and ULK1 provide a brief insight into potential 
changes occurring following cell stretching. The results showed no significant change in P62 
and PARK7 after 2 hours stretching. Given PARK7’s role in protein folding amongst other 
abilities, it was surprising to see it unchanged following cell stretching while in previous 
chapters, PARK7 increased in abundance with age in quadriceps. This may suggest a difference 
in protein control mechanisms between the short and the long term. A significant increase in 
the autophagy protein ULK1 was observed and is supported by Moller et al.’s work in humans 
that identified an increase in ULK1 following exercise (Moller et al., 2015). 
 While differences in the methodology are acknowledged, the data from quadriceps and 
soleus muscles can be briefly considered as it aids our understanding as an alternative 
perspective on ageing skeletal muscle. The results in figure 6.2.3 (A) identified no change to 
PARK7 following induced physical stress on the cells, this contrasts with the quadriceps results 
which identified an increase in PARK7 abundance with age through western blotting. As this 
was not observed following stretching of the cells, it raises interesting questions regarding the 
duration and intensity of the stretching. The quadriceps label free analysis identified p62 but 
not ULK1 in the dataset although it was not significantly changed with age. Neither p62 nor 
ULK1 were detected in the soleus label free dataset. It should be noted, however, that the 
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C2C12 cells were taken from female mice and therefore the differences may be subject to sex 
differences rather than ageing or physical stretching. 
 Although brief, the aim of this chapter was to identify an experimental protocol that 
would be suitable for further studies and provide enough protein for western blots which was 
achieved. This sets in place the potential for future experiments to assess proteomic changes in 
myotubes and other cell types following stretching. This outcome also supports the three R’s 
to replace, reduce or refine experiments involving animal models. Although this protocol does 
not contract the cells, the physical stress may induce further changes to the cellular proteome 
and transcriptome that have not yet been identified in vitro. 
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CHAPTER 7 
 
GENERAL DISCUSSIONS 
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 The work in this thesis aimed to improve understanding of how mouse skeletal muscle 
ages in two metabolically distinct muscles at both the global proteomic scale and specific redox 
changes in individual amino acids. The quadriceps and soleus muscles were examined in adult 
and old mice. The data are novel since no other study has used differential labelling combined 
with label free proteomics to analyse changes in redox state and protein abundance 
simultaneously. The global label free results highlighted changes to predominantly cytoskeletal 
proteins in the quadriceps with age whilst the metabolic machinery of the soleus appeared 
susceptible to age-related changes.  
Overall, the work in this thesis supports other studies in demonstrating the importance 
of understanding changes to the intracellular redox state in relation to changes in cysteine 
amino acids with age. The importance of cysteine as a conserved amino acid in strategic 
locations such as in redox enzyme’s active sites also, in a wider context of understanding how 
skeletal muscle ages (Klitgaard et al., 1990, Yang et al., 2016). In a broader context still, this 
work supports developments in the field of ROS biochemistry in ageing skeletal muscle by 
combining two proteomics techniques to elucidate both global changes to two different types 
of muscle as well as identifying changes to the redox proteome for individual cysteines amino 
acids (Ferreira and Reid, 2008). 
It was hypothesised that the two muscles would age differently based on their metabolic 
and functional backgrounds and the data presented in this thesis supports this. It was also 
hypothesised that we would observe changes to redox proteins with age, however it was unclear 
how exactly these changes would manifest in the two different forms of ageing muscle. 
Thiol signalling in skeletal muscle during ageing looked at the effect of changes to the 
intracellular redox environment and how this affected the mouse skeletal muscle. A number of 
studies have compared fast and slow twitch skeletal muscle ageing, however they used either 
215 
 
different species or muscle types (Demontis et al., 2013, Johnson et al., 2013, Leduc-Gaudet et 
al., 2015, Zhang and Gao, 2014). This study primarily used mass spectrometry to obtain a high-
resolution assessment of the global proteome of quadriceps and soleus muscle. Differential 
labelling of individual cysteine amino acids was used to allow assessment of changes to the 
intracellular redox state of specific proteins with age. This approach also used a range of 
techniques such as western blotting to determine changes to protein abundance with age and 
enzyme activity assays to assess whether those changes in abundance were reflected in enzymic 
activity changes. Histological analysis of the muscles showed a reduction in oxidative 
phosphorylation energy metabolism via succinate dehydrogenase for both quadriceps and 
soleus as they age. In addition to the label free proteomic analysis, pathway analysis in GOrilla 
and STRING protein-protein interactions were also performed on the label free dataset to 
highlight how ageing impacted intracellular pathways or interactions. 
 This section aims to highlight key changes seen in ageing skeletal muscle and to put 
the results into the wider context of the scientific literature, setting the scene for future work 
and discussing experimental limitations before outlining the conclusions of the thesis. 
Overall Comparisons of the Quadriceps and Soleus Data 
The quadriceps and soleus muscles were found to age in different ways as determined 
by the label free proteomics and differential labelling data. In the quadriceps, ageing 
predominantly affected cytoskeletal proteins suggesting a possible increase in cellular stiffness 
relating to increased abundance of cytoskeletal proteins with age. In contrast, ageing in the 
soleus predominantly affected energy metabolism proteins. In addition to this, the number of 
redox sensitive proteins was also reduced with age in both muscles together with an increase 
in the number of reduced proteins with age. 
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Redox Changes to the Skeletal Muscle Proteome 
We hypothesised that changes to the redox proteome would be observed with age, 
however the detected changes were not consistent across the different muscle types. 
Ageing in the quadriceps identified an increased abundance of cytoskeletal proteins 
with age such as troponins (TNNI2 and TNNT3) and actin (ACTS) while protein chaperones 
HSP70 and HSPB6 were down regulated with age. Interestingly none of the peroxiredoxins or 
thioredoxin proteins were changed in abundance with age which was unexpected given the 
previous suggestions of the free radical theory of ageing. In contrast, the soleus demonstrated 
a down regulation of a large number of energy metabolism proteins or their subunits with age. 
It was interesting to note that this was not straight forward though as aconitase, fructose 
bisphosphate aldolase, electron transfer flavoprotein subunit α and ATP synthase subunit α was 
all significantly up regulated with age in the soleus. This soleus data is supported by an earlier 
study that observed similar changes in adult and old skeletal muscle fibres (O'Connell et al., 
2007). 
The redox cysteine results identified differences in changes to the redox state of specific 
proteins however the differences between muscles was less pronounced. In the quadriceps 
cofilin-2 (Cys80) changed in its redox state by increasing in reduced form 7.21-fold. 
Interestingly, the next two highest changing proteins changed from being reversibly oxidised 
forms in adult quadriceps to becoming very reduced in old muscle. They were glucose 6-
phosphate isomerase (Cys321) and malate dehydrogenase (Cys154) increasing by 6.06 and 
6.80-fold respectively. The changes to cofilin-2 and malate dehydrogenase were also observed 
in another study that looked at rat skeletal muscle ageing (Donoghue et al., 2010). 
In the soleus a number of energy metabolism proteins were affected by changes to their 
redox states such as NADH ubiquinone (Ndufs1; Cys78) which saw a 28.7-fold increase in its 
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reduced state. Interestingly, two proteins identified as having significantly changed redox states 
in the quadriceps were also identified in the soleus. They were cofilin-2 (Cys80) with a 5.12-
fold increase and malate dehydrogenase 1 (Cys154) which had a 5.34-fold increase in reduced 
redox states. 
Thioredoxin 1 and Thioredoxin Reductase 1 are cytosol-based proteins and 
Thioredoxin 2 and Thioredoxin Reductase 2 are their mitochondrial equivalents, with a redox 
active cysteine at their active sites. This enables them to respond to changes in intracellular 
ROS concentrations by a change in oxidation state which affects the active site. Results from 
chapters 3 and 4 showed no change in abundance with age for either variant of Thioredoxin or 
Thioredoxin Reductase and no change was seen in either of their enzyme activities with age. 
The protein abundance result agrees with a study by Can et al. which analysed human serum 
levels of Thioredoxin 1 and also observed no change in old (Can et al., 2017). Several other 
studies have considered redox modifications to Thioredoxin or its effect in other organs 
(Dimauro et al., 2012, Kim et al., 2003), however none have looked at intracellular changes to 
protein abundance between fast and slow twitch muscles, and with age. 
 Peroxiredoxins showed very different responses in abundance in the quadriceps and 
soleus to ageing. Western blotting of quadriceps muscle identified no changes to protein 
abundance for Peroxiredoxins 1, 4 or 6, whereas the soleus demonstrated a significant decrease 
in Peroxiredoxin 1 and an increase in Peroxiredoxin 4 protein abundance with age. 
Peroxiredoxin 3 and 4 were not detected in the global label free proteomics data for the soleus 
due to limitations of detection, although in the quadriceps all six peroxiredoxins were detected. 
Other studies have examined Peroxiredoxins in a range of different species and systems, for 
example reporting a reduction in Peroxiredoxin 1 gene expression levels in the ageing human 
and its secretion in response to inflammation inducing production of inflammatory cytokines 
(Mullen et al., 2015). Peroxiredoxin 4 overexpression in Drosophila has been shown to 
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increase the inflammatory response and lead to an increase in longevity (Klichko et al., 2016). 
Studies of Peroxiredoxin 6 in neuronal Nitric Oxide Synthase knock-out mouse showed an up 
regulation of PRDX6 (Da Silva-Azevedo et al., 2009).  
This study is the first to demonstrate protein abundance changes in fast and slow twitch 
skeletal muscles and how they differ with age. Additionally this information builds upon 
previous studies from our lab that determined how changes to the Peroxiredoxin 6 redox state 
within the sciatic nerve might lead to a change in Peroxiredoxin 6 signalling (McDonagh et al., 
2016). Peroxiredoxins 2 (cytosolic), 3 and 5 (both mitochondrial) were only detected in 
quadriceps at 12 and 24 months. The results showed significant increases in mitochondrial 
Peroxiredoxin 3 and 5 with age. Studies have suggested Peroxiredoxin 3 may provide an ‘anti-
ageing’ effect by controlling mitochondrial homeostasis and removal of the protein has been 
demonstrated to reduce contractile force of skeletal muscle (Lee et al., 2014, Zhang et al., 
2016b). Peroxiredoxin 5 which is also mitochondrial, has not been described in detail in mouse 
skeletal muscle other than a single study describing its general function as a peroxynitrite 
reductase (Dubuisson et al., 2004). The speed of reactivity of Peroxiredoxin 2 and 3 were 
determined by Peskin et al. indicating that following hyperoxidation (which leads to 
inactivation of peroxiredoxins), Peroxiredoxin 3 had approximately a 10-fold higher rate 
constant for disulphide formation when compared to Peroxiredoxin 2 (Peskin et al., 2013). 
Hyperoxidation is described in detail in figure 1.4.1 (p.36). Briefly, hyperoxidation of 
peroxiredoxins occur where the first reactive cysteine reacts with H2O2 forming a sulphenic 
acid, this then condenses and a second H2O2 reacts with the (second) resolving cysteine on the 
protein. At this point the peroxiredoxin is said to be hyperoxidised (Peskin et al., 2013). The 
increased rate by which Peroxiredoxin 3 can form disulphide bonds when hyperoxidised may 
reflect higher requirement for control within the mitochondria, compared with the cytoplasm. 
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In addition to assessing individual peroxiredoxins, their sulphonylated forms 
(Peroxiredoxin-SO3H, for peroxiredoxins 1-4) were assessed in quadriceps and soleus muscle 
to determine the extent of post-translational modifications with age. Data for the quadriceps 
revealed a significant increase with age whereas the soleus showed no change. No other 
published studies appear to specifically describe the effect of mouse skeletal muscle ageing 
and its relation to sulphonylated proteins, although one study reported sulphonylated proteins 
in rats following X-ray irradiation at a single age point (Fedorova et al., 2010). 
Carbonylated proteins were assessed in both muscles with age and the quadriceps 
demonstrated a decease while no change was observed in the soleus. This was unexpected as 
it was assumed that ageing would cause an increase in reactive oxygen species and therefore 
an increase in carbonylated proteins with age. A number of other studies have identified 
carbonylated proteins in rat or mouse models (Meany et al., 2007, Radak et al., 2002, 
Carpentieri et al., 2016). Our data are in agreement with another study that demonstrated 
changes to carbonylated proteins in the mouse electron transport chain in mice with age 
(Choksi et al., 2008) but they examined quadriceps and pectoralis muscles. 
Glutathionylation was also examined in the quadriceps. This is another measurement 
which can indicate sustained intracellular ROS concentrations and a range of studies have 
highlighted its specific effects on skeletal muscle proteins such as Creatine kinase (Reddy et 
al., 2000), Sodium-Potassium ATPase pump activity (Juel, 2014) and Myosin and Actin 
(Passarelli et al., 2008, Moen et al., 2014, Dalle-Donne et al., 2003). The data obtained here 
showed a significant increase in glutathionylated proteins between muscle from adult and old 
mice. Further work is discussed below which will consider potential, specific targets following 
this initial observation. 
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Antioxidant proteins control reactive oxygen species and maintain redox homeostasis 
within skeletal muscle fibres. The work reported here examined both the cytosolic Cu-Zn 
superoxide dismutase (SOD1) and the mitochondrial Mn-Superoxide dismutase (SOD2). 
SOD1 was examined in both quadriceps and soleus while SOD2 was only tested in the 
quadriceps. A number of studies have tested SOD1 or SOD2 knock out mouse models to 
elucidate the importance of SOD activity in skeletal muscle and ageing (Nagahisa et al., 2016, 
Masser et al., 2016, McArdle et al., 2004b, Zhang et al., 2013). One study reported significant 
increases in SOD1 and SOD2 with age (Pietrangelo et al., 2015). The western blot results 
showed here showed a significant increase in SOD1 content in quadriceps from 3 to 12 months 
while the soleus content increased from 3 to 24 months of age. SOD2 did not change in protein 
abundance with age in the quadriceps. The SOD1 results broadly support the proposal that with 
age comes an increasing demand for ROS control in the cytoplasm for both muscle types. 
However, the lack of change in SOD2 in quadriceps may also reflect the reduction in 
mitochondria numbers as observed in ageing skeletal muscle (Alnaqeeb and Goldspink, 1987, 
Peterson et al., 2012). 
Experimental Considerations and Limitations 
Mass spectrometry is a very useful technique for assessing changes to proteins, either 
through their abundance using global analysis of a sample, or via differential labelling of 
specific amino acids to identify changes to their oxidation state. Mass spectrometry analysis is 
often supported by western blotting. This combination of the two methods has enabled a 
verification system that has yet to be surpassed, although it is not without limitations. In this 
thesis a number of experiments included information of the same protein from both techniques. 
Where they do not agree with each other, the data are assessed in the respective discussion 
chapter. Western blotting offers high specificity for a particular sequence, but mass 
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spectrometry is highly sensitive to detecting protein in a mixture. It is this combination that 
enabled a detailed analysis of protein changes skeletal muscle as it ages. 
Limitations of the Western blotting technique are that it is semi-quantitative, such that 
the results, whilst highly specific, only indicate a change in arbitrary units against a normalised 
background based on the amount of chemiluminescence detected. As previously described, 
normalisation of proteins utilised multiple bands from a Ponceau S stain which helped to 
indicate both equal protein loading across all lanes. Laboratory limitations include labour 
intensiveness since it requires multiple steps of membrane washing, multiple buffers and 
incubation with both a blocking agent and with the respective antibodies. Specificities of these 
steps such as wash time, buffer production methods and incubation time may vary from lab to 
lab and produce variables that must be accounted for (Anderson et al., 2011, Kurien and 
Scofield, 2006). The antibodies used, although highly specific, are often proprietary meaning 
that the actual sequence detected is not always public knowledge and therefore an antibody 
from different companies may produce different results (Gilda et al., 2015). The Western blots 
performed for this thesis all used exactly the same method for buffer preparation, antibody 
dilutions and blot image analysis. Western blot analysis of the soleus proved particularly 
difficult due to the limited amount of protein available from the small muscle. 
The mass spectrometry experiment analysed six adult and five old samples of muscle 
from individual mice whereas for western blotting only three biological samples from muscle 
at 3, 12 and 24 months of age were examined. The extra time point used in the western blot 
data was due to its timely availability during this study. The samples were from the same strains 
of mice, housed under the same conditions and no outliers were removed from the western blot 
plots as shown by the individual data-points. Although the blot data is interesting in 
demonstrating changes in peroxiredoxins, the mass spectrometry results are likely to be a more 
accurate picture of changes in protein abundance with age due to the increased sensitivity. It 
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should be noted that the confidence in the proteins detected is dependent upon the percentage 
of those detected. Therefore, proteins with only a single peptide detected would yield a very 
low confidence compared to proteins with many peptide strands identified. 
The limitations of mass spectrometry are changing rapidly due to improved techniques 
for sample preparation, protein fractionation, the mass spectrometers’ ability to quantitate 
detected proteins and bioanalytics software with improving search algorithms for matching 
detected sequences of peptides to protein databases for individual species (Deshmukh, 2016). 
The technique employed in this thesis was a data-dependent acquisition (DDA) which 
relied on detection of peptide sequences which were then compared to a known database of 
sequences to identify peptides and subsequently proteins (Egertson et al., 2015). This utilises 
consecutive time windows to fill the ion trap with the 10 most abundant ions fragmented by 
MS/MS, these ions are discarded, and the subsequent most abundant ions are fragmented until 
the dwell time has passed and the trap fills with a new set of ions. The clear drawback to this 
method is that it relies on peptide abundance during the initial run for subsequent detections 
with many low abundant ions failing to be fragmented by MS/MS and hence detected. This 
means highly abundant peptide sequences can overshadow those with a lower abundance in a 
given sample and as the skeletal muscle proteome contains over 50% contractile proteins, this 
is likely to skew the results of those proteins detected within samples (Deshmukh, 2016, 
Deshmukh et al., 2015, Ohlendieck, 2011). Alternatives to this limitation include high-
fractionation of protein samples to ensure separation and detection of very low abundance 
peptides. Another approach is to analyse single muscle fibres to ensure peptide quantitation is 
directly linked to approximate abundance within a muscle fibre type (Deshmukh et al., 2015). 
It is due to these limitations of the mass spectrometry technique that western blotting was also 
employed here as this enables detection of proteins of interest with high specificity 
(Ohlendieck, 2013).  
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As an alternative to the limitations of DDA, there is data independent analysis (DIA). 
An example of this is selective reaction monitoring (SRM) also referred to as multiple reaction 
monitoring (MRM) when scaled up. This identifies peptides via a unique fingerprint of the 
parent ion and the subsequent product ion, matching them and enabling an exact quantification 
of individual peptides from a sample (Aebersold et al., 2013, Gillet et al., 2012). SRM is 
hypothesis driven and relies on knowing which peptides to search for prior to the experiment. 
When targets of interest are defined then specific pathways or systems can be further quantified 
using this technique (Thomas and Zhang, 2016). However, SRM still has some limitations as 
it requires internal standards for quantification which need to be well characterised and 
calibrated, a lack of high throughput meaning only select peptides can be measured and 
reproducibility due to varying experimental methods and sample preparation (Gallien et al., 
2013).  
Another alternative mass spectrometry technique is SWATH-MS or sequential window 
of all theoretical fragment ion spectra mass spectrometry which analyses all detected peptide 
fragments in a mass range (Krisp and Molloy, 2017). This enables identification of peptides 
within a specific mass range and the data can be reprocessed at a later stage should new 
evidence come to light (Zhang et al., 2015). 
As a more general limitation of mass spectrometry the proposed peptides need to be 
analysable via mass spectrometry which immediately precludes a variety of potential targets 
from analysis or quantification via any current mass spectrometric method (Gallien et al., 2013, 
Xiao et al., 2012).  
Future Work 
Various additional experiments could add to the data obtained and further improve the 
understanding of ageing skeletal muscle. One example is the mass spectrometric analysis of S-
224 
 
sulphonylated proteins specifically, to understand these irreversible modifications in skeletal 
muscle. It would be interesting to see if the changes correlate to ageing muscle or specific 
conditions (Borotto et al., 2017). Next steps would include testing of different stretch 
conditions to see if there is a ‘sweet spot’ for stretching of myotubes followed by developing 
the cell stretch methodology to include the contraction phase. Subsequently changes to redox 
proteins following the increasingly physiologically relevant protocol would be a natural next 
step. Finally, a proteomic analysis of the cells before and after stretching would provide much 
needed insight into the effect of mechanical stretching on myotubes and determine whether any 
similarities to in vivo mechanisms exist. Furthermore, it would be building on the initial C2C12 
proteomics work performed by Deshmukh et al.(Deshmukh et al., 2015). 
Thesis Conclusions 
 This thesis has added to knowledge in the field of skeletal muscle ageing by assessing 
differences in two forms of muscle: the quadriceps, a predominantly fast twitch, Type II muscle 
and the soleus, a predominantly slow twitch, type I muscle and across three ages. The global 
label free proteomics assessment has showed a number of age-related changes not previously 
described and the differential labelling of specific cysteine residues gave an important insight 
into which proteins are susceptible to changes in the intracellular redox state. The data 
combined also showed how although certain proteins are susceptible to change with age, this 
may not affect their enzymatic activity. 
In conclusion this thesis has demonstrated that ageing affects thiol signalling in skeletal 
muscle ageing in a number of different ways. The global proteome analysis paints the two 
muscles as distinct and changing in clearly different ways with age however, the redox changes 
observed are far more conservative. 
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 and relating to muscle fibre type. This proves the overall hypothesis correct: that the 
two muscles will age differently due to their metabolic and functional backgrounds. The novel 
approach in the thesis combined label free relative quantitation of the global proteome with 
differential labelling for each muscle and between adult and old muscle samples to identify a 
range of age-associated changes for each muscle.  
It is hoped that this data may go some way to understanding the complexities of how 
different types of skeletal muscle age by providing a foundation for further research to 
understand why sarcopenia occurs and in time mitigate its outcomes. 
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Table 3.3.8.1 A The 44 proteins identified by differential labelling for redox, reduced and 
reversibly oxidised proteins detected in adult mouse quadriceps. 
 
 
 
 
 
F8WGM8 Actg1 - actin, gamma, cytoplasmic 1
F8VPN4 Agl - amylo-1,6-glucosidase, 4-alpha-glucanotransferase
Q9EQ20 Aldh6a1 - aldehyde dehydrogenase family 6, subfamily A1
D3Z7U0 Anxa11 - annexin A11
Q9CWJ9 Atic - 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
D3YYN7 Atp1a2 - ATPase, Na+/K+ transporting, alpha 2 polypeptide
A2AKV0 Atp5c1 - ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1
Q9CQQ7 Atp5f1 - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1
O88374 Bcat2 - branched chain aminotransferase 2, mitochondrial
Q8R4N0 Clybl - citrate lyase beta like protein
Q8R1G2 Cmbl - carboxymethylenebutenolidase-like (Pseudomonas)
P19536 Cox5b - cytochrome c oxidase, subunit Vb
D6RIN4 Dynll2 - dynein light chain LC8-type 2
O70251 Eef1b2 - eukaryotic translation elongation factor 1 beta 2
D3YY68 Eef1d - eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)
Q3UGC7 Eif3j1 - eukaryotic translation initiation factor 3, subunit J1
Q8BTU6 Eif4a2 - eukaryotic translation initiation factor 4A2
P97807 Fh1 - fumarate hydratase 1
Q9CPU0 Glo1 - glyoxalase 1
D3YUM8 Gm4950 - predicted pseudogene 4950
S4R1E5 Gpx4 - Glutathione peroxidase
E9Q5B5 Hk2 - hexokinase 2
Q61696 Hspa1a - heat shock protein 1A;
Q5EBG6 Hspb6 - heat shock protein, alpha-crystallin-related, B6
Q9D6R2 Idh3a - isocitrate dehydrogenase 3 (NAD+) alpha
Q80ZJ2 Impa1 - inositol (myo)-1(or 4)-monophosphatase 1
H3BLD4 Kdm2a - lysine (K)-specific demethylase 2A
P06151 Ldha - lactate dehydrogenase A
A2AMM0 Murc - muscle-related coiled-coil protein
P13542 Myh8 - myosin, heavy polypeptide 8, skeletal muscle, perinatal
Q9CPP6 Ndufa5 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5
F6ZFT1 Ndufab1 - NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1
E9QQ96 Obscn - obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
P62962 Pfn1 - profilin 1
D6RG50 Prkab2 - protein kinase, AMP-activated, beta 2 non-catalytic subunit
P12367 Prkar2a - protein kinase, cAMP dependent regulatory, type II alpha
A2AWQ9 Scrn3 - secernin 3
Q8BH59 Slc25a12 - solute carrier family 25 (mitochondrial carrier, Aralar), member 12
P48962 Slc25a4 - solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4
Q8JZR6 Slc4a8 - solute carrier family 4 (anion exchanger), member 8
P10639 Txn1 - thioredoxin 1
D3YZS3 Ube2l3 - ubiquitin-conjugating enzyme E2L 3
Q64727 Vcl - vinculin
P20152 Vim - vimentin
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Table 3.3.8.1 B The 133 proteins identified by differential labelling as redox, reduced and 
reversibly oxidised proteins detected in adult and old mouse quadriceps. 
 
 
 
 
 
 
 
 
 
P51174 Acadl - acyl-Coenzyme A dehydrogenase, long-chain
Q07417 Acads - acyl-Coenzyme A dehydrogenase, short chain
B1AR28 Acadvl - acyl-Coenzyme A dehydrogenase, very long chain
Q99KI0 Aco2 - aconitase 2, mitochondrial
P63268 Actg2 - actin, gamma 2, smooth muscle, enteric
O88990 Actn3 - actinin alpha 3
P28650 Adssl1 - adenylosuccinate synthetase like 1
P29699 Ahsg - alpha-2-HS-glycoprotein
Q9R0Y5 Ak1 - adenylate kinase 1
P45376 Akr1b3 - aldo-keto reductase family 1, member B3 (aldose reductase)
P07724 Alb - albumin
P47738 Aldh2 - aldehyde dehydrogenase 2, mitochondrial
P05064 Aldoa - aldolase A, fructose-bisphosphate
Q3V1D3 Ampd1 - adenosine monophosphate deaminase 1
F8WIT2 Anxa6 - annexin A6
Q8C0M9 Asrgl1 - asparaginase like 1
Q8R429 Atp2a1 - ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
D3Z6F5 Atp5a1 - ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1
B1ASE2 Atp5h - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d
Q6P1B9 Bin1 - bridging integrator 1
P14211 Calr - calreticulin
P16015 Car3 - carbonic anhydrase 3
P45591 Cfl2 - cofilin 2, muscle
P07310 Ckm - creatine kinase, muscl
Q6P8J7 Ckmt2 - creatine kinase, mitochondrial 2
P56391 Cox6b1 - cytochrome c oxidase, subunit VIb polypeptide 1
Q9CZU6 Cs - citrate synthase
O08749 Dld - dihydrolipoamide dehydrogenase
Q9D2G2 Dlst - dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)
Q8BK84 Dupd1 - dual specificity phosphatase and pro isomerase domain containing 1
F6T930 Echs1 - enoyl Coenzyme A hydratase, short chain, 1, mitochondrial
P58252 Eef2 - eukaryotic translation elongation factor 2
Q6PHC1 Eno1 - enolase 1, alpha non-neuron
B0QZL1 Eno1 - enolase 1, alpha non-neuron
P21550 Eno3 - enolase 3, beta muscle
Q99LC5 Etfa - electron transferring flavoprotein, alpha polypeptide
Q9DCW4 Etfb - electron transferring flavoprotein, beta polypeptide
P04117 Fabp4 - fatty acid binding protein 4, adipocyte
D3Z100 Fam98c - family with sequence similarity 98, member C
Q61554 Fbn1 - fibrillin 1
Q5STE3 Fstl4 - follistatin-like 4
P16858 Gapdh - glyceraldehyde-3-phosphate dehydrogenase
O55126 Gbas - glioblastoma amplified sequence
P05201 Got1 - glutamate oxaloacetate transaminase 1, soluble
P05202 Got2 - glutamate oxaloacetate transaminase 2, mitochondrial
E0CXN5 Gpd1 - glycerol-3-phosphate dehydrogenase 1 (soluble)
P06745 Gpi1 - glucose phosphate isomerase 1
P10649 Gstm1 - glutathione S-transferase, mu 1
D3YX76 Gstm2 - glutathione S-transferase, mu 2
E9Q024 Gstm5 - glutathione S-transferase, mu 5
Q61425 Hadh - hydroxyacyl-Coenzyme A dehydrogenase
A8DUK4 Hbb-b1 - hemoglobin, beta adult major chain
P70349 Hint1 - histidine triad nucleotide binding protein 1
Q91X72 Hpx - hemopexin
Q61316 Hspa4 - heat shock protein 4
Q504P4 Hspa8 - heat shock protein 8
P38647 Hspa9 - heat shock protein 9
P63038 Hspd1 - heat shock protein 1 (chaperonin)
P70404 Idh3g - isocitrate dehydrogenase 3 (NAD+), gamma
P01867 Igh3 - Ig gamma-2B chain C region
F6TQW2 Ighg2c - immunoglobulin heavy constant gamma 2C
A2AUC9 Kbtbd10 - kelch repeat and BTB (POZ) domain containing 10
D3YTY9 Kng1 - kininogen 1
P16045 Lgals1 - lectin, galactose binding, soluble 1
P04247 Mb - myoglobin
P14152 Mdh1 - malate dehydrogenase 1, NAD (soluble)
P08249 Mdh2 - malate dehydrogenase 2, NAD (mitochondrial)
P34884 Mif - macrophage migration inhibitory factor
P03899 mt-Nd3 - mitochondrially encoded NADH dehydrogenase 3
Q6P6L5 Mybpc1 - myosin binding protein C, slow-type
Q5XKE0 Mybpc2 - myosin binding protein C, fast-type
P70402 Mybph - myosin binding protein H
Q5SX39 Myh4 - myosin, heavy polypeptide 4, skeletal muscle
P05977 Myl1 - myosin, light polypeptide 1
P09542 Myl3 - myosin, light polypeptide 3
Q8VCR8 Mylk2 - myosin, light polypeptide kinase 2, skeletal muscle
P97457 Mylpf - myosin light chain, phosphorylatable, fast skeletal muscle
Q62234 Myom1 - myomesin 1
Q14BI5 Myom2 - myomesin 2
Q9QYG0 Ndrg2 - N-myc downstream regulated gene 2
Q99LC3 Ndufa10 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10
Q9CR61 Ndufb7 - NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7
D3YXX5 Ndufv1 - NADH dehydrogenase (ubiquinone) flavoprotein 1
Q01768 Nme2 - NME/NM23 nucleoside diphosphate kinase 2
P61971 Nutf2-ps1 - nuclear transport factor 2, pseudogene 1
Q60597 Ogdh - oxoglutarate dehydrogenase (lipoamide)
P09103 P4hb - prolyl 4-hydroxylase, beta polypeptide
A2A817 Park7 - Parkinson disease (autosomal recessive, early onset) 7
P35486 Pdha1 - pyruvate dehydrogenase E1 alpha 1
Q9D051 Pdhb - pyruvate dehydrogenase (lipoamide) beta
P70296 Pebp1 - phosphatidylethanolamine binding protein 1
P47857 Pfkm - phosphofructokinase, muscle
O70250 Pgam2 - phosphoglycerate mutase 2
P09411 Pgk1-rs7 - phosphoglycerate kinase-1, related sequence-7
Q9D0F9 Pgm2 - phosphoglucomutase 2
P52480 Pkm - pyruvate kinase, muscle
P17742 Ppia - peptidylprolyl isomerase A
P63330 Ppp2ca - protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform
P35700 Prdx1 - peroxiredoxin 1
P20108 Prdx3 - peroxiredoxin 3
G3UZJ4 Prdx5 - peroxiredoxin 5
Q9WUB3 Pygm - muscle glycogen phosphorylase
Q9DD03 Rab13 - RAB13, member RAS oncogene family
Q9CQ09 Rpl3l - ribosomal protein L3-like
Q3V1Z5 Rps4y2 - ribosomal protein S4, Y-linked 2
Q8K2B3 Sdha - succinate dehydrogenase complex, subunit A, flavoprotein (Fp
Q9CQA3 Sdhb - succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
F8WGB3 Sdhc - succinate dehydrogenase complex, subunit C
P07759 Serpina3k - serine (or cysteine) peptidase inhibitor, clade A, member 3K
Q60854 Serpinb6a - serine (or cysteine) peptidase inhibitor, clade B, member 6a
Q8VEM8 Slc25a3 - solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3
P08228 Sod1 - superoxide dismutase 1, soluble
Q7TQ48 Srl - sarcalumenin
Q9Z2I9 Sucla2 - succinate-Coenzyme A ligase, ADP-forming, beta subunit
Q923W1 Tgs1 - trimethylguanosine synthase homolog (S. cerevisiae)
P20801 Tnnc2 - troponin C2, fast
P13412 Tnni2 - troponin I, skeletal, fast 2
P17751 Tpi1 - triosephosphate isomerase 1
G5E8R0 Tpm1 - tropomyosin 1, alpha
Q6IRU2 Tpm4 - tropomyosin 4
P63028 Tpt1 - tumor protein, translationally-controlled 1
Q921I1 Trf - transferrin
D3YXQ9 Ttll13 - tubulin tyrosine ligase-like family, member 13
P61089 Ube2n - ubiquitin-conjugating enzyme E2N
Q91ZJ5 Ugp2 - UDP-glucose pyrophosphorylase 2
Q9CZ13 Uqcrc1 - ubiquinol-cytochrome c reductase core protein 1
Q9DB77 Uqcrc2 - ubiquinol cytochrome c reductase core protein 2
P99028 Uqcrh - ubiquinol-cytochrome c reductase hinge protein
Q01853 Vcp - valosin containing protein
Q60932 Vdac1 - voltage-dependent anion channel 1
D6REF3 Ywhae - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide
P61982 Ywhag - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
P63101 Ywhaz - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
P51174 Acadl - acyl-Coenzyme A dehydrogenase, long-chain
Q07417 Acads - acyl-Coenzyme A dehydrogenase, short chain
B1AR28 Acadvl - acyl-Coenzyme A dehydrogenase, very long chain
Q99KI0 Aco2 - aconitase 2, mitochondrial
P63268 Actg2 - actin, gamma 2, smooth muscle, enteric
O88990 Actn3 - actinin alpha 3
P28650 Adssl1 - adenylosuccinate synthetase like 1
P29699 Ahsg - alpha-2-HS-glycoprotein
Q9R0Y5 Ak1 - adenylate kinase 1
P45376 Akr1b3 - aldo-keto reductase family 1, member B3 (aldose reductase)
P07724 Alb - albumin
P47738 Aldh2 - aldehyde dehydrogenase 2, mitochondrial
P05064 Aldoa - aldolase A, fructose-bisphosphate
Q3V1D3 Ampd1 - adenosine monophosphate deaminase 1
F8WIT2 Anxa6 - annexin A6
Q8C0M9 Asrgl1 - asparaginase like 1
Q8R429 Atp2a1 - ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
D3Z6F5 Atp5a1 - ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1
B1ASE2 Atp5h - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d
Q6P1B9 Bin1 - bridging integrator 1
P14211 Calr - calreticulin
P16015 Car3 - carbonic anhydrase 3
P45591 Cfl2 - cofilin 2, muscle
P07310 Ckm - creatine kinase, muscl
Q6P8J7 Ckmt2 - creatine kinase, mitochondrial 2
P56391 Cox6b1 - cytochrome c oxidase, subunit VIb polypeptide 1
Q9CZU6 Cs - citrate synthase
O08749 Dld - dihydrolipoamide dehydrogenase
Q9D2G2 Dlst - dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)
Q8BK84 Dupd1 - dual specificity phosphatase and pro isomerase domain containing 1
F6T930 Echs1 - enoyl Coenzyme A hydratase, short chain, 1, mitochondrial
P58252 Eef2 - eukaryotic translation elongation factor 2
Q6PHC1 Eno1 - enolase 1, alpha non-neuron
B0QZL1 Eno1 - enolase 1, alpha non-neuron
P21550 Eno3 - enolase 3, beta muscle
Q99LC5 Etfa - electron transferring flavoprotein, alpha polypeptide
Q9DCW4 Etfb - electron transferring flavoprotein, beta polypeptide
P04117 Fabp4 - fatty acid binding protein 4, adipocyte
D3Z100 Fam98c - family with sequence similarity 98, member C
Q61554 Fbn1 - fibrillin 1
Q5STE3 Fstl4 - follistatin-like 4
P16858 Gapdh - glyceraldehyde-3-phosphate dehydrogenase
O55126 Gbas - glioblastoma amplified sequence
P05201 Got1 - glutamate oxaloacetate transaminase 1, soluble
P05202 Got2 - glutamate oxaloacetate transaminase 2, mitochondrial
E0CXN5 Gpd1 - glycerol-3-phosphate dehydrogenase 1 (soluble)
P06745 Gpi1 - glucose phosphate isomerase 1
P10649 Gstm1 - glutathione S-transferase, mu 1
D3YX76 Gstm2 - glutathione S-transferase, mu 2
E9Q024 Gstm5 - glutathione S-transferase, mu 5
Q61425 Hadh - hydroxyacyl-Coenzyme A dehydrogenase
A8DUK4 Hbb-b1 - hemoglobin, beta adult major chain
P70349 Hint1 - histidine triad nucleotide binding protein 1
Q91X72 Hpx - hemopexin
Q61316 Hspa4 - heat shock protein 4
Q504P4 Hspa8 - heat shock protein 8
P38647 Hspa9 - heat shock protein 9
P63038 Hspd1 - heat shock protein 1 (chaperonin)
P70404 Idh3g - isoc tr te dehydrogenase 3 (NAD+), amm
P01867 Igh3 - Ig gamma-2B chain C region
F6TQW2 Ighg2c - immunoglobulin heavy constant gamma 2C
A2AUC9 Kbtbd10 - kelch repeat and BTB (POZ) domain containing 10
D3YTY9 Kng1 - kininogen 1
P16045 Lgals1 - lectin, galactose binding, soluble 1
P04247 Mb - myoglobin
P14152 Mdh1 - malate dehydrogenase 1, NAD (soluble)
P08249 Mdh2 - malate dehydrogenase 2, NAD (mitochondrial)
P34884 Mif - macrophage migration inhibitory factor
P03899 mt-Nd3 - mitochondrially encoded NADH dehydrogenase 3
Q6P6L5 Mybpc1 - myosin binding protein C, slow-type
Q5XKE0 Mybpc2 - myosin binding protein C, fast-type
P70402 Mybph - myosin binding protein H
Q5SX39 Myh4 - myosin, heavy polypeptide 4, skeletal muscle
P05977 Myl1 - myosin, light polypeptide 1
P09542 Myl3 - myosin, light polypeptide 3
Q8VCR8 Mylk2 - myosin, light polypeptide kinase 2, skeletal muscle
P97457 Mylpf - myosin light chain, phosphorylatable, fast skeletal muscle
Q62234 Myom1 - myomesin 1
Q14BI5 Myom2 - myomesin 2
Q9QYG0 Ndrg2 - N-myc downstream regulated gene 2
Q99LC3 Ndufa10 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10
Q9CR61 Ndufb7 - NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7
D3YXX5 Ndufv1 - NADH dehydrogenase (ubiquinone) flavoprotein 1
Q01768 Nme2 - NME/NM23 nucleoside diphosphate kinase 2
P61971 Nutf2-ps1 - nuclear transport factor 2, pseudogene 1
Q60597 Ogdh - oxoglutarate dehydrogenase (lipoamide)
P09103 P4hb - prolyl 4-hydroxylase, beta polypeptide
A2A817 Park7 - Parkinson disease (autosomal recessive, early onset) 7
P35486 Pdha1 - pyruvate dehydrogenase E1 alpha 1
Q9D051 Pdhb - pyruvate dehydrogenase (lipoamide) beta
P70296 Pebp1 - phosphatidylethanolamine binding protein 1
P47857 Pfkm - phosphofructokinase, muscle
O70250 Pgam2 - phosphoglycerate mutase 2
P09411 Pgk1-rs7 - phosphoglycerate kinase-1, related sequence-7
Q9D0F9 Pgm2 - phosphoglucomutase 2
P52480 Pkm - pyruvate kinase, muscle
P17742 Ppia - peptidylprolyl isomerase A
P63330 Ppp2ca - protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform
P35700 Prdx1 - peroxiredoxin 1
P20108 Prdx3 - peroxiredoxin 3
G3UZJ4 Prdx5 - peroxiredoxin 5
Q9WUB3 Pygm - muscle glycogen phosphorylase
Q9DD03 Rab13 - RAB13, member RAS oncogene family
Q9CQ09 Rpl3l - ribosomal protein L3-like
Q3V1Z5 Rps4y2 - ribosomal protein S4, Y-linked 2
Q8K2B3 Sdha - succinate dehydrogenase complex, subunit A, flavoprotein (Fp
Q9CQA3 Sdhb - succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
F8WGB3 Sdhc - succinate dehydrogenase complex, subunit C
P07759 Serpina3k - serine (or cysteine) peptidase inhibitor, clade A, member 3K
Q60854 Serpinb6a - serine (or cysteine) peptidase inhibitor, clade B, member 6a
Q8VEM8 Slc25a3 - solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3
P08228 Sod1 - superoxide dismutase 1, soluble
Q7TQ48 Srl - sarcalumenin
Q9Z2I9 Sucla2 - succinate-Coenzyme A ligase, ADP-forming, beta subunit
Q923W1 Tgs1 - trimethylguanosine synthase homolog (S. cerevisiae)
P20801 Tnnc2 - troponin C2, fast
P13412 Tnni2 - troponin I, skeletal, fast 2
P17751 Tpi1 - triosephosphate isomerase 1
G5E8R0 Tpm1 - tropomyosin 1, alpha
Q6IRU2 Tpm4 - tropomyosin 4
P63028 Tpt1 - tumor protein, translationally-controlled 1
Q921I1 Trf - transferrin
D3YXQ9 Ttll13 - tubulin tyrosine ligase-like family, member 13
P61089 Ube2n - ubiquitin-conjugating enzyme E2N
Q91ZJ5 Ugp2 - UDP-glucose pyrophosphorylase 2
Q9CZ13 Uqcrc1 - ubiquinol-cytochrome c reductase core protein 1
Q9DB77 Uqcrc2 - ubiquinol cytochrome c reductase core protein 2
P99028 Uqcrh - ubiquinol-cytochrome c reductase hinge protein
Q01853 Vcp - valosin containing protein
Q60932 Vdac1 - voltage-dependent anion channel 1
D6REF3 Ywhae - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide
P61982 Ywhag - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
P63101 Ywhaz - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
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Table 3.3.8.1 C The 33 proteins identified by differential labelling for redox, reduced and 
reversibly oxidised proteins detected in old mouse quadriceps. 
 
 
 
 
 
 
 
 
 
 
 
E9Q1F2 Actg1 - actin, gamma, cytoplasmic 1
P28474 Adh5 - alcohol dehydrogenase 5 (class III), chi polypeptide
D3YVX6 Atp1a2 - ATPase, Na+/K+ transporting, alpha 2 polypeptide
P56382 Atp5e - ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
J3QP71 Bsg - basigin
F6QJN8 Capzb - capping protein (actin filament) muscle Z-line, beta
P10605 Ctsb - cathepsin B
F6Y6L6 Ctsd - cathepsin D
Q9CQ62 Decr1 - 2,4-dienoyl CoA reductase 1, mitochondrial
P62631 Eef1a2 - eukaryotic translation elongation factor 1 alpha 2
P70695 Fbp2 - fructose bisphosphatase 2
P50396 Gdi1 - guanosine diphosphate (GDP) dissociation inhibitor 1
Q61598 Gdi2 - guanosine diphosphate (GDP) dissociation inhibitor 2
Q64521 Gpd2 - glycerol phosphate dehydrogenase 2, mitochondrial
Q8BUV3 Gphn - gephyrin
P19157 Gstp1 - glutathione S-transferase, pi 1
E9Q5B6 Hnrnpd - heterogeneous nuclear ribonucleoprotein D
P06330 Ig heavy chain V region AC38 205.12
P01649 Ig kappa chain V-V regions
D3Z736 Ldha - lactate dehydrogenase A
D3Z6D8 Mapk3 - mitogen-activated protein kinase 3
F6Q3K8 Mpi - mannose phosphate isomerase
G3UW82 Myh2 - myosin, heavy polypeptide 2, skeletal muscle, adult
Q9CQ75 Ndufa2 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2
P29758 Oat - ornithine aminotransferase
F6V9F1 Pcmt1 - protein-L-isoaspartate (D-aspartate) O-methyltransferase 1
Q9CRA2 Pdlim5 - PDZ and LIM domain 5
D3Z0Y2 Prdx6 - peroxiredoxin 6
G3UXL2 Prps1l3 - phosphoribosyl pyrophosphate synthetase 1-like 3
P62889 Rpl30 - ribosomal protein L30
D3YV43 Rps3 - ribosomal protein S3
Q7TMY4 Thoc7 - THO complex 7 homolog (Drosophila)
P68037 Ube2l3 - ubiquitin-conjugating enzyme E2L 3
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Table 3.3.8.2 A The 21 redox proteins identified in adult mouse quadriceps. 
 
 
 
 
 
 
 
 
 
 
 
P28650 Adssl1 - adenylosuccinate synthetase like 1
F8VPN4 Agl - amylo-1,6-glucosidase, 4-alpha-glucanotransferase
P45376 Akr1b3 - aldo-keto reductase family 1, member B3 (aldose reductase)
Q3V1D3 Ampd1 - adenosine monophosphate deaminase 1
B1ASE2 Atp5h - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d
Q9CZU6 Cs - citrate synthase
Q60854 erpinb6a - serine (or cysteine) peptidase inhibitor, clade B, member 6a
Q99LC5 Etfa - electron transferring flavoprotein, alpha polypeptide
P97807 Fh1 - fumarate hydratase 1
A8DUK4 Hbb-b1 - hemoglobin, beta adult major chain
A2AUC9 Kbtbd10 - kelch repeat and BTB (POZ) domain containing 10
P06151 Ldha - lactate dehydrogenase A
Q5XKE0 Mybpc2 - myosin binding protein C, fast-type
P13542 Myh8 - myosin, heavy polypeptide 8, skeletal muscle, perinatal
Q9QYG0 Ndrg2 - N-myc downstream regulated gene 2
A2A817 Park7 - Parkinson disease (autosomal recessive, early onset) 7
P70296 Pebp1 - phosphatidylethanolamine binding protein 1
P09411 Pgk1-rs7 - phosphoglycerate kinase-1, related sequence-7
Q9D0F9 Pgm2 - phosphoglucomutase 2
P17742 Ppia - peptidylprolyl isomerase A
Q7TQ48 Srl - sarcalumenin
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Table 3.3.8.2 B The 43 redox proteins identified in both adult and old mouse quadriceps. 
 
 
Table 3.3.8.2 C The 8 redox proteins identified in adult mouse quadriceps.
 
 
 
P51174 Acadl - acyl-Coenzyme A dehydrogenase, long-chain
Q99KI0 Aco2 - aconitase 2, mitochondrial
P63268 Actg2 - actin, gamma 2, smooth muscle, enteric
P07724 Alb - albumin
P05064 Aldoa - aldolase A, fructose-bisphosphate
Q8R429 Atp2a1 - ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
P45591 Cfl2 - cofilin 2, muscle
P07310 Ckm - creatine kinase, muscle
Q6P8J7 Ckmt2 - creatine kinase, mitochondrial 2
O08749 Dld - dihydrolipoamide dehydrogenase
P58252 Eef2 - eukaryotic translation elongation factor 2
B0QZL1 Eno1 - enolase 1, alpha non-neuron
Q6PHC1 Eno1 - enolase 1, alpha non-neuron
P21550 Eno3 - enolase 3, beta muscle
D3Z100 Fam98c - family with sequence similarity 98, member C
P16858 Gapdh - glyceraldehyde-3-phosphate dehydrogenase
P05201 Got1 - glutamate oxaloacetate transaminase 1, soluble
P05202 Got2 - glutamate oxaloacetate transaminase 2, mitochondria
P06745 Gpi1 - glucose phosphate isomerase 1
Q504P4 Hspa8 - heat shock protein 8
P14152 Mdh1 - malate dehydrogenase 1, NAD (soluble)
P08249 Mdh2 - malate dehydrogenase 2, NAD (mitochondrial)
Q5SX39 Myh4 - myosin, heavy polypeptide 4, skeletal muscle
P97457 Mylpf - myosin light chain, phosphorylatable, fast skeletal muscle
Q14BI5 Myom2 - myomesin 2
D3YXX5 Ndufv1 - NADH dehydrogenase (ubiquinone) flavoprotein 1
Q01768 Nme2 - NME/NM23 nucleoside diphosphate kinase 2
P61971 Nutf2-ps1 - nuclear transport factor 2, pseudogene 1
Q60597 Ogdh - oxoglutarate dehydrogenase (lipoamide)
Q9D051 Pdhb - pyruvate dehydrogenase (lipoamide) beta
P47857 Pfkm - phosphofructokinase, muscle
O70250 Pgam2 - phosphoglycerate mutase 2
P52480 Pkm - pyruvate kinase, muscle
Q9WUB3 Pygm - muscle glycogen phosphorylase
P08228 superoxide dismutase 1, soluble
P13412 Tnni2 - troponin I, skeletal, fast 2
P17751 Tpi1 - triosephosphate isomerase 1
G5E8R0 Tpm1 - tropomyosin 1, alpha
Q6IRU2 Tpm4 - tropomyosin 4
Q9CZ13 Uqcrc1 - ubiquinol-cytochrome c reductase core protein 1
Q9DB77 Uqcrc2 - ubiquinol cytochrome c reductase core protein 2
D6REF3 Ywhae - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide
P61982 Ywhag - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
P56382 Atp5e - ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
P62631 Eef1a2 - eukaryotic translation elongation factor 1 alpha 2
P70349 Hint1 - histidine triad nucleotide binding protein 1
D3Z736 Ldha - lactate dehydrogenase A
G3UW82 Myh2 - myosin, heavy polypeptide 2, skeletal muscle, adult
F6V9F1 Pcmt1 - protein-L-isoaspartate (D-aspartate) O-methyltransferase 1
P07759 Serpina3k - serine (or cysteine) peptidase inhibitor, clade A, member 3K
P63101 Ywhaz - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
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Table 3.3.8.3 A The 37 reduced proteins identified in adult mouse quadriceps. 
 
 
 
 
 
 
 
F8WGM8 Actg1 - actin, gamma, cytoplasmic 1
Q9EQ20 Aldh6a1 - aldehyde dehydrogenase family 6, subfamily A1
D3Z7U0 Anxa11 - annexin A11
D3YYN7 Atp1a2 - ATPase, Na+/K+ transporting, alpha 2 polypeptide
A2AKV0 Atp5c1 - ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1
Q9CQQ7 Atp5f1 - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1
O88374 Bcat2 - branched chain aminotransferase 2, mitochondrial
Q8R4N0 Clybl - citrate lyase beta like
Q8R1G2 Cmbl - carboxymethylenebutenolidase-like (Pseudomonas)
D6RIN4 Dynll2 - dynein light chain LC8-type 2
O70251 Eef1b2 - eukaryotic translation elongation factor 1 beta 2
D3YY68 Eef1d - eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)
Q3UGC7 Eif3j1 - eukaryotic translation initiation factor 3, subunit J1
Q8BTU6 Eif4a2 - eukaryotic translation initiation factor 4A2
Q9CPU0 Glo1 - glyoxalase 1
D3YUM8 Gm4950 - predicted pseudogene 4950
S4R1E5 Gpx4 - Glutathione peroxidase
E9Q5B5 Hk2 - hexokinase 2
Q5EBG6 Hspb6 - heat shock protein, alpha-crystallin-related, B6
Q9D6R2 Idh3a - isocitrate dehydrogenase 3 (NAD+) alpha
Q80ZJ2 Impa1 - inositol (myo)-1(or 4)-monophosphatase 1
H3BLD4 Kdm2a - lysine (K)-specific demethylase 2A
A2AMM0 Murc - muscle-related coiled-coil protein
Q9CPP6 Ndufa5 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5
F6ZFT1 Ndufab1 - NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1
E9QQ96 Obscn - obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
P62962 Pfn1 - profilin 1
D6RG50 Prkab2 - protein kinase, AMP-activated, beta 2 non-catalytic subunit
P12367 Prkar2a - protein kinase, cAMP dependent regulatory, type II alpha
A2AWQ9 Scrn3 - secernin 3
Q8BH59 Slc25a12 - solute carrier family 25 (mitochondrial carrier, Aralar), member 12
P48962 Slc25a4 - solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4
Q8JZR6 Slc4a8 - solute carrier family 4 (anion exchanger), member 8
P10639 Txn1 - thioredoxin 1
D3YZS3 Ube2l3 - ubiquitin-conjugating enzyme E2L 3
Q64727 Vcl - vinculin
P20152 Vim - vimentin
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Table 3.3.8.3 B The 57 reduced proteins identified in both adult and old mouse quadriceps. 
 
 
 
Q07417 Acads - acyl-Coenzyme A dehydrogenase, short chain
B1AR28 Acadvl - acyl-Coenzyme A dehydrogenase, very long chain
O88990 Actn3 - actinin alpha
Q9R0Y5 Ak1 - adenylate kinase 1
P47738 Aldh2 - aldehyde dehydrogenase 2, mitochondrial
F8WIT2 Anxa6 - annexin A6
Q8C0M9 Asrgl1 - asparaginase like 1
D3Z6F5 Atp5a1 - ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1
Q6P1B9 Bin1 - bridging integrator 1
P16015 Car3 - carbonic anhydrase 3
Q9D2G2 Dlst - dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)
Q8BK84 Dupd1 - dual specificity phosphatase and pro isomerase domain containing 1
F6T930 Echs1 - Enoyl-CoA hydratase, mitochondrial
Q9DCW4 Etfb - electron transferring flavoprotein, beta polypeptide
P04117 Fabp4 - fatty acid binding protein 4, adipocyte
O55126 Gbas - glioblastoma amplified sequence
E0CXN5 Gpd1 - glycerol-3-phosphate dehydrogenase 1 (soluble)
P10649 Gstm1 - glutathione S-transferase, mu 1
D3YX76 Gstm2 - glutathione S-transferase, mu 2
E9Q024 Gstm5 - glutathione S-transferase, mu 5
Q61425 Hadh - hydroxyacyl-Coenzyme A dehydrogenase
Q61316 Hspa4 - heat shock protein 4
P38647 Hspa9 - heat shock protein 9
P63038 Hspd1 - heat shock protein 1 (chaperonin)
P70404 Idh3g - isocitrate dehydrogenase 3 (NAD+), gamma
P16045 Lgals1 - lectin, galactose binding, soluble 1
P04247 Mb - myoglobin
P34884 Mif - macrophage migration inhibitory factor
P03899 mt-Nd3 - mitochondrially encoded NADH dehydrogenase 3
Q6P6L5 Mybpc1 - myosin binding protein C, slow-type
P70402 Mybph - myosin binding protein H
P05977 Myl1 - myosin, light polypeptide 1
P09542 Myl3 - myosin, light polypeptide 3
Q8VCR8 Mylk2 - myosin, light polypeptide kinase 2, skeletal muscle
Q62234 Myom1 - myomesin 1
Q99LC3 Ndufa10 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10
P09103 P4hb - prolyl 4-hydroxylase, beta polypeptide
P35486 Pdha1 - pyruvate dehydrogenase E1 alpha
P63330 Ppp2ca - protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform
P35700 Prdx1 - peroxiredoxin 1
P20108 Prdx3 - peroxiredoxin 3
G3UZJ4 Prdx5 - peroxiredoxin 5
Q9DD03 Rab13 - RAB13, member RAS oncogene family
Q9CQ09 Rpl3l - ribosomal protein L3-like
Q3V1Z5 Rps4y2 - ribosomal protein S4, Y-linked 2
Q8K2B3 Sdha - succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
Q9CQA3 Sdhb - succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
F8WGB3 Sdhc - succinate dehydrogenase complex, subunit C, integral membrane protein
Q8VEM8 Slc25a3 - solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3
Q9Z2I9 Sucla2 - succinate-Coenzyme A ligase, ADP-forming, beta subunit
Q923W1 Tgs1 - trimethylguanosine synthase homolog (S. cerevisiae)
P20801 Tnnc2 - troponin C2, fast
P63028 Tpt1 - tumor protein, translationally-controlled 1
P61089 Ube2n - ubiquitin-conjugating enzyme E2N
Q91ZJ5 Ugp2 - UDP-glucose pyrophosphorylase
Q01853 Vcp - valosin containing protein
Q60932 Vdac1 - voltage-dependent anion channel
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Table 3.3.8.3 C The 38 reduced proteins identified in old mouse quadriceps. 
 
 
 
 
 
E9Q1F2 Actg1 - actin, gamma, cytoplasmic 1
P28474 Adh5 - alcohol dehydrogenase 5 (class III), chi polypeptide
P28650 Adssl1 - adenylosuccinate synthetase like 1
P45376 Akr1b3 - aldo-keto reductase family 1, member B3 (aldose reductase)
Q3V1D3 Ampd1 - adenosine monophosphate deaminase 1
D3YVX6 Atp1a2 - ATPase, Na+/K+ transporting, alpha 2 polypeptide
B1ASE2 Atp5h - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d
F6QJN8 Capzb - capping protein (actin filament) muscle Z-line, beta
Q9CZU6 Cs - citrate synthase
Q9CQ62 Decr1 - 2,4-dienoyl CoA reductase 1, mitochondrial
Q99LC5 Etfa - electron transferring flavoprotein, alpha polypeptide
P70695 Fbp2 - fructose bisphosphatase 2
P50396 Gdi1 - guanosine diphosphate (GDP) dissociation inhibitor 1
Q61598 Gdi2 - guanosine diphosphate (GDP) dissociation inhibitor 2
Q64521 Gpd2 - glycerol phosphate dehydrogenase 2, mitochondrial
Q8BUV3 Gphn - gephyrin
P19157 Gstp1 - glutathione S-transferase, pi 1
A8DUK4 Hbb-b1 - hemoglobin, beta adult major chain
E9Q5B6 Hnrnpd - heterogeneous nuclear ribonucleoprotein D
A2AUC9 Kbtbd10 - kelch repeat and BTB (POZ) domain containing 10
D3Z6D8 Mapk3 - mitogen-activated protein kinase 3
F6Q3K8 Mpi - mannose phosphate isomerase
Q5XKE0 Mybpc2 - myosin binding protein C, fast-type
Q9QYG0 Ndrg2 - N-myc downstream regulated gene
Q9CQ75 Ndufa2 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex,
P29758 Oat - ornithine aminotransferase
A2A817 Park7 - Parkinson disease (autosomal recessive, early onset) 7
Q9CRA2 Pdlim5 - PDZ and LIM domain 5
P70296 Pebp1 - phosphatidylethanolamine binding protein 1
P09411 Pgk1-rs7 - phosphoglycerate kinase-1, related sequence-7
Q9D0F9 Pgm2 - phosphoglucomutase 2
P17742 Ppia - peptidylprolyl isomerase A
G3UXL2 Prps1l3 - phosphoribosyl pyrophosphate synthetase 1-like 3
P62889 Rpl30 - ribosomal protein L30
D3YV43 Rps3 - ribosomal protein S3
Q60854 Serpinb6a - serine (or cysteine) peptidase inhibitor, clade B, member 6a
Q7TMY4 Thoc7 - THO complex 7 homolog (Drosophila)
P68037 Ube2l3 - ubiquitin-conjugating enzyme E2L 3
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Table 3.3.8.4 A The 7 reversibly oxidised proteins identified in adult mouse quadriceps.
Table 3.3.8.4 B The 14 reversibly oxidised proteins identified in both adult and old mouse 
quadriceps.
 
 
Table 3.3.8.4 C The 6 reversibly oxidised proteins identified in only old mouse quadriceps. 
 
 
 
P07724 Alb - albumin
Q9CWJ9 Atic - 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
P19536 Cox5b - cytochrome c oxidase, subunit Vb
P70349 Hint1 - histidine triad nucleotide binding protein 1
Q61696 Hspa1a - heat shock protein 1A
P07759 Serpina3k - serine (or cysteine) peptidase inhibitor, clade A, member 3K
P63101 Ywhaz - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
P29699 Ahsg - alpha-2-HS-glycoprotein
P14211 Calr - calreticulin
P56391 Cox6b1 - cytochrome c oxidase, subunit VIb polypeptide 1
Q61554 Fbn1 - fibrillin 1
Q5STE3 Fstl4 - follistatin-like 4
Q91X72 Hpx - hemopexin
P01867 Igh3 - Ig gamma-2B chain C region
F6TQW2 Ighg2c - immunoglobulin heavy constant gamma 2C
D3YTY9 Kng1 - kininogen 1
Q9CR61 Ndufb7 - NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7
Q7TQ48 Srl - sarcalumenin
Q921I1 Trf - transferrin
D3YXQ9 Ttll13 - tubulin tyrosine ligase-like family, member 13
P99028 Uqcrh - ubiquinol-cytochrome c reductase hinge protein
J3QP71 Bsg - basigin
P10605 Ctsb - cathepsin B
F6Y6L6 Ctsd - cathepsin D
P06330 Ig heavy chain V region AC38 205.12
P01649 Ig kappa chain V-V regions
D3Z0Y2 Prdx6 - peroxiredoxin 6
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Table 4.3.8.1 A The 46 differentially labelled proteins of redox, reduced and reversibly 
oxidised proteins detected in adult mouse soleus muscle. 
 
 
 
 
 
 
 
F7B1B6 Adck3 - aarF domain containing kinase 3
Q9R0Y5 Ak1 - adenylate kinase 1
P45376 Akr1b3 - aldo-keto reductase family 1, member B3 (aldose reductase)
P47738 Aldh2 - aldehyde dehydrogenase 2, mitochondrial
F8WIT2 Anxa6 - annexin A6
D3YYN7 Atp1a2 - ATPase, Na+/K+ transporting, alpha 2 polypeptide
Q6IRU5 Cltb - clathrin, light polypeptide (Lcb)
Q924X2 Cpt1b - carnitine palmitoyltransferase 1b, muscle
Q8BMF4 Dlat - dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex)
F7B227 Ech1 - enoyl coenzyme A hydratase 1, peroxisomal
P97447 Fhl1 - four and a half LIM domains 1
P50608 Fmod - fibromodulin
Q9DCM2 Gstk1 - glutathione S-transferase kappa 1
P19157 Gstp1 - glutathione S-transferase, pi 1
Q8BMS1 Hadha - hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit
Q99JY0 Hadhb - hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit
O88569 Hnrnpa2b1 - heterogeneous nuclear ribonucleoprotein A2/B1
Q61646 Hp - haptoglobin
P54071 Idh2 - isocitrate dehydrogenase 2 (NADP+), mitochondrial
Q9D6R2 Idh3a - isocitrate dehydrogenase 3 (NAD+) alpha
P70404 Idh3g - isocitrate dehydrogenase 3 (NAD+), gamma
A2AUC9 Kbtbd10 - kelch repeat and BTB (POZ) domain containing 10
P13542 Myh8 - myosin, heavy polypeptide 8, skeletal muscle, perinatal
Q62234 Myom1 - myomesin 1
Q9CQ75 Ndufa2 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2
Q9DCJ5 Ndufa8 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8
A2A813 Park7 - Parkinson disease (autosomal recessive, early onset) 7
P35486 Pdha1 - pyruvate dehydrogenase E1 alpha 1
Q9D051 Pdhb - pyruvate dehydrogenase (lipoamide) beta
O70400 Pdlim1 - PDZ and LIM domain 1 (elfin)
Q8CI51 Pdlim5 - PDZ and LIM domain 5
P17742 Ppia - peptidylprolyl isomerase A
P63330 Ppp2ca - protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform
P61027 Rab10 - RAB10, member RAS oncogene family
E9PZM7 Scaf11 - SR-related CTD-associated factor 11
Q9CQA3 Sdhb - succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
F8WGB3 Sdhc - succinate dehydrogenase complex, subunit C, integral membrane protein
Q9Z2Z6 Slc25a20 - solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20
P08228 Sod1 - superoxide dismutase 1, soluble
Q9Z2I9 Sucla2 - succinate-Coenzyme A ligase, ADP-forming, beta subunit
Q9WUM5 Suclg1 - succinate-CoA ligase, GDP-forming, alpha subunit
Q6IRU2 Tpm4 - tropomyosin 4
Q8BFR5 Tufm - Tu translation elongation factor, mitochondrial
F6T930 Unkown - entry obsolete in Uniprot as of October 2016
D6REF3 Ywhae - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide
E9QMD3 Zfhx3 - zinc finger homeobox 3
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Table 4.3.8.1 B The 127 differentially labelled proteins of redox, reduced and reversibly 
oxidised proteins detected in both adult and old mouse soleus muscle. 
 
 
 
 
 
 
 
 
 
 
P51174 Acadl - acyl-Coenzyme A dehydrogenase, long-chain
Q07417 Acads - acyl-Coenzyme A dehydrogenase, short chain
B1AR28 Acadvl - acyl-Coenzyme A dehydrogenase, very long chain
Q99KI0 Aco2 - aconitase 2, mitochondrial
O55137 Acot1 - acyl-CoA thioesterase 1
D3Z041 Acsl1 - acyl-CoA synthetase long-chain family member 1
Q8BFZ3 Actbl2 - actin, beta-like 2
P63268 Actg2 - actin, gamma 2, smooth muscle, enteric
Q9JI91 Actn2 - actinin alpha 2
P07724 Alb - albumin
P05064 Aldoa - aldolase A, fructose-bisphosphate
Q9WV06 Ankrd2 - ankyrin repeat domain 2 (stretch responsive muscle)
Q8R429 Atp2a1 - ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
B1ATS4 Atp2a3 - ATPase, Ca++ transporting, ubiquitous
D3Z6F5 Atp5a1 - ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1
A2AKV0 Atp5c1 - ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1
P56382 Atp5e - ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
B1ASE2 Atp5h - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d
D3Z2Y8 Bdh1 - 3-hydroxybutyrate dehydrogenase, type 1
Q6P1B9 Bin1 - bridging integrator 1
P14211 Calr - calreticulin
F6QJN8 Capzb - capping protein (actin filament) muscle Z-line, beta
P16015 Car3 - carbonic anhydrase 3
P24270 Cat - catalase
Q08857 Cd36 - CD36 antigen
P45591 Cfl2 - cofilin 2, muscle
P07310 Ckm - creatine kinase, muscle
Q6P8J7 Ckmt2 - creatine kinase, mitochondrial 2
Q9R0G6 Comp - cartilage oligomeric matrix protein
P56391 Cox6b1 - cytochrome c oxidase, subunit VIb polypeptide 1
Q9CZU6 Cs - citrate synthase
Q9D0M3 Cyc1 - cytochrome c-1
O35215 Ddt - D-dopachrome tautomerase
O08749 Dld - dihydrolipoamide dehydrogenase
Q9D2G2 Dlst - dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)
P62631 Eef1a2 - eukaryotic translation elongation factor 1 alpha 2
O70251 Eef1b2 - eukaryotic translation elongation factor 1 beta 2
B0QZL1 Eno1 - enolase 1, alpha non-neuron
P21550 Eno3 - enolase 3, beta muscle
Q99LC5 Etfa - electron transferring flavoprotein, alpha polypeptide
Q9DCW4 Etfb - electron transferring flavoprotein, beta polypeptide
Q921G7 Etfdh - electron transferring flavoprotein, dehydrogenase
P04117 Fabp4 - fatty acid binding protein 4, adipocyte
A2AQ53 Fbn1 - fibrillin 1
D3YW87 Flnc - filamin C, gamma
P16858 Gapdh - glyceraldehyde-3-phosphate dehydrogenase
O55126 Gbas - glioblastoma amplified sequence
Q9CPU0 Glo1 - glyoxalase 1
P05201 Got1 - glutamate oxaloacetate transaminase 1, soluble
P05202 Got2 - glutamate oxaloacetate transaminase 2, mitochondrial
P06745 Gpi1 - glucose phosphate isomerase 1
Q61425 Hadh - hydroxyacyl-Coenzyme A dehydrogenase
A8DUK4 Hbb-b1 - hemoglobin, beta adult major chain
Q91X72 Hpx - hemopexin
Q61316 Hspa4 - heat shock protein 4
Q504P4 Hspa8 - heat shock protein 8
P38647 Hspa9 - heat shock protein 9
Q9QZ57 Hspb3 - heat shock protein 3
P35385 Hspb7 - heat shock protein family, member 7 (cardiovascular)
D3Z736 Ldha - lactate dehydrogenase A
P16125 Ldhb - lactate dehydrogenase B
P48678 Lmna - lamin A
P04247 Mb - myoglobin
P14152 Mdh1 - malate dehydrogenase 1, NAD (soluble)
P08249 Mdh2 - malate dehydrogenase 2, NAD (mitochondrial)
P03899 mt-Nd3 - mitochondrially encoded NADH dehydrogenase 3
P16332 Mut - methylmalonyl-Coenzyme A mutase
Q6P6L5 Mybpc1 - myosin binding protein C, slow-type
G3UW82 Myh2 - myosin, heavy polypeptide 2, sk
Q91Z83 Myh7 - myosin, heavy polypeptide 7, cardiac muscle, beta
P05977 Myl1 - myosin, light polypeptide 1
P09542 Myl3 - myosin, light polypeptide 3
Q60605 Myl6 - myosin, light polypeptide 6, alkali, smooth muscle and non-muscle
Q8CI43 Myl6b - myosin, light polypeptide 6B
P97457 Mylpf - myosin light chain, phosphorylatable, fast
Q14BI5 Myom2 - myomesin 2
A2ABU4 Myom3 - myomesin family, member 3
Q9JIF9 Myot - myotilin
Q9QYG0 Ndrg2 - N-myc downstream regulated gene 2
Q9Z1P6 Ndufa7 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (B14.5a)
Q9DC69 Ndufa9 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9
F6ZFT1 Ndufab1 - NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1
Q9CR61 Ndufb7 - NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7
Q91VD9 Ndufs1 - NADH dehydrogenase (ubiquinone) Fe-S protein 1
F6RJ83 Ndufs2 - NADH dehydrogenase (ubiquinone) Fe-S protein 2
B1ARW4 Ndufs5 - NADH dehydrogenase (ubiquinone) Fe-S protein 5
P52503 Ndufs6 - NADH dehydrogenase (ubiquinone) Fe-S protein 6
D3Z0K1 Ndufv1 - NADH dehydrogenase (ubiquinone) flavoprotein 1
Q01768 Nme2 - NME/NM23 nucleoside diphosphate kinase 2
Q3UJQ9 Oxct1 - 3-oxoacid CoA transferase 1
Q5EBG6 Oxct1 - 3-oxoacid CoA transferase 1
P70296 Pebp1 - phosphatidylethanolamine binding protein 1
O70250 Pgam2 - phosphoglycerate mutase 2
Q9D0F9 Pgm2 - phosphoglucomutase 2
Q9DAK9 Phpt1 - phosphohistidine phosphatase 1
P52480 Pkm - pyruvate kinase, muscle
P20108 Prdx3 - peroxiredoxin 3
E9PUM3 Pygm - muscle glycogen phosphorylase
Q9DD03 Rab13 - RAB13, member RAS oncogene family
Q8BGH2 Samm50 - sorting and assembly machinery component 50 homolog (S. cerevisiae)
Q8K2B3 Sdha - succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
D6RHN2 Selenbp1 - selenium binding protein 1
Q5SX46 Slc25a11 - solute carrier family 25 (mitochondrial carrier oxoglutarate carrier), member 11
Q8BH59 Slc25a12 - solute carrier family 25 (mitochondrial carrier, Aralar), member 12
Q8VEM8 Slc25a3 - solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3
P48962 Slc25a4 - solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4
P09671 Sod2 - superoxide dismutase 2, mitochondrial
O70548 Tcap - titin-cap
Q9Z1T2 Thbs4 - thrombospondin 4
E9Q8P0 Tnnc1 - troponin C, cardiac/slow skeletal
P20801 Tnnc2 - troponin C2, fast
D3YUN3 Tnni1 - troponin I, skeletal, slow 1
P13412 Tnni2 - troponin I, skeletal, fast 2
P17751 Tpi1 - triosephosphate isomerase 1
G5E8R0 Tpm1 - tropomyosin 1, alpha
D3Z6I8 Tpm3 - tropomyosin 3, gamma
P63028 Tpt1 - tumor protein, translationally-controlled 1
Q921I1 Trf - transferrin
Q91ZJ5 Ugp2 - UDP-glucose pyrophosphorylase 2
Q9CZ13 Uqcrc1 - ubiquinol-cytochrome c reductase core protein 1
Q9DB77 Uqcrc2 - ubiquinol cytochrome c reductase core protein 2
P99028 Uqcrh - ubiquinol-cytochrome c reductase hinge protein
Q01853 Vcp - valosin containing protein
Q60932 Vdac1 - voltage-dependent anion channel 1
Q60931 Vdac3 - voltage-dependent anion channel 3
P61982 Ywhag - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
P63101 Ywhaz - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
P51174 Acadl - acyl-Coenzyme A dehydrogenase, long-chain
Q07417 Acads - acyl-Coenzyme A dehydrogenase, short chain
B1AR28 Acadvl - acyl-Coenzyme A dehydrogenase, very long chain
Q99KI0 Aco2 - aconitase 2, mitochondrial
O55137 Acot1 - acyl-CoA thioesterase 1
D3Z041 Acsl1 - acyl-CoA synthetase long-chain family member 1
Q8BFZ3 Actbl2 - actin, beta-like 2
P63268 Actg2 - actin, gamma 2, smooth muscle, enteric
Q9JI91 Actn2 - actinin alpha 2
P07724 Alb - albumin
P05064 Aldoa - aldolase A, fructose-bisphosphate
Q9WV06 Ankrd2 - ankyrin repeat domain 2 (stretch responsive muscle)
Q8R429 Atp2a1 - ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
B1ATS4 Atp2a3 - ATPase, Ca++ transporting, ubiquitous
D3Z6F5 Atp5a1 - ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1
A2AKV0 Atp5c1 - ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1
P56382 Atp5e - ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
B1ASE2 Atp5h - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d
D3Z2Y8 Bdh1 - 3-hydroxybutyrate dehydrogenase, type 1
Q6P1B9 Bin1 - bridging integrator 1
P14211 Calr - calreticulin
F6QJN8 Capzb - capping protein (actin filament) muscle Z-line, beta
P16015 Car3 - carbonic anhydrase 3
P24270 Cat - catalase
Q08857 Cd36 - CD36 antigen
P45591 Cfl2 - cofilin 2, muscle
P07310 Ckm - creatine kinase, muscle
Q6P8J7 Ckmt2 - creatine kinase, mitochondrial 2
Q9R0G6 Comp - cartilage oligomeric matrix protein
P56391 Cox6b1 - cytochrome c oxidase, subunit VIb polypeptide 1
Q9CZU6 Cs - citrate synthase
Q9D0M3 Cyc1 - cytochrome c-1
O35215 Ddt - D-dopachrome tautomerase
O08749 Dld - dihydrolipoamide dehydrogenase
Q9D2G2 Dlst - dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)
P62631 Eef1a2 - eukaryotic translation elongation factor 1 alpha 2
O70251 Eef1b2 - eukaryotic translation elongation factor 1 beta 2
B0QZL1 Eno1 - enolase 1, alpha non-neuron
P21550 Eno3 - enolase 3, beta muscle
Q99LC5 Etfa - electron transferring flavoprotein, alpha polypeptide
Q9DCW4 Etfb - electron transferring flavoprotein, beta polypeptide
Q921G7 Etfdh - electron transferring flavoprotein, dehydrogenase
P04117 Fabp4 - fatty acid binding protein 4, adipocyte
A2AQ53 Fbn1 - fibrillin 1
D3YW87 Flnc - filamin C, gamma
P16858 Gapdh - glyceraldehyde-3-phosphate dehydrogenase
O55126 Gbas - glioblastoma amplified sequence
Q9CPU0 Glo1 - glyoxalase 1
P05201 Got1 - glutamate oxaloacetate transaminase 1, soluble
P05202 Got2 - glutamate oxaloacetate transaminase 2, mitochondrial
P06745 Gpi1 - glucose phosphate isomerase 1
Q61425 Hadh - hydroxyacyl-Coenzyme A dehydrogenase
A8DUK4 Hbb-b1 - hemoglobin, beta adult major chain
Q91X72 Hpx - hemopexin
Q61316 Hspa4 - heat shock protein 4
Q504P4 Hspa8 - heat shock protein 8
P38647 Hspa9 - heat shock protein 9
Q9QZ57 Hspb3 - heat shock protein 3
P35385 Hspb7 - heat shock protein family, member 7 (cardiovascular)
D3Z736 Ldha - lactate dehydrogenase A
P16125 Ldhb - lactate dehydrogenase B
P48678 Lmna - lamin A
P04247 Mb - myoglobin
P14152 Mdh1 - malate dehydrogenase 1, NAD (soluble)
P08249 Mdh2 - malate dehydrogenase 2, NAD (mitochondrial)
P03899 mt-Nd3 - mitochondrially encoded NADH dehydrogenase 3
P16332 Mut - methylmalonyl-Coenzyme A mutase
Q6P6L5 Mybpc1 - myosin binding protein C, slow-type
G3UW82 Myh2 - myosin, heavy polypeptide 2, sk
Q91Z83 Myh7 - myosin, heavy polypeptide 7, cardiac muscle, beta
P05977 Myl1 - myosin, light polypeptide 1
P09542 Myl3 - myosin, light polypeptide 3
Q60605 Myl6 - myosin, light polypeptide 6, alkali, smooth muscle and non-muscle
Q8CI43 Myl6b - myosin, light polypeptide 6B
P97457 Mylpf - myosin light chain, phosphorylatable, fast
Q14BI5 Myom2 - myomesin 2
A2ABU4 Myom3 - myomesin family, member 3
Q9JIF9 Myot - myotilin
Q9QYG0 Ndrg2 - N-myc downstream regulated gene 2
Q9Z1P6 Ndufa7 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (B14.5a)
Q9DC69 Ndufa9 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9
F6ZFT1 Ndufab1 - NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1
Q9CR61 Ndufb7 - NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7
Q91VD9 Ndufs1 - NADH dehydrogenase (ubiquinone) Fe-S protein 1
F6RJ83 Ndufs2 - NADH dehydrogenase (ubiquinone) Fe-S protein 2
B1ARW4 Ndufs5 - NADH dehydrogenase (ubiquinone) Fe-S protein 5
P52503 Ndufs6 - NADH dehydrogenase (ubiquinone) Fe-S protein 6
D3Z0K1 Ndufv1 - NADH dehydrogenase (ubiquinone) flavoprotein 1
Q01768 Nme2 - NME/NM23 nucleoside diphosphate kinase 2
Q3UJQ9 Oxct1 - 3-oxoacid CoA transferase 1
Q5EBG6 Oxct1 - 3-oxoacid CoA transferase 1
P70296 Pebp1 - phosphatidylethanolamine binding protein 1
O70250 Pgam2 - phosphoglycerate mutase 2
Q9D0F9 Pgm2 - phosphoglucomutase 2
Q9DAK9 Phpt1 - phosphohistidine phosphatase 1
P52480 Pkm - pyruvate kinase, muscle
P20108 Prdx3 - peroxiredoxin 3
E9PUM3 Pygm - muscle glycogen phosphorylase
Q9DD03 Rab13 - RAB13, member RAS oncogene family
Q8BGH2 Samm50 - sorting and assembly machinery component 50 homolog (S. cerevisiae)
Q8K2B3 Sdha - succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
D6RHN2 Selenbp1 - selenium binding protein 1
Q5SX46 Slc25a11 - solute carrier family 25 (mitochondrial carrier oxoglutarate carrier), member 11
Q8BH59 Slc25a12 - solute carrier family 25 (mitochondrial carrier, Aralar), member 12
Q8VEM8 Slc25a3 - solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3
P48962 Slc25a4 - solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4
P09671 Sod2 - superoxide dismutase 2, mitochondrial
O70548 Tcap - titin-cap
Q9Z1T2 Thbs4 - thrombospondin 4
E9Q8P0 Tnnc1 - troponin C, cardiac/slow skeletal
P20801 Tnnc2 - troponin C2, fast
D3YUN3 Tnni1 - troponin I, skeletal, slow 1
P13412 Tnni2 - troponin I, skeletal, fast 2
P17751 Tpi1 - triosephosphate isomerase 1
G5E8R0 Tpm1 - tropomyosin 1, alpha
D3Z6I8 Tpm3 - tropomyosin 3, gamma
P63028 Tpt1 - tumor protein, translationally-controlled 1
Q921I1 Trf - transferrin
Q91ZJ5 Ugp2 - UDP-glucose pyrophosphorylase 2
Q9CZ13 Uqcrc1 - ubiquinol-cytochrome c reductase core protein 1
Q9DB77 Uqcrc2 - ubiquinol cytochrome c reductase core protein 2
P99028 Uqcrh - ubiquinol-cytochrome c reductase hinge protein
Q01853 Vcp - valosin containing protein
Q60932 Vdac1 - voltage-dependent anion channel 1
Q60931 Vdac3 - voltage-dependent anion channel 3
P61982 Ywhag - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
P63101 Ywhaz - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
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Table 4.3.8.1 C The 47 differentially labelled proteins of redox, reduced and reversibly 
oxidised proteins detected in old mouse soleus muscle. 
 
 
Q9EQ20 Aldh6a1 - aldehyde dehydrogenase family 6, subfamily A1
D3YYQ5 Amy1 - amylase 1, salivary
Q8VDN2 Atp1a1 - ATPase, Na+/K+ transporting, alpha 1 polypeptide
Q9CQQ7 Atp5f1 - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1
E9PY34 Cdc6 - cell division cycle 6
P52825 Cpt2 - carnitine palmitoyltransferase 2
P10605 Ctsb - cathepsin B
P97465 Dok1 - docking protein 1
P63168 Dynll1 - dynein light chain LC8-type 1
O35459 Ech1 - enoyl coenzyme A hydratase 1, peroxisomal
P58252 Eef2 - eukaryotic translation elongation factor 2
Q6PHC1 Eno1 - enolase 1
A2AEX7 Fhl1 - four and a half LIM domains 1
P26443 Glud1 - glutamate dehydrogenase 1
F8VPN3 Gm5160 - predicted gene 5160
D3YX79 Gm8394 - predicted gene 8394
S4R1E5 Gpx4 - Glutathione peroxidase
P63038 Hspd1 - heat shock protein 1 (chaperonin)
D6RIL6 Idh2 - isocitrate dehydrogenase 2 (NADP+), mitochondrial
P06330 Ig heavy chain V region AC38 205.12
P01644 Ig kappa chain V-V region HP R16.7
P01649 Ig kappa chain V-V regions
P01867 Igh3 - Ig gamma-2B chain C region
P16045 Lgals1 - lectin, galactose binding, soluble 1
Q5SX39 Myh4 - myosin, heavy polypeptide 4, skeletal muscle
Q7TMF3 Ndufa12 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12
Q9CQJ8 Ndufb9 - NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9
Q60597 Ogdh - oxoglutarate dehydrogenase (lipoamide)
P09103 P4hb - prolyl 4-hydroxylase, beta polypeptide
A2A817 Park7 - Parkinson disease (autosomal recessive, early onset) 7
Q9CRA2 Pdlim5 - PDZ and LIM domain 5
S4R1V0 PDZ and LIM domain protein 1
P47857 Pfkm - phosphofructokinase, muscle
P62715 Ppp2cb - protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform
D3Z0Y2 Prdx6 - peroxiredoxin 6
O09061 Psmb1 - proteasome (prosome, macropain) subunit, beta type 1
Q9R1P3 Psmb2 - proteasome (prosome, macropain) subunit, beta type 2
P08207 S100a10 - S100 calcium binding protein A10 (calpactin)
Q9D451 Sept12 - septin 12
P07759 Serpina3k - serine (or cysteine) peptidase inhibitor, clade A, member 3K
Q60854 Serpinb6a - serine (or cysteine) peptidase inhibitor, clade B, member 6a
Q91WK1 Spryd4 - SPRY domain containing 4
Q7TQ48 Srl - sarcalumenin
P58774 Tpm2 - tropomyosin 2, beta
D3YZT5 Vdac2 - voltage-dependent anion channel 2
P20152 Vim - vimentin
Q9CWQ3 Xrcc6bp1 - XRCC6 binding protein 1
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Table 4.3.8.2.A The 17 redox proteins identified in adult mouse soleus muscle. 
 
Table 4.3.8.2.B The 25 redox proteins identified in both adult and old mouse soleus muscle. 
 
 
 
P97447 Fhl1 - four and a half LIM domains 1
P16858 Gapdh - glyceraldehyde-3-phosphate dehydrogenase
D3Z0K1 Ndufv1 - NADH dehydrogenase (ubiquinone) flavoprotein 1
Q6P8J7 Ckmt2 - creatine kinase, mitochondrial
P13542 Myh8 - myosin, heavy polypeptide 8, skeletal muscle, perinatal
A2AUC9 Kbtbd10 - kelch repeat and BTB (POZ) domain containing 10
A2AQ53 Fbn1 - fibrillin 1
B0QZL1 Eno1 - enolase 1, alpha non-neuron
Q9CZ13 Uqcrc1 - ubiquinol-cytochrome c reductase core protein
P48962 Slc25a4 - solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4
P56382 Atp5e - ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
Q9DB77 Uqcrc2 - ubiquinol cytochrome c reductase core protein 2
O70400 Pdlim1 - PDZ and LIM domain 1 (elfin)
P08228 Sod1 - superoxide dismutase 1, soluble
P45591 Cfl2 - cofilin 2, muscle
Q6IRU2 Tpm4 - tropomyosin 4
P54071 Idh2 - isocitrate dehydrogenase 2 (NADP+), mitochondrial
P07724 Alb - albumin
P99028 Uqcrh - ubiquinol-cytochrome c reductase hinge protein
O08749 Dld - dihydrolipoamide dehydrogenase
G5E8R0 Tpm1 - tropomyosin 1, alpha
P17751 Tpi1 - triosephosphate isomerase 1
P16125 Ldhb - lactate dehydrogenase B
P63268 Actg2 - actin, gamma 2, smooth muscle, enteric
D3Z6I8 Tpm3 - tropomyosin 3, gamma
P08249 Mdh2 - malate dehydrogenase 2, NAD (mitochondrial)
B1ASE2 Atp5h - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit
Q921G7 Etfdh - electron transferring flavoprotein, dehydrogenase
P51174 Acadl - acyl-Coenzyme A dehydrogenase, long-chain
P97457 Mylpf - myosin light chain, phosphorylatable, fast skeletal muscle
P13412 Tnni2 - troponin I, skeletal, fast 2
D3Z736 Ldha - lactate dehydrogenase A
Q91VD9 Ndufs1 - NADH dehydrogenase (ubiquinone) Fe-S protein
D3YUN3 Tnni1 - troponin I, skeletal, slow 1
P14152 Mdh1 - malate dehydrogenase 1, NAD (soluble)
G3UW82 Myh2 - myosin, heavy polypeptide 2, skeletal muscle, adult
Q99KI0 Aco2 - aconitase 2, mitochondrial
P09542 Myl3 - myosin, light polypeptide 3
P05064 Aldoa - aldolase A, fructose-bisphosphate
P21550 Eno3 - enolase 3, beta muscle
P05202 Got2 - glutamate oxaloacetate transaminase 2, mitochondria
Q91Z83 Myh7 - myosin, heavy polypeptide 7, cardiac muscle, beta; Muscle contraction
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Table 4.3.8.2.C The 5 redox proteins identified in old mouse soleus muscle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q5SX39 Myh4 - myosin, heavy polypeptide 4, skeletal muscle
P58774 Tpm2 - tropomyosin 2, beta
Q6PHC1 Eno1 - enolase 1, alpha non-neuron
E9PY34 Cdc6 - cell division cycle 6
D3Z0Y2 Prdx6 - peroxiredoxin 6
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Table 4.3.8.3.A The 35 reduced proteins identified in adult mouse soleus muscle. 
 
 
 
 
 
 
 
 
 
 
F8WGB3 Sdhc - succinate dehydrogenase complex, subunit C, integral membrane protein
E9QMD3 Zfhx3 - zinc finger homeobox 3
P61027 Rab10 - RAB10, member RAS oncogene family
Q9R0Y5 Ak1 - adenylate kinase 1
P35486 Pdha1 - pyruvate dehydrogenase E1 alpha 1
Q9DCM2 Gstk1 - glutathione S-transferase kappa 1
O88569 Hnrnpa2b1 - heterogeneous nuclear ribonucleoprotein A2/B1
P63330 Ppp2ca - protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform
Q8BMS1 Hadha - hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit
F7B227 Ech1 - enoyl coenzyme A hydratase 1, peroxisomal
P19157 Gstp1 - glutathione S-transferase, pi 1
F7B1B6 Adck3 - aarF domain containing kinase 3
P47738 Aldh2 - aldehyde dehydrogenase 2, mitochondrial
Q9D6R2 Idh3a - isocitrate dehydrogenase 3 (NAD+) alpha
Q8CI51 Pdlim5 - PDZ and LIM domain 5
Q9WUM5 Suclg1 - succinate-CoA ligase, GDP-forming, alpha subunit
Q9D051 Pdhb - pyruvate dehydrogenase (lipoamide) bet
Q62234 Myom1 - myomesin 1
Q9CQA3 Sdhb - succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
Q8BFR5 Tufm - Tu translation elongation factor, mitochondrial
Q99JY0 Hadhb - hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit
P45376 Akr1b3 - aldo-keto reductase family 1, member B3 (aldose reductase)
F6T930 Akr1b1 - aldose reductase
Q8BMF4 Dlat - dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex)
Q9CQ75 Ndufa2 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex,
Q9Z2I9 Sucla2 - succinate-Coenzyme A ligase, ADP-forming, beta subuni
Q9Z2Z6 Slc25a20 - solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20
D6REF3 Ywhae - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide
D3YYN7 Atp1a2 - ATPase, Na+/K+ transporting, alpha 2 polypeptide
Q6IRU5 Cltb - clathrin, light polypeptide (Lcb); Clathrin is the major protein of the polyhedral coat of coated pits and vesicles
A2A813 Park7 - Parkinson disease (autosomal recessive, early onset) 7
P70404 Idh3g - isocitrate dehydrogenase 3 (NAD+), gamma
F8WIT2 Anxa6 - annexin A6; May associate with CD21. May regulate the release of Ca(2+) from intracellular stores
Q924X2 Cpt1b - carnitine palmitoyltransferase 1b, muscle
P17742 Ppia - peptidylprolyl isomerase A
259 
 
Table 4.3.8.3.B The 83 reduced proteins identified in both adult and old mouse soleus 
muscle. 
 
Q6P6L5 Mybpc1 - myosin binding protein C, slow-type
P04117 Fabp4 - fatty acid binding protein 4, adipocyte
D3Z041 Acsl1 - acyl-CoA synthetase long-chain family member 1
Q8R429 Atp2a1 - ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
Q61316 Hspa4 - heat shock protein 4
D3Z2Y8 Bdh1 - 3-hydroxybutyrate dehydrogenase, type 1
P38647 Hspa9 - heat shock protein 9
O70250 Pgam2 - phosphoglycerate mutase 2
O70251 Eef1b2 - eukaryotic translation elongation factor 1 beta 2
Q6P1B9 Bin1 - bridging integrator 1
A8DUK4 Hbb-b1 - hemoglobin, beta adult major chain
Q9QZ57 Hspb3 - heat shock protein 3
B1ATS4 Atp2a3 - ATPase, Ca++ transporting, ubiquitous
Q01768 Nme2 - NME/NM23 nucleoside diphosphate kinase 2
O55137 Acot1 - acyl-CoA thioesterase 1
P35385 Hspb7 - heat shock protein family, member 7 (cardiovascular)
Q14BI5 Myom2 - myomesin 2
Q8BGH2 Samm50 - sorting and assembly machinery component 50 homolog (S. cerevisiae)
P62631 Eef1a2 - eukaryotic translation elongation factor 1 alpha 2
A2AKV0 Atp5c1 - ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1
P04247 Mb - myoglobin
P05977 Myl1 - myosin, light polypeptide
P48678 Lmna - lamin A
Q9CZU6 Cs - citrate synthase
A2ABU4 Myom3 - myomesin family, member 3
Q9JIF9 Myot - myotilin
Q8K2B3 Sdha - succinate dehydrogenase complex, subunit A, flavoprotein (F
Q91ZJ5 Ugp2 - UDP-glucose pyrophosphorylase 2
P63101 Ywhaz - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
Q60605 Myl6 - myosin, light polypeptide 6, alkali, smooth muscle and non-muscle
Q9D0F9 Pgm2 - phosphoglucomutase 2
Q61425 Hadh - hydroxyacyl-Coenzyme A dehydrogenase
P03899 mt-Nd3 - mitochondrially encoded NADH dehydrogenase 3
P52503 Ndufs6 - NADH dehydrogenase (ubiquinone) Fe-S protein 6
Q01853 Vcp - valosin containing protein
F6RJ83 Ndufs2 - NADH dehydrogenase (ubiquinone) Fe-S protein 2
Q3UJQ9 Oxct1 - 3-oxoacid CoA transferase 1
P16332 Mut - methylmalonyl-Coenzyme A mutase
Q5EBG6 Hspb6 - heat shock protein, alpha-crystallin-related, B6
Q8VEM8 Slc25a3 - solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3
O55126 Gbas - glioblastoma amplified sequence
Q9QYG0 Ndrg2 - N-myc downstream regulated gene 2
P05201 Got1 - glutamate oxaloacetate transaminase 1, soluble
Q9D0M3 Cyc1 - cytochrome c-1
Q8CI43 Myl6b - myosin, light polypeptide 6B
Q8BFZ3 Actbl2 - actin, beta-like 2
D3YW87 Flnc - filamin C, gamma
B1AR28 Acadvl - acyl-Coenzyme A dehydrogenase, very long chain
P52480 Pkm - pyruvate kinase, muscle
P07310 Ckm - creatine kinase, muscle
P61982 Ywhag - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
Q8BH59 Slc25a12 - solute carrier family 25 (mitochondrial carrier, Aralar), member 1
F6QJN8 Capzb - capping protein (actin filament) muscle Z-line, beta
P06745 Gpi1 - glucose phosphate isomerase 1
P70296 Pebp1 - phosphatidylethanolamine binding protein 1
Q9WV06 Ankrd2 - ankyrin repeat domain 2 (stretch responsive muscle)
F6ZFT1 Ndufab1 - NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1
P20801 Tnnc2 - troponin C2, fast
Q07417 Acads - acyl-Coenzyme A dehydrogenase, short chain
Q9D2G2 Dlst - dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)
D3Z6F5 Atp5a1 - ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit
Q99LC5 Etfa - electron transferring flavoprotein, alpha polypeptide
E9Q8P0 Tnnc1 - troponin C, cardiac/slow skeletal
Q9Z1P6 Ndufa7 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (B14.5a)
Q9CPU0 Glo1 - glyoxalase 1
P09671 Sod2 - superoxide dismutase 2, mitochondrial
Q504P4 Hspa8 - heat shock protein 8
E9PUM3 Pygm - muscle glycogen phosphorylas
P63028 Tpt1 - tumor protein, translationally-controlled 1
Q9JI91 Actn2 - actinin alpha 2
Q5SX46 Slc25a11 - solute carrier family 25 (mitochondrial carrier oxoglutarate carrier), member 11
D6RHN2 Selenbp1 - selenium binding protein 1
Q60931 Vdac3 - voltage-dependent anion channel 3
P24270 Cat - catalase
Q60932 Vdac1 - voltage-dependent anion channel 1
Q9DAK9 Phpt1 - phosphohistidine phosphatase
P16015 Car3 - carbonic anhydrase 3
Q9DD03 Rab13 - RAB13, member RAS oncogene family
Q9DC69 Ndufa9 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9
P20108 Prdx3 - peroxiredoxin 3
O35215 Ddt - D-dopachrome tautomerase
O70548 Tcap - titin-cap
Q9DCW4 Etfb - electron transferring flavoprotein, beta polypeptide
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Table 4.3.8.3.C The 43 reduced proteins identified in old mouse soleus muscle. 
 
 
 
 
 
P97465 Dok1 - docking protein 1
P16858 Gapdh - glyceraldehyde-3-phosphate dehydrogenase
D3YYQ5 Amy1 - amylase 1, salivary
P63168 Dynll1 - dynein light chain LC8-type 1
S4R1E5 Gpx4 - Glutathione peroxidase
B0QZL1 Eno1 - enolase 1, alpha non-neuron
P20152 Vim - vimentin
P48962 Slc25a4 - solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4
S4R1V0 Pdlim1 - PDZ and LIM domain protein 1
Q60597 Ogdh - oxoglutarate dehydrogenase (lipoamide)
F8VPN3 Gm5160 - predicted gene 5160; PPIases accelerate the folding of proteins
P08207 S100a10 - S100 calcium binding protein A10 (calpactin)
P07759 Serpina3k - serine (or cysteine) peptidase inhibitor, clade A, member 3K
Q8VDN2 Atp1a1 - ATPase, Na+/K+ transporting, alpha 1 polypeptide
D3YX79 Gm8394 - predicted gene 8394
D3YZT5 Vdac2 - voltage-dependent anion channel 2
P16045 Lgals1 - lectin, galactose binding, soluble 1
P56382 Atp5e - ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
P47857 Pfkm - phosphofructokinase, muscle
A2AEX7 Fhl1 - four and a half LIM domains 1
Q9CQJ8 Ndufb9 - NADH dehydrogenase (ubiquinone) 1 beta subcomplex,
Q60854 Serpinb6a - serine (or cysteine) peptidase inhibitor, clade B, member 6a
Q91WK1 Spryd4 - SPRY domain containing 4
D6RIL6 Idh2 - isocitrate dehydrogenase 2 (NADP+), mitochondrial
Q9CQQ7 Atp5f1 - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1
Q7TMF3 Ndufa12 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1
Q9EQ20 Aldh6a1 - aldehyde dehydrogenase family 6, subfamily A1
Q9CZ13 Uqcrc1 - ubiquinol-cytochrome c reductase core protein 1
P62715 Ppp2cb - protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform
Q9DB77 Uqcrc2 - ubiquinol cytochrome c reductase core protein 2
Q9CRA2 Pdlim5 - PDZ and LIM domain 5
P09103 P4hb - prolyl 4-hydroxylase, beta polypeptide
P26443 Glud1 - glutamate dehydrogenase 1
A2A817 Park7 - Parkinson disease (autosomal recessive, early onset) 7
D3Z0K1 Ndufv1 - NADH dehydrogenase (ubiquinone) flavoprotein 1
Q9R1P3 Psmb2 - proteasome (prosome, macropain) subunit, beta type 2
Q6P8J7 Ckmt2 - creatine kinase, mitochondrial 2
O09061 Psmb1 - proteasome (prosome, macropain) subunit, beta type 1
P45591 Cfl2 - cofilin 2, muscle
P52825 Cpt2 - carnitine palmitoyltransferase 2
O35459 Ech1 - enoyl coenzyme A hydratase 1, peroxisomal
P58252 Eef2 - eukaryotic translation elongation factor 2
P63038 Hspd1 - heat shock protein 1 (chaperonin)
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Table 4.3.8.4.A The 4 reversibly oxidised proteins identified in adult mouse soleus muscle. 
 
 
 
Table 4.3.8.4.B The 9 reversibly oxidised proteins identified in both adult and old mouse 
soleus muscle. 
 
 
 
Table 4.3.8.4.C The 9 reversibly oxidised proteins identified in old mouse soleus muscle. 
 
 
 
 
 
 
 
 
Q61646 Hp - haptoglobin
Q9DCJ5 Ndufa8 - NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8
E9PZM7 Scaf11 - SR-related CTD-associated factor 11
P50608 Fmod - fibromodulin
Q9CR61 Ndufb7 - NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7
B1ARW4 Ndufs5 - NADH dehydrogenase (ubiquinone) Fe-S protein 5
P14211 Calr - calreticulin
Q9R0G6 Comp - cartilage oligomeric matrix protein
Q08857 Cd36 - CD36 antigen
Q9Z1T2 Thbs4 - thrombospondin 4
Q91X72 Hpx - hemopexin
Q921I1 Trf - transferrin
P56391 Cox6b1 - cytochrome c oxidase, subunit VIb polypeptide 1
P10605 Ctsb - cathepsin B
Q7TQ48 Srl - sarcalumenin
Q9CWQ3 Xrcc6bp1 - XRCC6 binding protein 1
Q9D451 Sept12 - septin 12
A2AQ53 Fbn1 - fibrillin 1
P01649 Ig kappa chain V-V-region
P01867 Igh-3 - Ig gamma-2B chain C region
P01644 Ig kappa chain V-V-region HP R16.7
P06330 Ig heavy chain V region AC38 205.12
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Table 5.3.1 Quadriceps Adult and Old Label Free VennDIS Tables 
Accession 
Number 
Protein 
P70170 Abcc9 - ATP-binding cassette, sub-family C (CFTR/MRP), member 
P60710 Actb - actin, β 
O88990 Actn3 - actinin α 3 
Q4VC17 Adamts18 - a disintegrin-like and metallopeptidase (reprolysin type) with 
thrombospondin type 1 motif, 18 
Q3U4G3 AI480653 - expressed sequence AI480653 
O88987 Akap3 - A kinase (PRKA) anchor protein 3 
P24549 Aldh1a1 - aldehyde dehydrogenase family 1, subfamily A 
Q8K009 Aldh1l2 - aldehyde dehydrogenase 1 family, member L2 
Q9DBF1 Aldh7a1 - aldehyde dehydrogenase family 7, member A1 
Q91Y97 Aldob - aldolase B, fructose-bisphosphate 
Q3V1D3 Ampd1 - adenosine monophosphate deaminase 
Q9DBT5 Ampd2 - adenosine monophosphate deaminase 
Q07076 Anxa7 - annexin A7 
Q8R146 Apeh - acylpeptide hydrolase 
Q8K4Z3 Apoa1bp - apolipoprotein A-I binding protein 
P06728 Apoa4 - apolipoprotein A-IV 
P84078 Arf1 - ADP-ribosylation factor 1 
Q80Y19 Arhgap11a - Rho GTPase activating protein 11A 
Q8R2G4 Art3 - ADP-ribosyltransferase 3 
Q7SIG6 Asap2 - ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 
Q8BSY0 Asph - aspartate-β-hydroxylase 
O08997 Atox1 - ATX1 (antioxidant protein 1) homolog 1 (yeas 
Q64518 Atp2a3 - ATPase, Ca++ transporting, ubiquitous 
O35855 Bcat2 - branched chain aminotransferase 2, mitochondri 
Q8R164 Bphl - biphenyl hydrolase-like (serine hydrolase, breast epithelial mucin-
associated antigen) 
P62960 bx1 - Y box protein 
P01027 C3 - complement component 3 
Q8K182 C8a - complement component 8, α polypeptide 
Q8R3Z5 Cacnb1 - calcium channel, voltage-dependent, β 1 subunit 
P54285 Cacnb3 - calcium channel, voltage-dependent, β 3 subunit 
Q9WUF3 Casp8ap2 - caspase 8 associated protein 2 
P08074 Cbr2 - carbonyl reductase 2 
Q8CII2 Cdc123 - cell division cycle 123 
Q8CC36 Cdnf - cerebral dopamine neurotrophic factor 
Q66K08 Cilp - cartilage intermediate layer protein, nucleotide pyrophosphohydrol 
Q9Z0H8 Clip2 - CAP-GLY domain containing linker protein 
Q8R4N0 Clybl - citrate lyase β like 
Q9D1A2 Cndp2 - CNDP dipeptidase 2 (metallopeptidase M20 family 
Q9CXX9 Cuedc2 - CUE domain containing 2 
Q9D8X1 Cutc - cutC copper transporter homolog (E.coli) 
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Q571I4 D8Ertd82e - DNA segment, Chr 8, ERATO Doi 82, expressed 
Q3U1J4 Ddb1 - damage specific DNA binding protein 1 
Q9DBB8 Dhdh - dihydrodiol dehydrogenase (dimeric) 
Q99PU8 Dhx30 - DEAH (Asp-Glu-Ala-His) box polypeptide 30 
Q8K1M6 Dnm1l - dynamin 1-like 
P59764 Dock4 - dedicator of cytokinesis 4 
P97399 Dspp - dentin sialophosphoprotein 
Q8BK84 Dupd1 - dual specificity phosphatase and pro isomerase domain containing 1 
Q9D8N0 Eef1g - eukaryotic translation elongation factor 1 γ 
Q9D485 Efhc2 - EF-hand domain (C-terminal) containing 2 
P10630 Eif4a2 - eukaryotic translation initiation factor 4A2 
Q80Y81 Elac2 - elaC homolog 2 (E. coli) 
Q80UY1 ENSMUSG00000024726 - RIKEN cDNA 2410127L17 gene 
Q8R0W0 Eppk1 - Epiplakin 
Q8CGC7 Eprs - glutamyl-prolyl-tRNA synthetase 
Q9D9R9 Fam186a - family with sequence similarity 186, member A 
Q8BR27 Fam214b - RIKEN cDNA B230312A22 gene 
Q9DCV4 Fam82b - family with sequence similarity 82, member B 
P70695 Fbp2 - fructose bisphosphatase 2 
Q9ESL9 Fgf20 - fibroblast growth factor 20 
Q9JJ28 Flii - flightless I homolog (Drosophila) 
A2AAE1 FSA - RIKEN cDNA 4932438A13 gene 
O35943 Fxn - frataxin 
Q9CZD3 Gars - glycyl-tRNA synthetase 
Q64737 Gart - phosphoribosylglycinamide formyltransferase 
Q8C494 Gm14492 - predicted gene 14492 
P50247 Gm4737 - predicted gene 4737 
P14115 Gm7536 - predicted gene 7536 
P13707 Gpd1 - glycerol-3-phosphate dehydrogenase 1 (soluble) 
Q64521 Gpd2 - glycerol phosphate dehydrogenase 2, mitochondrial 
Q8BUV3 Gphn - gephyrin 
Q61627 Grid1 - glutamate receptor, ionotropic, δ 1 
P15626 Gstm2 - glutathione S-transferase, μ 2 
P48774 Gstm5 - glutathione S-transferase, μ 5 
Q8K284 Gtf3c1 - general transcription factor III C 1 
P10922 H1f0 - H1 histone family, member 0 
O35668 Hap1 - huntingtin-associated protein 1 
P02089 Hbb-b2 - hemoglobin, β adult minor chai 
P84228 Hist2h3b - histone cluster 2, H3b 
O08528 Hk2 - hexokinase 2 
P06330 Ig heavy chain V region AC38 205.12 
Q07113 Igf2r - insulin-like growth factor 2 receptor 
O55023 Impa1 - inositol (myo)-1(or 4)-monophosphatase 1 
Q8CDK3 Iqub - IQ motif and ubiquitin domain containing 
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Q9Z329 Itpr2 - inositol 1,4,5-triphosphate receptor 
Q9Z351 Kcnq2 - potassium voltage-gated channel, subfamily Q, member 2 
Q6ZQ06 Kiaa1009 - RIKEN cDNA 4922501C03 gene 
Q8R0W1 Kiaa1737 - RIKEN cDNA 2310044G17 gene 
A2AJB1 Kiaa1984 - RIKEN cDNA 4921530D09 gene 
Q99PT9 Kif19a - kinesin family member 19A 
Q9QXL2 Kif21a - kinesin family member 21A 
Q9Z320 Krt27 - keratin 27 
B1AQ75 Krt36 - keratin 36 
Q6IMF0 Krt83 - keratin 83 
P48356 Lepr - leptin receptor 
Q9Z0S2 Lhx2 - LIM homeobox protein 2 
P37913 Lig1 - ligase I, DNA, ATP-dependent 
P55302 Lrpap1 - low density lipoprotein receptor-related protein associated protein 1 
Q8CI70 Lrrc20 - leucine rich repeat containing 20 
Q60767 Ly75 - lymphocyte antigen 75 
P70218 Map4k1 - mitogen-activated protein kinase kinase kinase kinase 1 
P47811 Mapk14 - mitogen-activated protein kinase 14 
Q3THS6 Mat2a - methionine adenosyltransferase II, alph 
P34884 Mif - macrophage migration inhibitory factor 
Q8BMD7 Morc4 - microrchidia 4 
P00158 mt-Cytb - mitochondrially encoded cytochrome b 
P04938 Mup11 - major urinary protein 11 
Q99JI1 Mustn1 - musculoskeletal, embryonic nuclear protein 1 
P70402 Mybph - myosin binding protein 
O08638 Myh11 - myosin, heavy polypeptide 11, smooth muscle 
Q8VDD5 Myh9 - myosin, heavy polypeptide 9, non-muscle 
Q6PDN3 Mylk - myosin, light polypeptide kinase 
Q8VCR8 Mylk2 - myosin, light polypeptide kinase 2, skeletal muscle 
P19246 Nefh - neurofilament, heavy polypeptide 
P08551 Nefl - neurofilament, light polypeptide 
Q9CQ45 Nenf - neuron derived neurotrophic factor 
P46662 Nf2 - neurofibromatosis 2 
Q9D1X0 Nol3 - nucleolar protein 3 (apoptosis repressor with CARD domain 
Q63850 Nup62 - nucleoporin 62 
P61971 Nutf2-ps1 - nuclear transport factor 2, pseudogene 
Q9CZ30 Ola1 - Obg-like ATPase 1 
Q9ESF1 Otof - otoferlin 
Q9DCL9 Paics - phosphoribosylaminoimidazole carboxylase, 
phosphoribosylaminoribosylaminoimidazole, succinocarboxamide synthetase 
Q91ZA3 Pcca - propionyl-Coenzyme A carboxylase, α polypeptide 
Q922R8 Pdia6 - protein disulfide isomerase associate 
P09041 Pgk2 - phosphoglycerate kinase 2 
Q8BZF8 Pgm5 - phosphoglucomutase 
P18826 Phka1 - phosphorylase kinase α 1 
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Q3TCV3 Pion - pigeon homolog (Drosophila) 
Q62028 Pla2r1 - phospholipase A2 receptor 1 
Q9Z1B3 Plcb1 - phospholipase C, β 1 
A2AP18 Plch2 - phospholipase C, η 2 
Q3USB7 Plcl1 - phospholipase C-like 1 
Q9R269 Ppl - periplakin 
Q62415 Ppp1r13b - protein phosphatase 1, regulatory (inhibitor) subunit 13B 
Q6R891 Ppp1r9b - protein phosphatase 1, regulatory subunit 9B 
P63328 Ppp3ca - protein phosphatase 3, catalytic subunit, α isoform 
P48453 Ppp3cb - protein phosphatase 3, catalytic subunit, β isoform 
O08807 PRDX4 - peroxiredoxin 4 
Q9DBC7 Prkar1a - protein kinase, cAMP dependent regulatory, type I, α 
O08795 Prkcsh - protein kinase C substrate 80K-H 
Q8BZ03 Prkd2 - protein kinase D2 
Q9D7G0 Prps1 - phosphoribosyl pyrophosphate synthetase 1 
Q8CI94 Pygb - brain glycogen phosphorylas 
Q9ET01 Pygl - liver glycogen phosphorylase 
Q8BVI4 Qdpr - quinoid dihydropteridine reductase 
P34057 Rcvrn - recoverin 
Q9EPQ2 Rpgrip1 - retinitis pigmentosa GTPase regulator interacting protein 1 
Q9CXW4 Rpl11 - ribosomal protein L11 
P47963 Rpl13 - ribosomal protein L13 
Q9CR57 Rpl14 - ribosomal protein L14 
P35980 Rpl18 - ribosomal protein L18 
P62830 Rpl23 - ribosomal protein L23 
P62889 Rpl30 - ribosomal protein L30 
Q6ZWV7 Rpl35 - ribosomal protein L35 
Q9D8E6 Rpl4 - ribosomal protein L4 
P12970 Rpl7a - ribosomal protein L7A 
P14869 Rplp0 - ribosomal protein, large, P0 
P62270 Rps18 - ribosomal protein S18 
P60867 Rps20 - ribosomal protein S20 
P62855 Rps26-ps1 - ribosomal protein S26, pseudogene 1 
P62908 Rps3 - ribosomal protein S3 
P97351 Rps3a - ribosomal protein S3A 
P62702 Rps4x - ribosomal protein S4, X-linked 
P62754 Rps6 - ribosomal protein S6 
P62082 Rps7 - ribosomal protein S7 
Q01730 Rsu1 - Ras suppressor protein 1 
O70622 Rtn2 - reticulon 2 (Z-band associated protein) 
Q9CQC9 Sar1b - SAR1 gene homolog B (S. cerevisiae 
Q64519 Sdc3 - syndecan 3 
Q9D665 Sdr42e1 - short chain dehydrogenase/reductase family 42E, member 1 
O70456 Sfn - stratifin 
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P82348 Sgcg - sarcoglycan, γ (dystrophin-associated glycoprote 
Q8CFH6 Sik2 - salt inducible kinase 2 
Q9QXX4 Slc25a13 - solute carrier family 25 (mitochondrial carrier, adenine nucleotide 
translocator), member 13 
Q922R5 Smek2 - SMEK homolog 2, suppressor of mek1 (Dictyostelium) 
Q8CI12 Smtnl2 - smoothelin-like 2 
P97443 Smyd1 - SET and MYND domain containing 1 
Q9CWR2 Smyd3 - SET and MYND domain containing 3 
Q8BK63 snk1a1 - casein kinase 1, α 1 
Q9QX47 Son - Son DNA binding protein 
Q9D2H6 Sp2 - Sp2 transcription factor 
Q80YT5 Spata20 - spermatogenesis associated 20 
P08032 Spna1 - spectrin α 
Q64105 Spr - sepiapterin reductase 
Q924W7 St5 - suppression of tumorigenicity 5 
Q9Z1Z2 Strap - serine/threonine kinase receptor associated protei 
Q8BJS4 Sun2 - Sad1 and UNC84 domain containing 2 
Q4FZC9 Syne3 - RIKEN cDNA 4831426I19 gene 
Q64729 Tgfbr1 - transforming growth factor, β receptor 
P39447 Tjp1 - tight junction protein 1 
Q64511 Top2b - topoisomerase (DNA) II bet 
Q8BV79 Trank1 - tetratricopeptide repeat and ankyrin repeat containing 1 
Q9CQN1 Trap1 - TNF receptor-associated protein 1 
Q80UG8 Ttll4 - tubulin tyrosine ligase-like family, member 4 
Q02053 Uba1 - ubiquitin-like modifier activating enzyme 1 
P61087 Ube2k - ubiquitin-conjugating enzyme E2K 
Q9CZY3 Ube2v1 - ubiquitin-conjugating enzyme E2 variant 1 
Q9D2M8 Ube2v2 - ubiquitin-conjugating enzyme E2 variant 
Q9CPX8 Uqcr11 - ubiquinol-cytochrome c reductase, complex III subunit X 
B1AY13 Usp24 - ubiquitin specific peptidase 24 
Q99MX1 Usp26 - ubiquitin specific peptidase 2 
Q91WQ3 Yars - tyrosyl-tRNA synthetase 
Q0P5X5 Zbbx - zinc finger, B-box domain containing 
Q8R173 Zdhhc3 - zinc finger, DHHC domain containing 3 
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Table 5.4.4 (A) & (B) Adult and Old Quadriceps and Redox Tables 
Accession 
Number 
Protein 
Q8R0P4 Aamdc - RIKEN cDNA 1810020D17 gene 
P51174 Acadl - acyl-Coenzyme A dehydrogenase, long-chain 
P45952 Acadm - acyl-Coenzyme A dehydrogenase, medium chain 
Q07417 Acads - acyl-Coenzyme A dehydrogenase, short chain 
P50544 Acadvl - acyl-Coenzyme A dehydrogenase, very long chain 
Q8QZT1 Acat1 - acetyl-Coenzyme A acetyltransferase 1 
Q99KI0 Aco2 - aconitase 2, mitochondrial 
Q9CQR4 Acot13 - acyl-CoA thioesterase 1 
Q9QYR9 Acot2 - acyl-CoA thioesterase 2 
P41216 Acsl1 - acyl-CoA synthetase long-chain family member 1 
P68134 Acta1 - actin, α 1, skeletal muscle 
Q8BFZ3 Actbl2 - actin, β-like 2 
P56375 Acyp2 - acylphosphatase 2, muscle type 
Q60936 Adck3 - aarF domain containing kinase 3 
P28474 Adh5 - alcohol dehydrogenase 5 (class III), chi polypeptid 
P28650 Adssl1 - adenylosuccinate synthetase like 1 
P29699 Ahsg - α-2-HS-glycoprotein; Probably involved in differentiation 
Q9R0Y5 Ak1 - adenylate kinase 1 
P45376 Akr1b3 - aldo-keto reductase family 1, member B3 (aldose reductase) 
P07724 Alb - albumi 
P47738 Aldh2 - aldehyde dehydrogenase 2, mitochondrial 
Q8CHT0 Aldh4a1 - aldehyde dehydrogenase 4 family, member A1 
Q9EQ20 Aldh6a1 - aldehyde dehydrogenase family 6, subfamily A 
P05064 Aldoa - aldolase A, fructose-bisphosphat 
Q8C8R3 Ank2 - ankyrin 2, brain 
Q9WV06 Ankrd2 - ankyrin repeat domain 2 (stretch responsive muscle) 
P48036 Anxa5 - annexin A5 
P14824 Anxa6 - annexin A6 
Q00623 Apoa1 - apolipoprotein A-I 
Q9WV35 Apobec2 - apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 
Q02013 Aqp1 - aquaporin 1 
Q69ZH9 Arhgap23 - Rho GTPase activating protein 23 
Q99PT1 Arhgdia - Rho GDP dissociation inhibitor (GDI) α 
Q3URY6 Armc2 - armadillo repeat containing 2 
Q8C0M9 Asrgl1 - asparaginase like 1 
Q9CWJ9 Atic - 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP 
cyclohydrolase 
Q6PIE5 Atp1a2 - ATPase, Na+/K+ transporting, α 2 polypeptide 
Q8R429 Atp2a1 - ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 
O55143 Atp2a2 - ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 
Q03265 Atp5a1 - ATP synthase, H+ transporting, mitochondrial F1 complex, α subunit 
1 
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P56480 Atp5b - ATP synthase, H+ transporting mitochondrial F1 complex, β subunit 
Q91VR2 Atp5c1 - ATP synthase, H+ transporting, mitochondrial F1 complex, γ 
polypeptide 1 
Q9D3D9 Atp5d - ATP synthase, H+ transporting, mitochondrial F1 complex, δ subunit 
P56382 Atp5e - ATP synthase, H+ transporting, mitochondrial F1 complex, ε subunit 
Q9CQQ7 Atp5f1 - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit 
B1 
Q9CR84 Atp5g1 - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit 
c1 (subunit 9) 
Q9DCX2 Atp5h - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit 
P97450 Atp5j - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F 
P56135 Atp5j2 - ATP synthase, H+ transporting, mitochondrial F0 complex, subunit 
F2 
Q06185 Atp5k - ATP synthase, H+ transporting, mitochondrial F1F0 complex, subunit 
Q9DB20 Atp5o - ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit 
Q9JLV1 Bag3 - BCL2-associated athanogene 
Q80ZF8 Bai3 - brain-specific angiogenesis inhibitor 3 
Q80VH0 Bank1 - B cell scaffold protein with ankyrin repeats 1 
Q9Z277 Baz1b - bromodomain adjacent to zinc finger domain, 1B 
Q80XN0 Bdh1 - 3-hydroxybutyrate dehydrogenase, type 1 
P28653 Bgn - biglycan 
O08539 Bin1 - bridging integrator 1 
P18572 Bsg - basigin 
O35658 C1qbp - complement component 1, q subcomponent binding protein 
Q52KB6 C2cd3 - C2 calcium-dependent domain containing 3 
P62204 Calm1 - calmodulin 1 
P14211 Calr - calreticulin 
O35887 Calu - calumeni 
Q9CYT6 Cap2 - CAP, adenylate cyclase-associated protein, 2 (yeast) 
P47754 Capza2 - capping protein (actin filament) muscle Z-line, α 2 
P47757 Capzb - capping protein (actin filament) muscle Z-line, β 
P16015 Car3 - carbonic anhydrase 3 
O09165 Casq1 - calsequestrin 1 
P24270 Cat - catalase 
P49817 Cav1 - caveolin 1, caveolae protein 
Q08857 Cd36 - CD36 antigen 
Q9WTR5 Cdh13 - cadherin 13 
P23953 Ces1c - carboxylesterase 1C 
Q8VCT4 Ces1d - carboxylesterase 1D 
P18760 Cfl1 - cofilin 1, non-muscle 
P45591 Cfl2 - cofilin 2, muscle 
Q9D1L0 Chchd2 - coiled-coil-helix-coiled-coil-helix domain containing 2 
Q9CRB9 Chchd3 - coiled-coil-helix-coiled-coil-helix domain containing 3 
Q04447 Ckb - creatine kinase, brain 
P07310 Ckm - creatine kinase, muscle 
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Q6P8J7 Ckmt2 - creatine kinase, mitochondrial 
Q8R1G2 Cmbl - carboxymethylenebutenolidase-like (Pseudomonas) 
Q9QXT0 Cnpy2 - canopy 2 homolog (zebrafish) 
P08122 Col4a2 - collagen, type IV, α 2 
Q8K1Z0 Coq9 - coenzyme Q9 homolog (yeast) 
P19783 Cox4i1 - cytochrome c oxidase subunit IV isoform 1 
P12787 Cox5a - cytochrome c oxidase, subunit V 
P19536 Cox5b - cytochrome c oxidase, subunit Vb 
P56391 Cox6b1 - cytochrome c oxidase, subunit VIb polypeptide 1 
Q9CPQ1 Cox6c - cytochrome c oxidase, subunit VIc 
P56392 Cox7a1 - cytochrome c oxidase, subunit VIIa 1 
P48771 Cox7a2 - cytochrome c oxidase, subunit VIIa 2 
P52825 Cpt2 - carnitine palmitoyltransferase 2 
P23927 Cryab - crystallin, α B 
Q9CZU6 Cs - citrate synthase 
Q9JKB3 Csda - cold shock domain protein A 
P18242 Ctsd - cathepsin D 
Q9D4H8 Cul2 - cullin 2 
Q9CQ89 Cuta - cutA divalent cation tolerance homolog (E. coli) 
Q9DCN2 Cyb5r3 - cytochrome b5 reductase 3 
Q9D0M3 Cyc1 - cytochrome c-1 
Q9D172 D10Jhu81e - DNA segment, Chr 10, Johns Hopkins University 81 expressed 
P31786 Dbi - diazepam binding inhibitor 
O35215 Ddt - D-dopachrome tautomerase 
Q9CQ62 Decr1 - 2,4-dienoyl CoA reductase 1, mitochondrial 
P31001 Des - desmin 
Q8BMF4 Dlat - dihydrolipoamide S-acetyltransferase (E2 component of pyruvate 
dehydrogenase complex) 
O08749 Dld - dihydrolipoamide dehydrogenase 
Q9D2G2 Dlst - dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-
glutarate complex) 
Q9Z2W0 Dnpep - aspartyl aminopeptidase 
Q9R0P5 Dstn - destrin 
Q9D0M5 Dynll2 - dynein light chain LC8-type 2 
O35459 Ech1 - enoyl coenzyme A hydratase 1, peroxisomal 
Q8BH95 Echs1 - enoyl Coenzyme A hydratase, short chain, 1, mitochondrial 
P42125 Eci1 - enoyl-Coenzyme A δ isomerase 1 
P62631 Eef1a2 - eukaryotic translation elongation factor 1 α 
O70251 Eef1b2 - eukaryotic translation elongation factor 1 β 2 
P57776 Eef1d - eukaryotic translation elongation factor 1 δ (guanine nucleotide 
exchange protein 
P58252 Eef2 - eukaryotic translation elongation factor 2 
Q8BH64 Ehd2 - EH-domain containing 2 
Q66JS6 Eif3j2 - eukaryotic translation initiation factor 3, subunit J2 
Q9EST3 Eif4enif1 - eukaryotic translation initiation factor 4E nuclear import factor 1 
270 
 
P17182 Eno1 - enolase 1, α non-neuron 
P17183 Eno2 - enolase 2, γ neurona 
P21550 Eno3 - enolase 3, β muscle 
Q6ZWR6 ENSMUSG00000096054 - Nesprin-1 
Q99LC5 Etfa - electron transferring flavoprotein, α polypeptide 
Q9DCW4 Etfb - electron transferring flavoprotein, β polypeptid 
Q921G7 Etfdh - electron transferring flavoprotein, dehydrogenas 
P11404 Fabp3 - fatty acid binding protein 3, muscle and heart 
P04117 Fabp4 - fatty acid binding protein 4, adipocyte 
Q61554 Fbn1 - fibrillin 1 
Q8K0E8 Fgb - fibrinogen β chain 
Q8VCM7 Fgg - fibrinogen γ chain 
P97807 Fh1 - fumarate hydratase 1 
P97447 Fhl1 - four and a half LIM domains 1 
P26883 Fkbp1a - FK506 binding protein 1a 
Q62446 Fkbp3 - FK506 binding protein 3 
Q8VHX6 Flnc - filamin C, γ 
P09528 Fth1 - ferritin heavy chain 1 
P16858 GAPDH - glyceraldehyde-3-phosphate dehydrogenase 
O55126 Gbas - glioblastoma amplified sequence 
P21614 Gc - group specific component 
Q61598 Gdi2 - guanosine diphosphate (GDP) dissociation inhibitor 2 
Q9CPU0 Glo1 - glyoxalase 1 
P26443 Glud1 - glutamate dehydrogenase 1 
P62897 Gm10053 - predicted gene 10053 
Q9CPQ8 Gm10221 - predicted gene 10221 
P05201 Got1 - glutamate oxaloacetate transaminase 1, solub 
P05202 Got2 - glutamate oxaloacetate transaminase 2, mitochondr 
P06745 Gpi1 - glucose phosphate isomerase 1 
Q8VHN7 Gpr98 - G protein-coupled receptor 98 
P46412 Gpx3 - glutathione peroxidase 3 
O70325 Gpx4 - glutathione peroxidase 4 
Q99LP6 Grpel1 - GrpE-like 1, mitochondrial 
P47791 Gsr - glutathione reductase 
P10649 Gstm1 - glutathione S-transferase, μ 1 
P19157 Gstp1 - glutathione S-transferase, π 1 
Q9R062 Gyg - glycogenin 
Q61425 Hadh - hydroxyacyl-Coenzyme A dehydrogenase 
Q8BMS1 Hadha - hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A 
thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), α subunit 
Q99JY0 Hadhb - hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A 
thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), β subunit 
Q99KB8 Hagh - hydroxyacyl glutathione hydrolase 
P01942 Hba-a1 - hemoglobin α, adult chain 1 
P02088 Hbb-b2 - hemoglobin, β adult minor chain 
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P51859 Hdgf - hepatoma-derived growth factor 
Q99L13 Hibadh - 3-hydroxyisobutyrate dehydrogenase 
P70349 Hint1 - histidine triad nucleotide binding protein 1 
P62806 Hist2h4 - histone cluster 2, H4 
P49312 Hnrnpa1 - heterogeneous nuclear ribonucleoprotein A1 
O88569 Hnrnpa2b1 - heterogeneous nuclear ribonucleoprotein A2/B1 
Q8BG05 Hnrnpa3 - heterogeneous nuclear ribonucleoprotein A3 
Q60668 Hnrnpd - heterogeneous nuclear ribonucleoprotein D 
Q91X72 Hpx - hemopexin 
P07901 Hsp90aa1 - heat shock protein 90, α (cytosolic), class A member 1 
P11499 Hsp90ab1 - heat shock protein 90 α (cytosolic), class B member 1 
P08113 Hsp90b1 - heat shock protein 90, β (Grp94), member 1 
Q61696 Hspa1a - heat shock protein 1A 
Q61316 Hspa4 - heat shock protein 4 
P20029 Hspa5 - heat shock protein 5 
P63017 Hspa8 - heat shock protein 8 
P38647 Hspa9 - heat shock protein 9 
P14602 Hspb1 - heat shock protein 1 
Q99PR8 Hspb2 - heat shock protein 2 
Q5EBG6 Hspb6 - heat shock protein, α-crystallin-related, B6 
P35385 Hspb7 - heat shock protein family, member 7 (cardiovascular) 
P63038 Hspd1 - heat shock protein 1 (chaperonin) 
Q64433 Hspe1 - heat shock protein 1 (chaperonin 10) 
P54071 IDH2 - isocitrate dehydrogenase 2 (NADP+), mitochondria 
Q9D6R2 Idh3a - isocitrate dehydrogenase 3 (NAD+) α 
P70404 Idh3g - isocitrate dehydrogenase 3 (NAD+), γ 
P01837 Ig κ chain C region 
P01649 Ig κ chain V-V regions 
P01867 Igh-3 - Ig γ-2B chain C region 
P01868 Ighg1 - Ig γ-1 chain C region secreted form 
P01864 Ighg2c - immunoglobulin heavy constant γ 2C 
P01872 Ighm - Ig μ chain C region 
Q8CAQ8 Immt - inner membrane protein, mitochondrial 
Q9JHI5 Ivd - isovaleryl coenzyme A dehydrogenase 
Q8VCD7 Kdm4c - lysine (K)-specific demethylase 4C 
O08677 Kng1 - kininogen 1 
P04104 Krt1 - keratin 1 
P02535 Krt10 - keratin 10 
Q3TTY5 Krt2 - keratin 2 
Q3UV17 Krt76 - keratin 76; Probably contributes to terminal cornification (By 
similarity) 
Q9JKS4 Ldb3 - LIM domain binding 3 
P06151 Ldha - lactate dehydrogenase A 
P16125 Ldhb - lactate dehydrogenase B 
P16045 Lgals1 - lectin, galactose binding, soluble 1 
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A2ARV4 Lrp2 - low density lipoprotein receptor-related protein 2 
P51885 Lum - lumican 
Q99JP0 Map4k3 - mitogen-activated protein kinase kinase kinase kinase 3 
O08911 Mapk12 - mitogen-activated protein kinase 12 
P04247 Mb - myoglobin 
P14152 Mdh1 - malate dehydrogenase 1, NAD (soluble) 
P08249 Mdh2 - malate dehydrogenase 2, NAD (mitochondrial) 
P06801 Me1 - malic enzyme 1, NADP(+)-dependent, cytosolic 
Q8CJ19 Mical3 - microtubule associated monoxygenase, calponin and LIM domain 
containing 3 
P56379 Mp68 - RIKEN cDNA 2010107E04 gene 
P63030 Mpc1 - mitochondrial pyruvate carrier 1 
Q9D023 Mpc2 - mitochondrial pyruvate carrier 2 
P26041 Msn - moesin 
P27546 Mtap4 - microtubule-associated protein 4 
P03930 mt-Atp8 - mitochondrially encoded ATP synthase 
P00397 mt-Co1 - mitochondrially encoded cytochrome c oxidase I 
P00405 mt-Co2 - mitochondrially encoded cytochrome c oxidase II 
P03888 mt-Nd1 - mitochondrially encoded NADH dehydrogenase 1 
P03893 mt-Nd2 - mitochondrially encoded NADH dehydrogenase 2 
P03899 mt-Nd3 - mitochondrially encoded NADH dehydrogenase 3 
P03911 mt-Nd4 - mitochondrially encoded NADH dehydrogenase 4 
A2AMM
0 
Murc - muscle-related coiled-coil protein 
P16332 Mut - methylmalonyl-Coenzyme A mutase 
Q5XKE0 Mybpc2 - myosin binding protein C, fast-typ 
P13541 Myh3 - myosin, heavy polypeptide 3, skeletal muscle, embryonic 
Q5SX39 Myh4 - myosin, heavy polypeptide 4, skeletal muscle 
A2AQP0 Myh7b - myosin, heavy chain 7B, cardiac muscle, β 
P13542 Myh8 - myosin, heavy polypeptide 8, skeletal muscle, perinatal 
P05977 Myl1 - myosin, light polypeptide 1 
P09542 Myl3 - myosin, light polypeptide 3 
Q60605 Myl6 - myosin, light polypeptide 6, alkali, smooth muscle and non-muscl 
P97457 Mylpf - myosin light chain, phosphorylatable, fast skeletal muscle 
Q9QZZ4 Myo15 - myosin XV 
P97479 Myo7a - myosin VIIA 
Q62234 Myom1 - myomesin 1 
Q9JIF9 Myot - myotilin 
P70670 Naca - nascent polypeptide-associated complex α polypeptide 
P09405 Ncl - nucleoli 
Q9QYG0 Ndrg2 - N-myc downstream regulated gene 
Q99LC3 Ndufa10 - NADH dehydrogenase (ubiquinone) 1 α subcomplex 10 
Q9D8B4 Ndufa11 - NADH dehydrogenase (ubiquinone) 1 α subcomplex 11 
Q7TMF3 Ndufa12 - NADH dehydrogenase (ubiquinone) 1 α subcomplex, 12 
Q9ERS2 Ndufa13 - NADH dehydrogenase (ubiquinone) 1 α subcomplex, 13 
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Q9CQ75 Ndufa2 - NADH dehydrogenase (ubiquinone) 1 α subcomplex, 2 
Q9CQ91 Ndufa3 - NADH dehydrogenase (ubiquinone) 1 α subcomplex, 3 
Q62425 Ndufa4 - NADH dehydrogenase (ubiquinone) 1 α subcomplex, 4 
Q9CPP6 Ndufa5 - NADH dehydrogenase (ubiquinone) 1 α subcomplex, 5 
Q9CQZ5 Ndufa6 - NADH dehydrogenase (ubiquinone) 1 α subcomplex, 6 (B14) 
Q9Z1P6 Ndufa7 - NADH dehydrogenase (ubiquinone) 1 α subcomplex, 7 (B14.5a) 
Q9DCJ5 Ndufa8 - NADH dehydrogenase (ubiquinone) 1 α subcomplex, 8 
Q9DC69 Ndufa9 - NADH dehydrogenase (ubiquinone) 1 α subcomplex, 9 
Q9CR21 Ndufab1 - NADH dehydrogenase (ubiquinone) 1, α/β subcomplex, 1 
Q9DCS9 Ndufb10 - NADH dehydrogenase (ubiquinone) 1 β subcomplex, 10 
O09111 Ndufb11 - NADH dehydrogenase (ubiquinone) 1 β subcomplex, 11 
Q9CQZ6 Ndufb3 - NADH dehydrogenase (ubiquinone) 1 β subcomplex 3 
Q9CQC7 Ndufb4 - NADH dehydrogenase (ubiquinone) 1 β subcomplex 4 
Q9CQH3 Ndufb5 - NADH dehydrogenase (ubiquinone) 1 β subcomplex, 5 
Q3UIU2 Ndufb6 - NADH dehydrogenase (ubiquinone) 1 β subcomplex, 6 
Q9CR61 Ndufb7 - NADH dehydrogenase (ubiquinone) 1 β subcomplex, 7 
Q9D6J5 Ndufb8 - NADH dehydrogenase (ubiquinone) 1 β subcomplex 8 
Q9CQJ8 Ndufb9 - NADH dehydrogenase (ubiquinone) 1 β subcomplex, 9 
Q9CQ54 Ndufc2 - NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 
Q91VD9 Ndufs1 - NADH dehydrogenase (ubiquinone) Fe-S protein 1 
Q91WD5 Ndufs2 - NADH dehydrogenase (ubiquinone) Fe-S protein 2 
Q9DCT2 Ndufs3 - NADH dehydrogenase (ubiquinone) Fe-S protein 3 
Q9CXZ1 Ndufs4 - NADH dehydrogenase (ubiquinone) Fe-S protein 4 
Q8K3J1 Ndufs8 - NADH dehydrogenase (ubiquinone) Fe-S protein 8 
Q91YT0 Ndufv1 - NADH dehydrogenase (ubiquinone) flavoprotein 1 
Q9D6J6 Ndufv2 - NADH dehydrogenase (ubiquinone) flavoprotein 2 
Q8BK30 Ndufv3 - NADH dehydrogenase (ubiquinone) flavoprotein 3 
P29595 Nedd8 - neural precursor cell expressed, developmentally down-regulated 
gene 8 
Q9JHW2 Nit2 - nitrilase family, member 2 
P15532 Nme1 - NME/NM23 nucleoside diphosphate kinase 1 
Q01768 Nme2 - NME/NM23 nucleoside diphosphate kinase 2 
Q11011 Npepps - aminopeptidase puromycin sensitive 
Q61937 Npm1 - nucleophosmin 1 
Q9CZ44 Nsfl1c - NSFL1 (p97) cofactor (p47) 
P29758 Oat - ornithine aminotransferase 
Q60597 Ogdh - oxoglutarate dehydrogenase (lipoamide) 
Q9D0K2 Oxct1 - 3-oxoacid CoA transferase 1 
P09103 P4hb - prolyl 4-hydroxylase, β polypeptide 
Q99LX0 Park7 - Parkinson disease (autosomal recessive, early onset) 7 
P23506 Pcmt1 - protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 
P35486 Pdha1 - pyruvate dehydrogenase E1 α 1 
Q9D051 Pdhb - pyruvate dehydrogenase (lipoamide) β 
Q8BKZ9 Pdhx - pyruvate dehydrogenase complex, component 
P27773 Pdia3 - protein disulfide isomerase associated 3 
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O70209 Pdlim3 - PDZ and LIM domain 3 
Q8CI51 Pdlim5 - PDZ and LIM domain 5 
P70296 Pebp1 - phosphatidylethanolamine binding protein 1 
P47857 Pfkm - phosphofructokinase, muscle 
P62962 Pfn1 - profilin 1 
Q9JJV2 Pfn2 - profilin 2 
Q9DBJ1 Pgam1 - phosphoglycerate mutase 1 
O70250 Pgam2 - phosphoglycerate mutase 2 
P09411 Pgk1-rs7 - phosphoglycerate kinase-1, related sequence-7 
Q9D0F9 Pgm2 - phosphoglucomutase 2 
P67778 Phb - prohibitin 
Q9DAK9 Phpt1 - phosphohistidine phosphatase 1 
P52480 Pkm - pyruvate kinase, muscle 
O88492 Plin4 - perilipin 4; 
Q9D819 Ppa1 - pyrophosphatase (inorganic) 1 
Q91VM9 Ppa2 - pyrophosphatase (inorganic) 2 
P17742 Ppia - peptidylprolyl isomerase A 
P24369 Ppib - peptidylprolyl isomerase B 
Q3UM45 Ppp1r7 - protein phosphatase 1, regulatory (inhibitor) subunit 7 
P63330 Ppp2ca - protein phosphatase 2 (formerly 2A), catalytic subunit, α isoform 
P35700 PRDX1 - peroxiredoxin 1 
Q61171 PRDX2 - peroxiredoxin 2 
P20108 PRDX3 - peroxiredoxin 3 
P99029 PRDX5 - peroxiredoxin 5 
O08709 PRDX6 - peroxiredoxin 6 
Q9JK53 Prelp - proline arginine-rich end leucine-rich repeat 
Q9QUR6 Prep - prolyl endopeptidase 
P12367 Prkar2a - protein kinase, cAMP dependent regulatory, type II α 
Q9Z2Y8 Prosc - proline synthetase co-transcribed 
Q9R1P4 Psma1 - proteasome (prosome, macropain) subunit, α type 1 
P49722 Psma2 - proteasome (prosome, macropain) subunit, α type 2 
O70435 Psma3 - proteasome (prosome, macropain) subunit, α type 3 
Q9R1P0 Psma4 - proteasome (prosome, macropain) subunit, α type 4 
Q9Z2U1 Psma5 - proteasome (prosome, macropain) subunit, α type 5 
Q9QUM9 Psma6 - proteasome (prosome, macropain) subunit, α type 6 
Q9Z2U0 Psma7 - proteasome (prosome, macropain) subunit, α type 7 
Q9R1P3 Psmb2 - proteasome (prosome, macropain) subunit, β type 2 
Q9R1P1 Psmb3 - proteasome (prosome, macropain) subunit, β type 3 
P99026 Psmb4 - proteasome (prosome, macropain) subunit, β type 4 
O55234 Psmb5 - proteasome (prosome, macropain) subunit, β type 5 
Q60692 Psmb6 - proteasome (prosome, macropain) subunit, β type 6 
P70195 Psmb7 - proteasome (prosome, macropain) subunit, β type 7 
Q60866 Pter - phosphotriesterase related 
P26350 Ptma - prothymosin α 
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Q9D0J8 Ptms - parathymosin 
O54724 Ptrf - polymerase I and transcript release factor 
P32848 Pvalb - parvalbumin 
Q9WUB3 Pygm - muscle glycogen phosphorylase 
Q61838 Pzp - pregnancy zone protein 
P51150 Rab7 - RAB7, member RAS oncogene family 
P54728 Rad23b - RAD23b homolog (S. cerevisiae 
P62827 Ran - RAN, member RAS oncogene family 
Q8BP92 Rcn2 - reticulocalbin 2 
P26043 Rdx - radixin 
P47955 Rplp1 - ribosomal protein, large, P1 
P99027 Rplp2 - ribosomal protein, large P2; Plays an important role in the elongation 
step of protein synthesis 
Q9CQR2 Rps21 - ribosomal protein S21 
P62858 Rps28 - ribosomal protein S28 
P14206 Rpsa - ribosomal protein SA 
P14069 S100a6 - S100 calcium binding protein A6 (calcyclin) 
Q3TMH2 Scrn3 - secernin 3 
Q8K2B3 Sdha - succinate dehydrogenase complex, subunit A, flavoprotein (Fp) 
Q9CQA3 Sdhb - succinate dehydrogenase complex, subunit B, iron sulfur (Ip 
Q9CZB0 Sdhc - succinate dehydrogenase complex, subunit C, integral membrane 
protein 
Q9CXV1 Sdhd - succinate dehydrogenase complex, subunit D, integral membrane protei 
Q63918 Sdpr - serum deprivation response 
P17563 Selenbp1 - selenium binding protein 1 
Q6P6M7 Sepsecs - Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase 
Q9CY58 Serbp1 - serpine1 mRNA binding protein 1 
P22599 Serpina1b - serine (or cysteine) preptidase inhibitor, clade A, member 1B 
Q00897 Serpina1d - serine (or cysteine) peptidase inhibitor, clade A, member 1D 
Q00898 Serpina1e - serine (or cysteine) peptidase inhibitor, clade A, member 1E 
P07759 Serpina3k - serine (or cysteine) peptidase inhibitor, clade A, member 3K 
Q60854 Serpinb6a - serine (or cysteine) peptidase inhibitor, clade B, member 6a 
P32261 Serpinc1 - serine (or cysteine) peptidase inhibitor, clade C (antithrombin), 
member 1 
Q9WUZ7 Sh3bgr - SH3-binding domain glutamic acid-rich protein 
Q9WTX5 Skp1a - S-phase kinase-associated protein 1A 
Q9CR62 Slc25a11 - solute carrier family 25 (mitochondrial carrier oxoglutarate 
carrier), member 1 
Q8BH59 Slc25a12 - solute carrier family 25 (mitochondrial carrier, Aralar), member 12 
Q8VEM8 Slc25a3 - solute carrier family 25 (mitochondrial carrier, phosphate carrier), 
member 3 
P48962 Slc25a4 - solute carrier family 25 (mitochondrial carrier, adenine nucleotide 
translocator), member 4 
Q9DC77 Smpx - small muscle protein, X-linked 
P08228 Sod1 - superoxide dismutase 1, soluble 
P09671 Sod2 - superoxide dismutase 2, mitochondrial 
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Q7TQ48 Srl - sarcalumenin 
Q99L47 St13 - suppression of tumorigenicity 13 
Q8K031 Stard8 - START domain containing 8 
Q60864 Stip1 - stress-induced phosphoprotein 1 
Q9Z2I9 Sucla2 - succinate-Coenzyme A ligase, ADP-forming, β subunit 
Q8R086 Suox - sulfite oxidase 
P18419 Svs4 - seminal vesicle secretory protein 4 
P30933 Svs5 - seminal vesicle secretory protein 5 
Q5SV85 Synrg - synergin, γ 
O89104 Sypl2 - synaptophysin-like 2 
Q93092 Taldo1 - transaldolase 1 
O70548 Tcap - titin-cap 
P62869 Tceb2 - transcription elongation factor B (SIII), polypeptide 
Q9Z1T2 Thbs4 - thrombospondin 4 
P20801 Tnnc2 - troponin C2, fast 
P13412 Tnni2 - troponin I, skeletal, fast 2 
Q9QZ47 Tnnt3 - troponin T3, skeletal, fast 
P17751 Tpi1 - triosephosphate isomerase 1 
P58771 Tpm1 - tropomyosin 1, α 
P58774 Tpm2 - tropomyosin 2, β 
P21107 Tpm3 - tropomyosin 3, γ 
P63028 Tpt1 - tumor protein, translationally-controlled 
Q921I1 Trf - transferrin 
A2ASS6 Ttn - titin 
P07309 Ttr - transthyretin 
P68372 Tubb4b - tubulin, β 4B class IVB 
Q8BFR5 Tufm - Tu translation elongation factor, mitochondria 
Q9Z0P5 Twf2 - twinfilin, actin-binding protein, homolog 2 (Drosophila) 
P10639 Txn1 - thioredoxin 1 
P68037 Ube2l3 - ubiquitin-conjugating enzyme E2L 3 
P61089 Ube2n - ubiquitin-conjugating enzyme E2N 
Q6P5E4 Uggt1 - UDP-glucose glycoprotein glucosyltransferase 1 
Q91ZJ5 Ugp2 - UDP-glucose pyrophosphorylase 2 
Q0KK59 Unc79 - unc-79 homolog (C. elegans) 
Q8R1I1 Uqcr10 - ubiquinol-cytochrome c reductase, complex III subunit X 
Q9D855 Uqcrb - ubiquinol-cytochrome c reductase binding protein 
Q9CZ13 Uqcrc1 - ubiquinol-cytochrome c reductase core protein 
Q9DB77 Uqcrc2 - ubiquinol cytochrome c reductase core protein 
Q9CR68 Uqcrfs1 - ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 
P99028 Uqcrh - ubiquinol-cytochrome c reductase hinge protein 
Q9CQ69 Uqcrq - ubiquinol-cytochrome c reductase, complex III subunit VII 
Q78IK2 Usmg5 - upregulated during skeletal muscle growth 5 
Q64727 Vcl - vinculin 
Q01853 Vcp - valosin containing protein 
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Q60932 Vdac1 - voltage-dependent anion channel 1 
Q60930 Vdac2 - voltage-dependent anion channel 2 
Q60931 Vdac3 - voltage-dependent anion channel 3 
P20152 Vim - vimentin 
Q9CQV8 Ywhab - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, β polypeptide 
P62259 Ywhae - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, ε polypeptide 
P61982 Ywhag - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, γ polypeptide 
P68510 Ywhah - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, η polypeptide 
P63101 Ywhaz - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, ζ polypeptide 
 
 
